
<html lang="en"     class="pb-page"  data-request-id="a1e3d6c9-d9d9-43e9-9df2-161c87bc885b"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;website:website:acspubs;article:article:10.1021/jm4004895;issue:issue:10.1021/jmcmar.2013.56.issue-11;pageGroup:string:Publication Pages;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Identification of C-2 Hydroxyethyl Imidazopyrrolopyridines as Potent JAK1 Inhibitors with Favorable Physicochemical Properties and High Selectivity over JAK2" /></meta><meta name="dc.Creator" content="Mark  Zak" /></meta><meta name="dc.Creator" content="Christopher A.  Hurley" /></meta><meta name="dc.Creator" content="Stuart I.  Ward" /></meta><meta name="dc.Creator" content="Philippe  Bergeron" /></meta><meta name="dc.Creator" content="Kathy  Barrett" /></meta><meta name="dc.Creator" content="Mercedesz  Balazs" /></meta><meta name="dc.Creator" content="Wade S.  Blair" /></meta><meta name="dc.Creator" content="Richard  Bull" /></meta><meta name="dc.Creator" content="Paroma  Chakravarty" /></meta><meta name="dc.Creator" content="Christine  Chang" /></meta><meta name="dc.Creator" content="Peter  Crackett" /></meta><meta name="dc.Creator" content="Gauri  Deshmukh" /></meta><meta name="dc.Creator" content="Jason  DeVoss" /></meta><meta name="dc.Creator" content="Peter S.  Dragovich" /></meta><meta name="dc.Creator" content="Charles  Eigenbrot" /></meta><meta name="dc.Creator" content="Charles  Ellwood" /></meta><meta name="dc.Creator" content="Simon  Gaines" /></meta><meta name="dc.Creator" content="Nico  Ghilardi" /></meta><meta name="dc.Creator" content="Paul  Gibbons" /></meta><meta name="dc.Creator" content="Stefan  Gradl" /></meta><meta name="dc.Creator" content="Peter  Gribling" /></meta><meta name="dc.Creator" content="Chris  Hamman" /></meta><meta name="dc.Creator" content="Eric  Harstad" /></meta><meta name="dc.Creator" content="Peter  Hewitt" /></meta><meta name="dc.Creator" content="Adam  Johnson" /></meta><meta name="dc.Creator" content="Tony  Johnson" /></meta><meta name="dc.Creator" content="Jane R.  Kenny" /></meta><meta name="dc.Creator" content="Michael F. T.  Koehler" /></meta><meta name="dc.Creator" content="Pawan  Bir Kohli" /></meta><meta name="dc.Creator" content="Sharada  Labadie" /></meta><meta name="dc.Creator" content="Wyne P.  Lee" /></meta><meta name="dc.Creator" content="Jiangpeng  Liao" /></meta><meta name="dc.Creator" content="Marya  Liimatta" /></meta><meta name="dc.Creator" content="Rohan  Mendonca" /></meta><meta name="dc.Creator" content="Raman  Narukulla" /></meta><meta name="dc.Creator" content="Rebecca  Pulk" /></meta><meta name="dc.Creator" content="Austin  Reeve" /></meta><meta name="dc.Creator" content="Scott  Savage" /></meta><meta name="dc.Creator" content="Steven  Shia" /></meta><meta name="dc.Creator" content="Micah  Steffek" /></meta><meta name="dc.Creator" content="Savita  Ubhayakar" /></meta><meta name="dc.Creator" content="Anne  van Abbema" /></meta><meta name="dc.Creator" content="Ignacio  Aliagas" /></meta><meta name="dc.Creator" content="Barbara  Avitabile-Woo" /></meta><meta name="dc.Creator" content="Yisong  Xiao" /></meta><meta name="dc.Creator" content="Jing  Yang" /></meta><meta name="dc.Creator" content="Janusz J.  Kulagowski" /></meta><meta name="dc.Description" content="Herein we report on the structure-based discovery of a C-2 hydroxyethyl moiety which provided consistently high levels of selectivity for JAK1 over JAK2 to the imidazopyrrolopyridine series of JAK1..." /></meta><meta name="Description" content="Herein we report on the structure-based discovery of a C-2 hydroxyethyl moiety which provided consistently high levels of selectivity for JAK1 over JAK2 to the imidazopyrrolopyridine series of JAK1..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="May 31, 2013" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm4004895" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2013 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm4004895" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm4004895" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm4004895" /></link>
        
    
    

<title>Identification of C-2 Hydroxyethyl Imidazopyrrolopyridines as Potent JAK1 Inhibitors with Favorable Physicochemical Properties and High Selectivity over JAK2 | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm4004895" /></meta><meta property="og:title" content="Identification of C-2 Hydroxyethyl Imidazopyrrolopyridines as Potent JAK1 Inhibitors with Favorable Physicochemical Properties and High Selectivity over JAK2" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0017.jpeg" /></meta><meta property="og:description" content="Herein we report on the structure-based discovery of a C-2 hydroxyethyl moiety which provided consistently high levels of selectivity for JAK1 over JAK2 to the imidazopyrrolopyridine series of JAK1 inhibitors. X-ray structures of a C-2 hydroxyethyl analogue in complex with both JAK1 and JAK2 revealed differential ligand/protein interactions between the two isoforms and offered an explanation for the observed selectivity. Analysis of historical data from related molecules was used to develop a set of physicochemical compound design parameters to impart desirable properties such as acceptable membrane permeability, potent whole blood activity, and a high degree of metabolic stability. This work culminated in the identification of a highly JAK1 selective compound (31) exhibiting favorable oral bioavailability across a range of preclinical species and robust efficacy in a rat CIA model." /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta><meta name="twitter:description" content="Herein we report on the structure-based discovery of a C-2 hydroxyethyl moiety which provided consistently high levels of selectivity for JAK1 over JAK2 to the imidazopyrrolopyridine series of JAK1 inhibitors. X-ray structures of a C-2 hydroxyethyl analogue in complex with both JAK1 and JAK2 revealed differential ligand/protein interactions between the two isoforms and offered an explanation for the observed selectivity. Analysis of historical data from related molecules was used to develop a set of physicochemical compound design parameters to impart desirable properties such as acceptable membrane permeability, potent whole blood activity, and a high degree of metabolic stability. This work culminated in the identification of a highly JAK1 selective compound (31) exhibiting favorable oral bioavailability across a range of preclinical species and robust efficacy in a rat CIA model." /></meta><meta name="twitter:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0017.jpeg" /></meta><meta name="twitter:title" content="Identification of C-2 Hydroxyethyl Imidazopyrrolopyridines as Potent JAK1 Inhibitors with Favorable Physicochemical Properties and High Selectivity over JAK2" /></meta>
        
            <meta property="og:type" content="Article" /></meta>
        

        
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm4004895"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/ke1q~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-6ee29527b3d8ff00a106.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm4004895">
            
        





































    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-12/achre4.2021.54.issue-12/20210615/achre4.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-6/amrcda.2021.2.issue-6/20210625/amrcda.2021.2.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-6/aabmcb.2021.4.issue-6/20210621/aabmcb.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-6/aaembp.2021.3.issue-6/20210622/aaembp.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-6/aaemcq.2021.4.issue-6/20210628/aaemcq.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-25/aamick.2021.13.issue-25/20210630/aamick.2021.13.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-6/aanmf6.2021.4.issue-6/20210625/aanmf6.2021.4.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-6/aapmcd.2021.3.issue-6/20210611/aapmcd.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-6/abseba.2021.7.issue-6/20210614/abseba.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-12/accacs.2021.11.issue-12/20210618/accacs.2021.11.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-6/acscii.2021.7.issue-6/20210623/acscii.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-6/acbcct.2021.16.issue-6/20210618/acbcct.2021.16.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-3/achsc5.2021.28.issue-3/20210524/achsc5.2021.28.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-12/acncdm.2021.12.issue-12/20210616/acncdm.2021.12.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-6/aesccq.2021.5.issue-6/20210617/aesccq.2021.5.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-6/aelccp.2021.6.issue-6/20210611/aelccp.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-6/aeecco.2021.1.issue-6/20210611/aeecco.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-6/aewcaa.2021.1.issue-6/20210611/aewcaa.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-5/afsthl.2021.1.issue-5/20210618/afsthl.2021.1.issue-5.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-6/aidcbc.2021.7.issue-6/20210611/aidcbc.2021.7.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-6/amlccd.2021.10.issue-6/20210615/amlccd.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-6/amlcef.2021.3.issue-6/20210607/amlcef.2021.3.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-6/amclct.2021.12.issue-6/20210610/amclct.2021.12.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-6/ancac3.2021.15.issue-6/20210622/ancac3.2021.15.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-25/acsodf.2021.6.issue-25/20210629/acsodf.2021.6.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-6/apchd5.2021.8.issue-6/20210616/apchd5.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-6/ascefj.2021.6.issue-6/20210625/ascefj.2021.6.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-25/ascecg.2021.9.issue-25/20210628/ascecg.2021.9.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-6/asbcd6.2021.10.issue-6/20210618/asbcd6.2021.10.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-25/ancham.2021.93.issue-25/20210629/ancham.2021.93.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-25/bichaw.2021.60.issue-25/20210629/bichaw.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-6/bcches.2021.32.issue-6/20210616/bcches.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-6/bomaf6.2021.22.issue-6/20210614/bomaf6.2021.22.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-24/cgeabj.2021.99.issue-24/20210628-01/cgeabj.2021.99.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-6/crtoec.2021.34.issue-6/20210621/crtoec.2021.34.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-12/chreay.2021.121.issue-12/20210623/chreay.2021.121.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-12/cmatex.2021.33.issue-12/20210622/cmatex.2021.33.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-6/cgdefu.2021.21.issue-6/20210602/cgdefu.2021.21.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-12/enfuem.2021.35.issue-12/20210617/enfuem.2021.35.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-12/esthag.2021.55.issue-12/20210615/esthag.2021.55.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-6/estlcu.2021.8.issue-6/20210608/estlcu.2021.8.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-25/iecred.2021.60.issue-25/20210630/iecred.2021.60.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-12/inocaj.2021.60.issue-12/20210621/inocaj.2021.60.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-6/jaaucr.2021.1.issue-6/20210628/jaaucr.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-25/jafcau.2021.69.issue-25/20210630/jafcau.2021.69.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-6/jceaax.2021.66.issue-6/20210610/jceaax.2021.66.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-6/jceda8.2021.98.issue-6/20210608/jceda8.2021.98.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-6/jcisd8.2021.61.issue-6/20210628/jcisd8.2021.61.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-6/jctcce.2021.17.issue-6/20210608/jctcce.2021.17.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-12/jmcmar.2021.64.issue-12/20210624/jmcmar.2021.64.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-6/jnprdf.2021.84.issue-6/20210625/jnprdf.2021.84.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-12/joceah.2021.86.issue-12/20210618/joceah.2021.86.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-24/jpcafh.2021.125.issue-24/20210624/jpcafh.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-24/jpcbfk.2021.125.issue-24/20210624/jpcbfk.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-24/jpccck.2021.125.issue-24/20210624/jpccck.2021.125.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-24/jpclcd.2021.12.issue-24/20210624/jpclcd.2021.12.issue-24.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-6/jprobs.2021.20.issue-6/20210604/jprobs.2021.20.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-25/jacsat.2021.143.issue-25/20210630/jacsat.2021.143.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-6/jamsef.2021.32.issue-6/20210602/jamsef.2021.32.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-25/langd5.2021.37.issue-25/20210629/langd5.2021.37.issue-25.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-12/mamobx.2021.54.issue-12/20210622/mamobx.2021.54.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-6/mpohbp.2021.18.issue-6/20210607/mpohbp.2021.18.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-12/nalefd.2021.21.issue-12/20210623/nalefd.2021.21.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-12/orlef7.2021.23.issue-12/20210618/orlef7.2021.23.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-6/oprdfk.2021.25.issue-6/20210618/oprdfk.2021.25.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-12/orgnd7.2021.40.issue-12/20210628/orgnd7.2021.40.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm4004895&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm4004895&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm4004895&amp;href=/doi/10.1021/jm4004895" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2013</span><span class="cit-fg-volume">, 56</span><span class="cit-fg-issue">, 11</span><span class="cit-fg-pageRange">, 4764-4785</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/56/11" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm4004889" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm4005048" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Identification of <i>C</i>-2 Hydroxyethyl Imidazopyrrolopyridines as Potent JAK1 Inhibitors with Favorable Physicochemical Properties and High Selectivity over JAK2</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark++Zak">Mark Zak</a></span><span class="author-xref-symbol "><sup>*</sup></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+A.++Hurley">Christopher A. Hurley</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stuart+I.++Ward">Stuart I. Ward</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Philippe++Bergeron">Philippe Bergeron</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kathy++Barrett">Kathy Barrett</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mercedesz++Balazs">Mercedesz Balazs</a></span><span class="author-xref-symbol author-aff-symbol"><sup>◆</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wade+S.++Blair">Wade S. Blair</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Richard++Bull">Richard Bull</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paroma++Chakravarty">Paroma Chakravarty</a></span><span class="author-xref-symbol author-aff-symbol"><sup>#</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christine++Chang">Christine Chang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Crackett">Peter Crackett</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Gauri++Deshmukh">Gauri Deshmukh</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jason++DeVoss">Jason DeVoss</a></span><span class="author-xref-symbol author-aff-symbol"><sup>◆</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter+S.++Dragovich">Peter S. Dragovich</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Charles++Eigenbrot">Charles Eigenbrot</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Charles++Ellwood">Charles Ellwood</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Simon++Gaines">Simon Gaines</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Nico++Ghilardi">Nico Ghilardi</a></span><span class="author-xref-symbol author-aff-symbol"><sup>∥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Paul++Gibbons">Paul Gibbons</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stefan++Gradl">Stefan Gradl</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Gribling">Peter Gribling</a></span><span class="author-xref-symbol author-aff-symbol"><sup>◆</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Chris++Hamman">Chris Hamman</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Eric++Harstad">Eric Harstad</a></span><span class="author-xref-symbol author-aff-symbol"><sup>⊥</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Peter++Hewitt">Peter Hewitt</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Adam++Johnson">Adam Johnson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Tony++Johnson">Tony Johnson</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jane+R.++Kenny">Jane R. Kenny</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michael+F.+T.++Koehler">Michael F. T. Koehler</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Pawan++Bir+Kohli">Pawan Bir Kohli</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Sharada++Labadie">Sharada Labadie</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Wyne+P.++Lee">Wyne P. Lee</a></span><span class="author-xref-symbol author-aff-symbol"><sup>◆</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jiangpeng++Liao">Jiangpeng Liao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>+</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Marya++Liimatta">Marya Liimatta</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rohan++Mendonca">Rohan Mendonca</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Raman++Narukulla">Raman Narukulla</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rebecca++Pulk">Rebecca Pulk</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Austin++Reeve">Austin Reeve</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Scott++Savage">Scott Savage</a></span><span class="author-xref-symbol author-aff-symbol"><sup>▽</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Steven++Shia">Steven Shia</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Micah++Steffek">Micah Steffek</a></span><span class="author-xref-symbol author-aff-symbol"><sup>○</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Savita++Ubhayakar">Savita Ubhayakar</a></span><span class="author-xref-symbol author-aff-symbol"><sup>§</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anne++van+Abbema">Anne van Abbema</a></span><span class="author-xref-symbol author-aff-symbol"><sup>‡</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Ignacio++Aliagas">Ignacio Aliagas</a></span><span class="author-xref-symbol author-aff-symbol"><sup>†</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Barbara++Avitabile-Woo">Barbara Avitabile-Woo</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Yisong++Xiao">Yisong Xiao</a></span><span class="author-xref-symbol author-aff-symbol"><sup>+</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jing++Yang">Jing Yang</a></span><span class="author-xref-symbol author-aff-symbol"><sup>+</sup></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Janusz+J.++Kulagowski">Janusz J. Kulagowski</a></span><span class="author-xref-symbol author-aff-symbol"><sup>¶</sup></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text"><sup>†</sup>Departments of Discovery Chemistry, <sup>‡</sup>Biochemical and Cellular Pharmacology, <sup>§</sup>Drug Metabolism and Pharmacokinetics, <sup>∥</sup>Immunology, <sup>⊥</sup>Safety Assessment, <sup>#</sup>Small Molecule Pharmaceutical Sciences, <sup>▽</sup>Small Molecule Process Chemistry, <sup>○</sup>Structural Biology, <sup>◆</sup>Translational Immunology, Genentech, Inc., 1 DNA Way, South San Francisco, California 94080, United States</span></div><div class="aff-info" id="aff2"><span class="aff-symbol">¶</span> <span class="aff-text">Argenta, 8/9 Spire Green Centre, Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div><div class="aff-info" id="aff3"><span class="aff-symbol">+</span> <span class="aff-text">WuXi AppTec Co., Ltd., 288 Fute Zhong Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div><div class="corresp-info"><strong>*</strong>Phone: 650-467-4533. E-mail: <a href="/cdn-cgi/l/email-protection#761b0c171d36111318135815191b"><span class="__cf_email__" data-cfemail="503d2a313b1037353e357e333f3d">[email protected]</span></a></div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm4004895&amp;href=/doi/10.1021%2Fjm4004895" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2013</span></span><span class="cit-volume">, 56</span><span class="cit-issue">, 11</span><span class="cit-pageRange">, 4764–4785</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">May 9, 2013</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>4 April 2013</li><li><span class="item_label"><b>Published</b> online</span>31 May 2013</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 13 June 2013</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm4004895" title="DOI URL">https://doi.org/10.1021/jm4004895</a></div><div class="article_header-article-copyright"><strong>Copyright © 2013 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D4764%26pageCount%3D22%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMark%2BZak%252C%2BChristopher%2BA.%2BHurley%252C%2BStuart%2BI.%2BWard%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D56%26issueNum%3D11%26contentID%3Djm4004895%26title%3DIdentification%2Bof%2BC-2%2BHydroxyethyl%2BImidazopyrrolopyridines%2Bas%2BPotent%2BJAK1%2BInhibitors%2Bwith%2BFavorable%2BPhysicochemical%2BProperties%2Band%2BHigh%2BSelectivity%2Bover%2BJAK2%26numPages%3D22%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D4785%26publicationDate%3DJune%2B2013">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm4004895"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3608</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">44</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm4004895" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Identification of C-2 Hydroxyethyl Imidazopyrrolopyridines as Potent JAK1 Inhibitors with Favorable Physicochemical Properties and High Selectivity over JAK2&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;Zak&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;A. Hurley&quot;},{&quot;first_name&quot;:&quot;Stuart&quot;,&quot;last_name&quot;:&quot;I. Ward&quot;},{&quot;first_name&quot;:&quot;Philippe&quot;,&quot;last_name&quot;:&quot;Bergeron&quot;},{&quot;first_name&quot;:&quot;Kathy&quot;,&quot;last_name&quot;:&quot;Barrett&quot;},{&quot;first_name&quot;:&quot;Mercedesz&quot;,&quot;last_name&quot;:&quot;Balazs&quot;},{&quot;first_name&quot;:&quot;Wade&quot;,&quot;last_name&quot;:&quot;S. Blair&quot;},{&quot;first_name&quot;:&quot;Richard&quot;,&quot;last_name&quot;:&quot;Bull&quot;},{&quot;first_name&quot;:&quot;Paroma&quot;,&quot;last_name&quot;:&quot;Chakravarty&quot;},{&quot;first_name&quot;:&quot;Christine&quot;,&quot;last_name&quot;:&quot;Chang&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Crackett&quot;},{&quot;first_name&quot;:&quot;Gauri&quot;,&quot;last_name&quot;:&quot;Deshmukh&quot;},{&quot;first_name&quot;:&quot;Jason&quot;,&quot;last_name&quot;:&quot;DeVoss&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;S. Dragovich&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;Eigenbrot&quot;},{&quot;first_name&quot;:&quot;Charles&quot;,&quot;last_name&quot;:&quot;Ellwood&quot;},{&quot;first_name&quot;:&quot;Simon&quot;,&quot;last_name&quot;:&quot;Gaines&quot;},{&quot;first_name&quot;:&quot;Nico&quot;,&quot;last_name&quot;:&quot;Ghilardi&quot;},{&quot;first_name&quot;:&quot;Paul&quot;,&quot;last_name&quot;:&quot;Gibbons&quot;},{&quot;first_name&quot;:&quot;Stefan&quot;,&quot;last_name&quot;:&quot;Gradl&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Gribling&quot;},{&quot;first_name&quot;:&quot;Chris&quot;,&quot;last_name&quot;:&quot;Hamman&quot;},{&quot;first_name&quot;:&quot;Eric&quot;,&quot;last_name&quot;:&quot;Harstad&quot;},{&quot;first_name&quot;:&quot;Peter&quot;,&quot;last_name&quot;:&quot;Hewitt&quot;},{&quot;first_name&quot;:&quot;Adam&quot;,&quot;last_name&quot;:&quot;Johnson&quot;},{&quot;first_name&quot;:&quot;Tony&quot;,&quot;last_name&quot;:&quot;Johnson&quot;},{&quot;first_name&quot;:&quot;Jane&quot;,&quot;last_name&quot;:&quot;R. Kenny&quot;},{&quot;first_name&quot;:&quot;Michael&quot;,&quot;last_name&quot;:&quot;F. T. Koehler&quot;},{&quot;first_name&quot;:&quot;Pawan&quot;,&quot;last_name&quot;:&quot;Bir Kohli&quot;},{&quot;first_name&quot;:&quot;Sharada&quot;,&quot;last_name&quot;:&quot;Labadie&quot;},{&quot;first_name&quot;:&quot;Wyne&quot;,&quot;last_name&quot;:&quot;P. Lee&quot;},{&quot;first_name&quot;:&quot;Jiangpeng&quot;,&quot;last_name&quot;:&quot;Liao&quot;},{&quot;first_name&quot;:&quot;Marya&quot;,&quot;last_name&quot;:&quot;Liimatta&quot;},{&quot;first_name&quot;:&quot;Rohan&quot;,&quot;last_name&quot;:&quot;Mendonca&quot;},{&quot;first_name&quot;:&quot;Raman&quot;,&quot;last_name&quot;:&quot;Narukulla&quot;},{&quot;first_name&quot;:&quot;Rebecca&quot;,&quot;last_name&quot;:&quot;Pulk&quot;},{&quot;first_name&quot;:&quot;Austin&quot;,&quot;last_name&quot;:&quot;Reeve&quot;},{&quot;first_name&quot;:&quot;Scott&quot;,&quot;last_name&quot;:&quot;Savage&quot;},{&quot;first_name&quot;:&quot;Steven&quot;,&quot;last_name&quot;:&quot;Shia&quot;},{&quot;first_name&quot;:&quot;Micah&quot;,&quot;last_name&quot;:&quot;Steffek&quot;},{&quot;first_name&quot;:&quot;Savita&quot;,&quot;last_name&quot;:&quot;Ubhayakar&quot;},{&quot;first_name&quot;:&quot;Anne&quot;,&quot;last_name&quot;:&quot;van Abbema&quot;},{&quot;first_name&quot;:&quot;Ignacio&quot;,&quot;last_name&quot;:&quot;Aliagas&quot;},{&quot;first_name&quot;:&quot;Barbara&quot;,&quot;last_name&quot;:&quot;Avitabile-Woo&quot;},{&quot;first_name&quot;:&quot;Yisong&quot;,&quot;last_name&quot;:&quot;Xiao&quot;},{&quot;first_name&quot;:&quot;Jing&quot;,&quot;last_name&quot;:&quot;Yang&quot;},{&quot;first_name&quot;:&quot;Janusz&quot;,&quot;last_name&quot;:&quot;J. Kulagowski&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2013&quot;,&quot;month&quot;:&quot;05&quot;,&quot;day&quot;:&quot;31&quot;,&quot;issue&quot;:&quot;11&quot;,&quot;volume&quot;:&quot;56&quot;,&quot;pages&quot;:&quot;4764-4785&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm4004895&quot;},&quot;abstract&quot;:&quot;Herein we report on the structure-based discovery of a C-2 hydroxyethyl moiety which provided consistently high levels of selectivity for JAK1 over JAK2 to the imidazopyrrolopyridine series of JAK1 inhibitors. X-ray structures of a C-2 hydroxyethyl analogue in complex with both JAK1 and JAK2 revealed differential ligand/protein interactions between the two isoforms and offered an explanation for the observed selectivity. Analysis of historical data from related molecules was used to develop a set of physicochemical compound design parameters to impart desirable properties such as acceptable membrane permeability, potent whole blood activity, and a high degree of metabolic stability. This work culminated in the identification of a highly JAK1 selective compound (31) exhibiting favorable oral bioavailability across a range of preclinical species and robust efficacy in a rat CIA model.&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4004895&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4004895" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4004895&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4004895" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm4004895&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4004895" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm4004895&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm4004895&amp;href=/doi/10.1021/jm4004895" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm4004895" /></input><a href="/doi/pdf/10.1021/jm4004895" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (4 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm4004895&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm4004895%26sid%3Dliteratum%253Aachs%26pmid%3D23659214%26genre%3Darticle%26aulast%3DZak%26date%3D2013%26atitle%3DIdentification%2Bof%2BC-2%2BHydroxyethyl%2BImidazopyrrolopyridines%2Bas%2BPotent%2BJAK1%2BInhibitors%2Bwith%2BFavorable%2BPhysicochemical%2BProperties%2Band%2BHigh%2BSelectivity%2Bover%2BJAK2%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D56%26issue%3D11%26spage%3D4764%26epage%3D4785%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=290758" title="Anatomy">Anatomy</a>,</li><li><a href="/action/doSearch?ConceptID=290723" title="Solutions">Solutions</a>,</li><li><a href="/action/doSearch?ConceptID=291316" title="Mixtures">Mixtures</a>,</li><li><a href="/action/doSearch?ConceptID=291667" title="Vacuum">Vacuum</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/56/11" title="Go to Volume 56, Issue 11"><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jmcmar.2013.56.issue-11/production/jmcmar.2013.56.issue-11.largecover.jpg" alt="Go to Volume 56, Issue 11"/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/medium/jm-2013-004895_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4004895&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Herein we report on the structure-based discovery of a <i>C</i>-2 hydroxyethyl moiety which provided consistently high levels of selectivity for JAK1 over JAK2 to the imidazopyrrolopyridine series of JAK1 inhibitors. X-ray structures of a <i>C</i>-2 hydroxyethyl analogue in complex with both JAK1 and JAK2 revealed differential ligand/protein interactions between the two isoforms and offered an explanation for the observed selectivity. Analysis of historical data from related molecules was used to develop a set of physicochemical compound design parameters to impart desirable properties such as acceptable membrane permeability, potent whole blood activity, and a high degree of metabolic stability. This work culminated in the identification of a highly JAK1 selective compound (<b>31</b>) exhibiting favorable oral bioavailability across a range of preclinical species and robust efficacy in a rat CIA model.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i1">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_05055" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_05055" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The Janus kinases (JAK1, JAK2, JAK3, and TYK2) are intracellular protein tyrosine kinases with essential roles in immune function,<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a> inflammation,<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> and hematopoiesis.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> Targeted inhibition of the JAKs has shown promise against associated hematopoietic and immunologic diseases, as evidenced by recent approvals of the multi-JAK inhibitors (<i>R</i>)-3-(4-(7<i>H</i>-pyrrolo[2,3-<i>d</i>]pyrimidin-4-yl)-1<i>H</i>-pyrazol-1-yl)-3-cyclopentylpropanenitrile (INCB018424)<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a> and <b>1</b> (CP-690,550)<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a> (see Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) for treatment of myelofibrosis and rheumatoid arthritis (RA), respectively.<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> Despite the clinical success of these agents, there may be benefit in identifying inhibitors with greater specificity for a single JAK isoform, particularly for immunologic diseases such as RA. As previously described, we believe selective JAK1 inhibition will be sufficient to treat RA while minimizing JAK2 inhibition could improve the therapeutic index by avoiding anemia.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> As such, we wished to identify potent and orally bioavailable small molecule inhibitors of JAK1, with selectivity over JAK2, as potential therapies for RA and other immunologic disorders.<a onclick="showRef(event, 'ref8 ref9'); return false;" href="javascript:void(0);" class="ref ref8 ref9">(8, 9)</a></div><div class="NLM_p">Our group has previously reported on the discovery and optimization of the imidazopyrrolopyridine series of JAK1 inhibitors, including the observation that a methyl group at the <i>C</i>-2 position may lead to improvements in JAK1 selectivity over JAK2.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> One particularly striking example of the <i>C</i>-2 methyl effect is exemplified by the matched pair comparison of compounds <b>2</b> and <b>3</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>a). As depicted in Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>b, the amplification of JAK1 selectivity may potentially be explained by the differential proximity of the methyl group in compound <b>3</b> to a key residue difference between JAK1 (E966, 3.4 Å) and JAK2 (D939, 5.1 Å). Despite this intriguing observation, the <i>C</i>-2 methyl group did not lead to consistently high levels of JAK1 selectivity. The nature of the group extending beneath the P-loop also played an important, yet poorly understood role, and groups other than the 4-piperidine present in <b>3</b> generally reduced JAK1 selectivity. Unfortunately, molecules containing the selectivity-enhancing 4-piperidine group possessed characteristics not compatible with orally administered therapeutics, including relatively weak target potency and poor membrane permeability. As part of our continued investigation of the imidazopyrrolopyridine series, we wished to discover molecules with JAK1 selectivity equal to or greater than <b>3</b> with improved MDCK permeability and JAK1 potency.</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/medium/jm-2013-004895_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0002.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (a) Matched pair analysis of <i>C</i>-2 H (<b>2</b>) and <i>C</i>-2 Me (<b>3</b>) imidazopyrrolopyridines. (b) X-ray structure of <b>3</b> in complex with JAK1 (gray, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EHZ">4EHZ</a>) overlaid with a key residue difference with JAK2 (green, D939 from structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4F09">4F09</a>). Superscript letters indicate the following: (<i>a</i>) arithmetic mean of at least three separate runs (<i>n</i> ≥ 3); (<i>b</i>) the average coefficient of variation was less than 0.3 times the mean for biochemical assays;<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> (<i>c</i>) JAK2 <i>K</i><sub>i</sub>/JAK1 <i>K</i><sub>i</sub>; (<i>d</i>) apparent permeability in MDCK transwell culture. A:B, apical-to-basolateral.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4004895&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Results and Discussion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_48316" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_48316" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">With the goal of achieving greater and more consistent selectivity for JAK1 over JAK2, we prepared a series of <i>C</i>-2 substituted alcohols (<b>5</b>–<b>13</b>, Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>) designed to engage in differential H-bonding interactions between E966 (JAK1) and D939 (JAK2). Alcohols were chosen due to their modest impact on parameters such as molecular weight, TPSA, and basicity relative to other potential H-bonding groups. We believed these attributes would allow for molecules to contain a broad spectrum of moieties extending beneath the P-loop while maintaining physicochemical parameters consistent with orally dosed therapeutics.<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> The initial SAR exploration of <i>C</i>-2 alcohols was carried out in combination with a cyclohexyl P-loop group due to improved potency and MDCK permeability relative to corresponding 4-piperidine analogues. The marketed drug <b>1</b> and the <i>C</i>-2 methyl imidazopyrrolopyridine <b>4</b><a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> are also included in Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a> for comparison. Compound <b>4</b> exhibited levels of JAK1 potency and ligand efficiency<a onclick="showRef(event, 'ref11 ref12'); return false;" href="javascript:void(0);" class="ref ref11 ref12">(11, 12)</a> comparable to <b>1</b>, yet only modest improvement to JAK1 vs JAK2 selectivity in both biochemical and cell-based assays. Gratifyingly, the hydroxylated analogue <b>5</b> maintained equivalent potency with improved JAK1 selectivity, supporting the hypothesis that a hydrogen bond donor at the <i>C</i>-2 position could better exploit the E966–D939 residue difference. The straight chain homologated analogue <b>6</b> was slightly less potent and selective, while the (<i>S</i>)-isomer (<b>7</b>) of the branched homologue subtly improved JAK1 selectivity relative to <b>5</b> but suffered from notably reduced potency. The corresponding (<i>R</i>)-isomer (<b>8</b>), however, offered a dramatic breakthrough in that it exhibited greater JAK1 selectivity than compound <b>3</b> while maintaining biochemical and cell-based potency equivalent to <b>1</b>. Further branching to give tertiary alcohol <b>9</b> was poorly tolerated from a potency perspective, while homologation of the secondary alcohol to produce compounds <b>10</b> and <b>11</b> led to no improvement relative to parent compounds <b>7</b> and <b>8</b>. Finally, chiral diols <b>12</b> and <b>13</b> were found to maintain potency but lose selectivity compared to <b>7</b> and <b>8</b>. Excited by the highly ligand efficient and predictably selective nature of the <i>C</i>-2 substituted hydroxyls, we evaluated the most promising analogues in additional assays.</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. JAK1 Potency and Selectivity of <b>1</b> and <i>C</i>-2 Substituted Imidazopyrrolopyridines <b>4</b>–<b>13</b></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/medium/jm-2013-004895_0011.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/medium/jm-2013-004895_0012.gif" alt="" id="fx2" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t1fn1"><div class="footnote" id="t1fn1"><sup>Table a</sup><p class="last">Ligand efficiency<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> = (−1.4log <i> K</i><sub>i</sub>)/(<i>n</i> heavy atoms).</p></div><div class="footnote" id="t1fn2"><sup>Table b</sup><p class="last">Ligand-lipophilicity efficiency<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> = (−log <i>K</i><sub>i</sub>) – (cLogP).</p></div><div class="footnote" id="t1fn3"><sup>Table c</sup><p class="last">Arithmetic mean of at least three separate runs (<i>n</i> ≥ 3).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></p></div><div class="footnote" id="t1fn4"><sup>Table d</sup><p class="last">The average coefficient of variation was less than 0.3 times the mean for biochemical assays.</p></div><div class="footnote" id="t1fn5"><sup>Table e</sup><p class="last">JAK2 <i>K</i><sub>i</sub>/JAK1 <i>K</i><sub>i</sub>.</p></div><div class="footnote" id="t1fn6"><sup>Table f</sup><p class="last">JAK1 cell-based assay.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></p></div><div class="footnote" id="t1fn7"><sup>Table g</sup><p class="last">The average coefficient of variation was less than 0.5 times the mean for cell-based assays.</p></div><div class="footnote" id="t1fn8"><sup>Table h</sup><p class="last">JAK2 cell-based assay.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></p></div><div class="footnote" id="t1fn9"><sup>Table i</sup><p class="last">(EPO pSTAT5 EC<sub>50</sub>)/(IL-6 pSTAT3 EC<sub>50</sub>).</p></div><div class="footnote" id="t1fn10"><sup>Table j</sup><p class="last">Not applicable.</p></div><div class="footnote" id="t1fn11"><sup>Table k</sup><p class="last">Single enantiomers. Known stereochemistry.</p></div><div class="footnote" id="t1fn12"><sup>Table l</sup><p class="last">Single enantiomers. Stereochemistry inferred from potency relationships between <b>7</b> and <b>8</b>.</p></div></div><div></div></div><div class="NLM_p">The effect of plasma proteins and other blood components on cell-based JAK1 inhibition was assessed by comparing the potencies of multiple compounds in the standard low serum cell-based assay (IL-6 pSTAT3) to the potencies in human whole blood.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> As shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, compound <b>1</b> maintained potent JAK1 cell-based inhibition in human whole blood, with no potency shift between the two assay formats. By contrast, several of the other compounds tested were much less potent in human whole blood, with compounds <b>6</b> and <b>11</b> notably shifting by greater than 10-fold. Examination of the limited data set in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> indicated that there was a relationship between cLogD<sub>7.4</sub><a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and the magnitude of potency loss in human whole blood for the imidazopyrrolopyridine series. The more lipophilic analogues <b>6</b>, <b>8</b>, and <b>11</b> showed larger shifts than the less lipophilic analogues <b>5</b>, and <b>13</b>.</div><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. Additional Data for <b>1</b> and <i>C</i>-2 Substituted Imidazopyrrolopyridines</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="justify" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">ex</th><th class="colsep0 rowsep0" align="center" char=".">IL-6 pSTAT3 EC<sub>50</sub>(nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a>,<a class="ref internalNav" href="#t2fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">whole blood EC<sub>50</sub>(nM)<a class="ref internalNav" href="#t2fn1" aria-label="a">a</a>,<a class="ref internalNav" href="#t2fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">whole blood shift<a class="ref internalNav" href="#t2fn4" aria-label="d">d</a></th><th class="colsep0 rowsep0" align="center" char=".">cLogD<sub>7.4</sub><a class="ref internalNav" href="#t2fn5" aria-label="e">e</a></th><th class="colsep0 rowsep0" align="center" char=".">TPSA (Å<sup>2</sup>)<a class="ref internalNav" href="#t2fn6" aria-label="f">f</a></th><th class="colsep0 rowsep0" align="center" char=".">MDCK <i>P</i><sub>app</sub> A:B<br /></br> (× 10<sup>–6</sup>cm/s)<a class="ref internalNav" href="#t2fn7" aria-label="g">g</a></th><th class="colsep0 rowsep0" align="center">HLM, HHep CL<sub>H</sub>(mL min<sup>–1</sup> kg<sup>–1</sup>)<a class="ref internalNav" href="#t2fn8" aria-label="h">h</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="char" char=".">53</td><td class="colsep0 rowsep0" align="char" char=".">43</td><td class="colsep0 rowsep0" align="justify">0.8</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">88</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>5</b></td><td class="colsep0 rowsep0" align="char" char=".">64</td><td class="colsep0 rowsep0" align="char" char=".">313</td><td class="colsep0 rowsep0" align="justify">4.9</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">66</td><td class="colsep0 rowsep0" align="char" char=".">24</td><td class="colsep0 rowsep0" align="left">5.6, 19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>6</b></td><td class="colsep0 rowsep0" align="char" char=".">130</td><td class="colsep0 rowsep0" align="char" char=".">1500</td><td class="colsep0 rowsep0" align="justify">12</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">66</td><td class="colsep0 rowsep0" align="char" char=".">23</td><td class="colsep0 rowsep0" align="left">5.3, 17</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>8</b></td><td class="colsep0 rowsep0" align="char" char=".">47</td><td class="colsep0 rowsep0" align="char" char=".">330</td><td class="colsep0 rowsep0" align="justify">7.0</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">66</td><td class="colsep0 rowsep0" align="char" char=".">23</td><td class="colsep0 rowsep0" align="left">4.5, 11</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>9</b></td><td class="colsep0 rowsep0" align="char" char=".">330</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="justify"> </td><td class="colsep0 rowsep0" align="char" char=".">2.6</td><td class="colsep0 rowsep0" align="char" char=".">66</td><td class="colsep0 rowsep0" align="char" char=".">19</td><td class="colsep0 rowsep0" align="left">5.8, 1.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>11</b></td><td class="colsep0 rowsep0" align="char" char=".">84</td><td class="colsep0 rowsep0" align="char" char=".">1600</td><td class="colsep0 rowsep0" align="justify">19</td><td class="colsep0 rowsep0" align="char" char=".">2.6</td><td class="colsep0 rowsep0" align="char" char=".">66</td><td class="colsep0 rowsep0" align="char" char=".">22</td><td class="colsep0 rowsep0" align="left">7.6, 12</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>13</b></td><td class="colsep0 rowsep0" align="char" char=".">69</td><td class="colsep0 rowsep0" align="char" char=".">220</td><td class="colsep0 rowsep0" align="justify">3.2</td><td class="colsep0 rowsep0" align="char" char=".">0.9</td><td class="colsep0 rowsep0" align="char" char=".">86</td><td class="colsep0 rowsep0" align="char" char=".">16</td><td class="colsep0 rowsep0" align="left">1.8, 6.8</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t2fn1"><div class="footnote" id="t2fn1"><sup>a</sup><p class="last">Arithmetic mean of at least three separate runs (<i>n</i> ≥ 3).</p></div><div class="footnote" id="t2fn2"><sup>b</sup><p class="last">JAK1 cell-based assay.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The average coefficient of variation was less than 0.5 times the mean for cell-based assays.</p></div><div class="footnote" id="t2fn3"><sup>c</sup><p class="last">JAK1 cell-based assay (IL-6 pSTAT3) run in the presence of whole blood.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></p></div><div class="footnote" id="t2fn4"><sup>d</sup><p class="last">(whole blood EC<sub>50</sub>)/(IL-6 pSTAT3 EC<sub>50</sub>).</p></div><div class="footnote" id="t2fn5"><sup>e</sup><p class="last">See ref <a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">14</a>.</p></div><div class="footnote" id="t2fn6"><sup>f</sup><p class="last">See ref <a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">15</a>.</p></div><div class="footnote" id="t2fn7"><sup>g</sup><p class="last">Apparent permeability in MDCK transwell culture. A:B, apical-to-basolateral. Mean of at least two separate runs (<i>n</i> ≥ 2).</p></div><div class="footnote" id="t2fn8"><sup>h</sup><p class="last">Hepatic clearance in the presence of human liver microsomes and human hepatocytes.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Mean of at least two separate runs (<i>n</i> ≥ 2).</p></div></div></div><div class="NLM_p">Additional relationships between the physical or structural properties of compounds and experimental outcomes in relevant assays are also noted in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>. MDCK permeability was very good for the monohydroxylated compounds but dropped slightly for the diol <b>13</b>, consistent with that compound’s significant increase in TPSA.<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> All compounds were found to show good to moderate in vitro stability in the presence of human liver microsomes (HLMs), however stability in human hepatocytes varied widely.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> A relationship was noted between the degree of branching surrounding the alcohol and human hepatocyte stability. The primary alcohols <b>5</b> and <b>6</b> were found to be highly unstable in hepatocytes, while the secondary and tertiary alcohols <b>8</b> and <b>9</b> exhibited moderate and very good stability, respectively. We believe the contrasting hepatocyte stability was related to the alcohols’ abilities to form phase two conjugates. Indeed, hepatocyte metabolism identification studies on analogues related to primary alcohol <b>5</b> and secondary alcohol <b>8</b> revealed significant glucuronidation of the former but minimal glucuronidation of the latter (data not shown). Although greater branching led to better agreement between the two in vitro metabolic stability assay formats, no compound became significantly more stable in the presence of human hepatocytes than in the presence of liver microsomes. Therefore, a high degree of HLM stability was desired as a prerequisite to acceptable human hepatocyte stability.</div><div class="NLM_p">The emerging trends noted in the limited data set presented in Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a> prompted us to perform more extensive properties analyses on existing compounds to ascertain whether an ideal range of calculated properties could be identified to balance low whole blood shift with acceptable membrane permeability and HLM stability. We have previously reported on <i>C</i>-2 H and methyl substituted imidazopyrrolopyridine compounds (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>, R = H or Me),<a onclick="showRef(event, 'ref7 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref9">(7, 9)</a> many of which were synthesized prior to initiation of the current work. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>a, analysis of this historical data set revealed that compounds with cLogD<sub>7.4</sub> greater than 2 possessed a high probability of exhibiting large whole blood shifts (>5×), whereas compounds with cLogD<sub>7.4</sub> <2 were more likely to fall into the low (<3×) or moderate (3×–5×) shift ranges.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/medium/jm-2013-004895_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0003.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Defining the ideal calculated property space of <i>C</i>-2 H and Me imidazopyrrolopyridines.<sup><i>a</i></sup> All compounds analyzed were synthesized prior to the imidazopyrrolopyridines in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. Superscript letters indicate the following: (<i>a</i>) compound structures and tabulated data are listed in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>; (<i>b</i>) (whole blood EC<sub>50</sub>)/(IL-6 pSTAT3 EC<sub>50</sub>);<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> (<i>c</i>) see ref <a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">14</a>; (<i>d</i>) oral bioavailability in the rat; (<i>e</i>) apparent permeability in MDCK transwell culture; A:B, apical-to-basolateral; (<i>f</i>) in vivo clearance in the rat after IV administration; (<i>g</i>) see ref <a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">15</a>; (<i>h</i>) experimental hepatic clearance in the presence of human liver microsomes;<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (<i>i</i>) prospectively calculated probability of being stable in the presence of human liver microsomes.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4004895&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>b illustrates the relationships between rat oral bioavailability and MDCK permeability in the <i>C</i>-2 H and methyl substituted imidazopyrrolopyridine series. It appeared that MDCK <i>P</i><sub>app</sub> (A:B) was an important determinant of oral bioavailability. MDCK <i>P</i><sub>app</sub> values of >3 × 10<sup>–6</sup> cm/s (A:B) often produced compounds falling into the high (>50%) or moderate (30–50%) bioavailability categories, while compounds possessing MDCK <i>P</i><sub>app</sub> (A:B) below than that value were often found to cluster in the low bioavailability class (%<i>F</i> < 30%). TPSA and cLogD<sub>7.4</sub> were found to be useful computational predictors of acceptable MDCK permeability. Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>c shows that compounds with TPSA values of >90 Å<sup>2</sup> or cLogD<sub>7.4</sub> <0.5 were less likely to demonstrate acceptable MDCK permeability (<i>P</i><sub>app</sub> A:B >3 × 10<sup>–6</sup> cm/s) than those with TPSA <90 Å<sup>2</sup> and cLogD<sub>7.4</sub> >0.5.</div><div class="NLM_p">As expected, high in vivo clearance could also erode oral bioavailability. Indeed, the compound in the bottom right quadrant of Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>b possessed extremely good MDCK permeability yet exhibited low bioavailability (presumably due to very high in vivo CL). In an effort to control in vivo CL, we wished to identify compounds with a high degree of metabolic stability in the presence of HLMs. We evaluated the ability of a computational model trained on a set of experimental HLM data to prospectively predict the probability of HLM stability of new compounds in the imidazopyrrolopyridine series.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a> Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>d shows the correlation between the model’s predicted probability of HLM stability and the experimental CL<sub>H</sub> values obtained by incubating compounds with HLMs. Indeed, the model indicated that imidazopyrrolopyridine compounds with calculated probabilities <0.5 were likely to possess poor metabolic stability, i.e., high (>15 mL min<sup>–1</sup> kg<sup>–1</sup>) or high–moderate (10–15 mL min<sup>–1</sup> kg<sup>–1</sup>) HLM CL<sub>H</sub>. By contrast, calculated probabilities of >0.5 resulted in an enriched proportion of molecules with good metabolic stability, i.e., low (<6.2 mL min<sup>–1</sup> kg<sup>–1</sup>) or low–moderate (6.2–10 mL min<sup>–1</sup> kg<sup>–1</sup>) experimental HLM CL<sub>H</sub> values.</div><div class="NLM_p">The correlations identified in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a> for the <i>C</i>-2 H and Me imidazopyrrolopyridine series are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>. A cLogD<sub>7.4</sub> range of 0.5–2.0 was desirable. Compounds with lower values often suffered from poor MDCK permeability, whereas analogues with higher values typically exhibited large whole blood potency shifts. An additional determinant of MDCK permeability was TPSA, with values of >90 Å<sup>2</sup> often associated with unacceptable permeability. Finally, compounds with calculated HLM stability probability <0.5 were found to be unlikely to possess satisfactory experimental metabolic stability in the presence of HLMs. These correlations in the <i>C</i>-2 H and Me series were used to define a set of compound design parameters for further optimization of the consistently JAK1 selective <i>C</i>-2 hydroxyl series. Among the <i>C</i>-2 hydroxyls, the (<i>R</i>)-hydroxyethyl analogue <b>8</b> appeared to offer the most promise for optimization. In addition to possessing the highest levels of JAK1 potency and selectivity of the monohydroxylated analogues (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>), its TPSA was substantially lower than that of diol <b>13</b>, allowing for many more acceptable combinations with P-loop groups to be designed. As such, the <i>C</i>-2 (<i>R</i>)-hydroxyethyl moiety was used for all further optimization work.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Compound Design Parameters for <i>C</i>-2 Hydroxyethyl Imidazopyrrolopyridines</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="center" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">calcd property</th><th class="colsep0 rowsep0" align="center">target value</th><th class="colsep0 rowsep0" align="center">rationale</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">cLogD<sub>7.4</sub><a class="ref internalNav" href="#t3fn1" aria-label="a">a</a></td><td class="colsep0 rowsep0" align="center">0.5–2.0</td><td class="colsep0 rowsep0" align="left">balance MDCK <i>P</i><sub>app</sub><a class="ref internalNav" href="#t3fn4" aria-label="d">d</a> with whole blood shift<a class="ref internalNav" href="#t3fn5" aria-label="e">e</a> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">TPSA<a class="ref internalNav" href="#t3fn2" aria-label="b">b</a></td><td class="colsep0 rowsep0" align="center">≤90 Å<sup>2</sup></td><td class="colsep0 rowsep0" align="left">MDCK <i>P</i><sub>app</sub><a class="ref internalNav" href="#t3fn4" aria-label="d">d</a></td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">HLM probability<a class="ref internalNav" href="#t3fn3" aria-label="c">c</a></td><td class="colsep0 rowsep0" align="center">>0.5</td><td class="colsep0 rowsep0" align="left">human liver microsome stability<a class="ref internalNav" href="#t3fn6" aria-label="f">f</a></td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t3fn1"><div class="footnote" id="t3fn1"><sup>a</sup><p class="last">See ref <a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">14</a>.</p></div><div class="footnote" id="t3fn2"><sup>b</sup><p class="last">See ref <a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">15</a>.</p></div><div class="footnote" id="t3fn3"><sup>c</sup><p class="last">Prospectively calculated probability of being stable in the presence of human liver microsomes.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></p></div><div class="footnote" id="t3fn4"><sup>d</sup><p class="last">Apparent permeability in MDCK transwell culture; A:B, apical-to-basolateral.</p></div><div class="footnote" id="t3fn5"><sup>e</sup><p class="last">(whole blood EC<sub>50</sub>)/(IL-6 pSTAT3 EC<sub>50</sub>).<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></p></div><div class="footnote" id="t3fn6"><sup>f</sup><p class="last">Experimental in vivo stability in the presence of human liver microsomes.</p></div></div></div><div class="NLM_p">The results of the P-loop optimization campaign are shown in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. All compounds in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> possessed calculated probabilities of HLM stability of ≥0.6 and, as expected from the analysis of the <i>C</i>-2 H and Me imidazopyrrolopyridines (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>d), the majority of them exhibited either low or moderate experimental HLM CL<sub>H</sub>. Human hepatocyte CL<sub>H</sub> values were generally in good agreement with the corresponding HLM values, indicating that significant metabolism by processes such as phase 2 conjugation or aldehyde oxidase activity was unlikely. As we have previously reported,<a onclick="showRef(event, 'ref7 ref9'); return false;" href="javascript:void(0);" class="ref ref7 ref9">(7, 9)</a> many <i>N</i>-substituted 4-piperidine P-loop groups exhibited high levels of JAK1 potency in the imidazopyrrolopyridine series and, given the ease of synthesis, appeared to offer an attractive means to tune physicochemical properties. Unfortunately, we found it difficult to identify substituted 4-piperidines with acceptable profiles when combined with the <i>C</i>-2 (<i>R</i>)-hydroxyethyl selectivity group. For example, compound <b>14</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>) fell within the desired calculated properties ranges but suffered from a large whole blood shift. A related analogue (<b>15</b>) possessed reasonable JAK1 potency in the biochemical and whole blood assays but fell outside the ideal cLogD<sub>7.4</sub> and TPSA ranges and suffered from low MDCK permeability. Although multiple other <i>N</i>-substituted 4-piperidine compounds were synthesized (data not shown), none balanced acceptable JAK1 potency with low whole blood shift and acceptable in vitro and in vivo DMPK properties. The much more synthetically complex <i>gem</i>-difluoro piperidine <b>16</b> was somewhat more promising in balancing reasonable JAK1 potency and selectivity with the other experimental parameters listed in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. <i>N</i>-substituted 3-piperidine groups were not successful (e.g., <b>17</b> and <b>18</b>), and similar to the 4-piperidine isomers, it was not possible to balance potency with the various other calculated and experimental parameters. Tetrahydropyran (THP) P-loop groups possessed ideal calculated properties, however, the 4-regioisomer <b>19</b> and the (<i>R</i>)-epimer of the 3-regioisomer (<b>20</b>) were disappointingly weak biochemical JAK1 inhibitors. In contrast, the (<i>S</i>)-epimer of the 3-THP regioisomer (<b>21</b>) was far more biochemically active, as well as being highly selective for JAK1 over JAK2 (>25× and >50× in biochemical and cell-based assays, respectively) and possessing good MDCK permeability and excellent metabolic stability. In addition, a very low whole blood shift allowed <b>21</b> to be the first <i>C</i>-2 hydroxyethyl compound to exhibit a whole blood JAK1 cellular EC<sub>50</sub> of <200 nM. A series of substituted cyclohexane and cyclopentane P-loop groups was then examined. The <i>cis</i> and <i>trans</i> 4-cyclohexanols <b>22</b> and <b>23</b> exhibited modest biochemical and cell-based JAK1 potency, while the optimal isomer<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> of the 3-cyclohexanol (<b>24</b>) showed improved potency, excellent JAK selectivity, and a low whole blood shift. Unfortunately, despite possessing cLogD<sub>7.4</sub> and TPSA values within the optimal calculated range, the MDCK permeability of <b>24</b> was low, potentially due to the presence of a third hydrogen-bond donor (HBD). Indeed, removal of the third HBD in the <i>trans</i> 4-methoxy analogue <b>25</b> led to much improved MDCK permeability. We previously found in the <i>C</i>-2 Me series that a 3-methoxy substituted cyclohexane P-loop group was not tolerated (data not shown), therefore a similar analogue was not synthesized in the <i>C</i>-2 (<i>R</i>)-hydroxyethyl series. Instead, we prepared the shielded 4-amino cyclohexanes <b>26</b>–<b>28</b>. The strongly electron withdrawing and lipophilic 2,2,2-trifluoroethyl group allowed compound <b>26</b> to achieve excellent MDCK permeability despite the presence of the third HBD. Gratifyingly, <b>26</b> also balanced robust JAK1 selectivity (>15× biochemical, >25× cell-based) and excellent metabolic stability with very potent whole blood JAK1 inhibition, comparable to that of <b>1</b> (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). The 2,2-difluoroethyl analogue <b>27</b> was also highly potent and even more selective than <b>26</b>, but it suffered from reduced MDCK permeability. The <i>cis</i> 1,4-diamino cyclohexane <b>28</b> suffered from reduced potency and decreased metabolic stability relative to the <i>trans</i> version <b>26</b>. Unlike the matched pair of <i>cis</i> and <i>trans</i> cyclohexanes <b>26</b> and <b>28</b>, the corresponding cyclopentanes <b>29</b> and <b>30</b> exhibited similar attributes. Both were promising, although the <i>cis</i> analogue <b>29</b> possessed better JAK1 selectivity. The final analogues examined in combination with the <i>C</i>-2 (<i>R</i>)-hydroxyethyl selectivity group were the cyano substituted cyclohexanes <b>31</b>–<b>34</b>. While residing at the upper limit of acceptable TPSA, these compounds contained only two HBDs, and were thus considered worthy of preparation. Although possessing borderline MDCK permeability and somewhat reduced potency in the cell-based JAK1 assay relative to the optimal trifluoroethyl substituted amines (e.g., <b>26</b> and <b>29</b>), compound <b>31</b> exhibited a low whole blood shift and, thus, maintained good whole blood potency. Notably, <b>31</b> also exhibited very high levels of JAK1 selectivity over JAK2 (>35× biochemical, >60× cell-based). The corresponding <i>cis</i> isomer <b>32</b> was slightly more potent, although at the cost of reduced JAK1 selectivity. The singly and doubly homologated <i>trans</i> isomers <b>33</b> and <b>34</b> were extremely potent in all biochemical and cell-based measures of the JAK1 inhibition (including in human whole blood), although JAK1 selectivity was reduced relative to <b>31</b>. One final note on the inhibitors in Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a> is that a high degree of ligand efficiency was maintained throughout the optimization effort, with the majority of sub-5 nM <i>K</i><sub>i</sub> compounds maintaining LE ≥ 0.45 and LLE ≥ 7.0.</div><div class="NLM_table-wrap" id="tbl4"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 4. SAR of <i>C</i>-2 (<i>R</i>)-Hydroxyethyl Imidazopyrrolopyridines</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/medium/jm-2013-004895_0013.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/medium/jm-2013-004895_0014.gif" alt="" id="fx4" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/medium/jm-2013-004895_0015.gif" alt="" id="GRAPHIC-d7e1959-autogenerated" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t4fn1"><div class="footnote" id="t4fn1"><sup>Table a</sup><p class="last">Ligand efficiency<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a> = (−1.4log <i>K</i><sub>i</sub>)/(<i>n</i> heavy atoms).</p></div><div class="footnote" id="t4fn2"><sup>Table b</sup><p class="last">Ligand-lipophilicity efficiency<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> = (−log <i>K</i><sub>i</sub>) – (cLogP).</p></div><div class="footnote" id="t4fn3"><sup>Table c</sup><p class="last">Arithmetic mean of at least three separate runs (<i>n</i> ≥ 3).</p></div><div class="footnote" id="t4fn4"><sup>Table d</sup><p class="last">The average coefficient of variation was less than 0.3 times the mean for biochemical assays.</p></div><div class="footnote" id="t4fn5"><sup>Table e</sup><p class="last">JAK2 <i>K</i><sub>i</sub>/JAK1 <i>K</i><sub>i</sub>.</p></div><div class="footnote" id="t4fn6"><sup>Table f</sup><p class="last">JAK1 cell-based assay.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The average coefficient of variation was less than 0.5 times the mean for cell-based assays.</p></div><div class="footnote" id="t4fn7"><sup>Table g</sup><p class="last">(EPO pSTAT5 EC<sub>50</sub>)/(IL-6 pSTAT3 EC<sub>50</sub>).</p></div><div class="footnote" id="t4fn8"><sup>Table h</sup><p class="last">JAK1 cell-based assay (IL-6 pSTAT3) run in the presence of whole blood.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a></p></div><div class="footnote" id="t4fn9"><sup>Table i</sup><p class="last">(whole blood EC<sub>50</sub>)/(IL-6 pSTAT3 EC<sub>50</sub>).</p></div><div class="footnote" id="t4fn10"><sup>Table j</sup><p class="last">Hepatic clearance in the presence of human liver microsomes and human hepatocytes.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Mean of at least two separate runs (<i>n</i> ≥ 2).</p></div><div class="footnote" id="t4fn11"><sup>Table k</sup><p class="last">See ref <a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">14</a>.</p></div><div class="footnote" id="t4fn12"><sup>Table l</sup><p class="last">See ref <a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">15</a>.</p></div><div class="footnote" id="t4fn13"><sup>Table m</sup><p class="last">Apparent permeability in MDCK transwell culture. A:B, apical-to-basolateral. Mean of at least two separate runs (<i>n</i> ≥ 2).</p></div><div class="footnote" id="t4fn14"><sup>Table n</sup><p class="last">Single, unknown 4-piperidine epimer.</p></div></div><div></div></div><div class="NLM_p">As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>, X-ray crystal structures of the highly JAK1 selective compound <b>31</b> were generated in complex with both JAK1 and JAK2. Compound <b>31</b> adopts broadly similar binding modes in the presence of each JAK isoform, with the pyrrolopyridine moiety contacting the hinge residues as expected, and the free lone pair of the imidazole ring interacting with a crystallographic water. Also similar between the two structures, the cyano group of the ligand does not interact directly with the P-loop but rather extends beneath it and likely participates in polar interactions with nearby crystallographic waters. An important difference between the two structures is observed in the region surrounding the key JAK1 (E966) vs JAK2 (D939) residue difference targeted by the <i>C</i>-2 hydroxy moiety. In the case of JAK1, the <i>C</i>-2 hydroxyethyl group forms a favorable direct H-bonding interaction with E966 at an optimal distance of 2.8 Å. The distance between the ligand and the corresponding residue in JAK2 (D939) is 4.3 Å, too far for a direct interaction. To satisfy the H-bonding partners of the ligand and D939, a bridging, and presumably entropically disfavored, water molecule is incorporated into the inhibitor–protein complex. We believe the suboptimal interaction between the <i>C</i>-2 hydroxyethyl group of the ligand and D939 of the protein produces the observed reduction in JAK2 potency and, hence, the excellent JAK1 selectivity.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/medium/jm-2013-004895_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) X-ray structure of <b>31</b> in complex with JAK1 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IVB">4IVB</a>, resolution = 1.9 Å). (b) X-ray structure of <b>31</b> in complex with JAK2 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IVA">4IVA</a>, resolution = 1.5 Å). A key residue difference between JAK1 (E966) and JAK2 (D939) is highlighted in green. Notable crystallographic waters are highlighted as red spheres. Hydrogen-bonding interactions are denoted as dashed lines. The electron density of the JAK1 structure was consistent with two main conformations of the P-loop. For the sake of clarity, only one of these is depicted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4004895&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Although the physicochemical properties of compound <b>31</b> allowed it to exhibit greater whole blood potency than the unsubstituted cyclohexane <b>8</b>, the cyano group was found to be detrimental to intrinsic JAK1 biochemical potency (JAK1 <i>K</i><sub>i</sub>: <b>31</b> = 1.9 nM, <b>8</b> = 0.8 nM). By comparison, both the singly and doubly homologated nitriles <b>33</b> and <b>34</b> exhibited improved JAK1 biochemical inhibition relative to the unsubstituted cyclohexane <b>8</b>. Crystal structures of <b>33</b> and <b>34</b> in complex with JAK1 were generated (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>a,b) and compared to those of both <b>31</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>a) and the published structure of <b>1</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>c).<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> All structures revealed very similar interactions with the hinge region of JAK1, with the imidazopyrrolopyridine (<b>31</b>, <b>33</b>, <b>34</b>) or pyrrolopyrimidine (<b>1</b>) cores contacting E957 and L959 and interacting with a crystallographic water molecule. The interaction between the hydroxyethyl moieties of <b>31</b>, <b>33</b>, and <b>34</b> and E966 were likewise found to be very similar. However, the overlay of the four JAK1 structures revealed a notable difference between the highly potent biochemical inhibitors (<b>1</b>, <b>33</b>, <b>34</b>) and the less potent inhibitor <b>31</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>d). The favorable interactions between the nitrile of <b>1</b> and the P-loop have previously been described.<a onclick="showRef(event, 'ref18 ref19'); return false;" href="javascript:void(0);" class="ref ref18 ref19">(18, 19)</a> Nitriles <b>33</b> and <b>34</b> adopt conformations comparable to <b>1</b>, extending up toward the P-loop and likely participating in similar favorable interactions. In contrast, and as noted above, the nitrile of <b>31</b> does not interact directly with the P-loop, but instead extends in an approximately perpendicular direction below it. This difference in nitrile placement may explain the reduced biochemical potency of <b>31</b> relative to <b>1</b>, <b>33</b>, and <b>34</b>.</div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/medium/jm-2013-004895_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a–c) X-ray structures of compounds <b>33</b>, <b>34</b>, and <b>1</b>, respectively, in complex with JAK1. PDB codes and resolutions are as follows: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IVC">4IVC</a>, 2.4 Å (a); <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IVD">4IVD</a>, 1.9 Å (b); <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EYG">3EYG</a>,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> 1.9 Å (c). A key residue difference between JAK1 (E966) and JAK2 (D939) is highlighted in green. Notable crystallographic waters are highlighted as red spheres. Hydrogen-bonding interactions are denoted as dashed lines. (d) Superposition of the ligands from the X-ray structures of <b>1</b>,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a><b>31</b>, <b>33</b>, and <b>34</b> in complex with JAK1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4004895&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In vivo DMPK and associated data for notable <i>C</i>-2 hydroxyethyl compounds are depicted in Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>. All compounds possessed uniformly high levels of pH 2 solubility, while pH 7.4 solubility was more variable and appeared to be influenced by lipophilicity. Indeed, the compounds with the lowest cLogD<sub>7.4</sub> values (<b>21</b> and <b>31</b>) possessed the best pH 7.4 solubility. Additionally, all compounds tested possessed low to moderate plasma protein binding across species. Similar to human hepatocytes, the in vitro rat and dog hepatocyte CL<sub>H</sub> values were found to be in the low to moderate range. The compounds were generally less stable in the presence of monkey hepatocytes, with typical in vitro CL<sub>H</sub> values in the moderate to high range. The in vivo PK profiles of the tricyclic compounds generally compared favorably with <b>1</b>. Moderate to high IV clearance was observed in the rat, yet oral exposure was better than expected, with the ratio of experimental bioavailability (<i>F</i>) to maximum theoretical bioavailability (<i>F</i><sub>max</sub>),<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> typically larger than one. In vivo dog clearance was typically moderate, although compounds <b>21</b> and <b>34</b> fell into the low and high ranges, respectively. Similar to the rat, dog oral exposure was generally greater than would be expected on the basis of IV clearance (i.e., the ratio of <i>F</i> to <i>F</i><sub>max</sub> was typically >1). A definitive explanation for the unexpectedly good oral exposure in rat and dog has not been established to date. The compounds profiled in monkey PK exhibited moderate IV clearance and lower <i>F</i>/<i>F</i><sub>max</sub> ratios than in other species. Indeed, the oral bioavailabilities of compounds <b>21</b> and <b>31</b> were very close to what would be predicted based on IV clearance (<i>F</i>/<i>F</i><sub>max</sub> ∼ 1). Compound <b>21</b> possessed the best rat and dog in vivo PK of all compounds tested, with IV clearance and oral exposure values superior to those reported for <b>1</b>. Monkey PK, however, was distinctly different and all IV and oral parameters were less favorable than in the rat or dog. It is notable that of all species tested, <b>21</b> was least stable in monkey hepatocytes and further that monkey hepatocytes were very predictive of in vivo clearance. It is possible that the moderate monkey PK parameters may be due at least in part to the intrinsically poorer metabolic stability of <b>21</b> in the monkey relative to other species. The most JAK1 selective compound in this work (<b>31</b>) exhibited moderate, yet consistent PK across all species tested, and compared favorably to the preclinical PK reported for <b>1</b>.</div><div class="NLM_table-wrap" id="tbl5"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 5. In Vivo PK Data for <b>1</b> and Selected <i>C</i>-2 (<i>R</i>)-Hydroxyethyl Imidazopyrrolopyridines</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="char" char="." /></col><col align="justify" /></col><col align="justify" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="justify" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">Ex</th><th class="colsep0 rowsep0" align="center">aq sol,<a class="ref internalNav" href="#t5fn1" aria-label="a">a</a> pH 2, pH 7.4</th><th class="colsep0 rowsep0" align="center">MDCK <i>P</i><sub>app</sub>A:B,B:A<br /></br> (× 10<sup>–6</sup>cm/s)<a class="ref internalNav" href="#t5fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center">species<a class="ref internalNav" href="#t5fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center" char=".">PPB<a class="ref internalNav" href="#t5fn4" aria-label="d">d</a> (%)</th><th class="colsep0 rowsep0" align="center">Hep CL<sub>H</sub><a class="ref internalNav" href="#t5fn5" aria-label="e">e</a>(mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center">CL<a class="ref internalNav" href="#t5fn6" aria-label="f">f</a>(mL min<sup>–1</sup> kg<sup>–1</sup>)</th><th class="colsep0 rowsep0" align="center" char="."><i>T</i><sub>1/2</sub><a class="ref internalNav" href="#t5fn6" aria-label="f">f</a> (h)</th><th class="colsep0 rowsep0" align="center" char=".">AUC<a class="ref internalNav" href="#t5fn7" aria-label="g">g</a>(μM·h)</th><th class="colsep0 rowsep0" align="center" char="."><i>C</i><sub>Max</sub><a class="ref internalNav" href="#t5fn7" aria-label="g">g</a> (μM)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i><a class="ref internalNav" href="#t5fn8" aria-label="h">h</a> (%)</th><th class="colsep0 rowsep0" align="center" char="."><i>F</i><sub>max</sub><a class="ref internalNav" href="#t5fn9" aria-label="i">i</a> (%)</th><th class="colsep0 rowsep0" align="center"><i>F</i>/<i>F</i><sub>max</sub></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b><a class="ref internalNav" href="#t5fn10" aria-label="j">j</a></td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">R</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="justify"> </td><td class="colsep0 rowsep0" align="justify">62</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="char" char=".">0.58</td><td class="colsep0 rowsep0" align="char" char=".">0.28</td><td class="colsep0 rowsep0" align="char" char=".">27</td><td class="colsep0 rowsep0" align="char" char=".">11</td><td class="colsep0 rowsep0" align="justify">2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="justify"> </td><td class="colsep0 rowsep0" align="justify">19</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">1.9</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">78</td><td class="colsep0 rowsep0" align="char" char=".">39</td><td class="colsep0 rowsep0" align="justify">2.0</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">M</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="justify"> </td><td class="colsep0 rowsep0" align="justify">18</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">2.0</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">48</td><td class="colsep0 rowsep0" align="char" char=".">59</td><td class="colsep0 rowsep0" align="justify">0.8</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="13" align="left">   </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="left">>4000, >4000</td><td class="colsep0 rowsep0" align="left">7.6, 8.6</td><td class="colsep0 rowsep0" align="left">R</td><td class="colsep0 rowsep0" align="char" char=".">39</td><td class="colsep0 rowsep0" align="justify">2.3</td><td class="colsep0 rowsep0" align="justify">22</td><td class="colsep0 rowsep0" align="char" char=".">1.5</td><td class="colsep0 rowsep0" align="char" char=".">10.7</td><td class="colsep0 rowsep0" align="char" char=".">5.2</td><td class="colsep0 rowsep0" align="char" char=".">197</td><td class="colsep0 rowsep0" align="char" char=".">69</td><td class="colsep0 rowsep0" align="justify">2.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="char" char=".">61</td><td class="colsep0 rowsep0" align="justify">4.9</td><td class="colsep0 rowsep0" align="justify">2.1</td><td class="colsep0 rowsep0" align="char" char=".">5.7</td><td class="colsep0 rowsep0" align="char" char=".">65.7</td><td class="colsep0 rowsep0" align="char" char=".">9.8</td><td class="colsep0 rowsep0" align="char" char=".">111</td><td class="colsep0 rowsep0" align="char" char=".">93</td><td class="colsep0 rowsep0" align="justify">1.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">M</td><td class="colsep0 rowsep0" align="char" char=".">54</td><td class="colsep0 rowsep0" align="justify">21</td><td class="colsep0 rowsep0" align="justify">19</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">4.3</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td><td class="colsep0 rowsep0" align="char" char=".">70</td><td class="colsep0 rowsep0" align="char" char=".">56</td><td class="colsep0 rowsep0" align="justify">1.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="13" align="left">   </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="left">3900, 130</td><td class="colsep0 rowsep0" align="left">6.7, 10</td><td class="colsep0 rowsep0" align="left">R</td><td class="colsep0 rowsep0" align="char" char=".">56</td><td class="colsep0 rowsep0" align="justify">11</td><td class="colsep0 rowsep0" align="justify">36</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">1.4</td><td class="colsep0 rowsep0" align="char" char=".">0.96</td><td class="colsep0 rowsep0" align="char" char=".">54</td><td class="colsep0 rowsep0" align="char" char=".">49</td><td class="colsep0 rowsep0" align="justify">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="char" char=".">55</td><td class="colsep0 rowsep0" align="justify">2.3</td><td class="colsep0 rowsep0" align="justify">13</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">9.9</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">139</td><td class="colsep0 rowsep0" align="char" char=".">58</td><td class="colsep0 rowsep0" align="justify">2.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">M</td><td class="colsep0 rowsep0" align="char" char=".">65</td><td class="colsep0 rowsep0" align="justify">26</td><td class="colsep0 rowsep0" align="justify"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="justify"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="13" align="left">   </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="left">>4000, 70</td><td class="colsep0 rowsep0" align="left">10, 18</td><td class="colsep0 rowsep0" align="left">R</td><td class="colsep0 rowsep0" align="char" char=".">49</td><td class="colsep0 rowsep0" align="justify">14</td><td class="colsep0 rowsep0" align="justify">55</td><td class="colsep0 rowsep0" align="char" char=".">1.1</td><td class="colsep0 rowsep0" align="char" char=".">1.0</td><td class="colsep0 rowsep0" align="char" char=".">0.98</td><td class="colsep0 rowsep0" align="char" char=".">61</td><td class="colsep0 rowsep0" align="char" char=".">29</td><td class="colsep0 rowsep0" align="justify">2.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="char" char=".">59</td><td class="colsep0 rowsep0" align="justify">9.8</td><td class="colsep0 rowsep0" align="justify">14</td><td class="colsep0 rowsep0" align="char" char=".">1.2</td><td class="colsep0 rowsep0" align="char" char=".">9.0</td><td class="colsep0 rowsep0" align="char" char=".">3.0</td><td class="colsep0 rowsep0" align="char" char=".">131</td><td class="colsep0 rowsep0" align="char" char=".">55</td><td class="colsep0 rowsep0" align="justify">2.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">M</td><td class="colsep0 rowsep0" align="char" char=".">56</td><td class="colsep0 rowsep0" align="justify">27</td><td class="colsep0 rowsep0" align="justify"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="justify"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="13" align="left">   </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="left">>4000, 1900</td><td class="colsep0 rowsep0" align="left">2.7, 4.7</td><td class="colsep0 rowsep0" align="left">R</td><td class="colsep0 rowsep0" align="char" char=".">38</td><td class="colsep0 rowsep0" align="justify">3.7</td><td class="colsep0 rowsep0" align="justify">60</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">0.94</td><td class="colsep0 rowsep0" align="char" char=".">0.42</td><td class="colsep0 rowsep0" align="char" char=".">52</td><td class="colsep0 rowsep0" align="char" char=".">14</td><td class="colsep0 rowsep0" align="justify">3.7</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="char" char=".">47</td><td class="colsep0 rowsep0" align="justify">3</td><td class="colsep0 rowsep0" align="justify">16</td><td class="colsep0 rowsep0" align="char" char=".">2.2</td><td class="colsep0 rowsep0" align="char" char=".">8.3</td><td class="colsep0 rowsep0" align="char" char=".">2.1</td><td class="colsep0 rowsep0" align="char" char=".">119</td><td class="colsep0 rowsep0" align="char" char=".">48</td><td class="colsep0 rowsep0" align="justify">2.5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">M</td><td class="colsep0 rowsep0" align="char" char=".">60</td><td class="colsep0 rowsep0" align="justify">2.4</td><td class="colsep0 rowsep0" align="justify">18</td><td class="colsep0 rowsep0" align="char" char=".">1.7</td><td class="colsep0 rowsep0" align="char" char=".">3.9</td><td class="colsep0 rowsep0" align="char" char=".">0.63</td><td class="colsep0 rowsep0" align="char" char=".">65</td><td class="colsep0 rowsep0" align="char" char=".">59</td><td class="colsep0 rowsep0" align="justify">1.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="13" align="left">   </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="left">>4000, 130</td><td class="colsep0 rowsep0" align="left">3.5, 4.9</td><td class="colsep0 rowsep0" align="left">R</td><td class="colsep0 rowsep0" align="char" char=".">63</td><td class="colsep0 rowsep0" align="justify">15</td><td class="colsep0 rowsep0" align="justify">38</td><td class="colsep0 rowsep0" align="char" char=".">0.5</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">0.93</td><td class="colsep0 rowsep0" align="char" char=".">49</td><td class="colsep0 rowsep0" align="char" char=".">54</td><td class="colsep0 rowsep0" align="justify">0.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="char" char=".">63</td><td class="colsep0 rowsep0" align="justify">12</td><td class="colsep0 rowsep0" align="justify">17</td><td class="colsep0 rowsep0" align="char" char=".">1.8</td><td class="colsep0 rowsep0" align="char" char=".">11.2</td><td class="colsep0 rowsep0" align="char" char=".">2.5</td><td class="colsep0 rowsep0" align="char" char=".">183</td><td class="colsep0 rowsep0" align="char" char=".">45</td><td class="colsep0 rowsep0" align="justify">4.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">M</td><td class="colsep0 rowsep0" align="char" char=".">70</td><td class="colsep0 rowsep0" align="justify">25</td><td class="colsep0 rowsep0" align="justify"> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="justify"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" colspan="13" align="left">   </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="left">>4000, 16</td><td class="colsep0 rowsep0" align="left">4.7, 9.3</td><td class="colsep0 rowsep0" align="left">R</td><td class="colsep0 rowsep0" align="char" char=".">68</td><td class="colsep0 rowsep0" align="justify">28</td><td class="colsep0 rowsep0" align="justify">126</td><td class="colsep0 rowsep0" align="char" char=".">0.6</td><td class="colsep0 rowsep0" align="char" char=".">0.42</td><td class="colsep0 rowsep0" align="char" char=".">0.22</td><td class="colsep0 rowsep0" align="char" char=".">50</td><td class="colsep0 rowsep0" align="char" char=".">0</td><td class="colsep0 rowsep0" align="justify"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">D</td><td class="colsep0 rowsep0" align="char" char=".">66</td><td class="colsep0 rowsep0" align="justify">11</td><td class="colsep0 rowsep0" align="justify">29</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">4.3</td><td class="colsep0 rowsep0" align="char" char=".">1.3</td><td class="colsep0 rowsep0" align="char" char=".">125</td><td class="colsep0 rowsep0" align="char" char=".">6</td><td class="colsep0 rowsep0" align="justify">20</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left"> </td><td class="colsep0 rowsep0" align="left">M</td><td class="colsep0 rowsep0" align="char" char=".">76</td><td class="colsep0 rowsep0" align="justify">36</td><td class="colsep0 rowsep0" align="justify">29</td><td class="colsep0 rowsep0" align="char" char=".">0.8</td><td class="colsep0 rowsep0" align="char" char=".">0.26</td><td class="colsep0 rowsep0" align="char" char=".">0.07</td><td class="colsep0 rowsep0" align="char" char=".">8</td><td class="colsep0 rowsep0" align="char" char=".">33</td><td class="colsep0 rowsep0" align="justify">0.2</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t5fn1"><div class="footnote" id="t5fn1"><sup>a</sup><p class="last">Thermodynamic solubility (reported in μM) of solid powder in aqueous buffer.</p></div><div class="footnote" id="t5fn2"><sup>b</sup><p class="last">Apparent permeability in MDCK transwell culture. A:B = apical-to-basolateral, B:A = basolateral-to-apical. Mean of at least two separate runs (<i>n</i> ≥ 2).</p></div><div class="footnote" id="t5fn3"><sup>c</sup><p class="last">Abbreviations as follows: R = rat, D = dog, M = monkey.</p></div><div class="footnote" id="t5fn4"><sup>d</sup><p class="last">Plasma protein binding.</p></div><div class="footnote" id="t5fn5"><sup>e</sup><p class="last">In vitro hepatic clearance in the presence of hepatocytes.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> Mean of at least two separate runs (<i>n</i> ≥ 2).</p></div><div class="footnote" id="t5fn6"><sup>f</sup><p class="last">In vivo parameters after IV dosing. CL = clearance; <i>T</i><sub>1/2</sub> = half-life. Compounds <b>21</b>, <b>26</b>, <b>29</b>, <b>31</b>, <b>33</b>, and <b>34</b> were formulated as solutions in PEG400/citrate buffer (pH 5) and dosed at 0.4 mg/kg. Data are the average from three separate animals.</p></div><div class="footnote" id="t5fn7"><sup>g</sup><p class="last">In vivo parameters after PO dosing. AUC = area under the curve, <i>C</i><sub>Max</sub> = maximum concentration. Compounds <b>21</b>, <b>26</b>, <b>29</b>, <b>31</b>, <b>33</b>, and <b>34</b> were formulated as suspensions in MCT and dosed at 2 mg/kg. Data are the average from three separate animals.</p></div><div class="footnote" id="t5fn8"><sup>h</sup><p class="last">Experimental oral bioavailability.</p></div><div class="footnote" id="t5fn9"><sup>i</sup><p class="last">Theoretical maximum achievable oral bioavailability.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a></p></div><div class="footnote" id="t5fn10"><sup>j</sup><p class="last">All values obtained or calculated from ref <a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">5</a>. PO parameters scaled to 2 mg/kg.</p></div></div></div><div class="NLM_p">The off target kinase activities of multiple <i>C</i>-2 hydroxyethyl-containing compounds were assessed in a panel of 285 kinases (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Each compound was tested at a low (0.01–0.15 μM) and high (0.1–1.0 μM) concentration. The concentrations were chosen based on biochemical potency against JAK1, with more potent compounds tested at lower concentrations. The JAK family kinases were included as controls in every panel tested and, as expected, each compound demonstrated virtually complete (>90%) inhibition of JAK1 at both concentrations tested. All compounds appeared to be relatively selective for the JAK family of kinases over the broader kinome at the lower concentration. However, at the higher concentration, the compounds began to differentiate significantly, with <b>29</b> and <b>31</b> showing the highest levels of selectivity. Indeed, at a 1 μM test concentration (≥500 × JAK1 <i>K</i><sub>i</sub>), the only non-JAK kinases inhibited by >50% were LRRK2 (72%) by compound <b>29</b> and CSF1R (75%) and the V561D mutant form of PDGFR-α (55%) by compound <b>31</b>.</div><div class="NLM_table-wrap" id="tbl6"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 6. Inhibition of a 285-Member Kinase Panel by Imidazopyrrolopyridine JAK1 Inhibitors<a class="ref internalNav" href="#t6fn1" aria-label="a">a</a></div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/medium/jm-2013-004895_0016.gif" alt="" id="fx5" /></img><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t6fn1"><div class="footnote" id="t6fn1"><sup>Table a</sup><p class="last">Off-target kinase inhibition assessed by SelectScreen Kinase Profiling Services (Invitrogen-Life Technologies, Madison, WI, USA). Each column contains 285 cells (one kinase per cell). The cells are colored as follows: green, < 50% inhibition; yellow, 50–75% inhibition; red, >75% inhibition; white, not tested. Identities of all kinases tested and corresponding % inhibition data may be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div></div><div></div></div><div class="NLM_p">Other off-target activities of these compounds are summarized in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a>. In biochemical assays, all compounds other than <b>1</b> were much less potent against JAK3 than JAK1, while the differential between TYK2 and JAK1 inhibition was smaller. No cellular measure of JAK3 inhibition independent from JAK1 was available, however, cellular TYK2 inhibition was measured in the IL-12 pSTAT4 assay. There was a consistently larger cell shift between the biochemical and cell-based measures of TYK2 inhibition relative to JAK1, thus compounds exhibited greater cellular selectivity for JAK1 vs TYK2 than would be expected based on their biochemical potencies. hERG inhibition was not a concern for the majority of the compounds tested, with typical IC<sub>50</sub> values of >100 μM being observed in a functional patch clamp assay. The nitrile-containing analogues <b>31</b>, <b>33</b>, and <b>34</b> showed consistent, yet weak reversible inhibition of CYP3A4 using a midazolam probe (IC<sub>50</sub> = 6.7–8.8 μM), however, the remaining isoforms were not inhibited up to the highest concentration tested (10 μM). Finally, none of the compounds tested in Table <a class="ref showTableEvent internalNav" data-ID="tbl7" href="#tbl7">7</a> showed time dependent inhibition of any CYP isoform tested (3A4, 2C9, 2D6, 2C19, 1A2).</div><div class="NLM_table-wrap" id="tbl7"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 7. Other Off-Target Inhibition of Selected Analogues</div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="justify" /></col><col align="justify" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center">ex</th><th class="colsep0 rowsep0" align="center">JAK3 <i>K</i><sub>i</sub>(nM)<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center">TYK2 <i>K</i><sub>i</sub>(nM)<a class="ref internalNav" href="#t7fn1" aria-label="a">a</a></th><th class="colsep0 rowsep0" align="center" char=".">IL-12 pSTAT4 EC<sub>50</sub>(nM)<a class="ref internalNav" href="#t7fn2" aria-label="b">b</a></th><th class="colsep0 rowsep0" align="center" char=".">hERG IC<sub>50</sub>(μM)<a class="ref internalNav" href="#t7fn3" aria-label="c">c</a></th><th class="colsep0 rowsep0" align="center">reversible CYP<br /></br>(IC<sub>50</sub>, μM)<br /></br>3A4(mid)<a class="ref internalNav" href="#t7fn4" aria-label="d">d</a>,other<a class="ref internalNav" href="#t7fn5" aria-label="e">e</a></th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>1</b></td><td class="colsep0 rowsep0" align="justify">0.4</td><td class="colsep0 rowsep0" align="justify">7.3</td><td class="colsep0 rowsep0" align="char" char=".">710</td><td class="colsep0 rowsep0" align="char" char="."> </td><td class="colsep0 rowsep0" align="left"> </td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>21</b></td><td class="colsep0 rowsep0" align="justify">110</td><td class="colsep0 rowsep0" align="justify">31</td><td class="colsep0 rowsep0" align="char" char=".">>5800</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="left">>10, >10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>26</b></td><td class="colsep0 rowsep0" align="justify">76</td><td class="colsep0 rowsep0" align="justify">3.4</td><td class="colsep0 rowsep0" align="char" char=".">310</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="left">>10, >10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>29</b></td><td class="colsep0 rowsep0" align="justify">53</td><td class="colsep0 rowsep0" align="justify">20</td><td class="colsep0 rowsep0" align="char" char=".">2200</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="left">>10, >10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>31</b></td><td class="colsep0 rowsep0" align="justify">280</td><td class="colsep0 rowsep0" align="justify">12</td><td class="colsep0 rowsep0" align="char" char=".">5600</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="left">7.9, >10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>33</b></td><td class="colsep0 rowsep0" align="justify">5.9</td><td class="colsep0 rowsep0" align="justify">0.4</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">>100</td><td class="colsep0 rowsep0" align="left">8.8, >10</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>34</b></td><td class="colsep0 rowsep0" align="justify">7.8</td><td class="colsep0 rowsep0" align="justify">1.7</td><td class="colsep0 rowsep0" align="char" char=".">980</td><td class="colsep0 rowsep0" align="char" char=".">20</td><td class="colsep0 rowsep0" align="left">6.7, >10</td></tr></tbody></table></div><div class="NLM_table-wrap-foot" id="IDtable-wrap-foot-t7fn1"><div class="footnote" id="t7fn1"><sup>a</sup><p class="last">Arithmetic mean of at least three separate runs (<i>n</i> ≥ 3). The average coefficient of variation was less than 0.3 times the mean for biochemical assays.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The biochemical JAK3 and TYK2 <i>K</i><sub>i</sub> values of the remaining compounds in this work are reported in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="footnote" id="t7fn2"><sup>b</sup><p class="last">TYK2 cell-based assay.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> The average coefficient of variation was less than 0.5 times the mean for cell-based assays.</p></div><div class="footnote" id="t7fn3"><sup>c</sup><p class="last">Patch clamp assay conducted by ChanTest.</p></div><div class="footnote" id="t7fn4"><sup>d</sup><p class="last">Reversible CYP3A4 inhibition measured in HLMs with midazolam as LCMS/MS probe.</p></div><div class="footnote" id="t7fn5"><sup>e</sup><p class="last">Other CYP isoforms tested (LCMS/MS probe used): 3A4 (testosterone), 2C9 (warfarin), 2D6 (dextromethorphan), 2C19 (mephenytoin), 1A2 (phenacetin).</p></div></div></div><div class="NLM_p">Because of multiple favorable features including high selectivity for JAK1 over the other JAK family members and the broader kinome, potent inhibition of cell-based JAK1 activity in human whole blood, high aqueous solubility, and consistent cross-species preclinical PK comparing favorably with <b>1</b>, compound <b>31</b> was further progressed to a collagen induced arthritis (CIA) efficacy study in the rat. As shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>a, compound <b>31</b> exhibited approximately dose proportional increases in plasma exposure when dosed orally in rats over a range of 20–500 mg/kg. These oral exposures were also close to dose proportional with the low dose rat PK study (2 mg/kg PO, Table <a class="ref showTableEvent internalNav" data-ID="tbl5" href="#tbl5">5</a>). The oral exposures reported in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>a did not change appreciably between day 10 of the CIA efficacy study, when the first daily dose of <b>31</b> was administered, and day 20 of the study, when the eleventh and final daily dose of <b>31</b> was delivered.</div><figure id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/medium/jm-2013-004895_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0006.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) Rat plasma exposures of <b>31</b> on days 10 and 20 of the CIA efficacy study.<sup><i>a</i></sup> (b) Mean ankle thicknesses of rats either treated or not treated with <b>31</b> in the CIA efficacy study.<sup><i>a</i></sup> Superscript letter indicates the following: (<i>a</i>) <b>31</b> was formulated in corn oil and dosed orally once daily at the indicated doses for 11 days. The first and last doses of <b>31</b> were administered on study days 10 and 20, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4004895&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">The results from the CIA efficacy model are shown in Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>b. Collagen-immunized animals receiving only the corn oil vehicle exhibited marked increases in ankle thicknesses due to arthritic disease (gray line), while robust suppression of inflammation was observed even in the group treated with the lowest dose of <b>31</b> (20 mg/kg). The mid-dose of <b>31</b> (100 mg/kg) fully suppressed inflammation and maintained ankle thicknesses equivalent to those of naïve animals untreated with collagen. Full suppression of inflammation was likewise observed in the high dose group (500 mg/kg of <b>31</b>). Given its selectivity profile against the JAK family and the broader kinome, it is likely that the robust CIA efficacy demonstrated by <b>31</b> is driven predominantly by JAK1 inhibition. As such, these CIA results appear to support the hypothesis that selective JAK1 inhibitors could provide treatments for patients suffering from rheumatoid arthritis and other immunologic disorders.</div></div><div id="sec3" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i10">Chemistry</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43241" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43241" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">The preparation of analogues <b>5</b>–<b>13</b> commenced with synthesis of dianiline intermediate <b>38</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>).<a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">(21)</a> S<sub>N</sub>Ar displacement of the activated aryl chloride <b>35</b><a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> by cyclohexylamine <b>36</b>, followed by reduction of the resulting aryl nitro <b>37</b>, produced dianiline <b>38</b>.</div><figure id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/medium/jm-2013-004895_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0007.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of Dianiline Intermediate <b>38</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4004895&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) DIPEA, <i>i</i>-PrOH, 80 °C; (ii) H<sub>2</sub>, Pd/C, EtOH, THF, 50 °C.</p></p></figure><div class="NLM_p">As shown in Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>, dianiline <b>38</b> was cyclized under multiple conditions to form various <i>C</i>-2 substituted imidazoles. Treatment of the dianiline <b>38</b> with the imidate formed by the action of Meerwein’s reagent<a onclick="showRef(event, 'ref22'); return false;" href="javascript:void(0);" class="ref ref22">(22)</a> on 2-hydroxyacetamide produced the primary alcohol <b>5a</b>.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> Coupling of <b>38</b> to ethyl 3-chloro-3-oxopropanoate, followed by dehydrative cyclization, yielded the ethyl ester-substituted imidazole <b>6a</b>, which was further reduced with sodium borohydride to produce homologated alcohol <b>6b</b>. Enantiopure secondary alcohols <b>7a</b> and <b>8a</b> were accessed by engaging <b>38</b> with the imidates derived from (<i>R</i>)-(+)-lactamide or (<i>S</i>)-(−)-lactamide, respectively. Oxidation of the secondary alcohol <b>7a</b> and reaction of the resulting ketone (<b>9a</b>) with methylmagnesium bromide afforded tertiary alcohol <b>9b</b>. Removal of the phenylsulfonyl protecting groups present in <b>5a</b>, <b>6b</b>, <b>7a</b>, <b>8a</b>, and <b>9b</b> under basic hydrolysis conditions afforded the corresponding final products <b>5</b>–<b>9</b>. Treatment of dianiline <b>38</b> with triethyl orthoformate led to <i>C</i>-2 unsubsituted imidazole <b>39</b>, which could be selectively deprotonated with (tmp)<sub>2</sub>Mg·2LiCl<a onclick="showRef(event, 'ref24'); return false;" href="javascript:void(0);" class="ref ref24">(24)</a> and trapped by either propionaldehyde or 2-(benzyloxy)acetaldehyde to provide racemic secondary alcohols <b>10a</b> and <b>12a</b>, respectively. Removal of the phenylsulfonamide protecting groups afforded free azaindoles <b>10b</b> and <b>12b</b>, which were further separated into their corresponding enantiopure components (<b>10b</b> → <b>10</b> + <b>11</b>, <b>12b</b> → <b>12c</b> + <b>13c</b>) via chiral preparative SFC. Removal of the benzyl groups present in <b>12c</b> and <b>13c</b> under standard conditions afforded diols <b>12</b> and <b>13</b>.</div><figure id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/medium/jm-2013-004895_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0008.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of <i>C</i>-2 Hydroxyl Substituted Imidazopyrrolopyridine Analogues <b>5</b>–<b>13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4004895&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 2-hydroxyacetamide, Et<sub>3</sub>(O<sup>+</sup>)BF<sub>4</sub><sup>–</sup>, THF,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> EtOH, 25–70 °C; (ii) NaOH, H<sub>2</sub>O, EtOH or EtOH/THF, 25–50 °C; (iii) TEA, ethyl 3-chloro-3-oxopropanoate, DCM, 25 °C, then AcOH, reflux; (iv) NaBH<sub>4</sub>, EtOH, 50 °C; (v) (<i>R</i>)-(+)-lactamide, Et<sub>3</sub>(O<sup>+</sup>)BF<sub>4</sub><sup>–</sup>, THF, EtOH, 25–70 °C; (vi) (<i>S</i>)-(−)-lactamide, Et<sub>3</sub>(O<sup>+</sup>)BF<sub>4</sub><sup>–</sup>, THF,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> EtOH, 25–70 °C; (vii) Dess–Martin periodinane, DCM, 25 °C; (viii) MeMgBr, THF, −10 to 25 °C; (ix) triethyl orthoformate, 82 °C; (x) (tmp)<sub>2</sub>Mg·2LiCl, propionaldehyde, THF, 0–25 °C; (xi) preparative chiral SFC; (xii) (tmp)<sub>2</sub>Mg·2LiCl, 2-(benzyloxy)acetaldehyde, THF, 0–25 °C; (xiii) Pd(OH)<sub>2</sub>/C, MeOH, EtOH, H<sub>2</sub>, 50 psi, 25 °C.</p></p></figure><div class="NLM_p">As shown in Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>, the aryl chloride present in <b>35</b> was similarly displaced with additional amines<a onclick="showRef(event, 'ref25'); return false;" href="javascript:void(0);" class="ref ref25">(25)</a><b>14a</b>–<b>17a</b>, <b>19a</b>–<b>24a</b>, <b>26a</b>, and <b>28a</b>–<b>34a</b>, then the nitro groups in the resulting products were reduced to the corresponding anilines to provide the <b>c</b> series of dianiline intermediates. Reaction of the dianilines with the imidate derived from (<i>R</i>)-(+)-lactamide provided the <b>d</b> series of (<i>R</i>)-alcohols. The phenylsulfonamide moieties present in <b>15d</b>, <b>16d</b>, <b>19d</b>–<b>24d</b>, and <b>31d</b>–<b>34d</b> were removed under hydrolytic conditions to provide final products <b>15</b>, <b>16</b>, <b>19</b>–<b>24</b>, and <b>31</b>–<b>34</b>, whereas intermediates <b>14d</b>, <b>17d</b>, <b>26d</b>, and <b>28d</b>–<b>30d</b> were further manipulated as described in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>.</div><figure id="sch3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/medium/jm-2013-004895_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0009.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of <i>C</i>-2 (<i>R</i>)-Hydroxyethyl Imidazopyrrolopyridine Analogues <b>15</b>, <b>16</b>, <b>19</b>–<b>24</b>, and <b>31</b>–<b>34</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4004895&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) DIPEA, <i>i</i>-PrOH, 75–83 °C; (ii) H<sub>2</sub>, Pd/C, EtOH or EtOH/THF or EtOAc, 23–50 °C; (ii′) Fe, NH<sub>4</sub>Cl, EtOH, H<sub>2</sub>O, reflux; (iii) (<i>R</i>)-(+)-lactamide, Et<sub>3</sub>(O<sup>+</sup>)BF<sub>4</sub><sup>–</sup>, THF,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> EtOH, 23–70 °C; (iv) NaOH, H<sub>2</sub>O, EtOH or EtOH/THF or MeOH/THF, 25–60 °C. (b) 4-Piperidine diastereomers separated by preparative chiral SFC. (c) Racemic mixture. (d) Diastereomeric mixture of 4-piperidine epimers.</p></p></figure><figure id="sch4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/medium/jm-2013-004895_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0010.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of <i>C</i>-2 (<i>R</i>)-Hydroxyethyl Imidazopyrrolopyridine Analogues <b>14</b>, <b>17</b>, <b>18</b>, and <b>26</b>–<b>30</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4004895&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) HCl/1,4-dioxane or TFA/H<sub>2</sub>O, 23 °C; (ii) 2,2,2-trifluoroethyl trifluoromethanesulfonate, TEA, DCM, DMF, 23 °C; (iii) NaOH, H<sub>2</sub>O, EtOH or EtOH/THF or MeOH/THF, 25–60 °C; (iv) EDC, 4-DMAP, DIPEA, 2-cyanoacetic acid (for <b>17</b>) or 3,3,3-trifluoropropanoic acid (for <b>18</b>), 23 °C; (v) 2,2,-difluoroethyl trifluoromethanesulfonate, TEA, DCM, DMF, 23 °C.</p></p></figure><div class="NLM_p last">As illustrated in Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>, the Boc groups of <b>14d</b>, <b>17d</b>, <b>26d</b>, and <b>28d</b>–<b>30d</b> were removed to liberate the corresponding free amino groups (<b>e</b> series of intermediates). Alkylation or acylation of the exposed amines and phenylsulfonamide hydrolysis delivered final compounds <b>14</b>, <b>17</b>, <b>18</b>, and <b>26</b>–<b>30</b>.</div></div><div id="sec4" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i15">Conclusion</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_04772" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_04772" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p last">Structure-based design targeting a key residue difference between JAK1 (E966) and JAK2 (D939) was employed to identify a <i>C</i>-2 (<i>R</i>)-hydroxyethyl group imparting consistent JAK1 selectivity to the imidazopyrrolopyridine series. X-ray structures of the highly selective inhibitor <b>31</b> in complex with both JAK1 and JAK2 (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>a,b) showed the <i>C</i>-2 (<i>R</i>)-hydroxyethyl group participating in differential interactions with the E966 and D939 residues and offered an explanation for the observed selectivity. Although early analogues (such as <b>8</b>) exhibited excellent potency in low serum measures of cell-based JAK1 inhibition (IL-6 pSTAT3 assay), a large shift in potency was observed in human whole blood. Analysis of historical data generated in the <i>C</i>-2 H<sup>9</sup> and methyl<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> imidazopyrrolopyridine series indicated that maintaining cLogD<sub>7.4</sub> <2 was important to minimizing whole blood shift. Additional analysis of the historical data provided further correlations of calculated physicochemical properties with acceptable membrane permeability and HLM stability. These analyses were used to formulate a set of physicochemical design parameters (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>) that were employed to optimize the highly JAK1 selective <i>C</i>-2 (<i>R</i>)-hydroxyethyl imidazopyrrolopyridine series. Multiple compounds with favorable features including excellent JAK1 vs JAK2 selectivity, potent cellular JAK1 inhibition in human whole blood, and promising oral pharmacokinetic parameters across multiple preclinical species were, thereby, identified (e.g., <b>21</b>, <b>26</b>, <b>29</b>, <b>31</b>). These compounds were found to show good levels of JAK family selectivity relative to the broader kinome, with <b>29</b> and <b>31</b> being particularly discriminating (Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a>). Finally, compound <b>31</b> was found to be highly efficacious in a rat CIA efficacy model (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>), supporting the hypothesis that selective JAK1 inhibition may be a viable method to treat RA and other immunologic disorders.</div></div><div id="sec5" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i16">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_67015" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_67015" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec5_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i17" class="anchor-spacer"></div><h3 class="article-section__title" id="_i17"> General</h3><div class="NLM_p last">Unless otherwise indicated, all reagents and solvents were purchased from commercial sources and used without further purification. Moisture or oxygen sensitive reactions were conducted under an atmosphere of argon or nitrogen gas. Unless otherwise stated, <sup>1</sup>H NMR spectra were recorded at 298–300 K using Varian Unity Inova or Bruker Avance DRX400 instruments operating at the indicated frequencies. Chemical shifts are expressed in ppm relative to an internal standard; tetramethylsilane (ppm = 0.00). The following abbreviations are used: br = broad signal, s = singlet, d = doublet, dd = doublet of doublets, t = triplet, q = quartet, m = multiplet. Purification by silica gel chromatography was carried out using either hand-packed glass columns or CombiFlash by Teledyne Isco systems with prepacked cartridges. Some basic compounds were purified by capture on SCX (strong cation exchange) sulfonic acid cartridges, followed by elution with methanolic ammonia. Chemical purities were >95% for all final compounds as assessed by LCMS. Further details on the LCMS conditions used for individual compounds may be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</div></div><div id="sec5_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i18" class="anchor-spacer"></div><h3 class="article-section__title" id="_i18"> Cyclohexyl-6-(phenylsulfonyl)-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)methanol (<b>5a</b>)</h3><div class="NLM_p last">Triethyloxonium tetrafluoroborate (3.81 g, 201 mmol) was added to a solution of 2-hydroxyacetamide (1.51 g, 201 mmol) in THF (100 mL) at 25 °C.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The reaction mixture was stirred at 25 °C for 2 h. After concentrating under vacuum, the resulting oil was dissolved in EtOH (50 mL), then added to a mixture of <b>38</b><a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> (2.92 g, 78.8 mmol) in EtOH (100 mL) and stirred at 75 °C for 80 min. The reaction mixture was cooled to 25 °C and allowed to stand for 2 h. The resulting precipitate was collected by filtration and purified by column chromatography on silica gel, eluting with EtOAc/heptane to afford 2.93 g (91%) of the title compound as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.67 (s, 1H), 8.14 (d, <i>J</i> = 8.0 Hz, 2H), 7.98 (s, 1H), 7.72–7.68 (m, 1H), 7.65–7.57 (m, 2H), 7.12 (s, 1H), 5.74–5.68 (m, 1H), 4.82–4.77 (m, 2H), 4.74–4.64 (m, 1H), 2.19–2.07 (m, 2H), 1.96–1.88 (m, 4H), 1.79–1.74 (m, 1H), 1.56–1.44 (m, 3H).</div></div><div id="sec5_3" class="NLM_sec NLM_sec_level_2"><div id="ac_i19" class="anchor-spacer"></div><h3 class="article-section__title" id="_i19"> (1-Cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)methanol (<b>5</b>)</h3><div class="NLM_p last">First, 1.0 mL of a 1 N aqueous solution of NaOH was added to a mixture of <b>5a</b> (224 mg, 0.54 mmol) in EtOH and THF (5 mL each). The reaction mixture was stirred at 50 °C for 1 h, then was cooled to 25 °C and poured into 100 mL of a half saturated aqueous solution of NaHCO<sub>3</sub>. The aqueous layer was extracted with EtOAc (2 × 100 mL), then the combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated under vacuum. The resulting solid was triturated with diethyl ether (2 × 15 mL), then dried under vacuum to afford the title product as an off-white solid (26.2 mg, 18%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.83 (s, 1H), 8.53 (s, 1H), 7.47 (s, 1H), 6.74 (s, 1H), 5.67 (s, 1H), 4.78 (d, <i>J</i> = 4.4 Hz, 2H), 4.75–4.61 (m, 1H), 2.39–2.20 (m, 2H), 2.02–1.87 (m, 4H), 1.86–1.74 (m, 1H), 1.62–1.37 (m, 3H). LCMS (method LCMS1, ESI): RT = 5.81 min, <i>m</i>/<i>z</i> = 271.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_4" class="NLM_sec NLM_sec_level_2"><div id="ac_i20" class="anchor-spacer"></div><h3 class="article-section__title" id="_i20"> Ethyl 2-(1-Cyclohexyl-6-(phenylsulfonyl)-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)acetate (<b>6a</b>)</h3><div class="NLM_p last">TEA (450 mg, 2.97 mmol) and ethyl 3-chloro-3-oxopropanoate (327 mg, 3.24 mmol) were added to a solution of <b>38</b><a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> (1.0 g, 2.7 mmol) in DCM (15 mL). The reaction mixture was stirred at 25 °C for 1 h, then concentrated under vacuum. Acetic acid (10 mL) was added to the residue, and the mixture was heated at reflux for 16 h. The reaction mixture was then cooled to 25 °C and concentrated under vacuum. The residue was purified by column chromatography on silica gel, eluting with EtOAc/heptane to afford 210 mg (16%) of the title compound as a yellow solid. This material was used in the next step without further purification or characterization.</div></div><div id="sec5_5" class="NLM_sec NLM_sec_level_2"><div id="ac_i21" class="anchor-spacer"></div><h3 class="article-section__title" id="_i21"> 2-(1-Cyclohexyl-6-(phenylsulfonyl)-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethanol (<b>6b</b>)</h3><div class="NLM_p last">Sodium borohydride was added to a solution of <b>6a</b> (210 mg, 0.45 mmol) in EtOH (5 mL). The reaction mixture was stirred at 50 °C for 30 min, then cooled to 25 °C and concentrated under vacuum. The residue was purified by column chromatography on silica gel, eluting with EtOAc/heptane to give the title compound (151 mg, 79%) as a gray solid. LCMS (method LCMS2, ESI): RT = 1.37 min, <i>m</i>/<i>z</i> = 425.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_6" class="NLM_sec NLM_sec_level_2"><div id="ac_i22" class="anchor-spacer"></div><h3 class="article-section__title" id="_i22"> 2-(1-Cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethanol (<b>6</b>)</h3><div class="NLM_p last">Sodium hydroxide (8 mL of a 2 N aqueous solution) was added to a solution of <b>6b</b> (151 mg, 0.35 mmol) in EtOH (4 mL). The reaction mixture was stirred at 25 °C for 16 h, then adjusted to pH ∼7 with HCl (2 N aqueous solution) and extracted with EtOAc (2 × 30 mL). The combined organic extracts were washed with water and brine (10 mL each), dried over MgSO<sub>4</sub>, filtered, and concentrated. The residue was purified by column chromatography on silica gel, eluting with EtOAc/heptane to give the title compound (42 mg, 39%) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.80 (s, 1H), 8.49 (s, 1H), 7.46 (s, 1H), 6.72 (s, 1H), 4.88 (t, <i>J</i> = 5.2 Hz, 1H), 4.56–4.43 (m, 1H), 3.87–3.81 (br, 2H), 3.13 (t, <i>J</i> = 6.7 Hz, 2H), 2.36–2.24 (m, 2H), 2.03–1.83 (m, 4H), 1.81–1.76 (m, 1H), 1.64–1.39 (m, 3H). LCMS (method LCMS3, ESI): RT = 3.17 min, <i>m</i>/<i>z</i> = 285.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_7" class="NLM_sec NLM_sec_level_2"><div id="ac_i23" class="anchor-spacer"></div><h3 class="article-section__title" id="_i23"> (<i>S</i>)-1-(1-Cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethanol (<b>7</b>)</h3><div class="NLM_p last">Synthesized by methods similar to those used for <b>8</b>, substituting (<i>S</i>)-(−)-lactamide for (<i>R</i>)-(+)-lactamide. Analytical chiral SFC (method SFC1): RT = 0.57 min. <sup>1</sup>H NMR and LCMS match <b>8</b>.</div></div><div id="sec5_8" class="NLM_sec NLM_sec_level_2"><div id="ac_i24" class="anchor-spacer"></div><h3 class="article-section__title" id="_i24"> (<i>R</i>)-1-(1-Cyclohexyl-6-(phenylsulfonyl)-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethanol (<b>8a</b>)</h3><div class="NLM_p last">Triethyloxonium tetrafluoroborate (0.569 g, 3.00 mmol) was added to a solution of (<i>R</i>)-(+)-lactamide (267 mg, 3.00 mmol) in THF (25 mL) at 25 °C.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The resulting suspension was stirred at 25 °C for 2 h, then was concentrated under reduced pressure to afford an oil. This material was dissolved in EtOH (10 mL), and the resulting solution was added to to a solution of <b>38</b><a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> (370 mg, 1.00 mmol) in EtOH (4 mL) at 25 °C. The reaction mixture was heated at 75 °C for 1 h, then was cooled to 25 °C and was partitioned between half-saturated aqueous NaHCO<sub>3</sub> (100 mL) and EtOAc (2 × 100 mL). The organic layers were dried over MgSO<sub>4</sub> and filtered, and the filtrate was concentrated under vacuum. Purification of the resulting solid by column chromatography on silica gel (gradient: 0–8% CH<sub>3</sub>OH in DCM) afforded the title compound (202 mg, 95%) as a gray solid. LCMS (method LCMS4, ESI): RT = 0.99 min, <i>m</i>/<i>z</i> = 425.3 [M + H]<sup>+</sup>.</div></div><div id="sec5_9" class="NLM_sec NLM_sec_level_2"><div id="ac_i25" class="anchor-spacer"></div><h3 class="article-section__title" id="_i25"> (<i>R</i>)-1-(1-Cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethanol (<b>8</b>)</h3><div class="NLM_p last">Sodium hydroxide (1 mL of a 1 N aqueous solution) was added to a solution of <b>8a</b> (203 mg, 0.48 mmol) in a 1:1 mixture of THF and EtOH (10 mL) at 25 °C. The reaction mixture was stirred at 50 °C for 1 h, then was cooled to 25 °C and was partitioned between half-saturated aqueous NaHCO<sub>3</sub> (100 mL) and EtOAc (2 × 125 mL). The combined organic layers were dried over MgSO<sub>4</sub> and filtered, and the filtrate was concentrated under reduced pressure. Purification of the residue by preparative HPLC (column: Gemini-NX, 5 cm × 10 cm, 10 μm; detection:, UV 254 nm; mobile phase A, water with 0.1% NH<sub>4</sub>OH; mobile phase B, CH<sub>3</sub>CN; flow rate, 120 mL/min; gradient 5–95% B over 15 min) afforded the title compound (46 mg, 34%) as an off-white solid. Analytical chiral SFC (method SFC1): RT = 0.54 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.84 (s, 1H), 8.55 (s, 1H), 7.47 (s, 1H), 6.74 (s, 1H), 5.66 (d, <i>J</i> = 6.5 Hz, 1H), 5.12 (p, <i>J</i> = 6.4 Hz, 1H), 4.91–4.76 (m, 1H), 2.41–2.22 (m, 2H), 2.02–1.84 (m, 4H), 1.80 (s, 1H), 1.64 (d, <i>J</i> = 6.4 Hz, 3H), 1.58–1.42 (m, 3H). LCMS (method LCMS5, ESI): RT = 6.56 min, <i>m</i>/<i>z</i> = 285.3 [M + H]<sup>+</sup>.</div></div><div id="sec5_10" class="NLM_sec NLM_sec_level_2"><div id="ac_i26" class="anchor-spacer"></div><h3 class="article-section__title" id="_i26"> 1-(1-Cyclohexyl-6-(phenylsulfonyl)-1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethanone (<b>9a</b>)</h3><div class="NLM_p last">Dess–Martin periodinane (1.2 g, 2.8 mmol) was added to a solution of <b>7a</b> (300 mg, 0.71 mmol) in DCM (5 mL). The reaction mixture was stirred for 30 min at 25 °C, then diluted with an additional 50 mL of DCM. The organic layer was washed with saturated aqueous NaHCO<sub>3</sub> solution, dried over MgSO<sub>4</sub>, and concentrated under vacuum to give the title compound (199 mg, 66%) as an off-white solid.</div></div><div id="sec5_11" class="NLM_sec NLM_sec_level_2"><div id="ac_i27" class="anchor-spacer"></div><h3 class="article-section__title" id="_i27"> 2-(1-Cyclohexyl-6-(phenylsulfonyl)-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)propan-2-ol (<b>9b</b>)</h3><div class="NLM_p last">To a solution of compound <b>9a</b> (198 mg, 0.47 mmol) in THF (5 mL) was added methylmagnesium bromide (1 mL of 1.0 M solution in dibutyl ether) at −10 °C. The reaction mixture was warmed to 25 °C and stirred at that temperature for 30 min. Water (10 mL) was added, and the mixture was extracted with EtOAc (2 × 10 mL). The combined extracts were washed with water and brine (10 mL each), dried over MgSO<sub>4</sub>, and concentrated under vacuum. The residue was purified by column chromatography on silica gel, eluting with EtOAc/heptane to afford 200 mg (97%) of the title compound as a gray solid. LCMS (method LCMS2, ESI): RT = 1.43 min, <i>m</i>/<i>z</i> = 439.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_12" class="NLM_sec NLM_sec_level_2"><div id="ac_i28" class="anchor-spacer"></div><h3 class="article-section__title" id="_i28"> 2-(1-Cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)propan-2-ol (<b>9</b>)</h3><div class="NLM_p last">NaOH (2 N aqueous solution, 10 mL) was added to a solution of <b>9b</b> (200 mg, 0.46 mmol) in EtOH (5 mL). The reaction mixture was stirred at 25 °C for 16 h, then the pH was adjusted to ∼7 with 2 N aqueous HCl solution. The mixture was extracted with EtOAc (2 × 15 mL). The combined organic layers were washed with water and brine (10 mL each), dried over MgSO<sub>4</sub>, filtered, and concentrated under vacuum. The residue was purified by column chromatography on silica gel, eluting with EtOAc/heptane to afford 90 mg of the title compound as a white solid (69%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.83 (s, 1H), 8.53 (s, 1H), 7.47 (s, 1H), 6.74 (s, 1H), 5.74 (s, 1H), 5.43 (t, <i>J</i> = 12.3 Hz, 1H), 2.50 (s, 6H), 2.37 (dd, <i>J</i> = 23.4, 11.2 Hz, 2H), 2.04–1.85 (m, 4H), 1.84–1.76 (m, 1H), 1.57–1.37 (m, 3H). LCMS (method LCMS3, ESI): RT = 3.47 min, <i>m</i>/<i>z</i> = 299.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_13" class="NLM_sec NLM_sec_level_2"><div id="ac_i29" class="anchor-spacer"></div><h3 class="article-section__title" id="_i29"> 1-Cyclohexyl-6-(phenylsulfonyl)-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridine (<b>39</b>)</h3><div class="NLM_p last">A suspension of <b>38</b><a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> (7.80 g, 21.1 mmol) in triethyl orthoformate (48 mL) was heated at 82 °C for 16 h. The reaction mixture was cooled to 25 °C and concentrated under vacuum. The residue was purified by column chromatography on silica gel, eluting with EtOAc/heptane to afford 5.34 g (68%) of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.72 (s, 1H), 8.46 (s, 1H), 8.15–8.10 (m, 2H), 7.97 (d, <i>J</i> = 4.0 Hz, 1H), 7.73–7.66 (m, 1H), 7.64–7.55 (m, 2H), 7.18 (d, <i>J</i> = 4.0 Hz, 1H), 4.64–4.49 (m, 1H), 2.15–2.03 (m, 2H), 1.91–1.68 (m, 5H), 1.67–1.51 (m, 2H), 1.36–1.21 (m, 1H). LCMS (method LCMS6, ESI): RT = 2.27 min, <i>m</i>/<i>z</i> = 381.3 [M + H]<sup>+</sup>.</div></div><div id="sec5_14" class="NLM_sec NLM_sec_level_2"><div id="ac_i30" class="anchor-spacer"></div><h3 class="article-section__title" id="_i30"> (±)-1-(1-Cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)propan-1-ol (<b>10b</b>)</h3><div class="NLM_p last">2,2,6,6-Tetramethylpiperidinemagnesium chloride lithium chloride complex (1 M solution in THF, 677 μL) was added to a solution of <b>39</b> (200 mg, 0.50 mmol) in THF (4 mL) at 0 °C. After stirring for 5 min at 0 °C, the reaction mixture was removed from the ice bath and stirred for 1 h at 25 °C. The reaction mixture was then added to a stirred solution of propionaldehyde (97 μL, 1.35 mmol) in THF (1 mL) and left to stir for 16 h. EtOH (5 mL) and sodium hydroxide (1 N aqueous solution, 5 mL) were then added, and the reaction mixture was stirred at 50 °C for 2 h. The reaction mixture was concentrated under vacuum and purified by column chromatography eluting with EtOAc/heptane to afford the racemic title compound (<b>10b</b>) as a white solid (18.1 mg, 12%).</div></div><div id="sec5_15" class="NLM_sec NLM_sec_level_2"><div id="ac_i31" class="anchor-spacer"></div><h3 class="article-section__title" id="_i31"> (<i>S</i>)-1-(1-Cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)propan-1-ol (<b>10</b>) and (<i>R</i>)-1-(1-Cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)propan-1-ol (<b>11</b>)</h3><div class="NLM_p last"><b>10b</b> was separated into its individual enantiomers by preparative chiral SFC (Lux Cellulose-1 column, 21.2 mm × 150 mm, 5 μm; detection, UV 220 nm; mobile phase A, CO<sub>2</sub>; mobile phase B, MeOH containing 0.1% NH<sub>4</sub>OH; flow rate, 70 mL/min; gradient, isocratic; A:B = 80:20). Isolation and concentration of the appropriate fractions afforded two products with the following characteristics. <b>10</b>: white solid. Analytical chiral SFC (method SFC2): RT = 0.48 min. <sup>1</sup>H NMR and LCMS match <b>11</b>. <b>11</b>: white solid. Analytical chiral SFC (method SFC2) RT = 0.45 min. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.85 (s, 1H), 8.54 (s, 1H), 7.47 (t, <i>J</i> = 3.0 Hz, 1H), 6.73 (s, 1H), 5.73–5.66 (m, 1H), 4.98–4.63 (m, 2H), 2.38–2.26 (m, 2H), 2.07–2.00 (m, 1H), 2.00–1.92 (m, 3H), 1.88 (d, <i>J</i> = 11.2 Hz, 2H), 1.83–1.78 (m, 1H), 1.56–1.43 (m, 3H), 0.98 (t, <i>J</i> = 7.4 Hz, 3H). LCMS (method LCMS3, ESI): RT = 3.46 min, <i>m</i>/<i>z</i> = 299.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_16" class="NLM_sec NLM_sec_level_2"><div id="ac_i32" class="anchor-spacer"></div><h3 class="article-section__title" id="_i32"> (±)-2-(Benzyloxy)-1-(1-cyclohexyl-6-(phenylsulfonyl)-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethanol (<b>12a</b>)</h3><div class="NLM_p last">A 1 M solution of 2,2,6,6-tetramethylpiperidinemagnesium chloride lithium chloride complex in THF (16.8 mL, 16.8 mmol) was added to a solution of <b>39</b> (5.34 g, 14.0 mmol) in anhydrous THF (100 mL) at 0 °C. The reaction mixture was stirred for 1 h at 0 °C, then added to a solution of 2-(benzyloxy)acetaldehyde (3.95 mL, 28.1 mmol) in THF (35 mL) at 0 °C. The mixture was stirred for 1 h at 0 °C, then slowly warmed to 25 °C. Stirring was continued for an additional 14 h, then a saturated aqueous solution of NH<sub>4</sub>Cl (50 mL) was added. The mixture was extracted with EtOAc (3 × 75 mL), then the combined organic layers were dried over MgSO<sub>4</sub>, filtered, and concentrated under vacuum. The residue was purified by column chromatography eluting with EtOAc/heptane to afford 6.56 g (88%) of the title compound as a foamy off-white solid. LCMS (method LCMS6, ESI): RT = 2.71 min, <i>m</i>/<i>z</i> = 531.3 [M + H]<sup>+</sup>.</div></div><div id="sec5_17" class="NLM_sec NLM_sec_level_2"><div id="ac_i33" class="anchor-spacer"></div><h3 class="article-section__title" id="_i33"> (±)-2-(Benzyloxy)-1-(1-cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethanol (<b>12b</b>)</h3><div class="NLM_p last">To a solution of <b>12a</b> (6.56 g, 12.4 mmol) in EtOH (50 mL) was added a 1 M solution of aqueous sodium hydroxide (24.7 mL, 24.7 mmol). The reaction mixture was stirred at 23 °C for 16 h, then a 1 M aqueous solution of HCl (25 mL) was added. The mixture was concentrated to dryness under vacuum, then an additional 100 mL of EtOH was added. The mixture was filtered, then the filtrate was concentrated under vacuum to afford the crude title product as an off-white solid.</div></div><div id="sec5_18" class="NLM_sec NLM_sec_level_2"><div id="ac_i34" class="anchor-spacer"></div><h3 class="article-section__title" id="_i34"> (<i>R</i>)-2-(Benzyloxy)-1-(1-cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethanol (<b>12c</b>) and (<i>S</i>)-2-(Benzyloxy)-1-(1-cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethanol (<b>13c</b>)</h3><div class="NLM_p last">The crude residue obtained in the previous step was purified and separated into its individual enantiomers by preparative chiral SFC (column: Lux Cellulose-1, 3 cm × 25 cm, 5 μm; detection, UV 220 nm; mobile phase A, CO<sub>2</sub>; mobile phase B, MeOH containing 0.1% dimethylamine; flow rate, 200 mL/min; gradient, isocratic; A:B = 70:30). First-eluting peak (<b>13c</b>): off-white solid (2.12 g, 44%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.82 (s, 1H), 8.53 (s, 1H), 7.46 (t, <i>J</i> = 2.9 Hz, 1H), 7.38–7.25 (m, 5H), 6.73 (s, 1H), 5.92 (d, <i>J</i> = 6.6 Hz, 1H), 5.17 (q, <i>J</i> = 6.3 Hz, 1H), 4.91–4.69 (m, 1H), 4.61 (s, 2H), 4.05 (dd, <i>J</i> = 10.1, 4.6 Hz, 1H), 3.93 (dd, <i>J</i> = 10.1, 7.4 Hz, 1H), 2.39–2.21 (m, 2H), 1.98–1.74 (m, 5H), 1.59–1.38 (m, 3H). LCMS (method LCMS5, ESI): RT = 10.7 min, <i>m</i>/<i>z</i> = 391.1 [M + H]<sup>+</sup>. Second-eluting peak (<b>12c</b>): off-white solid (1.53 g, 32%). <sup>1</sup>H NMR and LCMS match <b>13c</b>.</div></div><div id="sec5_19" class="NLM_sec NLM_sec_level_2"><div id="ac_i35" class="anchor-spacer"></div><h3 class="article-section__title" id="_i35"> (<i>R</i>)-1-(1-Cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethane-1,2-diol (<b>12</b>)</h3><div class="NLM_p last"><b>12c</b> was converted to <b>12</b> by the same method used to convert <b>13c</b> to <b>13</b>. The <sup>1</sup>H NMR and LCMS of <b>12</b> match those of <b>13</b>.</div></div><div id="sec5_20" class="NLM_sec NLM_sec_level_2"><div id="ac_i36" class="anchor-spacer"></div><h3 class="article-section__title" id="_i36"> (<i>S</i>)-1-(1-Cyclohexyl-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethane-1,2-diol (<b>13</b>)</h3><div class="NLM_p last">To a solution of <b>13c</b> (2.1 g, 5.3 mmol) in a 1:1 mixture of MeOH:EtOH (50 mL) was added 20% palladium hydroxide on carbon (371 mg). The reaction mixture was pressurized to 50 psi with hydrogen gas, then shaken on a Parr apparatus for 48 h. The reaction mixture was filtered through Celite, then the filtrate was concentrated under vacuum. The residue was purified by reverse phase HPLC (Gemini-NX column, 30 mm × 100 mm, 5 μm; detection, UV 230 nm; mobile phase A, water with 0.1% NH<sub>4</sub>OH; mobile phase B, CH<sub>3</sub>CN; flow rate, 60 mL/min; gradient 5–50% B over 10 min) to afford 253 mg (17%) the title product as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.82 (s, 1H), 8.54 (s, 1H), 7.46 (t, <i>J</i> = 3.0 Hz, 1H), 6.74 (dd, <i>J</i> = 3.5, 1.9 Hz, 1H), 5.76 (d, <i>J</i> = 6.4 Hz, 1H), 4.94 (q, <i>J</i> = 6.2 Hz, 1H), 4.82 (t, <i>J</i> = 6.0 Hz, 2H), 3.99–3.91 (m, 1H), 3.89–3.82 (m, 1H), 2.41–2.19 (m, 2H), 2.02–1.68 (m, 5H), 1.60–1.39 (m, 3H). LCMS (method LCMS5, ESI): RT = 10.7 min, <i>m</i>/<i>z</i> = 301.1 [M + H] <sup>+</sup>.</div></div><div id="sec5_21" class="NLM_sec NLM_sec_level_2"><div id="ac_i37" class="anchor-spacer"></div><h3 class="article-section__title" id="_i37"> (<i>R</i>)-1-(1-(1-(2,2,2-Trifluoroethyl)piperidin-4-yl)-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethanol (<b>14</b>)</h3><div class="NLM_p last"><b>14</b> was synthesized by methods similar to those used for <b>26</b>, substituting <i>tert</i>-butyl 4-aminopiperidine-1-carboxylate (<b>14a</b>) for <i>tert</i>-butyl (<i>trans</i>-4-aminocyclohexyl)carbamate (<b>26a</b>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.82 (s, 1H), 8.55 (s, 1H), 7.49 (t, <i>J</i> = 3.0 Hz, 1H), 6.90 (s, 1H), 5.68 (d, <i>J</i> = 6.6 Hz, 1H), 5.13 (t, <i>J</i> = 6.5 Hz, 1H), 4.93–4.81 (m, 1H), 3.38–3.30 (m, 2H), 3.21–3.11 (s, 2H), 2.66–2.55 (m, 4H), 1.93–1.81 (m, 2H), 1.63 (d, <i>J</i> = 6.4 Hz, 3H). LCMS (method LCMS7, ESI): RT = 3.02 min, <i>m</i>/<i>z</i> = 368.3 [M + H]<sup>+</sup>.</div></div><div id="sec5_22" class="NLM_sec NLM_sec_level_2"><div id="ac_i38" class="anchor-spacer"></div><h3 class="article-section__title" id="_i38"> (<i>R</i>)-3-(4-(2-(1-Hydroxyethyl)imidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-1(6<i>H</i>)-yl)piperidin-1-yl)propanenitrile (<b>15</b>)</h3><div class="NLM_p last"><b>15</b> was synthesized by methods similar to those used for <b>8</b>, substituting 3-(4-aminopiperidin-1-yl)propanenitrile (<b>15a</b>)<a onclick="showRef(event, 'ref26'); return false;" href="javascript:void(0);" class="ref ref26">(26)</a> for cyclohexylamine (<b>36</b>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.81 (s, 1H), 8.55 (s, 1H), 7.40 (t, <i>J</i> = 3.0 Hz, 1H), 7.00 (br s, 1H), 5.69 (d, <i>J</i> = 6.7 Hz, 1H), 5.13 (p, <i>J</i> = 6.5 Hz, 1H), 4.94–4.81 (m, 1H), 3.18–3.11 (m, 2H), 2.82–2.67 (m, 4H), 2.67–2.55 (m, 2H), 2.25 (t, <i>J</i> = 11.9 Hz, 2H), 1.94–1.84 (m, 2H), 1.63 (d, <i>J</i> = 6.4 Hz, 3H). LCMS (method LCMS7, ESI): RT = 1.38 min, <i>m</i>/<i>z</i> = 339.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_23" class="NLM_sec NLM_sec_level_2"><div id="ac_i39" class="anchor-spacer"></div><h3 class="article-section__title" id="_i39"> (1<i>R</i>)-1-(1-(1-Ethyl-3,3-difluoropiperidin-4-yl)-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethanol (<b>16</b>)</h3><div class="NLM_p last">A diastereomeric mixture of <b>16</b> and its 4-piperidine epimer was synthesized by methods similar to those used for <b>8</b>, substituting (±)-1-ethyl-3,3-difluoropiperidin-4-amine (<b>16a</b>)<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> for cyclohexylamine (<b>36</b>). The diastereomers were separated by preparative chiral SFC (Lux Cellulose-1 column: 21.2 mm × 250 mm, 5 μm; detection, UV 220 nm; mobile phase A, CO<sub>2</sub>; mobile phase B, MeOH containing 0.1% NH<sub>4</sub>OH; flow rate, 70 mL/min; gradient, isocratic; A:B = 85:15) to provide <b>16</b> (later eluting peak) as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.74 (s, 1H), 8.58 (s, 1H), 7.41 (t, <i>J</i> = 3.1 Hz, 1H), 6.74–6.62 (m, 1H), 5.75 (d, <i>J</i> = 7.4 Hz, 1H), 5.46–5.28 (m, 1H), 5.04 (p, <i>J</i> = 6.6 Hz, 1H), 3.38 (t, <i>J</i> = 11.8 Hz, 1H), 3.22–3.13 (m, 1H), 3.06 (qd, <i>J</i> = 12.4, 4.6 Hz, 1H), 2.69–2.53 (m, 3H), 2.33 (t, <i>J</i> = 11.7 Hz, 1H), 2.00–1.89 (m, 1H), 1.68 (d, <i>J</i> = 6.3 Hz, 3H), 1.11 (t, <i>J</i> = 7.1 Hz, 3H). LCMS (method LCMS1, ESI): RT = 2.96 min, <i>m</i>/<i>z</i> = 350.4 [M + H]<sup>+</sup>.</div></div><div id="sec5_24" class="NLM_sec NLM_sec_level_2"><div id="ac_i40" class="anchor-spacer"></div><h3 class="article-section__title" id="_i40"> (<i>R</i>)-<i>tert</i>-Butyl 3-(2-((<i>R</i>)-1-hydroxyethyl)-6-(phenylsulfonyl)imidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-1(6<i>H</i>)-yl)piperidine-1-carboxylate (<b>17d</b>)</h3><div class="NLM_p last"><b>17d</b> was synthesized by methods similar to those used for <b>8a</b>, substituting (<i>R</i>)-<i>tert</i>-butyl 3-aminopiperidine-1-carboxylate (<b>17a</b>) for cyclohexylamine (<b>36</b>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.72 (s, 1H), 8.14 (d, <i>J</i> = 7.6 Hz, 2H), 7.96 (d, <i>J</i> = 3.8 Hz, 1H), 7.75–7.58 (m, 3H), 7.21 (d, <i>J</i> = 3.7 Hz, 1H), 5.85–5.75 (m, 1H), 5.19–5.08 (m, 1H), 4.99–4.86 (m, 1H), 4.27–4.17 (m, 1H), 4.15–3.98 (m, 1H), 2.36–2.21 (m, 1H), 2.06–1.97 (m, 1H), 1.90 (br d, <i>J</i> = 12.1 Hz, 1H), 1.62 (d, <i>J</i> = 6.2 Hz, 3H), 1.51 (s, 3H), 1.38 (br s, 9H).</div></div><div id="sec5_25" class="NLM_sec NLM_sec_level_2"><div id="ac_i41" class="anchor-spacer"></div><h3 class="article-section__title" id="_i41"> (<i>R</i>)-1-(1-((<i>R</i>)-Piperidin-3-yl)-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethanol (<b>17f</b>)</h3><div class="NLM_p last"><b>17d</b> (8.09 g, 15.4 mmol) was stirred in a 4.0 M solution of hydrogen chloride in 1,4-dioxane (150 mL) for 3 h. The volatiles were removed under vacuum and the solids were washed with Et<sub>2</sub>O (3 × 100 mL) and isolated by filtration. The resulting hygroscopic white powder was dissolved in a 1.0 M solution of sodium hydroxide in water (100 mL) and EtOH (100 mL) and heated to 60 °C for 8 h. The crude reaction mixture was then concentrated onto silica gel and purified by column chromatography, eluting with a gradient of 0% to 20% 2 M NH<sub>3</sub> in MeOH in DCM, to provide the title compound as an off-white solid (2.70 g, 61%). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.83 (s, 1H), 8.54 (s, 1H), 7.48 (s, 1H), 6.84 (s, 1H), 5.66 (d, <i>J</i> = 6.5 Hz, 1H), 5.17–5.04 (m, 1H), 4.86 (s, 1H), 3.43–3.36 (m, 1H), 3.17 (d, <i>J</i> = 5.1 Hz, 1H), 3.10–2.94 (m, 2H), 2.75 (t, <i>J</i> = 11.9 Hz, 1H), 2.46–2.38 (m, 1H), 2.03–1.80 (m, 2H), 1.70–1.57 (m, 4H).</div></div><div id="sec5_26" class="NLM_sec NLM_sec_level_2"><div id="ac_i42" class="anchor-spacer"></div><h3 class="article-section__title" id="_i42"> 3-((<i>R</i>)-3-(2-((<i>R</i>)-1-Hydroxyethyl)imidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-1(6<i>H</i>)-yl)piperidin-1-yl)-3-oxopropanenitrile (<b>17</b>)</h3><div class="NLM_p last">EDC (77 mg, 0.40 mmol) was added to a solution of <b>17f</b> (60 mg, 0.21 mmol), 4-dimethylaminopyridine (10 mg, 0.08 mmol), DIPEA (80 μL, 0.46 mmol), and 2-cyanoacetic acid (34 mg, 0.40 mmol) in DMF (1 mL). The reaction mixture was stirred at 23 °C for 16 h, then diluted with EtOAc (10 mL). The organic layer was washed successively with 1 M aqueous HCl solution, saturated aqueous NaHCO<sub>3</sub> solution, and brine (1 × 3 mL each), then dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under vacuum. The residue was purified by preparative HPLC (column: Gemini-NX, 5 cm × 10 cm, 10 μm; detection, UV 254 nm; mobile phase A, water with 0.1% NH<sub>4</sub>OH; mobile phase B, CH<sub>3</sub>CN; flow rate, 120 mL/min; gradient 5–95% B over 15 min) to afford 50 mg (68%) of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.91 (s, 1H), 8.57 (d, <i>J</i> = 6.4 Hz, 1H), 8.32 (s, 1H), 7.49 (s, 1H), 6.80 (d, <i>J</i> = 13.8 Hz, 1H), 5.25–5.06 (m, 1H), 5.00–4.80 (m, 1H), 4.68–4.45 (m, 1H), 4.25–4.04 (m, 2H), 3.94–3.75 (m, 2H), 3.03–2.89 (m, 1H), 2.12–1.89 (m, 2H), 1.86–1.71 (m, 1H), 1.71–1.59 (m, 4H). LCMS (method LCMS8, ESI): RT = 2.70 min, <i>m</i>/<i>z</i> = 353.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_27" class="NLM_sec NLM_sec_level_2"><div id="ac_i43" class="anchor-spacer"></div><h3 class="article-section__title" id="_i43"> 3,3,3-Trifluoro-1-((<i>R</i>)-3-(2-((<i>R</i>)-1-hydroxyethyl)imidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-1(6<i>H</i>)-yl)piperidin-1-yl)propan-1-one (<b>18</b>)</h3><div class="NLM_p last"><b>18</b> was synthesized by methods similar to those used for <b>17</b>, substituting 3,3,3-trifluoropropanoic acid for 2-cyanoacetic acid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.92 (s, 1H), 8.58 (d, <i>J</i> = 8.4 Hz, 1H), 7.50 (s, 1H), 6.81 (d, <i>J</i> = 15.8 Hz, 1H), 5.85–5.70 (m, 1H), 5.24–5.06 (m, 1H), 4.98–4.79 (m, 1H), 4.73–4.51 (m, 1H), 4.04–3.91 (m, 1H), 3.86–3.66 (m, 2H), 2.93 (t, <i>J</i> = 14.1 Hz, 1H), 2.70–2.56 (m, 1H), 2.12–1.92 (m, 3H), 1.72–1.57 (m, 4H). LCMS (method LCMS3, ESI): RT = 3.05 min, <i>m</i>/<i>z</i> = 396.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_28" class="NLM_sec NLM_sec_level_2"><div id="ac_i44" class="anchor-spacer"></div><h3 class="article-section__title" id="_i44"> (<i>R</i>)-1-(1-(Tetrahydro-2<i>H</i>-pyran-4-yl)-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethanol (<b>19</b>)</h3><div class="NLM_p last"><b>19</b> was synthesized by methods similar to those used for <b>21</b>, substituting tetrahydro-2<i>H</i>-pyran-4-amine (<b>19a</b>) for (<i>S</i>)-tetrahydro-2<i>H</i>-pyran-3-amine (<b>21a</b>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.85 (s, 1H), 8.57 (s, 1H), 7.50 (s, 1H), 6.76 (s, 1H), 5.78–5.63 (m, 1H), 5.22–5.05 (m, 2H), 4.17–4.10 (m, 2H), 3.57 (t, <i>J</i> = 12.0 Hz, 2H), 2.70–2.53 (m, 2H), 1.92–1.80 (m, 2H), 1.65 (d, <i>J</i> = 6.4 Hz, 3H). LCMS (method LCMS3, ESI): RT = 2.65 min, <i>m</i>/<i>z</i> = 287.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_29" class="NLM_sec NLM_sec_level_2"><div id="ac_i45" class="anchor-spacer"></div><h3 class="article-section__title" id="_i45"> (<i>R</i>)-1-(1-((<i>R</i>)-Tetrahydro-2<i>H</i>-pyran-3-yl)-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethanol (<b>20</b>)</h3><div class="NLM_p last"><b>20</b> was synthesized by methods similar to those used for <b>21</b>, substituting (<i>R</i>)-tetrahydro-2<i>H</i>-pyran-3-amine (<b>20a</b>) for (<i>S</i>)-tetrahydro-2<i>H</i>-pyran-3-amine (<b>21a</b>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.88 (s, 1H), 8.56 (s, 1H), 7.50 (s, 1H), 6.86 (s, 1H), 5.72–5.64 (m, 1H), 5.19–5.09 (m, 1H), 5.04–4.95 (m, 1H), 4.10 (t, <i>J</i> = 11.2 Hz, 1H), 4.02–3.91 (m, 2H), 3.70 (t, <i>J</i> = 11.8 Hz, 1H), 2.68–2.50 (m, 1H), 2.11–2.03 (m, 1H), 1.96–1.80 (m, 2H), 1.65 (br s, 3H). LCMS (method LCMS3, ESI): RT = 2.72 min, <i>m</i>/<i>z</i> = 287.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_30" class="NLM_sec NLM_sec_level_2"><div id="ac_i46" class="anchor-spacer"></div><h3 class="article-section__title" id="_i46"> (<i>S</i>)-5-Nitro-1-(phenylsulfonyl)-<i>N</i>-(tetrahydro-2<i>H</i>-pyran-3-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-amine (<b>21b</b>)</h3><div class="NLM_p last">DIPEA (130 mL, 760 mmol) was added to a solution of (<i>S</i>)-tetrahydro-2<i>H</i>-pyran-3-amine (<b>21a</b>,<a onclick="showRef(event, 'ref28'); return false;" href="javascript:void(0);" class="ref ref28">(28)</a> 40.7 g, 296 mmol) and <b>35</b><a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> (100 g, 296 mmol) in isopropyl alcohol (1.0 L). The mixture was stirred at an internal temperature of 75 °C for 4 h. The mixture was then cooled slowly to 23 °C and allowed to stand for 16 h. The precipitate was collected by filtration and washed with cold isopropyl alcohol (100 mL). The solid was dried in a vacuum oven at 50 °C for 24 h to afford 114 g (96%) of the title compound as a yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.21 (d, <i>J</i> = 8.0 Hz, 1H), 9.11 (s, 1H), 8.19 (dd, <i>J</i> = 7.6, 1.6 Hz, 2H), 7.65–7.58 (m, 2H), 7.52 (t, <i>J</i> = 7.7 Hz, 2H), 6.75 (d, <i>J</i> = 4.1 Hz, 1H), 4.18–4.07 (m, 1H), 3.98 (dd, <i>J</i> = 11.5, 3.0 Hz, 1H), 3.81–3.65 (m, 2H), 3.57 (dd, <i>J</i> = 11.6, 6.5 Hz, 1H), 2.19–2.06 (m, 1H), 1.93–1.78 (m, 2H), 1.75–1.62 (m, 1H). LCMS (method LCMS9, ESI): RT = 1.63 min, <i>m</i>/<i>z</i> = 403.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_31" class="NLM_sec NLM_sec_level_2"><div id="ac_i47" class="anchor-spacer"></div><h3 class="article-section__title" id="_i47"> (<i>S</i>)-1-(Phenylsulfonyl)-<i>N</i><sup>4</sup>-(tetrahydro-2<i>H</i>-pyran-3-yl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridine-4,5-diamine (<b>21c</b>)</h3><div class="NLM_p last">Palladium on carbon (10%, 30.0 g, 28.2 mmol) was added to a solution of <b>21b</b> in EtOAc (2.5 L). The mixture was stirred at 23 °C under an atmosphere of hydrogen gas for 48 h, then filtered through Celite and washed with 10% MeOH in DCM (1 L). The filtrate was concentrated to afford 106 g (100%) of the title compound as an off-white solid. LCMS (method LCMS9, ESI): RT = 1.13 min, <i>m</i>/<i>z</i> = 373.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_32" class="NLM_sec NLM_sec_level_2"><div id="ac_i48" class="anchor-spacer"></div><h3 class="article-section__title" id="_i48"> (<i>R</i>)-1-(6-(Phenylsulfonyl)-1-((<i>S</i>)-tetrahydro-2<i>H</i>-pyran-3-yl)-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethanol (<b>21d</b>)</h3><div class="NLM_p last">(<i>R</i>)-(+)-lactamide (33.5 g, 376 mmol) was added to a suspension of triethyloxonium tetrafluoroborate (73.6 g, 376 mmol) in THF (800 mL).<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The reaction mixture was stirred for 1 h at 23 °C, during which time it became a clear solution. The solution was then added to a solution of <b>21c</b> (70.0 g, 188 mmol) in EtOH (1.5 L), and the reaction mixture was stirred at 67 °C for 2 h. The solution was then cooled to room temperature, and EtOAc (500 mL) was added. The mixture was allowed to stand for 16 h, then the resulting precipitate was collected by filtration, washed with cold EtOAc (50 mL), and dried under vacuum for 16 h to afford 60.9 g (80%) of the title compound as a yellow solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.71 (s, 1H), 8.18–8.09 (m, 2H), 7.99 (d, <i>J</i> = 4.0 Hz, 1H), 7.74–7.67 (m, 1H), 7.65–7.57 (m, 2H), 7.26 (d, <i>J</i> = 4.1 Hz, 1H), 5.82 (d, <i>J</i> = 6.4 Hz, 1H), 5.14 (p, <i>J</i> = 6.3 Hz, 1H), 5.08–4.94 (m, 1H), 3.95 (d, <i>J</i> = 8.3 Hz, 3H), 3.68 (t, <i>J</i> = 11.2 Hz, 1H), 2.46–2.30 (m, 1H), 2.07 (d, <i>J</i> = 11.7 Hz, 1H), 1.95–1.75 (m, 2H), 1.62 (d, <i>J</i> = 6.3 Hz, 3H). LCMS (method LCMS9, ESI): RT = 1.34 min, <i>m</i>/<i>z</i> = 427.2 [M + H]<sup>+</sup>. <sup>1</sup>H</div></div><div id="sec5_33" class="NLM_sec NLM_sec_level_2"><div id="ac_i49" class="anchor-spacer"></div><h3 class="article-section__title" id="_i49"> (<i>R</i>)-1-(1-((<i>S</i>)-Tetrahydro-2<i>H</i>-pyran-3-yl)-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethanol (<b>21</b>)</h3><div class="NLM_p last">To a suspension of <b>21d</b> (40.0 g, 93.8 mmol) in EtOH (50 mL) was added an aqueous solution of sodium hydroxide (9 M, 30 mL, 270 mmol). The reaction mixture was stirred for 1 h at 60 °C, then cooled to room temperature. The majority of the EtOH was removed under vacuum, then the remaining aqueous solution was cooled to 0 °C. The pH was adjusted to ∼7 with 37% aqueous hydrochloric acid solution. The resulting solid was removed by filtration. The filtrate was concentrated under vacuum, the residue was taken up in a 1:1 mixture of EtOH:EtOAc (200 mL), and the solid was removed with another filtration. The filtrate was concentrated, and the residue was dissolved in MeOH (150 mL) and treated with macroporous triethylammonium methylpolystyrene carbonate resin to remove the remaining phenylsulfonic acid. The resin was removed by filtration and washed with MeOH (30 mL). The filtrate was concentrated and the residue crystallized from hot CH<sub>3</sub>CN. The resulting solid was collected by filtration, washed with cold CH<sub>3</sub>CN, and then taken up in water (15 mL). The water was removed under vacuum to afford 10.6 g (40%) of the title compound as a white solid. 1H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.87 (s, 1H), 8.55 (s, 1H), 7.49 (d, <i>J</i> = 3.3 Hz, 1H), 6.85 (d, <i>J</i> = 3.4 Hz, 1H), 5.89–5.56 (m, 1H), 5.14 (q, <i>J</i> = 6.4 Hz, 1H), 5.08–4.94 (m, 1H), 4.11 (t, <i>J</i> = 11.1 Hz, 1H), 4.02–3.92 (m, 2H), 3.69 (td, <i>J</i> = 11.9, 2.5 Hz, 1H), 2.63–2.51 (m, 1H), 2.14–2.03 (m, 1H), 1.97–1.74 (m, 2H), 1.63 (d, <i>J</i> = 6.4 Hz, 3H). LCMS (method LCMS1, ESI): RT = 3.60 min, <i>m</i>/<i>z</i> = 287.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_34" class="NLM_sec NLM_sec_level_2"><div id="ac_i50" class="anchor-spacer"></div><h3 class="article-section__title" id="_i50"> <i>trans</i>-4-(2-((<i>R</i>)-1-Hydroxyethyl)imidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-1(6<i>H</i>)-yl)cyclohexanol (<b>22</b>)</h3><div class="NLM_p last"><b>22</b> was synthesized by methods similar to those used for <b>21</b>, substituting <i>trans</i>-4-aminocyclohexanol (<b>22a</b>) for (<i>S</i>)-tetrahydro-2<i>H</i>-pyran-3-amine (<b>21a</b>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.81 (s, 1H), 8.54 (s, 1H), 7.46 (d, <i>J</i> = 3.4 Hz, 1H), 6.66 (d, <i>J</i> = 3.5 Hz, 1H), 5.65 (br s, 1H), 5.12 (q, <i>J</i> = 6.4 Hz, 1H), 4.88–4.69 (m, 2H), 3.86–3.74 (m, 1H), 2.46–2.32 (m, 2H), 2.10–2.01 (m, 2H), 1.95–1.83 (m, 2H), 1.63 (d, <i>J</i> = 6.4 Hz, 3H), 1.53–1.39 (m, 2H). LCMS (method LCMS1, ESI): RT = 7.14 min, <i>m</i>/<i>z</i> = 301.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_35" class="NLM_sec NLM_sec_level_2"><div id="ac_i51" class="anchor-spacer"></div><h3 class="article-section__title" id="_i51"> <i>cis</i>-4-(2-((<i>R</i>)-1-Hydroxyethyl)imidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-1(6<i>H</i>)-yl)cyclohexanol (<b>23</b>)</h3><div class="NLM_p last"><b>23</b> was synthesized by methods similar to those used for <b>21</b>, substituting <i>cis</i>-4-aminocyclohexanol (<b>23a</b>) for (<i>S</i>)-tetrahydro-2<i>H</i>-pyran-3-amine (<b>21a</b>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.71 (s, 1H), 8.52 (s, 1H), 7.41 (s, 2H), 5.63 (br s, 1H), 5.11 (q, <i>J</i> = 6.5 Hz, 1H), 4.97–4.74 (m, 2H), 4.03 (s, 1H), 2.79–2.64 (m, 2H), 1.94–1.83 (m, 2H), 1.72–1.55 (m, 7H). LCMS (method LCMS1, ESI): RT = 7.18 min, <i>m</i>/<i>z</i> = 301.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_36" class="NLM_sec NLM_sec_level_2"><div id="ac_i52" class="anchor-spacer"></div><h3 class="article-section__title" id="_i52"> (1<i>R</i>,3<i>R</i>)-3-(2-((<i>R</i>)-1-Hydroxyethyl)imidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-1(6<i>H</i>)-yl)cyclohexanol (<b>24</b>)</h3><div class="NLM_p last"><b>24</b> was synthesized by methods similar to those used for <b>21</b>, substituting (1<i>R</i>,3<i>R</i>)-3-aminocyclohexanol (<b>24a</b>)<a onclick="showRef(event, 'ref29'); return false;" href="javascript:void(0);" class="ref ref29">(29)</a> for (<i>S</i>)-tetrahydro-2<i>H</i>-pyran-3-amine (<b>21a</b>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.80 (s, 1H), 8.52 (s, 1H), 7.45 (t, <i>J</i> = 2.6 Hz, 1H), 6.66 (d, <i>J</i> = 3.0 Hz, 1H), 5.77–5.45 (m, 1H), 5.40–5.24 (m, 1H), 5.14–5.02 (q, <i>J</i> = 6.5 Hz, 1H), 4.68 (br s, 1H), 4.22 (br s, 1H), 2.48–2.40 (m, 1H), 2.35–2.19 (m, 1H), 2.01–1.74 (m, 4H), 1.74–1.63 (m, 2H), 1.61 (d, <i>J</i> = 6.5 Hz, 3H). LCMS (method LCMS1, ESI): RT = 3.87 min, <i>m</i>/<i>z</i> = 301.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_37" class="NLM_sec NLM_sec_level_2"><div id="ac_i53" class="anchor-spacer"></div><h3 class="article-section__title" id="_i53"> (<i>R</i>)-1-(1-(<i>trans</i>-4-Methoxycyclohexyl)-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethanol (<b>25</b>).<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a></h3><div class="NLM_p last"><sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.85 (s, 1H), 8.54 (s, 1H), 7.47 (t, <i>J</i> = 3.0 Hz, 1H), 6.69 (m, 1H), 5.66 (d, <i>J</i> = 6.7 Hz, 1H), 5.12 (m, 1H), 4.84 (m, 1H), 3.54 (m, 4H), 2.39 (m, 2H), 2.24 (m, 2H), 1.94 (m, 2H), 1.63 (d, <i>J</i> = 6.5 Hz, 3H), 1.40 (m, 2H). LCMS (method LCMS11, ESI): RT = 2.34 min, <i>m</i>/<i>z</i> = 315.5 [M + H]<sup>+</sup>.</div></div><div id="sec5_38" class="NLM_sec NLM_sec_level_2"><div id="ac_i54" class="anchor-spacer"></div><h3 class="article-section__title" id="_i54"> (<i>R</i>)-1-(1-(<i>trans</i>-4-Aminocyclohexyl)-6-(phenylsulfonyl)-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethanol (<b>26e</b>)</h3><div class="NLM_p last"><b>26d</b> was synthesized by methods similar to those used for <b>31d</b>, substituting <i>tert</i>-butyl (<i>trans</i>-4-aminocyclohexyl)carbamate (<b>26a</b>) for <i>trans</i>-4-aminocyclohexanecarbonitrile trifluoroacetic acid salt (<b>31a</b>). <b>26d</b> (2.00 g, 3.71 mmol) was then added to a mixture of trifluoroacetic acid (10 mL) and water (1 mL). The reaction mixture was stirred at 23 °C for 1 h, then concentrated under vacuum. The residue was taken up in MeOH and purified by Isolute SCX column chromatography (gradient: MeOH to 2 M NH<sub>3</sub> in MeOH) to give 1.59 g (98%) of the title compound as an off-white solid. LCMS (method LCMS10, ESI): RT = 1.81 min, <i>m</i>/<i>z</i> = 440.3 [M + H]<sup>+</sup>.</div></div><div id="sec5_39" class="NLM_sec NLM_sec_level_2"><div id="ac_i55" class="anchor-spacer"></div><h3 class="article-section__title" id="_i55"> (<i>R</i>)-1-(1-(<i>trans</i>-4-((2,2,2-Trifluoroethyl)amino)cyclohexyl)-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethanol (<b>26</b>)</h3><div class="NLM_p last"><b>26e</b> (200 mg, 0.46 mmol) was dissolved in DCM (2 mL) and DMF (2 mL). TEA (254 μL, 1.84 mmol) was added, followed by 2,2,2-trifluoroethyl trifluoromethanesulfonate (131 μL, 0.91 mmol). The reaction mixture was stirred for 16 h at 23 °C. Water (10 mL) was added and the mixture was extracted with DCM (3 × 5 mL), and the combined organic extracts were dried (Na<sub>2</sub>SO<sub>4</sub>), filtered, and concentrated under vacuum. The residue was dissolved in MeOH (2 mL) and THF (2 mL), and 2 M aqueous NaOH (2 mL) was added. The reaction mixture was stirred at 23 °C for 2 h, then concentrated under vacuum. Then 1 M aqueous HCl solution (4 mL) was added to the residue, and the mixture was concentrated under vacuum. Purification by column chromatography on silica gel (gradient: DCM to 8% (2 M NH<sub>3</sub> in MeOH) in DCM) followed by trituration with CH<sub>3</sub>CN gave 77 mg (44%) of the title compound as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.82 (s, 1H), 8.54 (s, 1H), 7.47 (t, <i>J</i> = 3.0 Hz, 1H), 6.71–6.63 (dd, <i>J</i> = 3.5, 1.9 Hz, 1H), 5.64 (d, <i>J</i> = 6.5 Hz, 1H), 5.12 (p, <i>J</i> = 6.5 Hz, 1H), 4.89–4.74 (m, 1H), 3.42–3.31 (m, 2H), 2.92–2.74 (m, 1H), 2.46–2.29 (m, 3H), 2.07 (d, <i>J</i> = 12.2 Hz, 2H), 1.98–1.83 (m, 2H), 1.63 (d, <i>J</i> = 6.3 Hz, 3H), 1.40–1.22 (m, 2H). LCMS (method LCMS1, ESI): RT = 2.57 min, <i>m</i>/<i>z</i> = 382.4 [M + H]<sup>+</sup>.</div></div><div id="sec5_40" class="NLM_sec NLM_sec_level_2"><div id="ac_i56" class="anchor-spacer"></div><h3 class="article-section__title" id="_i56"> (<i>R</i>)-1-(1-(<i>trans</i>-4-((2,2-Difluoroethyl)amino)cyclohexyl)-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethanol (<b>27</b>)</h3><div class="NLM_p last"><b>27</b> was synthesized by methods similar to those used for <b>26</b>, substituting 2,2-difluoroethyl trifluoromethanesulfonate for 2,2,2-trifluoroethyl trifluoromethanesulfonate. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.81 (s, 1H), 8.54 (s, 1H), 7.46 (t, <i>J</i> = 2.9 Hz, 1H), 6.69 (t, <i>J</i> = 2.5 Hz, 1H), 6.01 (tt, <i>J</i> = 56.6, 4.3 Hz, 1H), 5.64 (d, <i>J</i> = 6.2 Hz, 1H), 5.12 (p, <i>J</i> = 6.5 Hz, 1H), 4.90–4.74 (m, 1H), 3.01 (t, <i>J</i> = 16.2 Hz, 2H), 2.89–2.72 (m, 1H), 2.38 (q, <i>J</i> = 12.8 Hz, 2H), 2.12 (d, <i>J</i> = 12.0 Hz, 2H), 2.01–1.83 (m, 3H), 1.63 (d, <i>J</i> = 6.4 Hz, 3H), 1.37–1.19 (m, 2H). LCMS (method LCMS1, ESI): RT = 2.20 min, <i>m</i>/<i>z</i> = 364.4 [M + H]<sup>+</sup>.</div></div><div id="sec5_41" class="NLM_sec NLM_sec_level_2"><div id="ac_i57" class="anchor-spacer"></div><h3 class="article-section__title" id="_i57"> (<i>R</i>)-1-(1-(<i>cis</i>-4-((2,2,2-Trifluoroethyl)amino)cyclohexyl)-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethanol (<b>28</b>)</h3><div class="NLM_p last"><b>28</b> was synthesized by methods similar to those used for <b>26</b>, substituting <i>tert</i>-butyl (<i>cis</i>-4-aminocyclohexyl)carbamate (<b>28a</b>)<a onclick="showRef(event, 'ref30'); return false;" href="javascript:void(0);" class="ref ref30">(30)</a> for <i>tert</i>-butyl (<i>trans</i>-4-aminocyclohexyl)carbamate (<b>26a</b>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.65 (s, 1H), 8.51 (s, 1H), 7.64 (s, 1H), 7.27 (t, <i>J</i> = 3.0 Hz, 1H), 5.62 (d, <i>J</i> = 6.0 Hz, 1H), 5.11 (p, <i>J</i> = 6.4 Hz, 1H), 4.81 (tt, <i>J</i> = 12.3, 4.2 Hz, 1H), 3.43–3.32 (m, 2H), 3.00 (s, 1H), 2.79–2.58 (m, 3H), 1.99 (d, <i>J</i> = 13.2 Hz, 2H), 1.72–1.52 (m, 7H). LCMS (method LCMS1, ESI): RT = 8.43 min, <i>m</i>/<i>z</i> = 382.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_42" class="NLM_sec NLM_sec_level_2"><div id="ac_i58" class="anchor-spacer"></div><h3 class="article-section__title" id="_i58"> (<i>R</i>)-1-(1-((1<i>S</i>,3<i>R</i>)-3-((2,2,2-Trifluoroethyl)amino)cyclopentyl)-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethanol (<b>29</b>)</h3><div class="NLM_p last"><b>29</b> was synthesized by methods similar to those used for <b>26</b>, substituting <i>tert</i>-butyl ((1<i>R</i>,3<i>S</i>)-3-aminocyclopentyl)carbamate (<b>29a</b>)<a onclick="showRef(event, 'ref31'); return false;" href="javascript:void(0);" class="ref ref31">(31)</a> for <i>tert</i>-butyl (<i>trans</i>-4-aminocyclohexyl)carbamate (<b>26a</b>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.80 (s, 1H), 8.54 (s, 1H), 7.42 (t, <i>J</i> = 3.0 Hz, 1H), 6.96 (dd, <i>J</i> = 3.4, 1.9 Hz, 1H), 5.65 (d, <i>J</i> = 6.5 Hz, 1H), 5.38–5.23 (m, 1H), 5.12 (p, <i>J</i> = 6.5 Hz, 1H), 3.43–3.33 (m, 1H), 3.30–3.21 (m, 2H), 2.81 (td, <i>J</i> = 7.7, 5.0 Hz, 1H), 2.42 (td, <i>J</i> = 12.0, 11.3, 6.6 Hz, 1H), 2.32 (dt, <i>J</i> = 13.2, 6.8 Hz, 1H), 2.24–2.00 (m, 3H), 1.93–1.80 (m, 1H), 1.62 (d, <i>J</i> = 6.5 Hz, 3H). LCMS (method LCMS1, ESI): RT = 7.54 min, <i>m</i>/<i>z</i> = 368.2 [M + H]<sup>+</sup>.</div></div><div id="sec5_43" class="NLM_sec NLM_sec_level_2"><div id="ac_i59" class="anchor-spacer"></div><h3 class="article-section__title" id="_i59"> (<i>R</i>)-1-(1-((1<i>S</i>,3<i>S</i>)-3-((2,2,2-Trifluoroethyl)amino)cyclopentyl)-1,6-dihydroimidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-2-yl)ethanol (<b>30</b>)</h3><div class="NLM_p last"><b>30</b> was synthesized by methods similar to those used for <b>26</b>, substituting <i>tert</i>-butyl ((1<i>S</i>,3<i>S</i>)-3-aminocyclopentyl)carbamate (<b>30a</b>)<a onclick="showRef(event, 'ref32'); return false;" href="javascript:void(0);" class="ref ref32">(32)</a> for <i>tert</i>-butyl (<i>trans</i>-4-aminocyclohexyl)carbamate (<b>26a</b>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.83 (s, 1H), 8.55 (s, 1H), 7.45 (t, <i>J</i> = 3.0 Hz, 1H), 6.49 (dd, <i>J</i> = 3.5, 1.8 Hz, 1H), 5.60 (d, <i>J</i> = 6.6 Hz, 1H), 5.52 (p, <i>J</i> = 9.5 Hz, 1H), 5.10 (p, <i>J</i> = 6.5 Hz, 1H), 3.71–3.62 (m, 1H), 3.32–3.20 (m, 2H), 2.64–2.56 (m, 1H), 2.48–2.11 (m, 4H), 2.06–1.96 (m, 1H), 1.71–1.62 (m, 1H), 1.64 (d, <i>J</i> = 6.4 Hz, 3H). LCMS (method LCMS1, ESI): RT = 2.58 min, <i>m</i>/<i>z</i> = 368.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_44" class="NLM_sec NLM_sec_level_2"><div id="ac_i60" class="anchor-spacer"></div><h3 class="article-section__title" id="_i60"> <i>trans</i>-4-((5-Nitro-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)amino)cyclohexanecarbonitrile (<b>31b</b>)</h3><div class="NLM_p last">A mixture of <i>trans</i>-4-aminocyclohexanecarbonitrile trifluoroacetic acid salt<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> (<b>31a</b>, 6.36 g, 26.7 mmol), <b>35</b><a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> (8.21 g, 24.3 mmol) and DIPEA (12.5 mL, 73.0 mmol) in isopropyl alcohol (200 mL) was heated at reflux for 3 h. The cooled mixture was filtered and the precipitate washed with isopropyl alcohol (100 mL) to afford 9.04 g (87%) of the title compound as a bright-yellow solid. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 9.11 (s, 1H), 9.07 (d, <i>J</i> = 7.7 Hz, 1H), 8.20 (m, 2H), 7.63 (m, 2H), 7.53 (m, 2H), 6.67 (d, <i>J</i> = 4.2 Hz, 1H), 4.06 (m, 1H), 2.66 (m, 1H), 2.24 (m, 4H), 1.83 (m, 2H), 1.58 (m, 2H). LCMS (method LCMS11, ESI): RT = 4.15 min, <i>m</i>/<i>z</i> = 426.0 [M + H]<sup>+</sup>.</div></div><div id="sec5_45" class="NLM_sec NLM_sec_level_2"><div id="ac_i61" class="anchor-spacer"></div><h3 class="article-section__title" id="_i61"> <i>trans</i>-4-((5-Amino-1-(phenylsulfonyl)-1<i>H</i>-pyrrolo[2,3-<i>b</i>]pyridin-4-yl)amino)cyclohexanecarbonitrile (<b>31c</b>)</h3><div class="NLM_p last">A suspension of <b>31b</b> (5.00 g, 11.8 mmol), iron powder (−325 mesh, 2.59 g, 47.0 mmol), and ammonium chloride (3.74 g, 70.5 mmol) in a mixture of EtOH and water (3:1, 400 mL) was mechanically stirred at reflux for 4 h. The cooled mixture was filtered through Celite. The filtrate was concentrated under vacuum to remove the majority of the EtOH, then the residual aqueous layer was extracted with DCM (3 × 100 mL). The combined extracts were washed with water and brine (100 mL each), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under vacuum. Purification by diethyl ether trituration afforded 4.51 g (97%) of the title compound as a light-gray solid. LCMS (method LCMS11, ESI): RT = 2.69 min, <i>m</i>/<i>z</i> = 396.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_46" class="NLM_sec NLM_sec_level_2"><div id="ac_i62" class="anchor-spacer"></div><h3 class="article-section__title" id="_i62"> <i>trans</i>-4-(2-((<i>R</i>)-1-Hydroxyethyl)-6-(phenylsulfonyl)imidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-1(6<i>H</i>)-yl)cyclohexanecarbonitrile (<b>31d</b>)</h3><div class="NLM_p last">A suspension of triethyloxonium tetrafluoroborate (5.36 g, 28.2 mmol) and (<i>R</i>)-(+)-lactamide (2.85 g, 32.0 mmol) in dry THF (40 mL) was stirred at 23 °C under a nitrogen atmosphere for 2 h.<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> The mixture was concentrated under vacuum and stirred in absolute EtOH (70 mL) for 10 min. <b>31c</b> (4.00 g, 10.1 mmol) was added, and the reaction mixture was heated at reflux for 2 h. The cooled mixture was concentrated under vacuum, and the residue was triturated with EtOAc to afford 4.50 g (99%) of the title compound as an off-white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 8.71 (s, 1H), 8.13 (m, 2H), 7.94 (d, <i>J</i> = 4.1 Hz, 1H), 7.69 (m, 1H), 7.61 (m, 2H), 7.25 (m, 1H), 5.74 (d, <i>J</i> = 6.7 Hz, 1H), 5.14 (m, 1H), 4.85 (m, 1H), 3.23 (m, 1H), 2.20 (m, 4H), 1.85 (m, 4H), 1.62 (d, <i>J</i> = 6.4 Hz, 3H). LCMS (method LCMS11, ESI): RT = 3.33 min, <i>m</i>/<i>z</i> = 450.3 [M + H]<sup>+</sup>.</div></div><div id="sec5_47" class="NLM_sec NLM_sec_level_2"><div id="ac_i63" class="anchor-spacer"></div><h3 class="article-section__title" id="_i63"> <i>trans</i>-4-(2-((<i>R</i>)-1-Hydroxyethyl)imidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-1(6<i>H</i>)-yl)cyclohexanecarbonitrile (<b>31</b>)</h3><div class="NLM_p last">A solution of <b>31d</b> (1.20 g, 2.67 mmol) in MeOH:THF (1:1, 150 mL) was treated with a 1 M solution of aqeuous sodium hydroxide (20 mL) and stirred at 23 °C for 3 h. The organic solvent was removed under vacuum, and the aqueous residue was extracted with EtOAc (3 × 20 mL). The combined organic extracts were washed with water and brine (20 mL each), dried over Na<sub>2</sub>SO<sub>4</sub>, filtered, and concentrated under vacuum. Purification by column chromatography on silica gel (gradient: 0–10% [2 M NH<sub>3</sub> in MeOH] in EtOAc) with further purification by reverse phase HPLC (XBridge Prep C18 OBD, 19 mm × 250 mm, 5 μm; detection, UV 220 and 254 nm; mobile phase A, water with 0.1% NH<sub>4</sub>OH; mobile phase B, CH<sub>3</sub>CN with 0.1% NH<sub>4</sub>OH; flow rate, 18 mL/min; gradient 5–75% B over 20 min) afforded 149 mg (18%) of the title compound as a white solid. <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.82 (s, 1H), 8.54 (s, 1H), 7.44 (t, <i>J</i> = 2.9 Hz, 1H), 6.79 (t, <i>J</i> = 2.5 Hz, 1H), 5.63 (d, <i>J</i> = 6.0 Hz, 1H), 5.13 (p, <i>J</i> = 6.3 Hz, 1H), 4.90–4.76 (m, 1H), 3.21–3.05 (m, 1H), 2.41–2.18 (m, 4H), 2.01–1.90 (m, 2H), 1.90–1.71 (m, 2H), 1.63 (d, <i>J</i> = 6.4 Hz, 3H). LCMS (method LCMS1, ESI): RT = 4.48 min, <i>m</i>/<i>z</i> = 310.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_48" class="NLM_sec NLM_sec_level_2"><div id="ac_i64" class="anchor-spacer"></div><h3 class="article-section__title" id="_i64"> <i>cis</i>-4-(2-((<i>R</i>)-1-Hydroxyethyl)imidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-1(6<i>H</i>)-yl)cyclohexanecarbonitrile (<b>32</b>)</h3><div class="NLM_p last"><b>32</b> was synthesized by methods similar to those used for <b>31</b>, substituting <i>cis</i>-4-aminocyclohexanecarbonitrile trifluoroacetic acid salt (<b>31a</b>)<a onclick="showRef(event, 'ref33'); return false;" href="javascript:void(0);" class="ref ref33">(33)</a> for <i>trans</i>-4-aminocyclohexanecarbonitrile trifluoroacetic acid salt (<b>32a</b>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.82 (s, 1H), 8.55 (s, 1H), 7.45 (t, <i>J</i> = 3.0 Hz, 1H), 7.18 (s, 1H), 5.65 (d, <i>J</i> = 6.8 Hz, 1H), 5.14 (p, <i>J</i> = 6.6 Hz, 1H), 4.89–4.76 (m, 1H), 3.34 (br s, 1H), 2.60–2.46 (m, 2H), 2.23–2.10 (m, 2H), 2.01–1.81 (m, 4H), 1.64 (d, <i>J</i> = 6.4 Hz, 3H). LCMS (method LCMS1, ESI): RT = 4.42 min, <i>m</i>/<i>z</i> = 310.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_49" class="NLM_sec NLM_sec_level_2"><div id="ac_i65" class="anchor-spacer"></div><h3 class="article-section__title" id="_i65"> 2-(<i>trans</i>-4-(2-((<i>R</i>)-1-Hydroxyethyl)imidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-1(6<i>H</i>)-yl)cyclohexyl)acetonitrile (<b>33</b>)</h3><div class="NLM_p last"><b>33</b> was synthesized by methods similar to those used for <b>31</b>, substituting 2-(<i>trans</i>-4-aminocyclohexyl)acetonitrile (<b>33a</b>)<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> for <i>trans</i>-4-aminocyclohexanecarbonitrile trifluoroacetic acid salt (<b>31a</b>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.82 (s, 1H), 8.54 (s, 1H), 7.45 (t, <i>J</i> = 2.9 Hz, 1H), 6.72 (t, <i>J</i> = 2.4 Hz, 1H), 5.66 (d, <i>J</i> = 6.2 Hz, 1H), 5.13 (p, <i>J</i> = 6.5 Hz, 1H), 4.90–4.76 (m, 1H), 2.59 (d, <i>J</i> = 5.8 Hz, 2H), 2.45–2.30 (m, 2H), 2.14–1.88 (m, 5H), 1.63 (d, <i>J</i> = 6.3 Hz, 3H), 1.49–1.29 (m, 2H). LCMS (method LCMS1, ESI): RT = 4.86 min, <i>m</i>/<i>z</i> = 324.1 [M + H]<sup>+</sup>.</div></div><div id="sec5_50" class="NLM_sec NLM_sec_level_2"><div id="ac_i66" class="anchor-spacer"></div><h3 class="article-section__title" id="_i66"> 3-(<i>trans</i>-4-(2-((<i>R</i>)-1-Hydroxyethyl)imidazo[4,5-<i>d</i>]pyrrolo[2,3-<i>b</i>]pyridin-1(6<i>H</i>)-yl)cyclohexyl)propanenitrile (<b>34</b>)</h3><div class="NLM_p last"><b>34</b> was synthesized by methods similar to those used for <b>31</b>, substituting 3-(<i>trans</i>-4-aminocyclohexyl)propanenitrile trifluoroacetic acid salt (<b>34a</b>)<a onclick="showRef(event, 'ref27'); return false;" href="javascript:void(0);" class="ref ref27">(27)</a> for <i>trans</i>-4-aminocyclohexanecarbonitrile trifluoroacetic acid salt (<b>31a</b>). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 11.82 (s, 1H), 8.54 (s, 1H), 7.47 (t, <i>J</i> = 3.0 Hz, 1H), 6.68 (t, <i>J</i> = 2.5 Hz, 1H), 5.64 (d, <i>J</i> = 5.5 Hz, 1H), 5.12 (p, <i>J</i> = 6.5 Hz, 1H), 4.90–4.73 (m, 1H), 2.61 (t, <i>J</i> = 7.3 Hz, 2H), 2.43–2.29 (m, 2H), 2.05–1.86 (m, 4H), 1.76–1.56 (m, 6H), 1.31–1.14 (m, 2H). LCMS (method LCMS1, ESI): RT = 6.13 min, <i>m</i>/<i>z</i> = 338.1 [M + H]<sup>+</sup>.</div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i67"><a href="/doi/suppl/10.1021/jm4004895">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_34260" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_34260" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Synthetic procedures for <b>16a</b>, <b>33a</b>, <b>34a</b>, and <b>25</b>; identities of kinases in Table <a class="ref showTableEvent internalNav" data-ID="tbl6" href="#tbl6">6</a> and % inhibition by <b>21</b>, <b>26</b>, <b>29</b>, <b>31</b>, <b>33</b>, and <b>34</b>; biochemical JAK3 and TYK2 <i>K</i><sub>i</sub> values of <b>1</b>–<b>34</b>; tabulated compound structures and data used to produce the graphs in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>. Details of: in vitro and in vivo ADME experimental procedures, JAK enzymatic and cellular assays (low serum and whole blood), in vitro hERG assay, CIA efficacy study of <b>31</b> in the rat, protein expression/purification, and crystallographic methods and procedures for <b>31</b> (in complex with JAK1 and JAK2) and <b>33</b> and <b>34</b> (in complex with JAK1), thermodynamic solubility methods, and analytical LCMS and SFC conditions. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm4004895/suppl_file/jm4004895_si_001.pdf">jm4004895_si_001.pdf (865.83 kb)</a></li></ul></div></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB numbers: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EHZ">4EHZ</a> for <b>2</b> complexed with JAK1, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4F09">4F09</a> for <b>2</b> complexed with JAK2, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IVB">4IVB</a> for <b>31</b> complexed with JAK1, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IVA">4IVA</a> for <b>31</b> complexed with JAK2, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IVC">4IVC</a> for <b>33</b> complexed with JAK1, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IVD">4IVD</a> for <b>34</b> complexed with JAK1.</p><div class="testing" data-doi="10.1021/jm4004895" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33418" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33418" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Author</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark Zak</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Safety Assessment, #Small Molecule Pharmaceutical Sciences, ▽Small Molecule Process Chemistry, ○Structural Biology, ◆Translational Immunology, Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong
Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#14796e757f5473717a713a777b79"><span class="__cf_email__" data-cfemail="b6dbccd7ddf6d1d3d8d398d5d9db">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher A. Hurley</span> - <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stuart I. Ward</span> - <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Philippe Bergeron</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Safety Assessment, #Small Molecule Pharmaceutical Sciences, ▽Small Molecule Process Chemistry, ○Structural Biology, ◆Translational Immunology, Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong
Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kathy Barrett</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Safety Assessment, #Small Molecule Pharmaceutical Sciences, ▽Small Molecule Process Chemistry, ○Structural Biology, ◆Translational Immunology, Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong
Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mercedesz Balazs</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Safety Assessment, #Small Molecule Pharmaceutical Sciences, ▽Small Molecule Process Chemistry, ○Structural Biology, ◆Translational Immunology, Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong
Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wade S. Blair</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Safety Assessment, #Small Molecule Pharmaceutical Sciences, ▽Small Molecule Process Chemistry, ○Structural Biology, ◆Translational Immunology, Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong
Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Richard Bull</span> - <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paroma Chakravarty</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Safety Assessment, #Small Molecule Pharmaceutical Sciences, ▽Small Molecule Process Chemistry, ○Structural Biology, ◆Translational Immunology, Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong
Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christine Chang</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Safety Assessment, #Small Molecule Pharmaceutical Sciences, ▽Small Molecule Process Chemistry, ○Structural Biology, ◆Translational Immunology, Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong
Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Crackett</span> - <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Gauri Deshmukh</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Safety Assessment, #Small Molecule Pharmaceutical Sciences, ▽Small Molecule Process Chemistry, ○Structural Biology, ◆Translational Immunology, Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong
Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jason DeVoss</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Safety Assessment, #Small Molecule Pharmaceutical Sciences, ▽Small Molecule Process Chemistry, ○Structural Biology, ◆Translational Immunology, Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong
Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter S. Dragovich</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Safety Assessment, #Small Molecule Pharmaceutical Sciences, ▽Small Molecule Process Chemistry, ○Structural Biology, ◆Translational Immunology, Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong
Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles Eigenbrot</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Safety Assessment, #Small Molecule Pharmaceutical Sciences, ▽Small Molecule Process Chemistry, ○Structural Biology, ◆Translational Immunology, Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong
Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Charles Ellwood</span> - <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Simon Gaines</span> - <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Nico Ghilardi</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Safety Assessment, #Small Molecule Pharmaceutical Sciences, ▽Small Molecule Process Chemistry, ○Structural Biology, ◆Translational Immunology, Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong
Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Paul Gibbons</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Safety Assessment, #Small Molecule Pharmaceutical Sciences, ▽Small Molecule Process Chemistry, ○Structural Biology, ◆Translational Immunology, Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong
Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stefan Gradl</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Safety Assessment, #Small Molecule Pharmaceutical Sciences, ▽Small Molecule Process Chemistry, ○Structural Biology, ◆Translational Immunology, Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong
Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Gribling</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Safety Assessment, #Small Molecule Pharmaceutical Sciences, ▽Small Molecule Process Chemistry, ○Structural Biology, ◆Translational Immunology, Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong
Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Chris Hamman</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Safety Assessment, #Small Molecule Pharmaceutical Sciences, ▽Small Molecule Process Chemistry, ○Structural Biology, ◆Translational Immunology, Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong
Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Eric Harstad</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Safety Assessment, #Small Molecule Pharmaceutical Sciences, ▽Small Molecule Process Chemistry, ○Structural Biology, ◆Translational Immunology, Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong
Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Peter Hewitt</span> - <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Adam Johnson</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Safety Assessment, #Small Molecule Pharmaceutical Sciences, ▽Small Molecule Process Chemistry, ○Structural Biology, ◆Translational Immunology, Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong
Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Tony Johnson</span> - <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jane R. Kenny</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Safety Assessment, #Small Molecule Pharmaceutical Sciences, ▽Small Molecule Process Chemistry, ○Structural Biology, ◆Translational Immunology, Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong
Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michael F. T. Koehler</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Safety Assessment, #Small Molecule Pharmaceutical Sciences, ▽Small Molecule Process Chemistry, ○Structural Biology, ◆Translational Immunology, Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong
Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Pawan Bir Kohli</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Safety Assessment, #Small Molecule Pharmaceutical Sciences, ▽Small Molecule Process Chemistry, ○Structural Biology, ◆Translational Immunology, Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong
Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Sharada Labadie</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Safety Assessment, #Small Molecule Pharmaceutical Sciences, ▽Small Molecule Process Chemistry, ○Structural Biology, ◆Translational Immunology, Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong
Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Wyne P. Lee</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Safety Assessment, #Small Molecule Pharmaceutical Sciences, ▽Small Molecule Process Chemistry, ○Structural Biology, ◆Translational Immunology, Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong
Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiangpeng Liao</span> - <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong
Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Marya Liimatta</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Safety Assessment, #Small Molecule Pharmaceutical Sciences, ▽Small Molecule Process Chemistry, ○Structural Biology, ◆Translational Immunology, Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong
Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rohan Mendonca</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Safety Assessment, #Small Molecule Pharmaceutical Sciences, ▽Small Molecule Process Chemistry, ○Structural Biology, ◆Translational Immunology, Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong
Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Raman Narukulla</span> - <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rebecca Pulk</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Safety Assessment, #Small Molecule Pharmaceutical Sciences, ▽Small Molecule Process Chemistry, ○Structural Biology, ◆Translational Immunology, Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong
Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Austin Reeve</span> - <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Scott Savage</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Safety Assessment, #Small Molecule Pharmaceutical Sciences, ▽Small Molecule Process Chemistry, ○Structural Biology, ◆Translational Immunology, Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong
Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Steven Shia</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Safety Assessment, #Small Molecule Pharmaceutical Sciences, ▽Small Molecule Process Chemistry, ○Structural Biology, ◆Translational Immunology, Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong
Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Micah Steffek</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Safety Assessment, #Small Molecule Pharmaceutical Sciences, ▽Small Molecule Process Chemistry, ○Structural Biology, ◆Translational Immunology, Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong
Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Savita Ubhayakar</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Safety Assessment, #Small Molecule Pharmaceutical Sciences, ▽Small Molecule Process Chemistry, ○Structural Biology, ◆Translational Immunology, Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong
Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anne van Abbema</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Safety Assessment, #Small Molecule Pharmaceutical Sciences, ▽Small Molecule Process Chemistry, ○Structural Biology, ◆Translational Immunology, Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong
Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Ignacio Aliagas</span> - <span class="hlFld-Affiliation affiliation">†Departments
of Discovery Chemistry, ‡Biochemical and Cellular Pharmacology, §Drug Metabolism and
Pharmacokinetics, ∥Immunology, ⊥Safety Assessment, #Small Molecule Pharmaceutical Sciences, ▽Small Molecule Process Chemistry, ○Structural Biology, ◆Translational Immunology, Genentech, Inc., 1 DNA Way, South San
Francisco, California 94080, United States</span>; 
    <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span>; 
    <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong
Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Barbara Avitabile-Woo</span> - <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Yisong Xiao</span> - <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong
Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jing Yang</span> - <span class="hlFld-Affiliation affiliation">WuXi AppTec Co., Ltd., 288 Fute Zhong
Road, Waigaoqiao Free Trade Zone, Shanghai 200131, P. R. China</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Janusz J. Kulagowski</span> - <span class="hlFld-Affiliation affiliation">Argenta, 8/9 Spire Green Centre,
Flex Meadow, Harlow, Essex CM19 5TR, United Kingdom</span></div></li></ul></li><li><span class="author-information-subsection-header">Author Contributions</span><p>The manuscript was written through contributions of all authors. All authors have given approval to the final version of the manuscript.</p></li><li></li><li><span class="author-information-subsection-header">Notes</span><p>The authors declare no competing financial interest.<br /></br></p></li></ul></div><div class="ack" id="ACK-d7e7072-autogenerated"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i70">Acknowledgment</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_27654" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_27654" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">We thank Michael Hayes, Mengling Wong, Baiwei Lin, Deven Wang, Yutao Jiang, and Yanzhou Liu for purification and analytical support; Daniel Hascall, Grady Howes, Gigi Yuen, Garima Porwal, and Mandy Yim for compound management support; Hoa Le and Qin Yue for ADME support; Emile Plise and Jonathan Cheng for MDCK data; Erlie Delarosa for hepatocyte stability; Ning Liu for microsomal stability studies; Suzanne Tay for TDI studies; Jasleen Sodhi for reversible CYP inhibition measurement; Quynh Ho for plasma protein binding measurement; Wei Jia, Po-Chang (Tom) Chiang, and Amy Sambrone for formulations support; Zhiyu Huang for collation of data from the rat CIA study.</p></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i71" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i71"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i72" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i72"> Abbreviations Used</h2><tr><td class="NLM_term">ADME</td><td class="NLM_def"><p class="first last">absorption, distribution, metabolism, and excretion</p></td></tr><tr><td class="NLM_term">AUC</td><td class="NLM_def"><p class="first last">area under the curve</p></td></tr><tr><td class="NLM_term">Bn</td><td class="NLM_def"><p class="first last">benzyl</p></td></tr><tr><td class="NLM_term">Boc</td><td class="NLM_def"><p class="first last"><i>tert</i>-butyl carbamate</p></td></tr><tr><td class="NLM_term">brine</td><td class="NLM_def"><p class="first last">a saturated aqueous solution of sodium chloride</p></td></tr><tr><td class="NLM_term">CH<sub>3</sub>CN</td><td class="NLM_def"><p class="first last">acetonitrile</p></td></tr><tr><td class="NLM_term">CIA</td><td class="NLM_def"><p class="first last">collagen induced arthritis</p></td></tr><tr><td class="NLM_term">CL</td><td class="NLM_def"><p class="first last">clearance</p></td></tr><tr><td class="NLM_term">CL<sub>H</sub></td><td class="NLM_def"><p class="first last">hepatic clearance, CL<sub>int</sub>, intrinsic clearance</p></td></tr><tr><td class="NLM_term">cLogD<sub>7.4</sub></td><td class="NLM_def"><p class="first last">calculated log of partition coefficient between octanol and pH<sub>7.4</sub> aqueous buffer</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>max</sub></td><td class="NLM_def"><p class="first last">maximum concentration</p></td></tr><tr><td class="NLM_term">CYP</td><td class="NLM_def"><p class="first last">cytochrome P450</p></td></tr><tr><td class="NLM_term">D</td><td class="NLM_def"><p class="first last">aspartic acid</p></td></tr><tr><td class="NLM_term">DCM</td><td class="NLM_def"><p class="first last">dichloromethane</p></td></tr><tr><td class="NLM_term">DEA</td><td class="NLM_def"><p class="first last">diethylamine, DIPEA, <i>N</i>,<i>N</i>-diisopropylethylamine</p></td></tr><tr><td class="NLM_term">DMF</td><td class="NLM_def"><p class="first last">dimethylformamide</p></td></tr><tr><td class="NLM_term">DMSO</td><td class="NLM_def"><p class="first last">dimethylsulfoxide</p></td></tr><tr><td class="NLM_term">E</td><td class="NLM_def"><p class="first last">glutamic acid</p></td></tr><tr><td class="NLM_term">EC<sub>50</sub></td><td class="NLM_def"><p class="first last">half-maximal effective concentration</p></td></tr><tr><td class="NLM_term">EPO</td><td class="NLM_def"><p class="first last">erythropoietin</p></td></tr><tr><td class="NLM_term">EtOAc</td><td class="NLM_def"><p class="first last">ethyl acetate</p></td></tr><tr><td class="NLM_term">EtOH</td><td class="NLM_def"><p class="first last">ethanol</p></td></tr><tr><td class="NLM_term">ex</td><td class="NLM_def"><p class="first last">example</p></td></tr><tr><td class="NLM_term"><i>F</i></td><td class="NLM_def"><p class="first last">oral bioavailability</p></td></tr><tr><td class="NLM_term"><i>F</i><sub>max</sub></td><td class="NLM_def"><p class="first last">theoretical maximum achievable oral bioavailability</p></td></tr><tr><td class="NLM_term">h</td><td class="NLM_def"><p class="first last">hour</p></td></tr><tr><td class="NLM_term">HBD</td><td class="NLM_def"><p class="first last">hydrogen-bond donor</p></td></tr><tr><td class="NLM_term">hERG</td><td class="NLM_def"><p class="first last">human ether-a-go-go-related gene</p></td></tr><tr><td class="NLM_term">HLM</td><td class="NLM_def"><p class="first last">human liver microsome</p></td></tr><tr><td class="NLM_term">HPLC</td><td class="NLM_def"><p class="first last">high performance liquid chromatography</p></td></tr><tr><td class="NLM_term">IL-6</td><td class="NLM_def"><p class="first last">interleukin-6</p></td></tr><tr><td class="NLM_term"><i>i</i>-PrOH</td><td class="NLM_def"><p class="first last">isopropyl alcohol</p></td></tr><tr><td class="NLM_term">IV</td><td class="NLM_def"><p class="first last">intravenous</p></td></tr><tr><td class="NLM_term">JAK</td><td class="NLM_def"><p class="first last">Janus kinase</p></td></tr><tr><td class="NLM_term">JAK1 biochemical selectivity index</td><td class="NLM_def"><p class="first last">JAK2 <i>K</i><sub>i</sub> ÷ JAK1 <i>K</i><sub>i</sub></p></td></tr><tr><td class="NLM_term">JAK1 cellular selectivity index</td><td class="NLM_def"><p class="first last">EPO-pSTAT5 EC<sub>50</sub> ÷ IL6-pSTAT3 EC<sub>50</sub></p></td></tr><tr><td class="NLM_term"><i>K</i><sub>i</sub></td><td class="NLM_def"><p class="first last">inhibition constant</p></td></tr><tr><td class="NLM_term">LCMS</td><td class="NLM_def"><p class="first last">liquid chromatography–mass spectrometry</p></td></tr><tr><td class="NLM_term">LE</td><td class="NLM_def"><p class="first last">ligand efficiency</p></td></tr><tr><td class="NLM_term">LLE</td><td class="NLM_def"><p class="first last">ligand-lipophilicity efficiency</p></td></tr><tr><td class="NLM_term">MCT</td><td class="NLM_def"><p class="first last">methyl cellulose/Tween</p></td></tr><tr><td class="NLM_term">MDCK</td><td class="NLM_def"><p class="first last">Madin–Darby canine kidney</p></td></tr><tr><td class="NLM_term">MeOH</td><td class="NLM_def"><p class="first last">methanol</p></td></tr><tr><td class="NLM_term">min</td><td class="NLM_def"><p class="first last">minute</p></td></tr><tr><td class="NLM_term"><i>P</i><sub>app</sub></td><td class="NLM_def"><p class="first last">apparent permeability</p></td></tr><tr><td class="NLM_term">PEG400</td><td class="NLM_def"><p class="first last">polyethylene glycol 400</p></td></tr><tr><td class="NLM_term">Ph</td><td class="NLM_def"><p class="first last">phenyl</p></td></tr><tr><td class="NLM_term">PK</td><td class="NLM_def"><p class="first last">pharmacokinetics</p></td></tr><tr><td class="NLM_term">PO</td><td class="NLM_def"><p class="first last">by mouth</p></td></tr><tr><td class="NLM_term">PPB</td><td class="NLM_def"><p class="first last">plasma protein binding</p></td></tr><tr><td class="NLM_term">PSI</td><td class="NLM_def"><p class="first last">pounds per square inch</p></td></tr><tr><td class="NLM_term">RA</td><td class="NLM_def"><p class="first last">rheumatoid arthritis</p></td></tr><tr><td class="NLM_term">RT</td><td class="NLM_def"><p class="first last">retention time</p></td></tr><tr><td class="NLM_term">SAR</td><td class="NLM_def"><p class="first last">structure–activity relationships</p></td></tr><tr><td class="NLM_term">SFC</td><td class="NLM_def"><p class="first last">supercritical fluid chromatography</p></td></tr><tr><td class="NLM_term">STAT</td><td class="NLM_def"><p class="first last">signal transducer and activator of transcription</p></td></tr><tr><td class="NLM_term">(tmp)<sub>2</sub>Mg·2LiCl</td><td class="NLM_def"><p class="first last">2,2,6,6-tetramethylpiperidinemagnesium chloride lithium chloride complex</p></td></tr><tr><td class="NLM_term">TEA</td><td class="NLM_def"><p class="first last">triethylamine</p></td></tr><tr><td class="NLM_term">TFA</td><td class="NLM_def"><p class="first last">trifluoroacetic acid</p></td></tr><tr><td class="NLM_term">THF</td><td class="NLM_def"><p class="first last">tetrahydrofuran</p></td></tr><tr><td class="NLM_term">TPSA</td><td class="NLM_def"><p class="first last">topological polar surface area</p></td></tr><tr><td class="NLM_term">UV</td><td class="NLM_def"><p class="first last">ultraviolet</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i73">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_33684" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_33684" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 33 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span> </span><span class="NLM_article-title">Jaks, STATs, cytokine signal transduction, and immunoregulation: are we there yet?</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=1-11&author=J.+J.+O%E2%80%99Shea&title=Jaks%2C+STATs%2C+cytokine+signal+transduction%2C+and+immunoregulation%3A+are+we+there+yet%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DJaks%252C%2520STATs%252C%2520cytokine%2520signal%2520transduction%252C%2520and%2520immunoregulation%253A%2520are%2520we%2520there%2520yet%253F%26jtitle%3DImmunity%26date%3D1997%26volume%3D7%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pesu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurence, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishore, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwillich, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span> </span><span class="NLM_article-title">Therapeutic targeting of Janus kinases</span> <span class="citation_source-journal">Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">223</span><span class="NLM_x">, </span> <span class="NLM_fpage">132</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm4004895&amp;key=10.1111%2Fj.1600-065X.2008.00644.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm4004895&amp;key=18613833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptlGls7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=223&publication_year=2008&pages=132-142&author=M.+Pesuauthor=A.+Laurenceauthor=N.+Kishoreauthor=S.+H.+Zwillichauthor=G.+Chanauthor=J.+J.+O%E2%80%99Shea&title=Therapeutic+targeting+of+Janus+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of Janus kinases</span></div><div class="casAuthors">Pesu, Marko; Laurence, Arian; Kishore, Nandini; Zwillich, Samuel H.; Chan, Gary; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">223</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">132-142</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Cytokines play pivotal roles in immunity and inflammation, and targeting cytokines and their receptors is an effective means of treating such disorders.  Type I and II cytokine receptors assoc. with Janus family kinases (JAKs) to effect intracellular signaling.  These structurally unique protein kinases play essential and specific roles in immune cell development and function.  One JAK, JAK3, has particularly selective functions.  Mutations of this kinase underlie severe combined immunodeficiency, indicative of its crit. role in the development and function of lymphocytes.  Because JAK3 appears not to have functions outside of hematopoietic cells, this kinase has been viewed as an excellent therapeutic target for the development of a new class of immunosuppressive drugs.  In fact, several companies are developing JAK3 inhibitors, and Phase II studies are underway.  Mutations of Tyk2 cause autosomal recessive hyperIgE syndrome, and in principle, Tyk2 inhibitors might also be useful as immunosuppressive drugs.  JAK2 gain-of-function mutations (V617F) underlie a subset of disorders collectively referred to as myeloproliferative diseases and phase 2 trials using JAK inhibitors are underway in this setting.  Thus, we are learning a great deal about the feasibility and effectiveness of targeting Janus kinases, and it appears likely that this will be a fruitful strategy in a variety of settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-VTmlwlhcv7Vg90H21EOLACvtfcHk0ljIZRoKGYVp-Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptlGls7c%253D&md5=73dc15932d0eaa312bc2588bdbce404c</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2008.00644.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2008.00644.x%26sid%3Dliteratum%253Aachs%26aulast%3DPesu%26aufirst%3DM.%26aulast%3DLaurence%26aufirst%3DA.%26aulast%3DKishore%26aufirst%3DN.%26aulast%3DZwillich%26aufirst%3DS.%2BH.%26aulast%3DChan%26aufirst%3DG.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DTherapeutic%2520targeting%2520of%2520Janus%2520kinases%26jtitle%3DImmunol.%2520Rev.%26date%3D2008%26volume%3D223%26spage%3D132%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2"><span><span class="NLM_contrib-group">O’Shea, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borie, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changelian, P. S.</span><span> </span><span class="NLM_article-title">A new modality for immunosuppression: targeting the JAK/STAT pathway</span> <span class="citation_source-journal">Nature Rev. Drug. Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">555</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=555-564&author=J.+J.+O%E2%80%99Sheaauthor=M.+Pesuauthor=D.+C.+Borieauthor=P.+S.+Changelian&title=A+new+modality+for+immunosuppression%3A+targeting+the+JAK%2FSTAT+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DPesu%26aufirst%3DM.%26aulast%3DBorie%26aufirst%3DD.%2BC.%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26atitle%3DA%2520new%2520modality%2520for%2520immunosuppression%253A%2520targeting%2520the%2520JAK%252FSTAT%2520pathway%26jtitle%3DNature%2520Rev.%2520Drug.%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D555%26epage%3D564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Clark, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamen, R.</span><span> </span><span class="NLM_article-title">The human hematopoietic colony-stimulating factors</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">236</span><span class="NLM_x">, </span> <span class="NLM_fpage">1229</span><span class="NLM_x">–</span> <span class="NLM_lpage">1237</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=236&publication_year=1987&pages=1229-1237&author=S.+C.+Clarkauthor=R.+Kamen&title=The+human+hematopoietic+colony-stimulating+factors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DS.%2BC.%26aulast%3DKamen%26aufirst%3DR.%26atitle%3DThe%2520human%2520hematopoietic%2520colony-stimulating%2520factors%26jtitle%3DScience%26date%3D1987%26volume%3D236%26spage%3D1229%26epage%3D1237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Metcalf, D.</span><span> </span><span class="NLM_article-title">The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=1989&pages=27-30&author=D.+Metcalf&title=The+molecular+control+of+cell+division%2C+differentiation+commitment+and+maturation+in+haemopoietic+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMetcalf%26aufirst%3DD.%26atitle%3DThe%2520molecular%2520control%2520of%2520cell%2520division%252C%2520differentiation%2520commitment%2520and%2520maturation%2520in%2520haemopoietic%2520cells%26jtitle%3DNature%26date%3D1989%26volume%3D339%26spage%3D27%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Witthuhn, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quelle, F. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvennoinen, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miura, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihle, J. N.</span><span> </span><span class="NLM_article-title">JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">236</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=1993&pages=227-236&author=B.+A.+Witthuhnauthor=F.+W.+Quelleauthor=O.+Silvennoinenauthor=T.+Yiauthor=B.+Tangauthor=O.+Miuraauthor=J.+N.+Ihle&title=JAK2+associates+with+the+erythropoietin+receptor+and+is+tyrosine+phosphorylated+and+activated+following+stimulation+with+erythropoietin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWitthuhn%26aufirst%3DB.%2BA.%26aulast%3DQuelle%26aufirst%3DF.%2BW.%26aulast%3DSilvennoinen%26aufirst%3DO.%26aulast%3DYi%26aufirst%3DT.%26aulast%3DTang%26aufirst%3DB.%26aulast%3DMiura%26aufirst%3DO.%26aulast%3DIhle%26aufirst%3DJ.%2BN.%26atitle%3DJAK2%2520associates%2520with%2520the%2520erythropoietin%2520receptor%2520and%2520is%2520tyrosine%2520phosphorylated%2520and%2520activated%2520following%2520stimulation%2520with%2520erythropoietin%26jtitle%3DCell%26date%3D1993%26volume%3D74%26spage%3D227%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Lin, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meloni, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galya, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span> </span><span class="NLM_article-title">Enantioselective synthesis of Janus kinase inhibitor INCB018424 via an organocatalytic aza-Michael reaction</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1999</span><span class="NLM_x">–</span> <span class="NLM_lpage">2002</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol900350k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=1999-2002&author=Q.+Linauthor=D.+Meloniauthor=Y.+Panauthor=M.+Xiaauthor=J.+Rodgersauthor=S.+Shepardauthor=M.+Liauthor=L.+Galyaauthor=B.+Metcalfauthor=T.+Y.+Yueauthor=P.+Liuauthor=J.+Zhou&title=Enantioselective+synthesis+of+Janus+kinase+inhibitor+INCB018424+via+an+organocatalytic+aza-Michael+reaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fol900350k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol900350k%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DQ.%26aulast%3DMeloni%26aufirst%3DD.%26aulast%3DPan%26aufirst%3DY.%26aulast%3DXia%26aufirst%3DM.%26aulast%3DRodgers%26aufirst%3DJ.%26aulast%3DShepard%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DGalya%26aufirst%3DL.%26aulast%3DMetcalf%26aufirst%3DB.%26aulast%3DYue%26aufirst%3DT.%2BY.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DEnantioselective%2520synthesis%2520of%2520Janus%2520kinase%2520inhibitor%2520INCB018424%2520via%2520an%2520organocatalytic%2520aza-Michael%2520reaction%26jtitle%3DOrg.%2520Lett.%26date%3D2009%26volume%3D11%26spage%3D1999%26epage%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Flanagan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blumenkopf, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brissette, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casavant, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shang-Poa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doty, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hines, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kent, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudlacz, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lillie, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCurdy, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munchhof, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strelevitz, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanyam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whipple, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changelian, P. S.</span><span> </span><span class="NLM_article-title">Discovery of CP-690,550: a potent and selective Janus kinase (JAK) inhibitor for the treatment of autoimmune diseases and organ transplant rejection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8468</span><span class="NLM_x">–</span> <span class="NLM_lpage">8484</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1004286" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVOgt7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8468-8484&author=M.+E.+Flanaganauthor=T.+A.+Blumenkopfauthor=W.+H.+Brissetteauthor=M.+F.+Brownauthor=J.+M.+Casavantauthor=C.+Shang-Poaauthor=J.+L.+Dotyauthor=E.+A.+Elliottauthor=M.+B.+Fisherauthor=M.+Hinesauthor=C.+Kentauthor=E.+M.+Kudlaczauthor=B.+M.+Lillieauthor=K.+S.+Magnusonauthor=S.+P.+McCurdyauthor=M.+J.+Munchhofauthor=B.+D.+Perryauthor=P.+S.+Sawyerauthor=T.+J.+Strelevitzauthor=C.+Subramanyamauthor=J.+Sunauthor=D.+A.+Whippleauthor=P.+S.+Changelian&title=Discovery+of+CP-690%2C550%3A+a+potent+and+selective+Janus+kinase+%28JAK%29+inhibitor+for+the+treatment+of+autoimmune+diseases+and+organ+transplant+rejection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of CP-690,550: A Potent and Selective Janus Kinase (JAK) Inhibitor for the Treatment of Autoimmune Diseases and Organ Transplant Rejection</span></div><div class="casAuthors">Flanagan, Mark E.; Blumenkopf, Todd A.; Brissette, William H.; Brown, Matthew F.; Casavant, Jeffrey M.; Chang, Shang-Poa; Doty, Jonathan L.; Elliott, Eileen A.; Fisher, Michael B.; Hines, Michael; Kent, Craig; Kudlacz, Elizabeth M.; Lillie, Brett M.; Magnuson, Kelly S.; McCurdy, Sandra P.; Munchhof, Michael J.; Perry, Bret D.; Sawyer, Perry S.; Strelevitz, Timothy J.; Subramanyam, Chakrapani; Sun, Jianmin; Whipple, David A.; Changelian, Paul S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8468-8484</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is a crit. need for safer and more convenient treatments for organ transplant rejection and autoimmune disorders such as rheumatoid arthritis.  Janus tyrosine kinases (JAK1, JAK3) are expressed in lymphoid cells and are involved in the signaling of multiple cytokines important for various T cell functions.  Blockade of the JAK1/JAK3-STAT pathway with a small mol. was anticipated to provide therapeutic immunosuppression/immunomodulation.  The Pfizer compd. library was screened against the catalytic domain of JAK3 resulting in the identification of a pyrrolopyrimidine-based series of inhibitors represented by the hexahydrocarbazolyl pyrrolopyrimidine CP-352,664.  Synthetic analogs of CP-352,664 were screened against the JAK enzymes and evaluated in an IL-2 induced T cell blast proliferation assay.  Select compds. were evaluated in rodent efficacy models of allograft rejection and destructive inflammatory arthritis.  Optimization within this chem. series led to identification of the cyanoacetylpiperidinylamino pyrrolopyrimidine CP-690,550, a potential first-in-class JAK inhibitor for treatment of autoimmune diseases and organ transplant rejection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbFS_8DSHkDbVg90H21EOLACvtfcHk0ljaukz1KieH0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVOgt7vP&md5=c1d31ce42ab3f1c1f3029c6f4f48df1a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm1004286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1004286%26sid%3Dliteratum%253Aachs%26aulast%3DFlanagan%26aufirst%3DM.%2BE.%26aulast%3DBlumenkopf%26aufirst%3DT.%2BA.%26aulast%3DBrissette%26aufirst%3DW.%2BH.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DCasavant%26aufirst%3DJ.%2BM.%26aulast%3DShang-Poa%26aufirst%3DC.%26aulast%3DDoty%26aufirst%3DJ.%2BL.%26aulast%3DElliott%26aufirst%3DE.%2BA.%26aulast%3DFisher%26aufirst%3DM.%2BB.%26aulast%3DHines%26aufirst%3DM.%26aulast%3DKent%26aufirst%3DC.%26aulast%3DKudlacz%26aufirst%3DE.%2BM.%26aulast%3DLillie%26aufirst%3DB.%2BM.%26aulast%3DMagnuson%26aufirst%3DK.%2BS.%26aulast%3DMcCurdy%26aufirst%3DS.%2BP.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DPerry%26aufirst%3DB.%2BD.%26aulast%3DSawyer%26aufirst%3DP.%2BS.%26aulast%3DStrelevitz%26aufirst%3DT.%2BJ.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DWhipple%26aufirst%3DD.%2BA.%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26atitle%3DDiscovery%2520of%2520CP-690%252C550%253A%2520a%2520potent%2520and%2520selective%2520Janus%2520kinase%2520%2528JAK%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520autoimmune%2520diseases%2520and%2520organ%2520transplant%2520rejection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8468%26epage%3D8484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6"><span>INCB018424/Ruxolitnib/Jakafi is FDA-approved for the treatment of myelofibrosis. Incyte Press Release. <a href="http://investor.incyte.com/phoenix.zhtmL?c=69764&amp;p=irol-newsArticle&amp;ID=1631201&amp;highlight" class="extLink">http://investor.incyte.com/phoenix.zhtmL?c=69764&p=irol-newsArticle&ID=1631201&highlight</a> (accessed March 27, 2013). CP-690,550/Tofacitinib/Xeljanz is FDA-approved for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response or intolerance to methotrexate. Pfizer Press Release. <a href="http://press.pfizer.com/press-release/multimedia-us-food-and-drug-administration-approves-pfizers-xeljanz-tofacitinib-citrat" class="extLink">http://press.pfizer.com/press-release/multimedia-us-food-and-drug-administration-approves-pfizers-xeljanz-tofacitinib-citrat</a> (accessed March 27, 2013).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=INCB018424%2FRuxolitnib%2FJakafi+is+FDA-approved+for+the+treatment+of+myelofibrosis.+Incyte+Press+Release.+http%3A%2F%2Finvestor.incyte.com%2Fphoenix.zhtmL%3Fc%3D69764%26p%3Dirol-newsArticle%26ID%3D1631201%26highlight+%28accessed+March+27%2C+2013%29.+CP-690%2C550%2FTofacitinib%2FXeljanz+is+FDA-approved+for+the+treatment+of+adults+with+moderately+to+severely+active+rheumatoid+arthritis+%28RA%29+who+have+had+an+inadequate+response+or+intolerance+to+methotrexate.+Pfizer+Press+Release.+http%3A%2F%2Fpress.pfizer.com%2Fpress-release%2Fmultimedia-us-food-and-drug-administration-approves-pfizers-xeljanz-tofacitinib-citrat+%28accessed+March+27%2C+2013%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Zak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendonca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balazs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeVoss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragovich, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eigenbrot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghilardi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gradl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanan, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harstad, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koehler, M. F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bir Kohli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulagowski, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labadie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liimatta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupardus, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxey, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubhayakar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Abbema, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span> </span><span class="NLM_article-title">Discovery and optimization of <i>C</i>-2 methyl imidazopyrrolopyridines as potent and orally bioavailable JAK1 inhibitors with selectivity over JAK2</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6176</span><span class="NLM_x">–</span> <span class="NLM_lpage">6193</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300628c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BC38Xos1SmtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6176-6193&author=M.+Zakauthor=R.+Mendoncaauthor=M.+Balazsauthor=K.+Barrettauthor=P.+Bergeronauthor=W.+S.+Blairauthor=C.+Changauthor=G.+Deshmukhauthor=J.+DeVossauthor=P.+S.+Dragovichauthor=C.+Eigenbrotauthor=N.+Ghilardiauthor=P.+Gibbonsauthor=S.+Gradlauthor=C.+Hammanauthor=E.+J.+Hananauthor=E.+Harstadauthor=P.+R.+Hewittauthor=C.+A.+Hurleyauthor=T.+Jinauthor=A.+Johnsonauthor=T.+Johnsonauthor=J.+R.+Kennyauthor=M.+F.+T.+Koehlerauthor=P.+Bir+Kohliauthor=J.+J.+Kulagowskiauthor=S.+Labadieauthor=J.+Liaoauthor=M.+Liimattaauthor=Z.+Linauthor=P.+J.+Lupardusauthor=R.+J.+Maxeyauthor=J.+M.+Murrayauthor=R.+Pulkauthor=M.+Rodriguezauthor=S.+Savageauthor=S.+Shiaauthor=M.+Steffekauthor=S.+Ubhayakarauthor=M.+Ultschauthor=A.+van+Abbemaauthor=S.+I.+Wardauthor=L.+Xiaoauthor=Y.+Xiao&title=Discovery+and+optimization+of+C-2+methyl+imidazopyrrolopyridines+as+potent+and+orally+bioavailable+JAK1+inhibitors+with+selectivity+over+JAK2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of C-2 Methyl Imidazopyrrolopyridines as Potent and Orally Bioavailable JAK1 Inhibitors with Selectivity over JAK2</span></div><div class="casAuthors">Zak, Mark; Mendonca, Rohan; Balazs, Mercedesz; Barrett, Kathy; Bergeron, Philippe; Blair, Wade S.; Chang, Christine; Deshmukh, Gauri; DeVoss, Jason; Dragovich, Peter S.; Eigenbrot, Charles; Ghilardi, Nico; Gibbons, Paul; Gradl, Stefan; Hamman, Chris; Hanan, Emily J.; Harstad, Eric; Hewitt, Peter R.; Hurley, Christopher A.; Jin, Tian; Johnson, Adam; Johnson, Tony; Kenny, Jane R.; Koehler, Michael F. T.; Bir Kohli, Pawan; Kulagowski, Janusz J.; Labadie, Sharada; Liao, Jiangpeng; Liimatta, Marya; Lin, Zhonghua; Lupardus, Patrick J.; Maxey, Robert J.; Murray, Jeremy M.; Pulk, Rebecca; Rodriguez, Madeleine; Savage, Scott; Shia, Steven; Steffek, Micah; Ubhayakar, Savita; Ultsch, Mark; van Abbema, Anne; Ward, Stuart I.; Xiao, Ling; Xiao, Yisong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6176-6193</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein we report the discovery of the C-2 Me substituted imidazopyrrolopyridine series and its optimization to provide potent and orally bioavailable JAK1 inhibitors with selectivity over JAK2.  The C-2 Me substituted inhibitor 4 exhibited not only improved JAK1 potency relative to unsubstituted compd. 3 but also notable JAK1 vs JAK2 selectivity (20-fold and >33-fold in biochem. and cell-based assays, resp.).  Features of the X-ray structures of 4 in complex with both JAK1 and JAK2 are delineated.  Efforts to improve the in vitro and in vivo ADME properties of 4 while maintaining JAK1 selectivity are described, culminating in the discovery of a highly optimized and balanced inhibitor (20).  Details of the biol. characterization of 20 are disclosed including JAK1 vs JAK2 selectivity levels, preclin. in vivo PK profiles, performance in an in vivo JAK1-mediated PK/PD model, and attributes of an X-ray structure in complex with JAK1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpogQqQMRvwKbVg90H21EOLACvtfcHk0ljaukz1KieH0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xos1SmtLg%253D&md5=8c57a4cb02fc245ed12f6f4efdb82318</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm300628c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300628c%26sid%3Dliteratum%253Aachs%26aulast%3DZak%26aufirst%3DM.%26aulast%3DMendonca%26aufirst%3DR.%26aulast%3DBalazs%26aufirst%3DM.%26aulast%3DBarrett%26aufirst%3DK.%26aulast%3DBergeron%26aufirst%3DP.%26aulast%3DBlair%26aufirst%3DW.%2BS.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DDeVoss%26aufirst%3DJ.%26aulast%3DDragovich%26aufirst%3DP.%2BS.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DGhilardi%26aufirst%3DN.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DGradl%26aufirst%3DS.%26aulast%3DHamman%26aufirst%3DC.%26aulast%3DHanan%26aufirst%3DE.%2BJ.%26aulast%3DHarstad%26aufirst%3DE.%26aulast%3DHewitt%26aufirst%3DP.%2BR.%26aulast%3DHurley%26aufirst%3DC.%2BA.%26aulast%3DJin%26aufirst%3DT.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DKenny%26aufirst%3DJ.%2BR.%26aulast%3DKoehler%26aufirst%3DM.%2BF.%2BT.%26aulast%3DBir%2BKohli%26aufirst%3DP.%26aulast%3DKulagowski%26aufirst%3DJ.%2BJ.%26aulast%3DLabadie%26aufirst%3DS.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DLupardus%26aufirst%3DP.%2BJ.%26aulast%3DMaxey%26aufirst%3DR.%2BJ.%26aulast%3DMurray%26aufirst%3DJ.%2BM.%26aulast%3DPulk%26aufirst%3DR.%26aulast%3DRodriguez%26aufirst%3DM.%26aulast%3DSavage%26aufirst%3DS.%26aulast%3DShia%26aufirst%3DS.%26aulast%3DSteffek%26aufirst%3DM.%26aulast%3DUbhayakar%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%26aulast%3Dvan%2BAbbema%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DS.%2BI.%26aulast%3DXiao%26aufirst%3DL.%26aulast%3DXiao%26aufirst%3DY.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520C-2%2520methyl%2520imidazopyrrolopyridines%2520as%2520potent%2520and%2520orally%2520bioavailable%2520JAK1%2520inhibitors%2520with%2520selectivity%2520over%2520JAK2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6176%26epage%3D6193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="note"><p class="first last">A summary of previous disclosures of compounds exhibiting JAK1 vs JAK2 selectivity is presented in ref <a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">9</a>. Additionally, a number of publications describing JAK2 inhibitors with varying JAK family and other kinase selectivity profiles have appeared recently. These include:</p></div><div class="NLM_citation" id="cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Schenkel, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deak, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emkey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunaydin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivieri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pistillo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geuns-Meyer, S.</span><span> </span><span class="NLM_article-title">Discovery of potent and highly selective thienopyridine Janus kinase 2 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">8440</span><span class="NLM_x">–</span> <span class="NLM_lpage">8450</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200911r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8440-8450&author=L.+B.+Schenkelauthor=X.+Huangauthor=A.+Chengauthor=H.+L.+Deakauthor=E.+Dohertyauthor=R.+Emkeyauthor=Y.+Guauthor=H.+Gunaydinauthor=J.+L.+Kimauthor=J.+Leeauthor=R.+Lobergauthor=P.+Olivieriauthor=J.+Pistilloauthor=J.+Tangauthor=Q.+Wanauthor=H.+L.+Wangauthor=S.+W.+Wangauthor=M.+C.+Wellsauthor=B.+Wuauthor=V.+Yuauthor=L.+Liuauthor=S.+Geuns-Meyer&title=Discovery+of+potent+and+highly+selective+thienopyridine+Janus+kinase+2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1021%2Fjm200911r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200911r%26sid%3Dliteratum%253Aachs%26aulast%3DSchenkel%26aufirst%3DL.%2BB.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DA.%26aulast%3DDeak%26aufirst%3DH.%2BL.%26aulast%3DDoherty%26aufirst%3DE.%26aulast%3DEmkey%26aufirst%3DR.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLoberg%26aufirst%3DR.%26aulast%3DOlivieri%26aufirst%3DP.%26aulast%3DPistillo%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DH.%2BL.%26aulast%3DWang%26aufirst%3DS.%2BW.%26aulast%3DWells%26aufirst%3DM.%2BC.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DGeuns-Meyer%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520highly%2520selective%2520thienopyridine%2520Janus%2520kinase%25202%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8440%26epage%3D8450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taoka, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otte, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinsmore, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenstein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewczak, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zugay-Murphy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. R.</span><span> </span><span class="NLM_article-title">Discovery of 1-amino-5<i>H</i>-pyrido[4,3-<i>b</i>]indol-4-carboxamide inhibitors of Janus kinase 2 (JAK2) for the treatment of myeloproliferative disorder</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7334</span><span class="NLM_x">–</span> <span class="NLM_lpage">7349</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200909u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7334-7349&author=J.+Limauthor=B.+Taokaauthor=R.+D.+Otteauthor=K.+Spencerauthor=C.+J.+Dinsmoreauthor=M.+D.+Altmanauthor=G.+Chanauthor=C.+Rosensteinauthor=S.+Sharmaauthor=H.+P.+Suauthor=A.+A.+Szewczakauthor=L.+Xuauthor=H.+Yinauthor=J.+Zugay-Murphyauthor=C.+G.+Marshallauthor=J.+R.+Young&title=Discovery+of+1-amino-5H-pyrido%5B4%2C3-b%5Dindol-4-carboxamide+inhibitors+of+Janus+kinase+2+%28JAK2%29+for+the+treatment+of+myeloproliferative+disorder"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1021%2Fjm200909u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200909u%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DJ.%26aulast%3DTaoka%26aufirst%3DB.%26aulast%3DOtte%26aufirst%3DR.%2BD.%26aulast%3DSpencer%26aufirst%3DK.%26aulast%3DDinsmore%26aufirst%3DC.%2BJ.%26aulast%3DAltman%26aufirst%3DM.%2BD.%26aulast%3DChan%26aufirst%3DG.%26aulast%3DRosenstein%26aufirst%3DC.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DSu%26aufirst%3DH.%2BP.%26aulast%3DSzewczak%26aufirst%3DA.%2BA.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DZugay-Murphy%26aufirst%3DJ.%26aulast%3DMarshall%26aufirst%3DC.%2BG.%26aulast%3DYoung%26aufirst%3DJ.%2BR.%26atitle%3DDiscovery%2520of%25201-amino-5H-pyrido%255B4%252C3-b%255Dindol-4-carboxamide%2520inhibitors%2520of%2520Janus%2520kinase%25202%2520%2528JAK2%2529%2520for%2520the%2520treatment%2520of%2520myeloproliferative%2520disorder%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7334%26epage%3D7349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Siu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozina, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenstein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathur, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mo, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouthillette, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rush, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinsmore, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. R.</span><span> </span><span class="NLM_article-title">The discovery of tricyclic pyridone JAK2 inhibitors. Part 1: hit to lead</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">7421</span><span class="NLM_x">–</span> <span class="NLM_lpage">7425</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=7421-7425&author=T.+Siuauthor=E.+S.+Kozinaauthor=J.+Jungauthor=C.+Rosensteinauthor=A.+Mathurauthor=M.+D.+Altmanauthor=G.+Chanauthor=L.+Xuauthor=E.+Bachmanauthor=J.+R.+Moauthor=M.+Bouthilletteauthor=T.+Rushauthor=C.+J.+Dinsmoreauthor=C.+G.+Marshallauthor=J.+R.+Young&title=The+discovery+of+tricyclic+pyridone+JAK2+inhibitors.+Part+1%3A+hit+to+lead"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiu%26aufirst%3DT.%26aulast%3DKozina%26aufirst%3DE.%2BS.%26aulast%3DJung%26aufirst%3DJ.%26aulast%3DRosenstein%26aufirst%3DC.%26aulast%3DMathur%26aufirst%3DA.%26aulast%3DAltman%26aufirst%3DM.%2BD.%26aulast%3DChan%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DBachman%26aufirst%3DE.%26aulast%3DMo%26aufirst%3DJ.%2BR.%26aulast%3DBouthillette%26aufirst%3DM.%26aulast%3DRush%26aufirst%3DT.%26aulast%3DDinsmore%26aufirst%3DC.%2BJ.%26aulast%3DMarshall%26aufirst%3DC.%2BG.%26aulast%3DYoung%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520discovery%2520of%2520tricyclic%2520pyridone%2520JAK2%2520inhibitors.%2520Part%25201%253A%2520hit%2520to%2520lead%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D7421%26epage%3D7425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">William, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulsen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teo, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagaraj, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ong, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaraman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasha, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ethirajulu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B. W.</span><span> </span><span class="NLM_article-title">Discovery of the macrocycle 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (SB1518), a potent Janus kinase 2/Fms-like tyrosine kinase-3 (JAK2/FLT3) inhibitor for the treatment of myelofibrosis and lymphoma</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">4638</span><span class="NLM_x">–</span> <span class="NLM_lpage">4658</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200326p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4638-4658&author=A.+D.+Williamauthor=A.+C.+Leeauthor=S.+Blanchardauthor=A.+Poulsenauthor=E.+L.+Teoauthor=H.+Nagarajauthor=E.+Tanauthor=D.+Chenauthor=M.+Williamsauthor=E.+T.+Sunauthor=K.+C.+Gohauthor=W.+C.+Ongauthor=S.+K.+Gohauthor=S.+Hartauthor=R.+Jayaramanauthor=M.+K.+Pashaauthor=K.+Ethirajuluauthor=J.+M.+Woodauthor=B.+W.+Dymock&title=Discovery+of+the+macrocycle+11-%282-pyrrolidin-1-yl-ethoxy%29-14%2C19-dioxa-5%2C7%2C26-triaza-tetracyclo%5B19.3.1.1%282%2C6%29.1%288%2C12%29%5Dheptacosa-1%2825%29%2C2%2826%29%2C3%2C5%2C8%2C10%2C12%2827%29%2C16%2C21%2C23-decaene+%28SB1518%29%2C+a+potent+Janus+kinase+2%2FFms-like+tyrosine+kinase-3+%28JAK2%2FFLT3%29+inhibitor+for+the+treatment+of+myelofibrosis+and+lymphoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=10.1021%2Fjm200326p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200326p%26sid%3Dliteratum%253Aachs%26aulast%3DWilliam%26aufirst%3DA.%2BD.%26aulast%3DLee%26aufirst%3DA.%2BC.%26aulast%3DBlanchard%26aufirst%3DS.%26aulast%3DPoulsen%26aufirst%3DA.%26aulast%3DTeo%26aufirst%3DE.%2BL.%26aulast%3DNagaraj%26aufirst%3DH.%26aulast%3DTan%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DE.%2BT.%26aulast%3DGoh%26aufirst%3DK.%2BC.%26aulast%3DOng%26aufirst%3DW.%2BC.%26aulast%3DGoh%26aufirst%3DS.%2BK.%26aulast%3DHart%26aufirst%3DS.%26aulast%3DJayaraman%26aufirst%3DR.%26aulast%3DPasha%26aufirst%3DM.%2BK.%26aulast%3DEthirajulu%26aufirst%3DK.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DDymock%26aufirst%3DB.%2BW.%26atitle%3DDiscovery%2520of%2520the%2520macrocycle%252011-%25282-pyrrolidin-1-yl-ethoxy%2529-14%252C19-dioxa-5%252C7%252C26-triaza-tetracyclo%255B19.3.1.1%25282%252C6%2529.1%25288%252C12%2529%255Dheptacosa-1%252825%2529%252C2%252826%2529%252C3%252C5%252C8%252C10%252C12%252827%2529%252C16%252C21%252C23-decaene%2520%2528SB1518%2529%252C%2520a%2520potent%2520Janus%2520kinase%25202%252FFms-like%2520tyrosine%2520kinase-3%2520%2528JAK2%252FFLT3%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520myelofibrosis%2520and%2520lymphoma%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4638%26epage%3D4658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Ioannidis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almeida, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollard, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alimzhanov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bebernitz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huszar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinda, M.</span><span> </span><span class="NLM_article-title">Discovery of 5-chloro-<i>N</i>2-[(1<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethyl]-<i>N</i>4-(5-methyl-1<i>H</i>-pyrazol-3-yl)pyrimidine-2,4-diamine (AZD1480) as a novel inhibitor of the Jak/Stat pathway</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">262</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1011319" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8e&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFarsr%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=262-276&author=S.+Ioannidisauthor=M.+L.+Lambauthor=T.+Wangauthor=L.+Almeidaauthor=M.+H.+Blockauthor=A.+M.+Daviesauthor=B.+Pengauthor=M.+Suauthor=H.+J.+Zhangauthor=E.+Hoffmannauthor=C.+Rivardauthor=I.+Greenauthor=T.+Howardauthor=H.+Pollardauthor=J.+Readauthor=M.+Alimzhanovauthor=G.+Bebernitzauthor=K.+Bellauthor=M.+Yeauthor=D.+Huszarauthor=M.+Zinda&title=Discovery+of+5-chloro-N2-%5B%281S%29-1-%285-fluoropyrimidin-2-yl%29ethyl%5D-N4-%285-methyl-1H-pyrazol-3-yl%29pyrimidine-2%2C4-diamine+%28AZD1480%29+as+a+novel+inhibitor+of+the+Jak%2FStat+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8eR"><div class="casContent"><span class="casTitleNuber">8e</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 5-Chloro-N2-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine (AZD1480) as a Novel Inhibitor of the Jak/Stat Pathway</span></div><div class="casAuthors">Ioannidis, Stephanos; Lamb, Michelle L.; Wang, Tao; Almeida, Lynsie; Block, Michael H.; Davies, Audrey M.; Peng, Bo; Su, Mei; Zhang, Hai-Jun; Hoffmann, Ethan; Rivard, Caroline; Green, Isabelle; Howard, Tina; Pollard, Hannah; Read, Jon; Alimzhanov, Marat; Bebernitz, Geraldine; Bell, Kirsten; Ye, Min-Wei; Huszar, Dennis; Zinda, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">262-276</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The myeloproliferative neoplasms, polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis are a heterogeneous but related group of hematol. malignancies characterized by clonal expansion of one or more myeloid lineages.  The discovery of the Jak2 V617F gain of function mutation highlighted Jak2 as a potential therapeutic target in the MPNs.  Herein, we disclose the discovery of a series of pyrazol-3-yl pyrimidin-4-amines and the identification of 9e (AZD1480) as a potent Jak2 inhibitor.  9E inhibits signaling and proliferation of Jak2 V617F cell lines in vitro, demonstrates in vivo efficacy in a TEL-Jak2 model, has excellent phys. properties and preclin. pharmacokinetics, and is currently being evaluated in Phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMG6RQUv4HqbVg90H21EOLACvtfcHk0lhvBe5g7DJ1FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFarsr%252FN&md5=c8141c5b0e25a007e68b6e2567a576fe</span></div><a href="/servlet/linkout?suffix=cit8e&amp;dbid=16384&amp;doi=10.1021%2Fjm1011319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1011319%26sid%3Dliteratum%253Aachs%26aulast%3DIoannidis%26aufirst%3DS.%26aulast%3DLamb%26aufirst%3DM.%2BL.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DAlmeida%26aufirst%3DL.%26aulast%3DBlock%26aufirst%3DM.%2BH.%26aulast%3DDavies%26aufirst%3DA.%2BM.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DSu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DH.%2BJ.%26aulast%3DHoffmann%26aufirst%3DE.%26aulast%3DRivard%26aufirst%3DC.%26aulast%3DGreen%26aufirst%3DI.%26aulast%3DHoward%26aufirst%3DT.%26aulast%3DPollard%26aufirst%3DH.%26aulast%3DRead%26aufirst%3DJ.%26aulast%3DAlimzhanov%26aufirst%3DM.%26aulast%3DBebernitz%26aufirst%3DG.%26aulast%3DBell%26aufirst%3DK.%26aulast%3DYe%26aufirst%3DM.%26aulast%3DHuszar%26aufirst%3DD.%26aulast%3DZinda%26aufirst%3DM.%26atitle%3DDiscovery%2520of%25205-chloro-N2-%255B%25281S%2529-1-%25285-fluoropyrimidin-2-yl%2529ethyl%255D-N4-%25285-methyl-1H-pyrazol-3-yl%2529pyrimidine-2%252C4-diamine%2520%2528AZD1480%2529%2520as%2520a%2520novel%2520inhibitor%2520of%2520the%2520Jak%252FStat%2520pathway%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D262%26epage%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Wernig, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharas, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okabe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leeman, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cullen, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gozo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowell, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doukas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noronha, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soll, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tefferi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span> </span><span class="NLM_article-title">Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">320</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8f&amp;dbid=16&amp;doi=10.1021%2Fjm4004895&amp;key=10.1016%2Fj.ccr.2008.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8f&amp;dbid=8&amp;doi=10.1021%2Fjm4004895&amp;key=18394554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8f&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkslSjtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=311-320&author=G.+Wernigauthor=M.+G.+Kharasauthor=R.+Okabeauthor=S.+A.+Mooreauthor=D.+S.+Leemanauthor=D.+E.+Cullenauthor=M.+Gozoauthor=E.+P.+McDowellauthor=R.+L.+Levineauthor=J.+Doukasauthor=C.+C.+Makauthor=G.+Noronhaauthor=M.+Martinauthor=Y.+D.+Koauthor=B.+H.+Leeauthor=R.+M.+Sollauthor=A.+Tefferiauthor=J.+D.+Hoodauthor=D.+G.+Gilliland&title=Efficacy+of+TG101348%2C+a+selective+JAK2+inhibitor%2C+in+treatment+of+a+murine+model+of+JAK2V617F-induced+polycythemia+vera"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8fR"><div class="casContent"><span class="casTitleNuber">8f</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera</span></div><div class="casAuthors">Wernig, Gerlinde; Kharas, Michael G.; Okabe, Rachel; Moore, Sandra A.; Leeman, Dena S.; Cullen, Dana E.; Gozo, Maricel; McDowell, Elizabeth P.; Levine, Ross L.; Doukas, John; Mak, Chi Ching; Noronha, Glenn; Martin, Michael; Ko, Yon D.; Lee, Benjamin H.; Soll, Richard M.; Tefferi, Ayalew; Hood, John D.; Gilliland, D. Gary</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-320</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We report that TG101348, a selective small-mol. inhibitor of JAK2 with an in vitro IC50 of ∼3 nM, shows therapeutic efficacy in a murine model of myeloproliferative disease induced by the JAK2V617F mutation.  In treated animals, there was a statistically significant redn. in hematocrit and leukocyte count, a dose-dependent redn./elimination of extramedullary hematopoiesis, and, at least in some instances, evidence for attenuation of myelofibrosis.  There were no apparent toxicities and no effect on T cell no.  In vivo responses were correlated with surrogate endpoints, including redn./elimination of JAK2V617F disease burden assessed by quant. genomic PCR, suppression of endogenous erythroid colony formation, and in vivo inhibition of JAK-STAT signal transduction as assessed by flow cytometric measurement of phosphorylated Stat5.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSJOc4cS_lO7Vg90H21EOLACvtfcHk0lhvBe5g7DJ1FA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkslSjtrs%253D&md5=3dd923595cafebb6439dd67f026735be</span></div><a href="/servlet/linkout?suffix=cit8f&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2008.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2008.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DWernig%26aufirst%3DG.%26aulast%3DKharas%26aufirst%3DM.%2BG.%26aulast%3DOkabe%26aufirst%3DR.%26aulast%3DMoore%26aufirst%3DS.%2BA.%26aulast%3DLeeman%26aufirst%3DD.%2BS.%26aulast%3DCullen%26aufirst%3DD.%2BE.%26aulast%3DGozo%26aufirst%3DM.%26aulast%3DMcDowell%26aufirst%3DE.%2BP.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DDoukas%26aufirst%3DJ.%26aulast%3DMak%26aufirst%3DC.%2BC.%26aulast%3DNoronha%26aufirst%3DG.%26aulast%3DMartin%26aufirst%3DM.%26aulast%3DKo%26aufirst%3DY.%2BD.%26aulast%3DLee%26aufirst%3DB.%2BH.%26aulast%3DSoll%26aufirst%3DR.%2BM.%26aulast%3DTefferi%26aufirst%3DA.%26aulast%3DHood%26aufirst%3DJ.%2BD.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26atitle%3DEfficacy%2520of%2520TG101348%252C%2520a%2520selective%2520JAK2%2520inhibitor%252C%2520in%2520treatment%2520of%2520a%2520murine%2520model%2520of%2520JAK2V617F-induced%2520polycythemia%2520vera%26jtitle%3DCancer%2520Cell%26date%3D2008%26volume%3D13%26spage%3D311%26epage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Burns, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourke, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donohue, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrugia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feutrill, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joffe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kling, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nero, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shackleford, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sikanyika, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Styles, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treutlein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilks, A. F.</span><span> </span><span class="NLM_article-title">Phenylaminopyrimidines as inhibitors of Janus kinases (JAKs)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5887</span><span class="NLM_x">–</span> <span class="NLM_lpage">5892</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5887-5892&author=C.+J.+Burnsauthor=D.+G.+Bourkeauthor=L.+Andrauauthor=X.+Buauthor=S.+A.+Charmanauthor=A.+C.+Donohueauthor=E.+Fantinoauthor=M.+Farrugiaauthor=J.+T.+Feutrillauthor=M.+Joffeauthor=M.+R.+Klingauthor=M.+Kurekauthor=T.+L.+Neroauthor=T.+Nguyenauthor=J.+T.+Palmerauthor=I.+Phillipsauthor=D.+M.+Shacklefordauthor=H.+Sikanyikaauthor=M.+Stylesauthor=S.+Suauthor=H.+Treutleinauthor=J.+Zengauthor=A.+F.+Wilks&title=Phenylaminopyrimidines+as+inhibitors+of+Janus+kinases+%28JAKs%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26aulast%3DBourke%26aufirst%3DD.%2BG.%26aulast%3DAndrau%26aufirst%3DL.%26aulast%3DBu%26aufirst%3DX.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DDonohue%26aufirst%3DA.%2BC.%26aulast%3DFantino%26aufirst%3DE.%26aulast%3DFarrugia%26aufirst%3DM.%26aulast%3DFeutrill%26aufirst%3DJ.%2BT.%26aulast%3DJoffe%26aufirst%3DM.%26aulast%3DKling%26aufirst%3DM.%2BR.%26aulast%3DKurek%26aufirst%3DM.%26aulast%3DNero%26aufirst%3DT.%2BL.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DPhillips%26aufirst%3DI.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DSikanyika%26aufirst%3DH.%26aulast%3DStyles%26aufirst%3DM.%26aulast%3DSu%26aufirst%3DS.%26aulast%3DTreutlein%26aufirst%3DH.%26aulast%3DZeng%26aufirst%3DJ.%26aulast%3DWilks%26aufirst%3DA.%2BF.%26atitle%3DPhenylaminopyrimidines%2520as%2520inhibitors%2520of%2520Janus%2520kinases%2520%2528JAKs%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5887%26epage%3D5892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit8h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Hexner, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serdikoff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swider, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emerson, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobrzanski, P.</span><span> </span><span class="NLM_article-title">Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">5663</span><span class="NLM_x">–</span> <span class="NLM_lpage">5671</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2008&pages=5663-5671&author=E.+O.+Hexnerauthor=C.+Serdikoffauthor=M.+Janauthor=C.+R.+Swiderauthor=C.+Robinsonauthor=S.+Yangauthor=T.+Angelesauthor=S.+G.+Emersonauthor=M.+Carrollauthor=B.+Ruggeriauthor=P.+Dobrzanski&title=Lestaurtinib+%28CEP701%29+is+a+JAK2+inhibitor+that+suppresses+JAK2%2FSTAT5+signaling+and+the+proliferation+of+primary+erythroid+cells+from+patients+with+myeloproliferative+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHexner%26aufirst%3DE.%2BO.%26aulast%3DSerdikoff%26aufirst%3DC.%26aulast%3DJan%26aufirst%3DM.%26aulast%3DSwider%26aufirst%3DC.%2BR.%26aulast%3DRobinson%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DAngeles%26aufirst%3DT.%26aulast%3DEmerson%26aufirst%3DS.%2BG.%26aulast%3DCarroll%26aufirst%3DM.%26aulast%3DRuggeri%26aufirst%3DB.%26aulast%3DDobrzanski%26aufirst%3DP.%26atitle%3DLestaurtinib%2520%2528CEP701%2529%2520is%2520a%2520JAK2%2520inhibitor%2520that%2520suppresses%2520JAK2%252FSTAT5%2520signaling%2520and%2520the%2520proliferation%2520of%2520primary%2520erythroid%2520cells%2520from%2520patients%2520with%2520myeloproliferative%2520disorders%26jtitle%3DBlood%26date%3D2008%26volume%3D111%26spage%3D5663%26epage%3D5671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Kulagowski, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bull, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyke, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eigenbrot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghilardi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liimatta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bir Kohli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxey, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendonca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narukulla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubhayakar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Abbema, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waszkowycz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zak, M.</span><span> </span><span class="NLM_article-title">Identification of Imidazo-pyrrolopyridines as Novel and Potent JAK1 Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5901</span><span class="NLM_x">–</span> <span class="NLM_lpage">5921</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300438j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BC38XntVOktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5901-5921&author=J.+J.+Kulagowskiauthor=W.+Blairauthor=R.+J.+Bullauthor=C.+Changauthor=G.+Deshmukhauthor=H.+J.+Dykeauthor=C.+Eigenbrotauthor=N.+Ghilardiauthor=P.+Gibbonsauthor=T.+K.+Harrisonauthor=P.+R.+Hewittauthor=M.+Liimattaauthor=C.+A.+Hurleyauthor=A.+Johnsonauthor=T.+Johnsonauthor=J.+R.+Kennyauthor=P.+Bir+Kohliauthor=R.+J.+Maxeyauthor=R.+Mendoncaauthor=K.+Mortaraauthor=J.+Murrayauthor=R.+Narukullaauthor=S.+Shiaauthor=M.+Steffekauthor=S.+Ubhayakarauthor=M.+Ultschauthor=A.+van+Abbemaauthor=S.+I.+Wardauthor=B.+Waszkowyczauthor=M.+Zak&title=Identification+of+Imidazo-pyrrolopyridines+as+Novel+and+Potent+JAK1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Imidazo-Pyrrolopyridines as Novel and Potent JAK1 Inhibitors</span></div><div class="casAuthors">Kulagowski, Janusz J.; Blair, Wade; Bull, Richard J.; Chang, Christine; Deshmukh, Gauri; Dyke, Hazel J.; Eigenbrot, Charles; Ghilardi, Nico; Gibbons, Paul; Harrison, Trevor K.; Hewitt, Peter R.; Liimatta, Marya; Hurley, Christopher A.; Johnson, Adam; Johnson, Tony; Kenny, Jane R.; Bir Kohli, Pawan; Maxey, Robert J.; Mendonca, Rohan; Mortara, Kyle; Murray, Jeremy; Narukulla, Raman; Shia, Steven; Steffek, Micah; Ubhayakar, Savita; Ultsch, Mark; van Abbema, Anne; Ward, Stuart I.; Waszkowycz, Bohdan; Zak, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5901-5921</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A therapeutic rationale is proposed for the treatment of inflammatory diseases, such as rheumatoid arthritis (RA), by specific targeting of the JAK1 pathway.  Examn. of the preferred binding conformation of clin. effective, pan-JAK inhibitor 1 led to identification of a novel, tricyclic hinge binding scaffold 3.  Exploration of SAR through a series of cycloamino and cycloalkylamino analogs demonstrated this template to be highly tolerant of substitution, with a predisposition to moderate selectivity for the JAK1 isoform over JAK2.  This study culminated in the identification of subnanomolar JAK1 inhibitors such as 22 and 49, having excellent cell potency, good rat pharmacokinetic characteristics, and excellent kinase selectivity.  Detn. of the binding modes of the series in JAK1 and JAK2 by X-ray crystallog. supported the design of analogs to enhance affinity and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpamrk0bG1MK7Vg90H21EOLACvtfcHk0li5yVEm0J4XTw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntVOktL0%253D&md5=d91bc0e24abf14adcf44caf61e3e879f</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm300438j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300438j%26sid%3Dliteratum%253Aachs%26aulast%3DKulagowski%26aufirst%3DJ.%2BJ.%26aulast%3DBlair%26aufirst%3DW.%26aulast%3DBull%26aufirst%3DR.%2BJ.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DDyke%26aufirst%3DH.%2BJ.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DGhilardi%26aufirst%3DN.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DHarrison%26aufirst%3DT.%2BK.%26aulast%3DHewitt%26aufirst%3DP.%2BR.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DHurley%26aufirst%3DC.%2BA.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DKenny%26aufirst%3DJ.%2BR.%26aulast%3DBir%2BKohli%26aufirst%3DP.%26aulast%3DMaxey%26aufirst%3DR.%2BJ.%26aulast%3DMendonca%26aufirst%3DR.%26aulast%3DMortara%26aufirst%3DK.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DNarukulla%26aufirst%3DR.%26aulast%3DShia%26aufirst%3DS.%26aulast%3DSteffek%26aufirst%3DM.%26aulast%3DUbhayakar%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%26aulast%3Dvan%2BAbbema%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DS.%2BI.%26aulast%3DWaszkowycz%26aufirst%3DB.%26aulast%3DZak%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520Imidazo-pyrrolopyridines%2520as%2520Novel%2520and%2520Potent%2520JAK1%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5901%26epage%3D5921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><div class="note"><p class="first last">We recently reported on a series of <i>C</i>-2 amine-containing inhibitors capped with groups such as amides and sulfonamides. Although these groups imparted consistent JAK1 selectivity, they also produced large increases in TPSA. As such, the only P-loop combinations with sufficient membrane permeability for acceptable cell potency and oral bioavailability were highly lipophilic and nonpolar (such as cycloalkanes and norbornanes).</p></div><span class="NLM_contrib-group">Labadie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragovich, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eigenbrot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghilardi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohli, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulagowski, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liimatta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupardus, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendonca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubhayakar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Abbema, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zak, M.</span><span> </span><span class="NLM_article-title">Structure-based discovery of C-2 substituted imidazo-pyrrolopyridine JAK1 inhibitors with improved selectivity over JAK2</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">7627</span><span class="NLM_x">–</span> <span class="NLM_lpage">7633</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=7627-7633&author=S.+Labadieauthor=P.+S.+Dragovichauthor=K.+Barrettauthor=W.+S.+Blairauthor=P.+Bergeronauthor=C.+Changauthor=G.+Deshmukhauthor=C.+Eigenbrotauthor=N.+Ghilardiauthor=P.+Gibbonsauthor=C.+A.+Hurleyauthor=A.+Johnsonauthor=J.+R.+Kennyauthor=P.+B.+Kohliauthor=J.+J.+Kulagowskiauthor=M.+Liimattaauthor=P.+J.+Lupardusauthor=R.+Mendoncaauthor=J.+M.+Murrayauthor=R.+Pulkauthor=S.+Shiaauthor=M.+Steffekauthor=S.+Ubhayakarauthor=M.+Ultschauthor=A.+van+Abbemaauthor=S.+I.+Wardauthor=M.+Zak&title=Structure-based+discovery+of+C-2+substituted+imidazo-pyrrolopyridine+JAK1+inhibitors+with+improved+selectivity+over+JAK2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLabadie%26aufirst%3DS.%26aulast%3DDragovich%26aufirst%3DP.%2BS.%26aulast%3DBarrett%26aufirst%3DK.%26aulast%3DBlair%26aufirst%3DW.%2BS.%26aulast%3DBergeron%26aufirst%3DP.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DGhilardi%26aufirst%3DN.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DHurley%26aufirst%3DC.%2BA.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DKenny%26aufirst%3DJ.%2BR.%26aulast%3DKohli%26aufirst%3DP.%2BB.%26aulast%3DKulagowski%26aufirst%3DJ.%2BJ.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DLupardus%26aufirst%3DP.%2BJ.%26aulast%3DMendonca%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DJ.%2BM.%26aulast%3DPulk%26aufirst%3DR.%26aulast%3DShia%26aufirst%3DS.%26aulast%3DSteffek%26aufirst%3DM.%26aulast%3DUbhayakar%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%26aulast%3Dvan%2BAbbema%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DS.%2BI.%26aulast%3DZak%26aufirst%3DM.%26atitle%3DStructure-based%2520discovery%2520of%2520C-2%2520substituted%2520imidazo-pyrrolopyridine%2520JAK1%2520inhibitors%2520with%2520improved%2520selectivity%2520over%2520JAK2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D7627%26epage%3D7633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kuntz, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollman, P. A.</span><span> </span><span class="NLM_article-title">The maximal affinity of ligands</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">9997</span><span class="NLM_x">–</span> <span class="NLM_lpage">10002</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Fjm4004895&amp;key=10.1073%2Fpnas.96.18.9997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Fjm4004895&amp;key=10468550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADyaK1MXlvFehu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=9997-10002&author=I.+D.+Kuntzauthor=K.+Chenauthor=K.+A.+Sharpauthor=P.+A.+Kollman&title=The+maximal+affinity+of+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">The maximal affinity of ligands</span></div><div class="casAuthors">Kuntz, I. D.; Chen, K.; Sharp, K. A.; Kollman, P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">9997-10002</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We explore the question of what are the best ligands for macromol. targets.  A survey of exptl. data on a large no. of the strongest-binding ligands indicates that the free energy of binding increases with the no. of nonhydrogen atoms with an initial slope of ≈-1.5 kcal/mol (1 cal = 4.18 J) per atom.  For ligands that contain more than 15 nonhydrogen atoms, the free energy of binding increases very little with relative mol. mass.  This nonlinearity is largely ascribed to nonthermodynamic factors.  An anal. of the dominant interactions suggests that van der Waals interactions and hydrophobic effects provide a reasonable basis for understanding binding affinities across the entire set of ligands.  Interesting outliers that bind unusually strongly on a per atom basis include metal ions, covalently attached ligands, and a few well known complexes such as biotin-avidin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0L6KZhR0TxbVg90H21EOLACvtfcHk0lixIKX7gn9epQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvFehu7s%253D&md5=46fe894b016f3041831a2f0b71f812b1</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.18.9997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.18.9997%26sid%3Dliteratum%253Aachs%26aulast%3DKuntz%26aufirst%3DI.%2BD.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DSharp%26aufirst%3DK.%2BA.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26atitle%3DThe%2520maximal%2520affinity%2520of%2520ligands%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci%2520U.%2520S.%2520A.%26date%3D1999%26volume%3D96%26spage%3D9997%26epage%3D10002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Fjm4004895&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Fjm4004895&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eZeic23IbW1gLntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ryckmans, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correia, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, T.</span><span> </span><span class="NLM_article-title">Rapid assessment of a novel series of selective CB<sub>2</sub> agonists using parallel synthesis protocols: a lipophilic efficiency (LipE) analysis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4406</span><span class="NLM_x">–</span> <span class="NLM_lpage">4409</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Fjm4004895&amp;key=10.1016%2Fj.bmcl.2009.05.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Fjm4004895&amp;key=19500981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4406-4409&author=T.+Ryckmansauthor=M.+P.+Edwardsauthor=V.+A.+Horneauthor=A.+M.+Correiaauthor=D.+R.+Owenauthor=L.+R.+Thompsonauthor=I.+Tranauthor=M.+F.+Tuttauthor=T.+Young&title=Rapid+assessment+of+a+novel+series+of+selective+CB2+agonists+using+parallel+synthesis+protocols%3A+a+lipophilic+efficiency+%28LipE%29+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis</span></div><div class="casAuthors">Ryckmans, Thomas; Edwards, Martin P.; Horne, Val A.; Correia, Ana Monica; Owen, Dafydd R.; Thompson, Lisa R.; Tran, Isabelle; Tutt, Michelle F.; Young, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4406-4409</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of libraries were designed using the 1-(cyclopropylmethyl)-2-alkyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-5-ium templates 2a-b, and Sulfonamide derivs. 11a-n proved to be potent agonists of the CB2 receptor.  Anal. of the Lipophilic Efficiency (LipE) of potent compds. provided new insight for the design of potent, metabolically stable CB2 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1cihq9YHuO7Vg90H21EOLACvtfcHk0lixIKX7gn9epQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D&md5=b62d97e5f52a594cfdd510f32d2e566f</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.062%26sid%3Dliteratum%253Aachs%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DHorne%26aufirst%3DV.%2BA.%26aulast%3DCorreia%26aufirst%3DA.%2BM.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DThompson%26aufirst%3DL.%2BR.%26aulast%3DTran%26aufirst%3DI.%26aulast%3DTutt%26aufirst%3DM.%2BF.%26aulast%3DYoung%26aufirst%3DT.%26atitle%3DRapid%2520assessment%2520of%2520a%2520novel%2520series%2520of%2520selective%2520CB2%2520agonists%2520using%2520parallel%2520synthesis%2520protocols%253A%2520a%2520lipophilic%2520efficiency%2520%2528LipE%2529%2520analysis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4406%26epage%3D4409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="note"><p class="first last">Descriptions of the biochemical and cell-based assays are provided in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14c"><span> Prior to synthesis, predicted LogD values were calculated using the MoKa sofware (<a href="http://www.moldiscovery.com" class="extLink">www.moldiscovery.com</a>, (ref <span class="NLM_xref">14</span>)) and a custom p<i>K</i><sub>a</sub> model (ref <span class="NLM_xref">14</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Prior+to+synthesis%2C+predicted+LogD+values+were+calculated+using+the+MoKa+sofware+%28www.moldiscovery.com%2C+%28ref+14%29%29+and+a+custom+pKa+model+%28ref+14%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Milletti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storchi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sforna, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruciani, G.</span><span> </span><span class="NLM_article-title">New and original pKa prediction method using grid molecular interaction fields</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2172</span><span class="NLM_x">–</span> <span class="NLM_lpage">2181</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci700018y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSnsLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=2172-2181&author=F.+Millettiauthor=L.+Storchiauthor=G.+Sfornaauthor=G.+Cruciani&title=New+and+original+pKa+prediction+method+using+grid+molecular+interaction+fields"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">New and Original pKa Prediction Method Using Grid Molecular Interaction Fields</span></div><div class="casAuthors">Milletti, Francesca; Storchi, Loriano; Sforna, Gianluca; Cruciani, Gabriele</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2172-2181</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">One of the most important physicochem. properties of a mol. is pKa.  It is known that two parameters imperative in ADME profiling, soly., and lipophilicity are governed by pKa, and receptor binding can be influenced by pKa.  Because most drugs are ionized in physiol. conditions, pKa is particularly relevant to medicinal chem.  Despite the numerous advances in high-throughput measurements, in silico detn. is still the fastest and cheapest way of obtaining pKa.  This paper presents a new original computational method for pKa prediction of org. compds.  Descriptors were generated using the program GRID, and these descriptors are based on mol. interaction fields precomputed on a set of mol. fragments.  The new method was developed, trained, and cross-validated by using a large and diverse data set of 24 617 pKa values.  This paper presents the results for a class of 421 acidic nitrogen compds. (RMSE = 0.41, r2 = 0.97, q2 = 0.87) and for a class of 947 six-membered N-heterocyclic bases (RMSE = 0.60, r2 = 0.93, q2 = 0.85).  For external validation 28 novel compds. were selected that covered nine different ionizable groups, and 39 pKa values could be exptl. detd. by spectral gradient anal. (SGA).  Comparison of exptl. pKa with calcd. pKa demonstrated that the predictive ability of the method is good (external set, r2 = 0.85, RMSE = 0.90).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzEk0uiS1E6rVg90H21EOLACvtfcHk0liTCfQjM-Gs1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSnsLrF&md5=f2b1dec853ccb0ef1a40540d234232fb</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1021%2Fci700018y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci700018y%26sid%3Dliteratum%253Aachs%26aulast%3DMilletti%26aufirst%3DF.%26aulast%3DStorchi%26aufirst%3DL.%26aulast%3DSforna%26aufirst%3DG.%26aulast%3DCruciani%26aufirst%3DG.%26atitle%3DNew%2520and%2520original%2520pKa%2520prediction%2520method%2520using%2520grid%2520molecular%2520interaction%2520fields%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2007%26volume%3D47%26spage%3D2172%26epage%3D2181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Milletti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storchi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goracci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bendels, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruciani, G.</span><span> </span><span class="NLM_article-title">Extending p<i>K</i><sub>a</sub> prediction accuracy: high-throughput p<i>K</i><sub>a</sub> measurements to understand p<i>K</i><sub>a</sub> modulation of new chemical series</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">4270</span><span class="NLM_x">–</span> <span class="NLM_lpage">4279</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Fjm4004895&amp;key=10.1016%2Fj.ejmech.2010.06.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Fjm4004895&amp;key=20633962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvFKhtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=4270-4279&author=F.+Millettiauthor=L.+Storchiauthor=L.+Goracciauthor=S.+Bendelsauthor=B.+Wagnerauthor=M.+Kansyauthor=G.+Cruciani&title=Extending+pKa+prediction+accuracy%3A+high-throughput+pKa+measurements+to+understand+pKa+modulation+of+new+chemical+series"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Extending pKa prediction accuracy: High-throughput pKa measurements to understand pKa modulation of new chemical series</span></div><div class="casAuthors">Milletti, Francesca; Storchi, Loriano; Goracci, Laura; Bendels, Stefanie; Wagner, Bjoern; Kansy, Manfred; Cruciani, Gabriele</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4270-4279</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">We have recently developed a tool, MoKα, to predict the pKa of org. compds. using a large dataset of over 26,500 literature pKa values as a training set.  However, predicting accurately pKa (<0.5 pH units) remains challenging for novel series, and this can be a drawback in the optimization of activity and ADME properties of lead compds.  To address this issue it is important to expand our knowledge of pKa determinants, therefore we have conducted high-throughput pKa measurements by using Spectral Gradient Anal. (SGA) on novel series of compds. selected from vendor databases.  Here we report our findings on the effect of specific chem. groups and steric constraints on the pKa of common functionalities in medicinal chem., such as amines, sulfonamides, and amides.  Furthermore, we report the pKa of ionizable groups that were not well represented in the database of literature pKa of MoKα, such as hydrazide derivs.  These findings helped us to enhance MoKα, which is here benchmarked on a set of exptl. pKa values from the Roche inhouse library (N = 5581; RMSE = 1.09; R2 = 0.82).  The accuracy of the predictions was greatly improved (RMSE = 0.49, R2 = 0.96) after training the software by using the automated tool Kibitzer with 6226 pK a values taken from a different set of Roche compds. appropriately selected, and this demonstrates the value of using high-throughput pKa measurements to expand the training set of pKa values used by the software MoKα.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxQ9UJOAhB-rVg90H21EOLACvtfcHk0liTCfQjM-Gs1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvFKhtLo%253D&md5=e4c579032df7fa37ec3551c69a09257a</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2010.06.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2010.06.026%26sid%3Dliteratum%253Aachs%26aulast%3DMilletti%26aufirst%3DF.%26aulast%3DStorchi%26aufirst%3DL.%26aulast%3DGoracci%26aufirst%3DL.%26aulast%3DBendels%26aufirst%3DS.%26aulast%3DWagner%26aufirst%3DB.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DCruciani%26aufirst%3DG.%26atitle%3DExtending%2520pKa%2520prediction%2520accuracy%253A%2520high-throughput%2520pKa%2520measurements%2520to%2520understand%2520pKa%2520modulation%2520of%2520new%2520chemical%2520series%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D4270%26epage%3D4279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Ertl, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohde, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selzer, P.</span><span> </span><span class="NLM_article-title">Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3714</span><span class="NLM_x">–</span> <span class="NLM_lpage">3717</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000942e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3714-3717&author=P.+Ertlauthor=B.+Rohdeauthor=P.+Selzer&title=Fast+calculation+of+molecular+polar+surface+area+as+a+sum+of+fragment-based+contributions+and+its+application+to+the+prediction+of+drug+transport+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties</span></div><div class="casAuthors">Ertl, Peter; Rohde, Bernhard; Selzer, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3714-3717</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. polar surface area (PSA), i.e., surface belonging to polar atoms, is a descriptor that was shown to correlate well with passive mol. transport through membranes and, therefore, allows prediction of transport properties of drugs.  The calcn. of PSA, however, is rather time-consuming because of the necessity to generate a reasonable 3D mol. geometry and the calcn. of the surface itself.  A new approach for the calcn. of the PSA is presented here, based on the summation of tabulated surface contributions of polar fragments.  The method, termed topol. PSA (TPSA), provides results which are practically identical with the 3D PSA (the correlation coeff. between 3D PSA and fragment-based TPSA for 34 810 mols. from the World Drug Index is 0.99), while the computation speed is 2-3 orders of magnitude faster.  The new methodol. may, therefore, be used for fast bioavailability screening of virtual libraries having millions of mols.  This article describes the new methodol. and shows the results of validation studies based on sets of published absorption data, including intestinal absorption, Caco-2 monolayer penetration, and blood-brain barrier penetration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhP6Qncx_h6LVg90H21EOLACvtfcHk0liTCfQjM-Gs1g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D&md5=23ae4e7708bd8ddeb4a24ad160a29bd6</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm000942e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000942e%26sid%3Dliteratum%253Aachs%26aulast%3DErtl%26aufirst%3DP.%26aulast%3DRohde%26aufirst%3DB.%26aulast%3DSelzer%26aufirst%3DP.%26atitle%3DFast%2520calculation%2520of%2520molecular%2520polar%2520surface%2520area%2520as%2520a%2520sum%2520of%2520fragment-based%2520contributions%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520drug%2520transport%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3714%26epage%3D3717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><div class="note"><p class="first last">In vitro metabolic stability in the presence of liver microsomes and hepatocytes is expressed as hepatic clearance (CL<sub>H</sub>). CL<sub>H</sub> is derived from the well stirred model according to the following equation: CL<sub>H</sub> = (CL<sub>int</sub>·LBF)/(CL<sub>int</sub> + LBF), where CL<sub>int</sub> is intrinsic clearance and LBF is liver blood flow. The fraction unbound in the incubation and in blood are assumed to be 1. Human CL<sub>H</sub> values (units = mL min<sup>–1</sup> kg<sup>–1</sup>) are categorized are as follows: <6.2 = low, 6.2–15 = moderate, >15 = high. Further details on the in vitro metabolic stability experiments used to measure CL<sub>int</sub> may be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> and in:</p></div><span class="NLM_contrib-group">Halladay, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffer, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinhababu, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khojasteh-Bakht, S. C.</span><span> </span><span class="NLM_article-title">Metabolic stability screen for drug discovery using cassette analysis and column switching</span> <span class="citation_source-journal">Drug Metab. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm4004895&amp;key=10.2174%2F187231207779814364" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm4004895&amp;key=19356021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtleru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2007&pages=67-72&author=J.+S.+Halladayauthor=S.+Wongauthor=S.+M.+Jafferauthor=A.+K.+Sinhababuauthor=S.+C.+Khojasteh-Bakht&title=Metabolic+stability+screen+for+drug+discovery+using+cassette+analysis+and+column+switching"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic stability screen for drug discovery using cassette analysis and column switching</span></div><div class="casAuthors">Halladay, Jason S.; Wong, Susan; Jaffer, Sharmin M.; Sinhababu, Achintya K.; Khojasteh-Bakht, S. Cyrus</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-72</span>CODEN:
                <span class="NLM_cas:coden">DMLRBM</span>;
        ISSN:<span class="NLM_cas:issn">1872-3128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">In vitro metabolic stability assays are used to screen compds. for stability in the presence of various drug metabolizing enzymes, usually cytochrome P 450 in liver prepns. (e.g., liver microsomes).  High-throughput metabolic stability assays using pooling methods have been developed to keep pace with screening requirements at the lead ADME optimization stage.  In our lab., we have improved the metabolic stability assay using the cassette anal. method, column switching, and incorporated time saving techniques in method development to yield a robust method which reduces data turnaround time, increases compd. throughput, and maximizes mass spectrometer usage.  This method can det. metabolic stability using microsomes or hepatocytes from any species.  We describe our findings following incubation of 40 different compds. with human liver microsomes and anal. by the cassette and discrete anal. methods.  Similar metabolic stability results were obtained using the cassette anal. and discrete anal. method.  An overall 70% time savings was achieved by pooling four new compds. into one sample for method development/MS optimization, cassetting four samples into one sample to minimize the no. of injections on LC/MS/MS anal., and using a column switching system to analyze the samples, which results in a two-fold decrease in the LC/MS/MS anal. time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKzVSm6sBe1bVg90H21EOLACvtfcHk0ljlkT5frEsw6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtleru74%253D&md5=e00c66b3ca6a1eaee107c4eb81e07bf5</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F187231207779814364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187231207779814364%26sid%3Dliteratum%253Aachs%26aulast%3DHalladay%26aufirst%3DJ.%2BS.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DJaffer%26aufirst%3DS.%2BM.%26aulast%3DSinhababu%26aufirst%3DA.%2BK.%26aulast%3DKhojasteh-Bakht%26aufirst%3DS.%2BC.%26atitle%3DMetabolic%2520stability%2520screen%2520for%2520drug%2520discovery%2520using%2520cassette%2520analysis%2520and%2520column%2520switching%26jtitle%3DDrug%2520Metab.%2520Lett.%26date%3D2007%26volume%3D1%26spage%3D67%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="note"><p class="first last">QSAR models used to prospectively predict metabolic stability have previously been described (refs <a onclick="showRef(event, 'cit17a cit17b cit17c cit17d cit17e'); return false;" href="javascript:void(0);" class="ref cit17a cit17b cit17c cit17d cit17e">17a−17e</a>). Similarly, an internal HLM stability model was developed using experimental data from 18000 compounds spanning a variety of Genentech projects and scaffolds. A regression model was built in Pipeline Pilot (ref <a onclick="showRef(event, 'cit17f'); return false;" href="javascript:void(0);" class="ref cit17f">17f</a>) using a Support Vector Machine (refs <a onclick="showRef(event, 'cit17g'); return false;" href="javascript:void(0);" class="ref cit17g">17g</a>,<a onclick="showRef(event, 'cit17h'); return false;" href="javascript:void(0);" class="ref cit17h">17h</a>) methodology implemented in the R-Statistics (ref <a onclick="showRef(event, 'cit17i'); return false;" href="javascript:void(0);" class="ref cit17i">17i</a>) package. The following descriptors, available in Pipeline Pilot, were used: ALogP, molecular weight, number of H-bond donors, number of H-bond acceptors, number of rotatable bonds, number of atoms, number of rings, number of aromatic rings, molecular surface area, molecular polar surface area, AlogP counts (ref <a onclick="showRef(event, 'cit17j'); return false;" href="javascript:void(0);" class="ref cit17j">17j</a>), E-state keys (ref <a onclick="showRef(event, 'cit17k'); return false;" href="javascript:void(0);" class="ref cit17k">17k</a>), MDL Public Keys (refs <a onclick="showRef(event, 'cit17l'); return false;" href="javascript:void(0);" class="ref cit17l">17l</a>,<a onclick="showRef(event, 'cit17m'); return false;" href="javascript:void(0);" class="ref cit17m">17m</a>), and FCFP4 fingerprints (refs <a onclick="showRef(event, 'cit17n'); return false;" href="javascript:void(0);" class="ref cit17n">17n</a>,<a onclick="showRef(event, 'cit17o'); return false;" href="javascript:void(0);" class="ref cit17o">17o</a>). The predicted clearance was converted to the probability of a compound being stable based on a total clearance cutoff of 13 mL min<sup>–1</sup> kg<sup>–1</sup> as described in ref <a onclick="showRef(event, 'cit17p'); return false;" href="javascript:void(0);" class="ref cit17p">17p</a>. The structures of and predicted and experimental HLM stability data associated with the compounds in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>d are tabulated in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="NLM_citation" id="cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lee, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cucurull-Sanchez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, Y. H. J.</span><span> </span><span class="NLM_article-title">Development of in silico models for human liver microsomal stability</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">665</span><span class="NLM_x">–</span> <span class="NLM_lpage">673</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=665-673&author=P.+H.+Leeauthor=L.+Cucurull-Sanchezauthor=J.+Luauthor=Y.+H.+J.+Du&title=Development+of+in+silico+models+for+human+liver+microsomal+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DP.%2BH.%26aulast%3DCucurull-Sanchez%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DDu%26aufirst%3DY.%2BH.%2BJ.%26atitle%3DDevelopment%2520of%2520in%2520silico%2520models%2520for%2520human%2520liver%2520microsomal%2520stability%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2007%26volume%3D21%26spage%3D665%26epage%3D673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ekins, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gifford, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waller, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunin, B. A.</span><span> </span><span class="NLM_article-title">Using Open Source Computational Tools for Predicting Human Metabolic Stability and Additional Absorption, Distribution, Metabolism, Excretion, and Toxicity Properties</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">2083</span><span class="NLM_x">–</span> <span class="NLM_lpage">2090</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=2083-2090&author=S.+Ekinsauthor=R.+R.+Guptaauthor=E.+M.+Giffordauthor=T.+Listonauthor=C.+L.+Wallerauthor=M.+Hohmanauthor=B.+A.+Bunin&title=Using+Open+Source+Computational+Tools+for+Predicting+Human+Metabolic+Stability+and+Additional+Absorption%2C+Distribution%2C+Metabolism%2C+Excretion%2C+and+Toxicity+Properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEkins%26aufirst%3DS.%26aulast%3DGupta%26aufirst%3DR.%2BR.%26aulast%3DGifford%26aufirst%3DE.%2BM.%26aulast%3DListon%26aufirst%3DT.%26aulast%3DWaller%26aufirst%3DC.%2BL.%26aulast%3DHohman%26aufirst%3DM.%26aulast%3DBunin%26aufirst%3DB.%2BA.%26atitle%3DUsing%2520Open%2520Source%2520Computational%2520Tools%2520for%2520Predicting%2520Human%2520Metabolic%2520Stability%2520and%2520Additional%2520Absorption%252C%2520Distribution%252C%2520Metabolism%252C%2520Excretion%252C%2520and%2520Toxicity%2520Properties%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26spage%3D2083%26epage%3D2090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hu, Y. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unwalla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bikker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, C.</span><span> </span><span class="NLM_article-title">Development of QSAR models for microsomal stability: identification of good and bad structural features for rat, human and mouse microsomal stability</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=23-35&author=Y.+B.+Huauthor=R.+Unwallaauthor=R.+A.+Dennyauthor=J.+Bikkerauthor=L.+Diauthor=C.+Humblet&title=Development+of+QSAR+models+for+microsomal+stability%3A+identification+of+good+and+bad+structural+features+for+rat%2C+human+and+mouse+microsomal+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%2BB.%26aulast%3DUnwalla%26aufirst%3DR.%26aulast%3DDenny%26aufirst%3DR.%2BA.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DDevelopment%2520of%2520QSAR%2520models%2520for%2520microsomal%2520stability%253A%2520identification%2520of%2520good%2520and%2520bad%2520structural%2520features%2520for%2520rat%252C%2520human%2520and%2520mouse%2520microsomal%2520stability%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2010%26volume%3D24%26spage%3D23%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Sakiyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honma, T.</span><span> </span><span class="NLM_article-title">Predicting human liver microsomal stability with machine learning techniques</span> <span class="citation_source-journal">J. Mol. Graphics Modell.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">907</span><span class="NLM_x">–</span> <span class="NLM_lpage">915</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=16&amp;doi=10.1021%2Fjm4004895&amp;key=10.1016%2Fj.jmgm.2007.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=8&amp;doi=10.1021%2Fjm4004895&amp;key=17683964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVOksL7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=907-915&author=Y.+Sakiyamaauthor=H.+Yukiauthor=T.+Moriyaauthor=K.+Hattoriauthor=M.+Suzukiauthor=K.+Shimadaauthor=T.+Honma&title=Predicting+human+liver+microsomal+stability+with+machine+learning+techniques"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17dR"><div class="casContent"><span class="casTitleNuber">17d</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting human liver microsomal stability with machine learning techniques</span></div><div class="casAuthors">Sakiyama, Yojiro; Yuki, Hitomi; Moriya, Takashi; Hattori, Kazunari; Suzuki, Misaki; Shimada, Kaoru; Honma, Teruki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics & Modelling</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">907-915</span>CODEN:
                <span class="NLM_cas:coden">JMGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1093-3263</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">To ensure a continuing pipeline in pharmaceutical research, lead candidates must possess appropriate metabolic stability in the drug discovery process.  In vitro ADMET (absorption, distribution, metab., elimination, and toxicity) screening provides us with useful information regarding the metabolic stability of compds.  However, before the synthesis stage, an efficient process is required in order to deal with the vast quantity of data from large compd. libraries and high-throughput screening.  Here we have derived a relationship between the chem. structure and its metabolic stability for a data set of inhouse compds. by means of various in silico machine learning such as random forest, support vector machine (SVM), logistic regression, and recursive partitioning.  For model building, 1952 proprietary compds. comprising two classes (stable/unstable) were used with 193 descriptors calcd. by Mol. Operating Environment.  The results using test compds. have demonstrated that all classifiers yielded satisfactory results (accuracy > 0.8, sensitivity > 0.9, specificity > 0.6, and precision > 0.8).  Above all, classification by random forest as well as SVM yielded kappa values of approx. 0.7 in an independent validation set, slightly higher than other classification tools.  These results suggest that nonlinear/ensemble-based classification methods might prove useful in the area of in silico ADME modeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHqP0YZdkk8bVg90H21EOLACvtfcHk0ljlkT5frEsw6g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVOksL7K&md5=26a7b42e84a7d5f4fdc3ac42444c4dc2</span></div><a href="/servlet/linkout?suffix=cit17d&amp;dbid=16384&amp;doi=10.1016%2Fj.jmgm.2007.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmgm.2007.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DSakiyama%26aufirst%3DY.%26aulast%3DYuki%26aufirst%3DH.%26aulast%3DMoriya%26aufirst%3DT.%26aulast%3DHattori%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DShimada%26aufirst%3DK.%26aulast%3DHonma%26aufirst%3DT.%26atitle%3DPredicting%2520human%2520liver%2520microsomal%2520stability%2520with%2520machine%2520learning%2520techniques%26jtitle%3DJ.%2520Mol.%2520Graphics%2520Modell.%26date%3D2008%26volume%3D26%26spage%3D907%26epage%3D915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Langowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, A.</span><span> </span><span class="NLM_article-title">Computer systems for the prediction of xenobiotic metabolism</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">415</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17e&amp;dbid=16&amp;doi=10.1021%2Fjm4004895&amp;key=10.1016%2FS0169-409X%2802%2900011-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17e&amp;dbid=8&amp;doi=10.1021%2Fjm4004895&amp;key=11922955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17e&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BD38Xitlarurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2002&pages=407-415&author=J.+Langowskiauthor=A.+Long&title=Computer+systems+for+the+prediction+of+xenobiotic+metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17eR"><div class="casContent"><span class="casTitleNuber">17e</span><div class="casTitle"><span class="NLM_cas:atitle">Computer systems for the prediction of xenobiotic metabolism</span></div><div class="casAuthors">Langowski, Jan; Long, Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">407-415</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  The aim of pharmaceutical research and development is to ensure a continuing pipeline of new chem. entities (NCEs) displaying high therapeutic efficacy with few or no side effects.  Failure of promising lead candidates late in the drug discovery processes is regarded as com. unacceptable in today's increasingly competitive business environment.  An inappropriate ADME/Toxicity profile in humans is the major cause of failure of lead candidates in late clin. stages of drug development.  Combinatorial chem. techniques coupled with high throughput screening protocols means that pharmaceutical companies are now dealing with an unprecedented no. of NCEs on an annual basis.  As a consequence, screening for undesirable ADME/Toxicity properties in the early stages of drug development, preferably pre-synthesis, is now considered the essential paradigm.  In silico assessment of NCEs is rapidly emerging as the next wave of technol. for early ADME/Toxicity prediction.  In this review, we discuss the major com. available products for the assessing the potential metabolic activity of xenobiotic substances in mammalian systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7VWmlpZzEN7Vg90H21EOLACvtfcHk0ljBwix4CqM1dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xitlarurw%253D&md5=22cdfcc6286a06331b459ada2bdfb116</span></div><a href="/servlet/linkout?suffix=cit17e&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2802%2900011-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252802%252900011-X%26sid%3Dliteratum%253Aachs%26aulast%3DLangowski%26aufirst%3DJ.%26aulast%3DLong%26aufirst%3DA.%26atitle%3DComputer%2520systems%2520for%2520the%2520prediction%2520of%2520xenobiotic%2520metabolism%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2002%26volume%3D54%26spage%3D407%26epage%3D415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17f"><span><span class="NLM_label">(f) </span>Pipeline Pilot, <span class="NLM_edition">v7.5</span>; <span class="NLM_publisher-name">Accelrys Inc.</span>: <span class="NLM_publisher-loc">San Diego, CA</span>; <a href="http://accelrys.com/products/pipeline-pilot/" class="extLink">http://accelrys.com/products/pipeline-pilot/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Pipeline+Pilot%2C+v7.5%3B+Accelrys+Inc.%3A+San+Diego%2C+CA%3B+http%3A%2F%2Faccelrys.com%2Fproducts%2Fpipeline-pilot%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DPipeline%2520Pilot%26pub%3DAccelrys%2520Inc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Warmuth, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Putta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemmen, C.</span><span> </span><span class="NLM_article-title">Active learning with support vector machines in the drug discovery process</span> <span class="citation_source-journal">J. Chem. Inf. Comput. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">667</span><span class="NLM_x">–</span> <span class="NLM_lpage">673</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci025620t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17g&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVOjtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2003&pages=667-673&author=M.+K.+Warmuthauthor=J.+Liaoauthor=G.+Ratschauthor=M.+Mathiesonauthor=S.+Puttaauthor=C.+Lemmen&title=Active+learning+with+support+vector+machines+in+the+drug+discovery+process"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17gR"><div class="casContent"><span class="casTitleNuber">17g</span><div class="casTitle"><span class="NLM_cas:atitle">Active Learning with Support Vector Machines in the Drug Discovery Process</span></div><div class="casAuthors">Warmuth, Manfred K.; Liao, Jun; Raetsch, Gunnar; Mathieson, Michael; Putta, Santosh; Lemmen, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">667-673</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We investigate the following data mining problem from computer-aided drug design: from a large collection of compds., find those that bind to a target mol. in as few iterations of biochem. testing as possible.  In each iteration a comparatively small batch of compds. is screened for binding activity toward this target.  We employed the so-called "active learning paradigm" from Machine Learning for selecting the successive batches.  Our main selection strategy is based on the max. margin hyperplane-generated by "Support Vector Machines".  This hyperplane separates the current set of active from the inactive compds. and has the largest possible distance from any labeled compd.  We perform a thorough comparative study of various other selection strategies on data sets provided by DuPont Pharmaceuticals and show that the strategies based on the max. margin hyperplane clearly outperform the simpler ones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHjRog0YMu-bVg90H21EOLACvtfcHk0ljBwix4CqM1dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVOjtbk%253D&md5=0b618cf608a54dbec37c820e7fdf1fab</span></div><a href="/servlet/linkout?suffix=cit17g&amp;dbid=16384&amp;doi=10.1021%2Fci025620t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci025620t%26sid%3Dliteratum%253Aachs%26aulast%3DWarmuth%26aufirst%3DM.%2BK.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DRatsch%26aufirst%3DG.%26aulast%3DMathieson%26aufirst%3DM.%26aulast%3DPutta%26aufirst%3DS.%26aulast%3DLemmen%26aufirst%3DC.%26atitle%3DActive%2520learning%2520with%2520support%2520vector%2520machines%2520in%2520the%2520drug%2520discovery%2520process%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D2003%26volume%3D43%26spage%3D667%26epage%3D673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Ivanciuc, O.</span><span> </span><span class="NLM_article-title">Applications of support vector machines in chemistry</span> <span class="citation_source-journal">Rev. Comput. Chem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">400</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17h&amp;dbid=16&amp;doi=10.1021%2Fjm4004895&amp;key=10.1002%2F9780470116449.ch6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17h&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BD2sXisFWquro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2007&pages=291-400&author=O.+Ivanciuc&title=Applications+of+support+vector+machines+in+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17hR"><div class="casContent"><span class="casTitleNuber">17h</span><div class="casTitle"><span class="NLM_cas:atitle">Applications of support vector machines in chemistry</span></div><div class="casAuthors">Ivanciuc, Ovidiu</div><div class="citationInfo"><span class="NLM_cas:title">Reviews in Computational Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">291-400</span>CODEN:
                <span class="NLM_cas:coden">RCCHEY</span>;
        ISSN:<span class="NLM_cas:issn">1069-3599</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH</span>)
        </div><div class="casAbstract">A review.  Kernel-based techniques (such as support vector machines, Bayes point machines, kernel principal component anal., and Gaussian processes) represent a major development in machine learning algorithms.  Support vector machines (SVM) are group of supervised learning methods that can be applied to classification or regression.  SVM find numerous applications in chem., such as drug design, quant. structure-activity relationship (QSAR), chemometrics, sensors (for prediction of sensor data), chem. engineering (fault detection and process modeling), and text mining (automatic recognition of scientific information).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUVx9qkWtwmLVg90H21EOLACvtfcHk0ljBwix4CqM1dA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXisFWquro%253D&md5=e03e7f81c77e322395ad747e917c3489</span></div><a href="/servlet/linkout?suffix=cit17h&amp;dbid=16384&amp;doi=10.1002%2F9780470116449.ch6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F9780470116449.ch6%26sid%3Dliteratum%253Aachs%26aulast%3DIvanciuc%26aufirst%3DO.%26atitle%3DApplications%2520of%2520support%2520vector%2520machines%2520in%2520chemistry%26jtitle%3DRev.%2520Comput.%2520Chem%26date%3D2007%26volume%3D23%26spage%3D291%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17i"><span><span class="NLM_label">(i) </span>R Project for Statistical Computing, (R-3.2.1); <a href="http://www.r-project.org/" class="extLink">www.r-project.org/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=R+Project+for+Statistical+Computing%2C+%28R-3.2.1%29%3B+www.r-project.org%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DR%2520Project%2520for%2520Statistical%2520Computing%252C%2520%2528R-3.2.1%2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Ghose, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viswanadhan, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendoloski, J. J.</span><span> </span><span class="NLM_article-title">Prediction of hydrophobic (lipophilic) properties of small organic molecules using fragmental methods: an analysis of ALOGP and CLOGP methods</span> <span class="citation_source-journal">J. Phys. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">3762</span><span class="NLM_x">–</span> <span class="NLM_lpage">3772</span></span><div class="citationLinks">[<a href="/doi/10.1021/jp980230o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1998&pages=3762-3772&author=A.+K.+Ghoseauthor=V.+N.+Viswanadhanauthor=J.+J.+Wendoloski&title=Prediction+of+hydrophobic+%28lipophilic%29+properties+of+small+organic+molecules+using+fragmental+methods%3A+an+analysis+of+ALOGP+and+CLOGP+methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17j&amp;dbid=16384&amp;doi=10.1021%2Fjp980230o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp980230o%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DViswanadhan%26aufirst%3DV.%2BN.%26aulast%3DWendoloski%26aufirst%3DJ.%2BJ.%26atitle%3DPrediction%2520of%2520hydrophobic%2520%2528lipophilic%2529%2520properties%2520of%2520small%2520organic%2520molecules%2520using%2520fragmental%2520methods%253A%2520an%2520analysis%2520of%2520ALOGP%2520and%2520CLOGP%2520methods%26jtitle%3DJ.%2520Phys.%2520Chem.%26date%3D1998%26volume%3D102%26spage%3D3762%26epage%3D3772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17k"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group">Hall, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kier, L. B.</span><span> </span><span class="NLM_article-title">The E-state as the basis for molecular structure space definition and structure similarity</span> <span class="citation_source-journal">J. Chem. Inf. Comput. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">784</span><span class="NLM_x">–</span> <span class="NLM_lpage">791</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci990140w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17k&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitFCqt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2000&pages=784-791&author=L.+H.+Hallauthor=L.+B.+Kier&title=The+E-state+as+the+basis+for+molecular+structure+space+definition+and+structure+similarity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17kR"><div class="casContent"><span class="casTitleNuber">17k</span><div class="casTitle"><span class="NLM_cas:atitle">The E-state as the basis for molecular structure space definition and structure similarity</span></div><div class="casAuthors">Hall, Lowell H.; Kier, Lemont B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">784-791</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The electrotopol. state (E-state) is presented as a representation of mol. structure useful for definition of a space for chem. structures.  This E-state representation provides the basis for chem. database management.  The E-state formalism is presented along with its extension to the atom-type E-state.  An approach to database organization, using polychlorobiphenyls as examples, reveals the descriptive power of the E-state paradigm.  A well-organized chem. database may be searched to find structures similar to a target structure with the expectation that such structures may exhibit properties similar to the target.  Searches using the atom-type E-state indexes are demonstrated with two example drug mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWamwEV3jxR7Vg90H21EOLACvtfcHk0lgsRpmymogdGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitFCqt7k%253D&md5=6b8643b23ea396e9cbda90e2e489da26</span></div><a href="/servlet/linkout?suffix=cit17k&amp;dbid=16384&amp;doi=10.1021%2Fci990140w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci990140w%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DL.%2BH.%26aulast%3DKier%26aufirst%3DL.%2BB.%26atitle%3DThe%2520E-state%2520as%2520the%2520basis%2520for%2520molecular%2520structure%2520space%2520definition%2520and%2520structure%2520similarity%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D2000%26volume%3D40%26spage%3D784%26epage%3D791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group">Durant, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leland, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nourse, J. G.</span><span> </span><span class="NLM_article-title">Reoptimization of MDL keys for use in drug discovery</span> <span class="citation_source-journal">J. Chem. Inf. Comput. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1273</span><span class="NLM_x">–</span> <span class="NLM_lpage">1280</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci010132r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17l&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BD38XmvFKktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2002&pages=1273-1280&author=J.+L.+Durantauthor=B.+A.+Lelandauthor=D.+R.+Henryauthor=J.+G.+Nourse&title=Reoptimization+of+MDL+keys+for+use+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17lR"><div class="casContent"><span class="casTitleNuber">17l</span><div class="casTitle"><span class="NLM_cas:atitle">Reoptimization of MDL Keys for Use in Drug Discovery</span></div><div class="casAuthors">Durant, Joseph L.; Leland, Burton A.; Henry, Douglas R.; Nourse, James G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1273-1280</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">For a no. of years MDL products have exposed both 166 bit and 960 bit keysets based on 2D descriptors.  These keysets were originally constructed and optimized for substructure searching.  We report on improvements in the performance of MDL keysets which are reoptimized for use in mol. similarity.  Classification performance for a test data set of 957 compds. was increased from 0.65 for the 166 bit keyset and 0.67 for the 960 bit keyset to 0.71 for a surprisal S/N pruned keyset contg. 208 bits and 0.71 for a genetic algorithm optimized keyset contg. 548 bits.  We present an overview of the underlying technol. supporting the definition of descriptors and the encoding of these descriptors into keysets.  This technol. allows definition of descriptors as combinations of atom properties, bond properties, and at. neighborhoods at various topol. sepns. as well as supporting a no. of custom descriptors.  These descriptors can then be used to set one or more bits in a keyset.  We constructed various keysets and optimized their performance in clustering bioactive substances.  Performance was measured using methodol. developed by Briem and Lessel. "Directed pruning" was carried out by eliminating bits from the keysets on the basis of random selection, values of the surprisal of the bit, or values of the surprisal S/N ratio of the bit.  The random pruning expt. highlighted the insensitivity of keyset performance for keyset lengths of more than 1000 bits.  Contrary to initial expectations, pruning on the basis of the surprisal values of the various bits resulted in keysets which underperformed those resulting from random pruning.  In contrast, pruning on the basis of the surprisal S/N ratio was found to yield keysets which performed better than those resulting from random pruning.  We also explored the use of genetic algorithms in the selection of optimal keysets.  Once more the performance was only a weak function of keyset size, and the optimizations failed to identify a single globally optimal keyset.  Instead multiple, equally optimal keysets could be produced which had relatively low overlap of the descriptors they encoded.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR2BdLvQ_QybVg90H21EOLACvtfcHk0lgsRpmymogdGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmvFKktLY%253D&md5=424323cf6bab93c4356ace7575d3f0ca</span></div><a href="/servlet/linkout?suffix=cit17l&amp;dbid=16384&amp;doi=10.1021%2Fci010132r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci010132r%26sid%3Dliteratum%253Aachs%26aulast%3DDurant%26aufirst%3DJ.%2BL.%26aulast%3DLeland%26aufirst%3DB.%2BA.%26aulast%3DHenry%26aufirst%3DD.%2BR.%26aulast%3DNourse%26aufirst%3DJ.%2BG.%26atitle%3DReoptimization%2520of%2520MDL%2520keys%2520for%2520use%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D2002%26volume%3D42%26spage%3D1273%26epage%3D1280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17m"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group">Henry, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durant, J. L.</span><span> </span><span class="NLM_article-title">Optimization of MDL substructure search keys for the prediction of activity and toxicity</span> <span class="citation_source-journal">Chemom. Chemoinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">894</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">156</span></span><div class="citationLinks">[<a href="/doi/10.1021/bk-2005-0894.ch010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=894&publication_year=2005&pages=145-156&author=D.+R.+Henryauthor=J.+L.+Durant&title=Optimization+of+MDL+substructure+search+keys+for+the+prediction+of+activity+and+toxicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17m&amp;dbid=16384&amp;doi=10.1021%2Fbk-2005-0894.ch010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbk-2005-0894.ch010%26sid%3Dliteratum%253Aachs%26aulast%3DHenry%26aufirst%3DD.%2BR.%26aulast%3DDurant%26aufirst%3DJ.%2BL.%26atitle%3DOptimization%2520of%2520MDL%2520substructure%2520search%2520keys%2520for%2520the%2520prediction%2520of%2520activity%2520and%2520toxicity%26jtitle%3DChemom.%2520Chemoinf.%26date%3D2005%26volume%3D894%26spage%3D145%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17n"><span><span class="NLM_label">(n) </span><span class="NLM_contrib-group">Muchmore, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmunds, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajduk, P. J.</span><span> </span><span class="NLM_article-title">Cheminformatic Tools for Medicinal Chemists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4830</span><span class="NLM_x">–</span> <span class="NLM_lpage">4841</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100164z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4830-4841&author=S.+W.+Muchmoreauthor=J.+J.+Edmundsauthor=K.+D.+Stewartauthor=P.+J.+Hajduk&title=Cheminformatic+Tools+for+Medicinal+Chemists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17n&amp;dbid=16384&amp;doi=10.1021%2Fjm100164z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100164z%26sid%3Dliteratum%253Aachs%26aulast%3DMuchmore%26aufirst%3DS.%2BW.%26aulast%3DEdmunds%26aufirst%3DJ.%2BJ.%26aulast%3DStewart%26aufirst%3DK.%2BD.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26atitle%3DCheminformatic%2520Tools%2520for%2520Medicinal%2520Chemists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4830%26epage%3D4841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17o"><span><span class="NLM_label">(o) </span><span class="NLM_contrib-group">Rogers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, M.</span><span> </span><span class="NLM_article-title">Extended-Connectivity Fingerprints</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">742</span><span class="NLM_x">–</span> <span class="NLM_lpage">754</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci100050t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17o&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlt1Onsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=742-754&author=D.+Rogersauthor=M.+Hahn&title=Extended-Connectivity+Fingerprints"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17oR"><div class="casContent"><span class="casTitleNuber">17o</span><div class="casTitle"><span class="NLM_cas:atitle">Extended-Connectivity Fingerprints</span></div><div class="casAuthors">Rogers, David; Hahn, Mathew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">742-754</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Extended-connectivity fingerprints (ECFPs) are a novel class of topol. fingerprints for mol. characterization.  Historically, topol. fingerprints were developed for substructure and similarity searching.  ECFPs were developed specifically for structure-activity modeling.  ECFPs are circular fingerprints with a no. of useful qualities: they can be very rapidly calcd.; they are not predefined and can represent an essentially infinite no. of different mol. features (including stereochem. information); their features represent the presence of particular substructures, allowing easier interpretation of anal. results; and the ECFP algorithm can be tailored to generate different types of circular fingerprints, optimized for different uses.  While the use of ECFPs has been widely adopted and validated, a description of their implementation has not previously been presented in the literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra43orI-Y7lbVg90H21EOLACvtfcHk0lgsRpmymogdGw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlt1Onsbg%253D&md5=cd6c736cd7a3d280b67f5316acce8006</span></div><a href="/servlet/linkout?suffix=cit17o&amp;dbid=16384&amp;doi=10.1021%2Fci100050t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci100050t%26sid%3Dliteratum%253Aachs%26aulast%3DRogers%26aufirst%3DD.%26aulast%3DHahn%26aufirst%3DM.%26atitle%3DExtended-Connectivity%2520Fingerprints%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D742%26epage%3D754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit17p"><span><span class="NLM_label">(p) </span><span class="NLM_contrib-group">Ortwine, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aliagas, I.</span><span> </span><span class="NLM_article-title">Physicochemical and DMPK in silico models: facilitating their use by medicinal chemists</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1153</span><span class="NLM_x">–</span> <span class="NLM_lpage">1161</span></span><div class="citationLinks">[<a href="/doi/10.1021/mp3006193" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17p&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitlCisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=1153-1161&author=D.+F.+Ortwineauthor=I.+Aliagas&title=Physicochemical+and+DMPK+in+silico+models%3A+facilitating+their+use+by+medicinal+chemists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit17pR"><div class="casContent"><span class="casTitleNuber">17p</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical and DMPK In Silico Models: Facilitating Their Use by Medicinal Chemists</span></div><div class="casAuthors">Ortwine, Daniel F.; Aliagas, Ignacio</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1153-1161</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  It is known that the developability of drugs is related to their physicochem. and DMPK properties.  Given the time and expense involved in discovering and developing new drugs, maximizing the chance of success by calcg. properties ahead of chem. synthesis and testing, and only acting on those candidates whose properties fall into a desired range, would seem to make sense.  This paper provides an overview of calculable physicochem. and DMPK properties, an assessment of their relative difficulty of their calcn. and accuracy, and available software.  Methods companies have employed to communicate results will be discussed, including the use of composite scoring functions and ranking schemes.  Calcns. do no good if chemists will not use them to prioritize synthesis decisions.  Strategies are presented for facilitating model usage.  An approach adopted at Genentech for presenting results that involves the close coupling of property calcns. with 3D structure based drug design is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr8BxpmosD5bVg90H21EOLACvtfcHk0lg-rAmN7rg4xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitlCisrc%253D&md5=84324c98019337caa0570d6711d7877d</span></div><a href="/servlet/linkout?suffix=cit17p&amp;dbid=16384&amp;doi=10.1021%2Fmp3006193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp3006193%26sid%3Dliteratum%253Aachs%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DAliagas%26aufirst%3DI.%26atitle%3DPhysicochemical%2520and%2520DMPK%2520in%2520silico%2520models%253A%2520facilitating%2520their%2520use%2520by%2520medicinal%2520chemists%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2013%26volume%3D10%26spage%3D1153%26epage%3D1161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Williams, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamert, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walden, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilks, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossjohn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucet, I. S.</span><span> </span><span class="NLM_article-title">Dissecting specificity in the Janus kinases: the structures of JAK-specific inhibitors complexed to the JAK1 and JAK2 protein tyrosine kinase domains</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">387</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm4004895&amp;key=10.1016%2Fj.jmb.2009.01.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm4004895&amp;key=19361440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivVegtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2009&pages=219-232&author=N.+K.+Williamsauthor=R.+S.+Bamertauthor=O.+Patelauthor=C.+Wangauthor=P.+M.+Waldenauthor=A.+F.+Wilksauthor=E.+Fantinoauthor=J.+Rossjohnauthor=I.+S.+Lucet&title=Dissecting+specificity+in+the+Janus+kinases%3A+the+structures+of+JAK-specific+inhibitors+complexed+to+the+JAK1+and+JAK2+protein+tyrosine+kinase+domains"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Dissecting Specificity in the Janus Kinases: The Structures of JAK-Specific Inhibitors Complexed to the JAK1 and JAK2 Protein Tyrosine Kinase Domains</span></div><div class="casAuthors">Williams, Neal K.; Bamert, Rebecca S.; Patel, Onisha; Wang, Christina; Walden, Patricia M.; Wilks, Andrew F.; Fantino, Emmanuelle; Rossjohn, Jamie; Lucet, Isabelle S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">387</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">219-232</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The Janus kinases (JAKs) are a pivotal family of protein tyrosine kinases (PTKs) that play prominent roles in numerous cytokine signaling pathways, with aberrant JAK activity assocd. with a variety of hematopoietic malignancies, cardiovascular diseases and immune-related disorders.  Whereas the structures of the JAK2 and JAK3 PTK domains have been detd., the structure of the JAK1 PTK domain is unknown.  Here, we report the high-resoln. crystal structures of the "active form" of the JAK1 PTK domain in complex with two JAK inhibitors, a tetracyclic pyridone 2-t-butyl-9-fluoro-3,6-dihydro-7H-benz[h]-imidaz[4,5-f]isoquinoline-7-one (CMP6) and (3R,4R)-3-[4-methyl-3-[N-methyl-N-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropionitrile (CP-690,550), and compare them with the corresponding JAK2 PTK inhibitor complexes.  Both inhibitors bound in a similar manner to JAK1, namely buried deep within a constricted ATP-binding site, thereby providing a basis for the potent inhibition of JAK1.  As expected, the mode of inhibitor binding in JAK1 was very similar to that obsd. in JAK2, highlighting the challenges in developing JAK-specific inhibitors that target the ATP-binding site.  Nevertheless, differences surrounding the JAK1 and JAK2 ATP-binding sites were apparent, thereby providing a platform for the rational design of JAK2- and JAK1-specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQDLkMkCgiLbVg90H21EOLACvtfcHk0lg-rAmN7rg4xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivVegtbo%253D&md5=79957755d04323057b5acf7e9d2c56ca</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2009.01.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2009.01.041%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DN.%2BK.%26aulast%3DBamert%26aufirst%3DR.%2BS.%26aulast%3DPatel%26aufirst%3DO.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWalden%26aufirst%3DP.%2BM.%26aulast%3DWilks%26aufirst%3DA.%2BF.%26aulast%3DFantino%26aufirst%3DE.%26aulast%3DRossjohn%26aufirst%3DJ.%26aulast%3DLucet%26aufirst%3DI.%2BS.%26atitle%3DDissecting%2520specificity%2520in%2520the%2520Janus%2520kinases%253A%2520the%2520structures%2520of%2520JAK-specific%2520inhibitors%2520complexed%2520to%2520the%2520JAK1%2520and%2520JAK2%2520protein%2520tyrosine%2520kinase%2520domains%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D387%26spage%3D219%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Chrencik, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patny, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korniski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmons, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gormley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommers, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenbrink, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomasselli, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, T. E.</span><span> </span><span class="NLM_article-title">Structural and thermodynamic characterization of the TYK2 and JAK3 kinase domains in complex with CP-690550 and CMP-6</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">400</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">433</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm4004895&amp;key=10.1016%2Fj.jmb.2010.05.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm4004895&amp;key=20478313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1ylt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=2010&pages=413-433&author=J.+E.+Chrencikauthor=A.+Patnyauthor=I.+K.+Leungauthor=B.+Korniskiauthor=T.+L.+Emmonsauthor=T.+Hallauthor=R.+A.+Weinbergauthor=J.+A.+Gormleyauthor=J.+M.+Williamsauthor=J.+E.+Dayauthor=J.+L.+Hirschauthor=J.+R.+Kieferauthor=J.+W.+Leoneauthor=H.+D.+Fischerauthor=C.+D.+Sommersauthor=H.+C.+Huangauthor=E.+J.+Jacobsenauthor=R.+E.+Tenbrinkauthor=A.+G.+Tomasselliauthor=T.+E.+Benson&title=Structural+and+thermodynamic+characterization+of+the+TYK2+and+JAK3+kinase+domains+in+complex+with+CP-690550+and+CMP-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP-690550 and CMP-6</span></div><div class="casAuthors">Chrencik, Jill E.; Patny, Akshay; Leung, Iris K.; Korniski, Brian; Emmons, Thomas L.; Hall, Troii; Weinberg, Robin A.; Gormley, Jennifer A.; Williams, Jennifer M.; Day, Jacqueline E.; Hirsch, Jeffrey L.; Kiefer, James R.; Leone, Joseph W.; Fischer, H. David; Sommers, Cynthia D.; Huang, Horng-Chih; Jacobsen, E. J.; Tenbrink, Ruth E.; Tomasselli, Alfredo G.; Benson, Timothy E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">400</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">413-433</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Janus kinases (JAKs) are crit. regulators of cytokine pathways and attractive targets of therapeutic value in both inflammatory and myeloproliferative diseases.  Although the crystal structures of active JAK1 and JAK2 kinase domains have been reported recently with the clin. compd. CP-690550, the structures of both TYK2 and JAK3 with CP-690550 have remained outstanding.  Here, we report the crystal structures of TYK2, a first in class structure, and JAK3 in complex with PAN-JAK inhibitors CP-690550 ((3R,4R)-3-[4-methyl-3-[N-methyl-N-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropionitrile) and CMP-6 (tetracyclic pyridone 2-t-butyl-9-fluoro-3,6-dihydro-7H-benz[h]-imidaz[4,5-f]isoquinoline-7-one), both of which bind in the ATP-binding cavities of both JAK isoenzymes in orientations similar to that obsd. in crystal structures of JAK1 and JAK2.  Addnl., a complete thermodn. characterization of JAK/CP-690550 complex formation was completed by isothermal titrn. calorimetry, indicating the crit. role of the nitrile group from the CP-690550 compd.  Finally, computational anal. using WaterMap further highlights the crit. positioning of the CP-690550 nitrile group in the displacement of an unfavorable water mol. beneath the glycine-rich loop.  Taken together, the data emphasize the outstanding properties of the kinome-selective JAK inhibitor CP-690550, as well as the challenges in obtaining JAK isoenzyme-selective inhibitors due to the overall structural and sequence similarities between the TYK2, JAK1, JAK2 and JAK3 isoenzymes.  Nevertheless, subtle amino acid variations of residues lining the ligand-binding cavity of the JAK enzymes, as well as the global positioning of the glycine-rich loop, might provide the initial clues to obtaining JAK-isoenzyme selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5dnGkvq0jPbVg90H21EOLACvtfcHk0lg-rAmN7rg4xw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1ylt7g%253D&md5=1b1efc3d6f913143dc9113e4ac1c4c60</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2010.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2010.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DChrencik%26aufirst%3DJ.%2BE.%26aulast%3DPatny%26aufirst%3DA.%26aulast%3DLeung%26aufirst%3DI.%2BK.%26aulast%3DKorniski%26aufirst%3DB.%26aulast%3DEmmons%26aufirst%3DT.%2BL.%26aulast%3DHall%26aufirst%3DT.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26aulast%3DGormley%26aufirst%3DJ.%2BA.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DDay%26aufirst%3DJ.%2BE.%26aulast%3DHirsch%26aufirst%3DJ.%2BL.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DLeone%26aufirst%3DJ.%2BW.%26aulast%3DFischer%26aufirst%3DH.%2BD.%26aulast%3DSommers%26aufirst%3DC.%2BD.%26aulast%3DHuang%26aufirst%3DH.%2BC.%26aulast%3DJacobsen%26aufirst%3DE.%2BJ.%26aulast%3DTenbrink%26aufirst%3DR.%2BE.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DBenson%26aufirst%3DT.%2BE.%26atitle%3DStructural%2520and%2520thermodynamic%2520characterization%2520of%2520the%2520TYK2%2520and%2520JAK3%2520kinase%2520domains%2520in%2520complex%2520with%2520CP-690550%2520and%2520CMP-6%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D400%26spage%3D413%26epage%3D433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><div class="note"><p class="first last">The maximum achievable oral bioavailability (<i>F</i><sub>max</sub>) is the product of the fraction absorbed (<i>F</i><sub>a</sub>), the fraction escaping intestinal metabolism (<i>F</i><sub>g</sub>), and the fraction escaping hepatic metabolism (<i>F</i><sub>h</sub>), as expressed by the equation: <i>F</i><sub>max</sub> = <i>F</i><sub>a</sub>·<i>F</i><sub>g</sub>·<i>F</i><sub>h</sub>. Assuming a best case scenario of no intestinal wall metabolism, and complete absorption of the oral dose (<i>F</i><sub>g</sub> and <i>F</i><sub>a</sub> = 1), the equation is simplified to <i>F</i><sub>max</sub> = <i>F</i><sub>h</sub>. Because <i>F</i><sub>h</sub> = 1 – CL/<i>Q</i><sub>h</sub>, where CL is clearance and <i>Q</i><sub>h</sub> is hepatic blood flow, it is apparent that the maximum achievable bioavailability should be controlled by clearance according to the equation: <i>F</i><sub>max</sub> = 1 – CL/<i>Q</i><sub>h</sub>. Hepatic blood flows of 70, 31, and 44 mL min<sup>–1</sup> kg<sup>–1</sup> were used for rat, dog, and cyno <i>F</i><sub>max</sub> calculations, respectively. See:</p></div><span class="NLM_contrib-group">Rautio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumpulainen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heimbach, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliyai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Järvinen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savolainen, J.</span><span> </span><span class="NLM_article-title">Prodrugs: design and clinical applications</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">270</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=255-270&author=J.+Rautioauthor=H.+Kumpulainenauthor=T.+Heimbachauthor=R.+Oliyaiauthor=D.+Ohauthor=T.+J%C3%A4rvinenauthor=J.+Savolainen&title=Prodrugs%3A+design+and+clinical+applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRautio%26aufirst%3DJ.%26aulast%3DKumpulainen%26aufirst%3DH.%26aulast%3DHeimbach%26aufirst%3DT.%26aulast%3DOliyai%26aufirst%3DR.%26aulast%3DOh%26aufirst%3DD.%26aulast%3DJ%25C3%25A4rvinen%26aufirst%3DT.%26aulast%3DSavolainen%26aufirst%3DJ.%26atitle%3DProdrugs%253A%2520design%2520and%2520clinical%2520applications%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D255%26epage%3D270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="note"><p class="first last">Detailed experimental procedures were previously published in ref <a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">7</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref22"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref22'); return false;" data-citation="" class="refNumLink">22</a></strong><div class="NLM_citation" id="cit22"><span><span class="NLM_contrib-group">Meerwein, H.</span><span> </span><span class="NLM_article-title">Triethyloxonium fluoroborate</span>.  <span class="citation_source-journal">Org. Synth.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1080</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1973&pages=1080&author=H.+Meerwein&title=Triethyloxonium+fluoroborate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeerwein%26aufirst%3DH.%26atitle%3DTriethyloxonium%2520fluoroborate%26jtitle%3DOrg.%2520Synth.%26date%3D1973%26volume%3D5%26spage%3D1080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref23"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref23'); return false;" data-citation="" class="refNumLink">23</a></strong><div class="NLM_citation" id="cit23a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">In some instances when the imidate formation with triethyloxonium tetrafluoroborate was performed in THF, polymerization of the solvent occurred to form a viscous mass and the reaction could not be continued. Similar observations were previously reported:</p></div><span class="NLM_contrib-group">Vartak, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crooks, P. A.</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span></span><div class="citationLinks">[<a href="/doi/10.1021/op8002689" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=In+some+instances+when+the+imidate+formation+with+triethyloxonium+tetrafluoroborate+was+performed+in+THF%2C+polymerization+of+the+solvent+occurred+to+form+a+viscous+mass+and+the+reaction+could+not+be+continued.+Similar+observations+were+previously+reported%3AVartak%2C+A.+P.%3B+Crooks%2C+P.+A.Org.+Process+Res.+Dev.+2009%2C+13%2C+415"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1021%2Fop8002689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop8002689%26sid%3Dliteratum%253Aachs%26aulast%3DVartak%26aufirst%3DA.%2BP.%26aulast%3DCrooks%26aufirst%3DP.%2BA.%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2009%26volume%3D13%26spage%3D415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit23b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">Imidate formation can also be carried out in DCM:</p></div><span class="NLM_contrib-group">Kiessling, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClure, C. K.</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=16&amp;doi=10.1021%2Fjm4004895&amp;key=10.1080%2F00397919708004212" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADyaK2sXhsVKhs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Imidate+formation+can+also+be+carried+out+in+DCM%3AKiessling%2C+A.+J.%3B+McClure%2C+C.+K.Synth.+Commun.+1997%2C+27%2C+923"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit23bR"><div class="casContent"><span class="casTitleNuber">23b</span><div class="casTitle"><span class="NLM_cas:atitle">The conversion of amides to esters with Meerwein's reagent. Application to the synthesis of a carfentanil precursor</span></div><div class="casAuthors">Kiessling, Anthony J.; McClure, Cynthia K.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">923-937</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Dekker</span>)
        </div><div class="casAbstract">An efficient two step transformation of 1° and 2° amides to Me and Et esters has been developed using trimethyl- and triethyloxonium tetrafluoroborates and dil. acid.  This methodol. was applied to 1-benzyl-4-phenylamino-4-piperidinecarboxamide, a precursor in the synthesis of carfentanil, to produce the Me ester in 60% yield and the Et ester in 80% yield.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpYd1ptRbsPrVg90H21EOLACvtfcHk0lig0xGNYRwSiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhsVKhs7w%253D&md5=5fbc207d2766914932d48fec7cfeed5e</span></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1080%2F00397919708004212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919708004212%26sid%3Dliteratum%253Aachs%26aulast%3DKiessling%26aufirst%3DA.%2BJ.%26aulast%3DMcClure%26aufirst%3DC.%2BK.%26jtitle%3DSynth.%2520Commun.%26date%3D1997%26volume%3D27%26spage%3D923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref24"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref24'); return false;" data-citation="" class="refNumLink">24</a></strong><div class="NLM_citation" id="cit24"><span><span class="NLM_contrib-group">Clososki, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohbogner, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knochel, P.</span><span> </span><span class="NLM_article-title">Direct Magnesiation of Polyfunctionalized Arenes and Heteroarenes Using (tmp)<sub>2</sub>Mg·2LiCl</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">7681</span><span class="NLM_x">–</span> <span class="NLM_lpage">7684</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm4004895&amp;key=10.1002%2Fanie.200701487" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1Sis7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=7681-7684&author=G.+C.+Clososkiauthor=C.+J.+Rohbognerauthor=P.+Knochel&title=Direct+Magnesiation+of+Polyfunctionalized+Arenes+and+Heteroarenes+Using+%28tmp%292Mg%C2%B72LiCl"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Direct magnesiation of polyfunctionalized arenes and heteroarenes using (tmp)2Mg·2LiCl</span></div><div class="casAuthors">Clososki, Giuliano C.; Rohbogner, Christoph J.; Knochel, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">7681-7684</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Outstripping lithium bases: A wide range of polyfunctional aryl and heteroaryl magnesium reagents were efficiently prepd. in THF by direct magnesiation with (tmp)2Mg·2 LiCl, an exceptionally active base.  These compds. can serve as intermediates in natural product synthesis.  In an example, a palladium-catalyzed cross-coupling reaction is used to prep. a deriv. of salicylic acid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopEYCo4TfzVLVg90H21EOLACvtfcHk0lig0xGNYRwSiQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1Sis7%252FJ&md5=5ce38a6493e68eba86e153bc744b61c5</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fanie.200701487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200701487%26sid%3Dliteratum%253Aachs%26aulast%3DClososki%26aufirst%3DG.%2BC.%26aulast%3DRohbogner%26aufirst%3DC.%2BJ.%26aulast%3DKnochel%26aufirst%3DP.%26atitle%3DDirect%2520Magnesiation%2520of%2520Polyfunctionalized%2520Arenes%2520and%2520Heteroarenes%2520Using%2520%2528tmp%25292Mg%25C2%25B72LiCl%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2007%26volume%3D46%26spage%3D7681%26epage%3D7684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref25"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref25'); return false;" data-citation="" class="refNumLink">25</a></strong><div class="note"><p class="first last">All amines were either purchased from commercial sources, synthesized as described in the references in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> or synthesized by the methods in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref26"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref26'); return false;" data-citation="" class="refNumLink">26</a></strong><div class="NLM_citation" id="cit26"><span><span class="NLM_contrib-group">Broo, A.; Holm, P.; Judkins, R.; Li, L.; Lindstedt-Alstermark, E.; Sandberg, P.; Swanson, M.; Weidolf, L.; Mrickmann, K.</span><span> </span><span class="NLM_article-title">Non-anilinic derivatives of isothiazol-3(2<i>H</i>)-one 1,2-dioxides as Liver X receptor modulators</span>. WO2006073366,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=A.+Broo&author=P.+Holm&author=R.+Judkins&author=L.+Li&author=E.+Lindstedt-Alstermark&author=P.+Sandberg&author=M.+Swanson&author=L.+Weidolf&author=K.+Mrickmann&title=Non-anilinic+derivatives+of+isothiazol-3%282H%29-one+1%2C2-dioxides+as+Liver+X+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBroo%26aufirst%3DA.%26atitle%3DNon-anilinic%2520derivatives%2520of%2520isothiazol-3%25282H%2529-one%25201%252C2-dioxides%2520as%2520Liver%2520X%2520receptor%2520modulators%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref27"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref27'); return false;" data-citation="" class="refNumLink">27</a></strong><div class="note"><p class="first last">Prepared as described in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="ref28"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref28'); return false;" data-citation="" class="refNumLink">28</a></strong><div class="NLM_citation" id="cit28"><span><span class="NLM_contrib-group">Savage, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, G.</span><span> </span><span class="NLM_article-title">Kilogram synthesis of (<i>S</i>)-3-aminopyran from <span class="smallcaps smallerCapital">l</span>-glutamic acid</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">987</span><span class="NLM_x">–</span> <span class="NLM_lpage">990</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2013&pages=987-990&author=S.+Savageauthor=S.+Babuauthor=M.+Zakauthor=Z.+Maoauthor=J.+Caoauthor=Y.+Geauthor=D.+Maauthor=G.+Jiang&title=Kilogram+synthesis+of+%28S%29-3-aminopyran+from+l-glutamic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSavage%26aufirst%3DS.%26aulast%3DBabu%26aufirst%3DS.%26aulast%3DZak%26aufirst%3DM.%26aulast%3DMao%26aufirst%3DZ.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DGe%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DD.%26aulast%3DJiang%26aufirst%3DG.%26atitle%3DKilogram%2520synthesis%2520of%2520%2528S%2529-3-aminopyran%2520from%2520l-glutamic%2520acid%26jtitle%3DSynlett%26date%3D2013%26volume%3D24%26spage%3D987%26epage%3D990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref29"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref29'); return false;" data-citation="" class="refNumLink">29</a></strong><div class="NLM_citation" id="cit29"><span><span class="NLM_contrib-group">Brocklehurst, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laumen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Vecchia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vögtle, M.</span><span> </span><span class="NLM_article-title">Diastereoisomeric salt formation and enzyme-catalyzed kinetic resolution as complementary methods for the chiral separation of <i>cis</i>-/<i>trans</i>-enantiomers of 3-aminocyclohexanol</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">294</span><span class="NLM_x">–</span> <span class="NLM_lpage">300</span></span><div class="citationLinks">[<a href="/doi/10.1021/op1002424" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2011&pages=294-300&author=C.+E.+Brocklehurstauthor=K.+Laumenauthor=L.+La+Vecchiaauthor=D.+Shawauthor=M.+V%C3%B6gtle&title=Diastereoisomeric+salt+formation+and+enzyme-catalyzed+kinetic+resolution+as+complementary+methods+for+the+chiral+separation+of+cis-%2Ftrans-enantiomers+of+3-aminocyclohexanol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fop1002424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop1002424%26sid%3Dliteratum%253Aachs%26aulast%3DBrocklehurst%26aufirst%3DC.%2BE.%26aulast%3DLaumen%26aufirst%3DK.%26aulast%3DLa%2BVecchia%26aufirst%3DL.%26aulast%3DShaw%26aufirst%3DD.%26aulast%3DV%25C3%25B6gtle%26aufirst%3DM.%26atitle%3DDiastereoisomeric%2520salt%2520formation%2520and%2520enzyme-catalyzed%2520kinetic%2520resolution%2520as%2520complementary%2520methods%2520for%2520the%2520chiral%2520separation%2520of%2520cis-%252Ftrans-enantiomers%2520of%25203-aminocyclohexanol%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2011%26volume%3D15%26spage%3D294%26epage%3D300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref30"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref30'); return false;" data-citation="" class="refNumLink">30</a></strong><div class="NLM_citation" id="cit30"><span><span class="NLM_contrib-group">Sekiguchi, Y.; Kanuma, K.; Omodera, K.; Busujima, T.; Tran, T.; Han, S.; Casper, M.; Kramer, B. A.; Semple, G.; Zou, N.</span><span> </span><span class="NLM_article-title">Quinoline, tetrahydroquinoline and pyrimidine derivatives as MCH antagonist</span>. EP1464335,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=Y.+Sekiguchi&author=K.+Kanuma&author=K.+Omodera&author=T.+Busujima&author=T.+Tran&author=S.+Han&author=M.+Casper&author=B.+A.+Kramer&author=G.+Semple&author=N.+Zou&title=Quinoline%2C+tetrahydroquinoline+and+pyrimidine+derivatives+as+MCH+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSekiguchi%26aufirst%3DY.%26atitle%3DQuinoline%252C%2520tetrahydroquinoline%2520and%2520pyrimidine%2520derivatives%2520as%2520MCH%2520antagonist%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref31"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref31'); return false;" data-citation="" class="refNumLink">31</a></strong><div class="NLM_citation" id="cit31"><span><span class="NLM_contrib-group">Sekiguchi, Y.i; Kanuma, K.; Omodera, K.; Busujima, T.; Tran, T.; Han, S.; Casper, M.; Kramer, B. A.</span><span> </span><span class="NLM_article-title">Preparation of novel quinazolines as MCH receptor antagonists</span>. WO2004087680,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=Y.i+Sekiguchi&author=K.+Kanuma&author=K.+Omodera&author=T.+Busujima&author=T.+Tran&author=S.+Han&author=M.+Casper&author=B.+A.+Kramer&title=Preparation+of+novel+quinazolines+as+MCH+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSekiguchi%26aufirst%3DY.i%26atitle%3DPreparation%2520of%2520novel%2520quinazolines%2520as%2520MCH%2520receptor%2520antagonists%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref32"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref32'); return false;" data-citation="" class="refNumLink">32</a></strong><div class="NLM_citation" id="cit32"><span><span class="NLM_contrib-group">Thompson, W.; Young, S. D.; Phillips, B. T.; Munson, P.; Whitter, W.; Liverton, N.; Dieckhaus, C.; Butcher, J.; Mccauley, J. A.; Mcintyre, C. J.; Layton, M. E.; Sanderson, P. E.</span><span> </span><span class="NLM_article-title">4-Cycloalkylaminopyrazolopyrimidine NMDA/NR2B antagonists</span>. US20050054658.<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=W.+Thompson&author=S.+D.+Young&author=B.+T.+Phillips&author=P.+Munson&author=W.+Whitter&author=N.+Liverton&author=C.+Dieckhaus&author=J.+Butcher&author=J.+A.+Mccauley&author=C.+J.+Mcintyre&author=M.+E.+Layton&author=P.+E.+Sanderson&title=4-Cycloalkylaminopyrazolopyrimidine+NMDA%2FNR2B+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DW.%26atitle%3D4-Cycloalkylaminopyrazolopyrimidine%2520NMDA%252FNR2B%2520antagonists%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref33"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref33'); return false;" data-citation="" class="refNumLink">33</a></strong><div class="NLM_citation" id="cit33"><span><span class="NLM_contrib-group">Aahlin, K.; Arvidsson, P. I.; Besidski, Y.; Nilsson, L. I.</span><span> </span><span class="NLM_article-title">Preparation of cyano group containing isoindoline derivatives for treating pain disorders</span>. WO2009145719,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=K.+Aahlin&author=P.+I.+Arvidsson&author=Y.+Besidski&author=L.+I.+Nilsson&title=Preparation+of+cyano+group+containing+isoindoline+derivatives+for+treating+pain+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAahlin%26aufirst%3DK.%26atitle%3DPreparation%2520of%2520cyano%2520group%2520containing%2520isoindoline%2520derivatives%2520for%2520treating%2520pain%2520disorders%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2'],'ref3':['cit3a','cit3b','cit3c'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6'],'ref7':['cit7'],'ref8':['cit8a','cit8b','cit8c','cit8d','cit8e','cit8f','cit8g','cit8h'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11a','cit11b'],'ref12':['cit12a','cit12b'],'ref13':[],'ref14':['cit14c','cit14a','cit14b'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17a','cit17b','cit17c','cit17d','cit17e','cit17f','cit17g','cit17h','cit17i','cit17j','cit17k','cit17l','cit17m','cit17n','cit17o','cit17p'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':[],'ref22':['cit22'],'ref23':['cit23a','cit23b'],'ref24':['cit24'],'ref25':[],'ref26':['cit26'],'ref27':[],'ref28':['cit28'],'ref29':['cit29'],'ref30':['cit30'],'ref31':['cit31'],'ref32':['cit32'],'ref33':['cit33']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 44 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Maria Galvez-Llompart, Riccardo Ocello, Laura Rullo, Serena Stamatakos, Irene Alessandrini, Riccardo Zanni, Iñaki Tuñón, Andrea Cavalli, Sanzio Candeletti, Matteo Masetti, Patrizia Romualdi, <span class="NLM_string-name hlFld-ContribAuthor">Maurizio Recanatini</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting the JAK/STAT Pathway: A Combined Ligand- and Target-Based Approach. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2021,</strong> <em>61 </em>
                                    (6)
                                     , 3091-3108. <a href="https://doi.org/10.1021/acs.jcim.0c01468" title="DOI URL">https://doi.org/10.1021/acs.jcim.0c01468</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.0c01468&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.0c01468%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DTargeting%252Bthe%252BJAK%25252FSTAT%252BPathway%25253A%252BA%252BCombined%252BLigand-%252Band%252BTarget-Based%252BApproach%26aulast%3DGalvez-Llompart%26aufirst%3DMaria%26date%3D2021%26date%3D2021%26date%3D2020%26date%3D22122020%26date%3D17052021%26volume%3D61%26issue%3D6%26spage%3D3091%26epage%3D3108" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Kristi A. Leonard, Lisa A. Madge, Paul J. Krawczuk, Aihua Wang, Kevin D. Kreutter, Genesis M. Bacani, Wenying Chai, Russell C. Smith, Mark S. Tichenor, Michael C. Harris, Ravi Malaviya, Mark Seierstad, Marguerite E. Johnson, Jennifer D. Venable, Suzie Kim, Gavin C. Hirst, Ashok S. Mathur, Tadimeti S. Rao, James P. Edwards, Michele C. Rizzolio, <span class="NLM_string-name hlFld-ContribAuthor">Tatiana Koudriakova</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a Gut-Restricted JAK Inhibitor for the Treatment of Inflammatory Bowel Disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>63 </em>
                                    (6)
                                     , 2915-2929. <a href="https://doi.org/10.1021/acs.jmedchem.9b01439" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.9b01439</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.9b01439&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.9b01439%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BGut-Restricted%252BJAK%252BInhibitor%252Bfor%252Bthe%252BTreatment%252Bof%252BInflammatory%252BBowel%252BDisease%26aulast%3DLeonard%26aufirst%3DKristi%2BA.%26date%3D2020%26date%3D2020%26date%3D2019%26date%3D30082019%26date%3D16032020%26date%3D05032020%26volume%3D63%26issue%3D6%26spage%3D2915%26epage%3D2929" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Wei Chen, Yuqing Deng, Ellery Russell, Yujie Wu, Robert Abel, <span class="NLM_string-name hlFld-ContribAuthor">Lingle Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Accurate Calculation of Relative Binding Free Energies between Ligands with Different Net Charges. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Theory and Computation</span><span> <strong>2018,</strong> <em>14 </em>
                                    (12)
                                     , 6346-6358. <a href="https://doi.org/10.1021/acs.jctc.8b00825" title="DOI URL">https://doi.org/10.1021/acs.jctc.8b00825</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jctc.8b00825&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jctc.8b00825%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Theory%2520and%2520Computation%26atitle%3DAccurate%252BCalculation%252Bof%252BRelative%252BBinding%252BFree%252BEnergies%252Bbetween%252BLigands%252Bwith%252BDifferent%252BNet%252BCharges%26aulast%3DChen%26aufirst%3DWei%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D07082018%26date%3D12112018%26date%3D30102018%26volume%3D14%26issue%3D12%26spage%3D6346%26epage%3D6358" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Marian C. Bryan, <span class="NLM_string-name hlFld-ContribAuthor">Naomi S. Rajapaksa</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase Inhibitors for the Treatment of Immunological Disorders: Recent Advances. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (20)
                                     , 9030-9058. <a href="https://doi.org/10.1021/acs.jmedchem.8b00667" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.8b00667</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.8b00667&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.8b00667%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DKinase%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BImmunological%252BDisorders%25253A%252BRecent%252BAdvances%26aulast%3DBryan%26aufirst%3DMarian%2BC.%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D26042018%26date%3D15062018%26date%3D05062018%26volume%3D61%26issue%3D20%26spage%3D9030%26epage%3D9058" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael L.  Vazquez</span>, <span class="hlFld-ContribAuthor ">Neelu  Kaila</span>, <span class="hlFld-ContribAuthor ">Joseph W.  Strohbach</span>, <span class="hlFld-ContribAuthor ">John D.  Trzupek</span>, <span class="hlFld-ContribAuthor ">Matthew F.  Brown</span>, <span class="hlFld-ContribAuthor ">Mark E.  Flanagan</span>, <span class="hlFld-ContribAuthor ">Mark J.  Mitton-Fry</span>, <span class="hlFld-ContribAuthor ">Timothy A.  Johnson</span>, <span class="hlFld-ContribAuthor ">Ruth E.  TenBrink</span>, <span class="hlFld-ContribAuthor ">Eric P.  Arnold</span>, <span class="hlFld-ContribAuthor ">Arindrajit  Basak</span>, <span class="hlFld-ContribAuthor ">Steven E.  Heasley</span>, <span class="hlFld-ContribAuthor ">Soojin  Kwon</span>, <span class="hlFld-ContribAuthor ">Jonathan  Langille</span>, <span class="hlFld-ContribAuthor ">Mihir D.  Parikh</span>, <span class="hlFld-ContribAuthor ">Sarah H.  Griffin</span>, <span class="hlFld-ContribAuthor ">Jeffrey M.  Casavant</span>, <span class="hlFld-ContribAuthor ">Brian A.  Duclos</span>, <span class="hlFld-ContribAuthor ">Ashley E.  Fenwick</span>, <span class="hlFld-ContribAuthor ">Thomas M.  Harris</span>, <span class="hlFld-ContribAuthor ">Seungil  Han</span>, <span class="hlFld-ContribAuthor ">Nicole  Caspers</span>, <span class="hlFld-ContribAuthor ">Martin E.  Dowty</span>, <span class="hlFld-ContribAuthor ">Xin  Yang</span>, <span class="hlFld-ContribAuthor ">Mary Ellen  Banker</span>, <span class="hlFld-ContribAuthor ">Martin  Hegen</span>, <span class="hlFld-ContribAuthor ">Peter T.  Symanowicz</span>, <span class="hlFld-ContribAuthor ">Li  Li</span>, <span class="hlFld-ContribAuthor ">Lu  Wang</span>, <span class="hlFld-ContribAuthor ">Tsung H.  Lin</span>, <span class="hlFld-ContribAuthor ">Jason  Jussif</span>, <span class="hlFld-ContribAuthor ">James D.  Clark</span>, <span class="hlFld-ContribAuthor ">Jean-Baptiste  Telliez</span>, <span class="hlFld-ContribAuthor ">Ralph P.  Robinson</span>, and <span class="hlFld-ContribAuthor ">Ray  Unwalla</span>  . </span><span class="cited-content_cbyCitation_article-title">Identification of N-{cis-3-[Methyl(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]cyclobutyl}propane-1-sulfonamide (PF-04965842): A Selective JAK1 Clinical Candidate for the Treatment of Autoimmune Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2018,</strong> <em>61 </em>
                                    (3)
                                     , 1130-1152. <a href="https://doi.org/10.1021/acs.jmedchem.7b01598" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01598</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01598&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01598%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DIdentification%252Bof%252BN-%25257Bcis-3-%25255BMethyl%2525287H-pyrrolo%25255B2%25252C3-d%25255Dpyrimidin-4-yl%252529amino%25255Dcyclobutyl%25257Dpropane-1-sulfonamide%252B%252528PF-04965842%252529%25253A%252BA%252BSelective%252BJAK1%252BClinical%252BCandidate%252Bfor%252Bthe%252BTreatment%252Bof%252BAutoimmune%252BDiseases%26aulast%3DVazquez%26aufirst%3DMichael%2BL.%26date%3D2018%26date%3D2018%26date%3D2017%26date%3D30102017%26date%3D23012018%26date%3D08022018%26date%3D03012018%26volume%3D61%26issue%3D3%26spage%3D1130%26epage%3D1152" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tony  Siu</span>, <span class="hlFld-ContribAuthor ">Jason  Brubaker</span>, <span class="hlFld-ContribAuthor ">Peter  Fuller</span>, <span class="hlFld-ContribAuthor ">Luis  Torres</span>, <span class="hlFld-ContribAuthor ">Hongbo  Zeng</span>, <span class="hlFld-ContribAuthor ">Joshua  Close</span>, <span class="hlFld-ContribAuthor ">Dawn M.  Mampreian</span>, <span class="hlFld-ContribAuthor ">Feng  Shi</span>, <span class="hlFld-ContribAuthor ">Duan  Liu</span>, <span class="hlFld-ContribAuthor ">Xavier  Fradera</span>, <span class="hlFld-ContribAuthor ">Kevin  Johnson</span>, <span class="hlFld-ContribAuthor ">Nathan  Bays</span>, <span class="hlFld-ContribAuthor ">Elma  Kadic</span>, <span class="hlFld-ContribAuthor ">Fang  He</span>, <span class="hlFld-ContribAuthor ">Peter  Goldenblatt</span>, <span class="hlFld-ContribAuthor ">Lynsey  Shaffer</span>, <span class="hlFld-ContribAuthor ">Sangita B.  Patel</span>, <span class="hlFld-ContribAuthor ">Charles A.  Lesburg</span>, <span class="hlFld-ContribAuthor ">Carla  Alpert</span>, <span class="hlFld-ContribAuthor ">Lauren  Dorosh</span>, <span class="hlFld-ContribAuthor ">Sujal V.  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Hongshi  Yu</span>, <span class="hlFld-ContribAuthor ">Joel  Klappenbach</span>, <span class="hlFld-ContribAuthor ">Fiona  Elwood</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Dinsmore</span>, <span class="hlFld-ContribAuthor ">Rafael  Fernandez</span>, <span class="hlFld-ContribAuthor ">Lily  Moy</span>, and <span class="hlFld-ContribAuthor ">Jonathan R.  Young</span>  . </span><span class="cited-content_cbyCitation_article-title">The Discovery of 3-((4-Chloro-3-methoxyphenyl)amino)-1-((3R,4S)-4-cyanotetrahydro-2H-pyran-3-yl)-1H-pyrazole-4-carboxamide, a Highly Ligand Efficient and Efficacious Janus Kinase 1 Selective Inhibitor with Favorable Pharmacokinetic Properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (23)
                                     , 9676-9690. <a href="https://doi.org/10.1021/acs.jmedchem.7b01135" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b01135</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b01135&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b01135%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252BDiscovery%252Bof%252B3-%252528%2525284-Chloro-3-methoxyphenyl%252529amino%252529-1-%252528%2525283R%25252C4S%252529-4-cyanotetrahydro-2H-pyran-3-yl%252529-1H-pyrazole-4-carboxamide%25252C%252Ba%252BHighly%252BLigand%252BEfficient%252Band%252BEfficacious%252BJanus%252BKinase%252B1%252BSelective%252BInhibitor%252Bwith%252BFavorable%252BPharmacokinetic%252BProperties%26aulast%3DSiu%26aufirst%3DTony%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D04082017%26date%3D04122017%26date%3D14122017%26date%3D20112017%26volume%3D60%26issue%3D23%26spage%3D9676%26epage%3D9690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Lianbin  Yao</span>, <span class="hlFld-ContribAuthor ">Nurulhuda  Mustafa</span>, <span class="hlFld-ContribAuthor ">Eng Chong  Tan</span>, <span class="hlFld-ContribAuthor ">Anders  Poulsen</span>, <span class="hlFld-ContribAuthor ">Prachi  Singh</span>, <span class="hlFld-ContribAuthor ">Minh-Dao  Duong-Thi</span>, <span class="hlFld-ContribAuthor ">Jeannie X. T.  Lee</span>, <span class="hlFld-ContribAuthor ">Pondy Murugappan  Ramanujulu</span>, <span class="hlFld-ContribAuthor ">Wee Joo  Chng</span>, <span class="hlFld-ContribAuthor ">Jeffrey J. Y.  Yen</span>, <span class="hlFld-ContribAuthor ">Sten  Ohlson</span>, and <span class="hlFld-ContribAuthor ">Brian W.  Dymock</span>  . </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Ligand Efficient Dual Inhibitors of Janus Kinase (JAK) and Histone Deacetylase (HDAC) Based on Ruxolitinib and Vorinostat. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (20)
                                     , 8336-8357. <a href="https://doi.org/10.1021/acs.jmedchem.7b00678" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00678</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00678&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00678%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BLigand%252BEfficient%252BDual%252BInhibitors%252Bof%252BJanus%252BKinase%252B%252528JAK%252529%252Band%252BHistone%252BDeacetylase%252B%252528HDAC%252529%252BBased%252Bon%252BRuxolitinib%252Band%252BVorinostat%26aulast%3DYao%26aufirst%3DLianbin%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D11052017%26date%3D10102017%26date%3D26102017%26date%3D27092017%26volume%3D60%26issue%3D20%26spage%3D8336%26epage%3D8357" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dávid  Bajusz</span>, <span class="hlFld-ContribAuthor ">György G.  Ferenczy</span>, and <span class="hlFld-ContribAuthor ">György M.  Keserű</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Subtype Selective Janus Kinase (JAK) Inhibitors by Structure-Based Virtual Screening. </span><span class="cited-content_cbyCitation_journal-name">Journal of Chemical Information and Modeling</span><span> <strong>2016,</strong> <em>56 </em>
                                    (1)
                                     , 234-247. <a href="https://doi.org/10.1021/acs.jcim.5b00634" title="DOI URL">https://doi.org/10.1021/acs.jcim.5b00634</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jcim.5b00634&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jcim.5b00634%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Chemical%2520Information%2520and%2520Modeling%26atitle%3DDiscovery%252Bof%252BSubtype%252BSelective%252BJanus%252BKinase%252B%252528JAK%252529%252BInhibitors%252Bby%252BStructure-Based%252BVirtual%252BScreening%26aulast%3DBajusz%26aufirst%3DD%25C3%25A1vid%26date%3D2016%26date%3D2015%26date%3D2015%26date%3D18102015%26date%3D31122015%26date%3D25012016%26date%3D18122015%26volume%3D56%26issue%3D1%26spage%3D234%26epage%3D247" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peng  Zhan</span>, <span class="hlFld-ContribAuthor ">Yukihiro  Itoh</span>, <span class="hlFld-ContribAuthor ">Takayoshi  Suzuki</span>, and <span class="hlFld-ContribAuthor ">Xinyong  Liu</span>  . </span><span class="cited-content_cbyCitation_article-title">Strategies for the Discovery of Target-Specific or Isoform-Selective Modulators. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (19)
                                     , 7611-7633. <a href="https://doi.org/10.1021/acs.jmedchem.5b00229" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b00229</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b00229&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b00229%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DStrategies%252Bfor%252Bthe%252BDiscovery%252Bof%252BTarget-Specific%252Bor%252BIsoform-Selective%252BModulators%26aulast%3DZhan%26aufirst%3DPeng%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D09022015%26date%3D01072015%26date%3D08102015%26date%3D18062015%26volume%3D58%26issue%3D19%26spage%3D7611%26epage%3D7633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mi Kyoung  Kim</span>, <span class="hlFld-ContribAuthor ">Heerim  Shin</span>, <span class="hlFld-ContribAuthor ">Kwang-su  Park</span>, <span class="hlFld-ContribAuthor ">Hyungmi  Kim</span>, <span class="hlFld-ContribAuthor ">Jiseon  Park</span>, <span class="hlFld-ContribAuthor ">Kangjeon  Kim</span>, <span class="hlFld-ContribAuthor ">Joonwoo  Nam</span>, <span class="hlFld-ContribAuthor ">Hyunah  Choo</span>, and <span class="hlFld-ContribAuthor ">Youhoon  Chong</span>  . </span><span class="cited-content_cbyCitation_article-title">Benzimidazole Derivatives as Potent JAK1-Selective Inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>58 </em>
                                    (18)
                                     , 7596-7602. <a href="https://doi.org/10.1021/acs.jmedchem.5b01263" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01263</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01263&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01263%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DBenzimidazole%252BDerivatives%252Bas%252BPotent%252BJAK1-Selective%252BInhibitors%26aulast%3DKim%26aufirst%3DMi%2BKyoung%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D10052015%26date%3D15092015%26date%3D24092015%26date%3D09092015%26volume%3D58%26issue%3D18%26spage%3D7596%26epage%3D7602" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Emily J.  Hanan</span>, <span class="hlFld-ContribAuthor ">Charles  Eigenbrot</span>, <span class="hlFld-ContribAuthor ">Marian C.  Bryan</span>, <span class="hlFld-ContribAuthor ">Daniel J.  Burdick</span>, <span class="hlFld-ContribAuthor ">Bryan K.  Chan</span>, <span class="hlFld-ContribAuthor ">Yuan  Chen</span>, <span class="hlFld-ContribAuthor ">Jennafer  Dotson</span>, <span class="hlFld-ContribAuthor ">Robert A.  Heald</span>, <span class="hlFld-ContribAuthor ">Philip S.  Jackson</span>, <span class="hlFld-ContribAuthor ">Hank  La</span>, <span class="hlFld-ContribAuthor ">Michael D.  Lainchbury</span>, <span class="hlFld-ContribAuthor ">Shiva  Malek</span>, <span class="hlFld-ContribAuthor ">Hans E.  Purkey</span>, <span class="hlFld-ContribAuthor ">Gabriele  Schaefer</span>, <span class="hlFld-ContribAuthor ">Stephen  Schmidt</span>, <span class="hlFld-ContribAuthor ">Eileen M.  Seward</span>, <span class="hlFld-ContribAuthor ">Steve  Sideris</span>, <span class="hlFld-ContribAuthor ">Christine  Tam</span>, <span class="hlFld-ContribAuthor ">Shumei  Wang</span>, <span class="hlFld-ContribAuthor ">Siew Kuen  Yeap</span>, <span class="hlFld-ContribAuthor ">Ivana  Yen</span>, <span class="hlFld-ContribAuthor ">Jianping  Yin</span>, <span class="hlFld-ContribAuthor ">Christine  Yu</span>, <span class="hlFld-ContribAuthor ">Inna  Zilberleyb</span>, and <span class="hlFld-ContribAuthor ">Timothy P.  Heffron</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Selective and Noncovalent Diaminopyrimidine-Based Inhibitors of Epidermal Growth Factor Receptor Containing the T790M Resistance Mutation. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (23)
                                     , 10176-10191. <a href="https://doi.org/10.1021/jm501578n" title="DOI URL">https://doi.org/10.1021/jm501578n</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501578n&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501578n%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BSelective%252Band%252BNoncovalent%252BDiaminopyrimidine-Based%252BInhibitors%252Bof%252BEpidermal%252BGrowth%252BFactor%252BReceptor%252BContaining%252Bthe%252BT790M%252BResistance%252BMutation%26aulast%3DHanan%26aufirst%3DEmily%2BJ.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D13102014%26date%3D20112014%26date%3D11122014%26date%3D10112014%26volume%3D57%26issue%3D23%26spage%3D10176%26epage%3D10191" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christel J.  Menet</span>, <span class="hlFld-ContribAuthor ">Stephen R  Fletcher</span>, <span class="hlFld-ContribAuthor ">Guy  Van Lommen</span>, <span class="hlFld-ContribAuthor ">Raphael  Geney</span>, <span class="hlFld-ContribAuthor ">Javier  Blanc</span>, <span class="hlFld-ContribAuthor ">Koen  Smits</span>, <span class="hlFld-ContribAuthor ">Nolwenn  Jouannigot</span>, <span class="hlFld-ContribAuthor ">Pierre  Deprez</span>, <span class="hlFld-ContribAuthor ">Ellen M.  van der Aar</span>, <span class="hlFld-ContribAuthor ">Philippe  Clement-Lacroix</span>, <span class="hlFld-ContribAuthor ">Liên  Lepescheux</span>, <span class="hlFld-ContribAuthor ">René  Galien</span>, <span class="hlFld-ContribAuthor ">Béatrice  Vayssiere</span>, <span class="hlFld-ContribAuthor ">Luc  Nelles</span>, <span class="hlFld-ContribAuthor ">Thierry  Christophe</span>, <span class="hlFld-ContribAuthor ">Reginald  Brys</span>, <span class="hlFld-ContribAuthor ">Muriel  Uhring</span>, <span class="hlFld-ContribAuthor ">Fabrice  Ciesielski</span>, and <span class="hlFld-ContribAuthor ">Luc  Van Rompaey</span>  . </span><span class="cited-content_cbyCitation_article-title">Triazolopyridines as Selective JAK1 Inhibitors: From Hit Identification to GLPG0634. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (22)
                                     , 9323-9342. <a href="https://doi.org/10.1021/jm501262q" title="DOI URL">https://doi.org/10.1021/jm501262q</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm501262q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm501262q%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DTriazolopyridines%252Bas%252BSelective%252BJAK1%252BInhibitors%25253A%252BFrom%252BHit%252BIdentification%252Bto%252BGLPG0634%26aulast%3DMenet%26aufirst%3DChristel%2BJ.%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D02042014%26date%3D17112014%26date%3D26112014%26date%3D04112014%26volume%3D57%26issue%3D22%26spage%3D9323%26epage%3D9342" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">James D.  Clark</span>, <span class="hlFld-ContribAuthor ">Mark E.  Flanagan</span>, and <span class="hlFld-ContribAuthor ">Jean-Baptiste  Telliez</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery and Development of Janus Kinase (JAK) Inhibitors for Inflammatory Diseases. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (12)
                                     , 5023-5038. <a href="https://doi.org/10.1021/jm401490p" title="DOI URL">https://doi.org/10.1021/jm401490p</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm401490p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm401490p%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Band%252BDevelopment%252Bof%252BJanus%252BKinase%252B%252528JAK%252529%252BInhibitors%252Bfor%252BInflammatory%252BDiseases%26aulast%3DClark%26aufirst%3DJames%2BD.%26date%3D2014%26date%3D2014%26date%3D2013%26date%3D25092013%26date%3D23012014%26date%3D26062014%26date%3D13012014%26volume%3D57%26issue%3D12%26spage%3D5023%26epage%3D5038" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pengfei  Xu</span>, <span class="hlFld-ContribAuthor ">Pei  Shen</span>, <span class="hlFld-ContribAuthor ">Hai  Wang</span>, <span class="hlFld-ContribAuthor ">Lian  Qin</span>, <span class="hlFld-ContribAuthor ">Jie  Ren</span>, <span class="hlFld-ContribAuthor ">Qiushuang  Sun</span>, <span class="hlFld-ContribAuthor ">Raoling  Ge</span>, <span class="hlFld-ContribAuthor ">Jinlei  Bian</span>, <span class="hlFld-ContribAuthor ">Yi  Zhong</span>, <span class="hlFld-ContribAuthor ">Zhiyu  Li</span>, <span class="hlFld-ContribAuthor ">JuBo  Wang</span>, <span class="hlFld-ContribAuthor ">Zhixia  Qiu</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of imidazopyrrolopyridines derivatives as novel and selective inhibitors of JAK2. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>218 </em>, 113394. <a href="https://doi.org/10.1016/j.ejmech.2021.113394" title="DOI URL">https://doi.org/10.1016/j.ejmech.2021.113394</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2021.113394&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2021.113394%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bimidazopyrrolopyridines%252Bderivatives%252Bas%252Bnovel%252Band%252Bselective%252Binhibitors%252Bof%252BJAK2%26aulast%3DXu%26aufirst%3DPengfei%26date%3D2021%26volume%3D218%26spage%3D113394" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Robert M.  Borzilleri</span>, <span class="hlFld-ContribAuthor ">Amy C.  Hart</span>, <span class="hlFld-ContribAuthor ">Ryan  Moslin</span>, <span class="hlFld-ContribAuthor ">John S.  Tokarski</span>, <span class="hlFld-ContribAuthor ">Stephen T.  Wrobleski</span>. </span><span class="cited-content_cbyCitation_article-title">JAK
              Family Inhibitors for Autoimmune Diseases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,, 1-86. <a href="https://doi.org/10.1002/0471266949.bmc279" title="DOI URL">https://doi.org/10.1002/0471266949.bmc279</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/0471266949.bmc279&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F0471266949.bmc279%26sid%3Dliteratum%253Aachs%26atitle%3DJAK%252BFamily%252BInhibitors%252Bfor%252BAutoimmune%252BDiseases%26aulast%3DBorzilleri%26aufirst%3DRobert%2BM.%26date%3D2021%26date%3D2021%26spage%3D1%26epage%3D86%26pub%3DWiley%26atitle%3DBurger%252527s%252BMedicinal%252BChemistry%252Band%252BDrug%252BDiscovery%26aulast%3DAbraham%26aufirst%3DDonald%2BJ.%26date%3D2003%26date%3D2003%26volume%3D64" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiamin  Zheng</span>, <span class="hlFld-ContribAuthor ">Jun  Wu</span>, <span class="hlFld-ContribAuthor ">Xiao  Ding</span>, <span class="hlFld-ContribAuthor ">Hong C.  Shen</span>, <span class="hlFld-ContribAuthor ">Ge  Zou</span>. </span><span class="cited-content_cbyCitation_article-title">Small molecule approaches to treat autoimmune and inflammatory diseases (Part I): Kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2021,</strong> <em>38 </em>, 127862. <a href="https://doi.org/10.1016/j.bmcl.2021.127862" title="DOI URL">https://doi.org/10.1016/j.bmcl.2021.127862</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2021.127862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2021.127862%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DSmall%252Bmolecule%252Bapproaches%252Bto%252Btreat%252Bautoimmune%252Band%252Binflammatory%252Bdiseases%252B%252528Part%252BI%252529%25253A%252BKinase%252Binhibitors%26aulast%3DZheng%26aufirst%3DJiamin%26date%3D2021%26volume%3D38%26spage%3D127862" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chang  Xu</span>, <span class="hlFld-ContribAuthor ">Ran  Cheng</span>, <span class="hlFld-ContribAuthor ">Yun‐Cheng  Luo</span>, <span class="hlFld-ContribAuthor ">Ming‐Kuan  Wang</span>, <span class="hlFld-ContribAuthor ">Xingang  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">trans
              ‐Selective Aryldifluoroalkylation of Endocyclic Enecarbamates and Enamides by Nickel Catalysis. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie</span><span> <strong>2020,</strong> <em>132 </em>
                                    (42)
                                     , 18900-18906. <a href="https://doi.org/10.1002/ange.202008498" title="DOI URL">https://doi.org/10.1002/ange.202008498</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/ange.202008498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fange.202008498%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%26atitle%3Dtrans%252B%2525E2%252580%252590Selective%252BAryldifluoroalkylation%252Bof%252BEndocyclic%252BEnecarbamates%252Band%252BEnamides%252Bby%252BNickel%252BCatalysis%26aulast%3DXu%26aufirst%3DChang%26date%3D2020%26date%3D2020%26volume%3D132%26issue%3D42%26spage%3D18900%26epage%3D18906" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chang  Xu</span>, <span class="hlFld-ContribAuthor ">Ran  Cheng</span>, <span class="hlFld-ContribAuthor ">Yun‐Cheng  Luo</span>, <span class="hlFld-ContribAuthor ">Ming‐Kuan  Wang</span>, <span class="hlFld-ContribAuthor ">Xingang  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">trans
              ‐Selective Aryldifluoroalkylation of Endocyclic Enecarbamates and Enamides by Nickel Catalysis. </span><span class="cited-content_cbyCitation_journal-name">Angewandte Chemie International Edition</span><span> <strong>2020,</strong> <em>59 </em>
                                    (42)
                                     , 18741-18747. <a href="https://doi.org/10.1002/anie.202008498" title="DOI URL">https://doi.org/10.1002/anie.202008498</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/anie.202008498&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fanie.202008498%26sid%3Dliteratum%253Aachs%26jtitle%3DAngewandte%2520Chemie%2520International%2520Edition%26atitle%3Dtrans%252B%2525E2%252580%252590Selective%252BAryldifluoroalkylation%252Bof%252BEndocyclic%252BEnecarbamates%252Band%252BEnamides%252Bby%252BNickel%252BCatalysis%26aulast%3DXu%26aufirst%3DChang%26date%3D2020%26date%3D2020%26volume%3D59%26issue%3D42%26spage%3D18741%26epage%3D18747" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Safa  Daoud</span>, <span class="hlFld-ContribAuthor ">Mutasem O.  Taha</span>. </span><span class="cited-content_cbyCitation_article-title">Pharmacophore modeling of JAK1: A target infested with activity-cliffs. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2020,</strong> <em>99 </em>, 107615. <a href="https://doi.org/10.1016/j.jmgm.2020.107615" title="DOI URL">https://doi.org/10.1016/j.jmgm.2020.107615</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2020.107615&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2020.107615%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DPharmacophore%252Bmodeling%252Bof%252BJAK1%25253A%252BA%252Btarget%252Binfested%252Bwith%252Bactivity-cliffs%26aulast%3DDaoud%26aufirst%3DSafa%26date%3D2020%26volume%3D99%26spage%3D107615" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Amy E  Defnet</span>, <span class="hlFld-ContribAuthor ">Jeffery D  Hasday</span>, <span class="hlFld-ContribAuthor ">Paul  Shapiro</span>. </span><span class="cited-content_cbyCitation_article-title">Kinase inhibitors in the treatment of obstructive pulmonary diseases. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Pharmacology</span><span> <strong>2020,</strong> <em>51 </em>, 11-18. <a href="https://doi.org/10.1016/j.coph.2020.03.005" title="DOI URL">https://doi.org/10.1016/j.coph.2020.03.005</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.coph.2020.03.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.coph.2020.03.005%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Pharmacology%26atitle%3DKinase%252Binhibitors%252Bin%252Bthe%252Btreatment%252Bof%252Bobstructive%252Bpulmonary%252Bdiseases%26aulast%3DDefnet%26aufirst%3DAmy%2BE%26date%3D2020%26volume%3D51%26spage%3D11%26epage%3D18" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pengfei  Xu</span>, <span class="hlFld-ContribAuthor ">Pei  Shen</span>, <span class="hlFld-ContribAuthor ">Bin  Yu</span>, <span class="hlFld-ContribAuthor ">Xi  Xu</span>, <span class="hlFld-ContribAuthor ">Raoling  Ge</span>, <span class="hlFld-ContribAuthor ">Xinying  Cheng</span>, <span class="hlFld-ContribAuthor ">Qiuyu  Chen</span>, <span class="hlFld-ContribAuthor ">Jinlei  Bian</span>, <span class="hlFld-ContribAuthor ">Zhiyu  Li</span>, <span class="hlFld-ContribAuthor ">JuBo  Wang</span>. </span><span class="cited-content_cbyCitation_article-title">Janus kinases (JAKs): The efficient therapeutic targets for autoimmune diseases and myeloproliferative disorders. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2020,</strong> <em>192 </em>, 112155. <a href="https://doi.org/10.1016/j.ejmech.2020.112155" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.112155</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.112155&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.112155%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DJanus%252Bkinases%252B%252528JAKs%252529%25253A%252BThe%252Befficient%252Btherapeutic%252Btargets%252Bfor%252Bautoimmune%252Bdiseases%252Band%252Bmyeloproliferative%252Bdisorders%26aulast%3DXu%26aufirst%3DPengfei%26date%3D2020%26volume%3D192%26spage%3D112155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dávid  Bajusz</span>, <span class="hlFld-ContribAuthor ">Anita  Rácz</span>, <span class="hlFld-ContribAuthor ">Károly  Héberger</span>. </span><span class="cited-content_cbyCitation_article-title">Comparison of Data Fusion Methods as Consensus Scores for Ensemble Docking. </span><span class="cited-content_cbyCitation_journal-name">Molecules</span><span> <strong>2019,</strong> <em>24 </em>
                                    (15)
                                     , 2690. <a href="https://doi.org/10.3390/molecules24152690" title="DOI URL">https://doi.org/10.3390/molecules24152690</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3390/molecules24152690&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3390%2Fmolecules24152690%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecules%26atitle%3DComparison%252Bof%252BData%252BFusion%252BMethods%252Bas%252BConsensus%252BScores%252Bfor%252BEnsemble%252BDocking%26aulast%3DBajusz%26aufirst%3DD%25C3%25A1vid%26date%3D2019%26date%3D2019%26volume%3D24%26issue%3D15%26spage%3D2690" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Emily J.  Hanan</span>, <span class="hlFld-ContribAuthor ">Patrick  Lupardus</span>, <span class="hlFld-ContribAuthor ">David G.  Brown</span>, <span class="hlFld-ContribAuthor ">Colin  Robinson</span>, <span class="hlFld-ContribAuthor ">Michael  Siu</span>, <span class="hlFld-ContribAuthor ">Joseph P.  Lyssikatos</span>, <span class="hlFld-ContribAuthor ">F. Anthony  Romero</span>, <span class="hlFld-ContribAuthor ">Guiling  Zhao</span>, <span class="hlFld-ContribAuthor ">Terry  Kellar</span>, <span class="hlFld-ContribAuthor ">Rohan  Mendonca</span>, <span class="hlFld-ContribAuthor ">Nicholas C.  Ray</span>, <span class="hlFld-ContribAuthor ">Simon C.  Goodacre</span>, <span class="hlFld-ContribAuthor ">Peter H.  Crackett</span>, <span class="hlFld-ContribAuthor ">Neville  McLean</span>, <span class="hlFld-ContribAuthor ">Christopher A.  Hurley</span>, <span class="hlFld-ContribAuthor ">Po-wai  Yuen</span>, <span class="hlFld-ContribAuthor ">Yun-Xing  Cheng</span>, <span class="hlFld-ContribAuthor ">Xiongcai  Liu</span>, <span class="hlFld-ContribAuthor ">Marya  Liimatta</span>, <span class="hlFld-ContribAuthor ">Pawan Bir  Kohli</span>, <span class="hlFld-ContribAuthor ">Jim  Nonomiya</span>, <span class="hlFld-ContribAuthor ">Gary  Salmon</span>, <span class="hlFld-ContribAuthor ">Gerry  Buckley</span>, <span class="hlFld-ContribAuthor ">Julia  Lloyd</span>, <span class="hlFld-ContribAuthor ">Paul  Gibbons</span>, <span class="hlFld-ContribAuthor ">Nico  Ghilardi</span>, <span class="hlFld-ContribAuthor ">Jane R.  Kenny</span>, <span class="hlFld-ContribAuthor ">Adam  Johnson</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of a class of highly potent Janus Kinase 1/2 (JAK1/2) inhibitors demonstrating effective cell-based blockade of IL-13 signaling. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>29 </em>
                                    (12)
                                     , 1522-1531. <a href="https://doi.org/10.1016/j.bmcl.2019.04.008" title="DOI URL">https://doi.org/10.1016/j.bmcl.2019.04.008</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2019.04.008&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2019.04.008%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDiscovery%252Bof%252Ba%252Bclass%252Bof%252Bhighly%252Bpotent%252BJanus%252BKinase%252B1%25252F2%252B%252528JAK1%25252F2%252529%252Binhibitors%252Bdemonstrating%252Beffective%252Bcell-based%252Bblockade%252Bof%252BIL-13%252Bsignaling%26aulast%3DZak%26aufirst%3DMark%26date%3D2019%26volume%3D29%26issue%3D12%26spage%3D1522%26epage%3D1531" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Patricia  Martín-Rodríguez</span>, <span class="hlFld-ContribAuthor ">Borja  Guerra</span>, <span class="hlFld-ContribAuthor ">Idaira  Hueso-Falcón</span>, <span class="hlFld-ContribAuthor ">Haidee  Aranda-Tavío</span>, <span class="hlFld-ContribAuthor ">Juan  Díaz-Chico</span>, <span class="hlFld-ContribAuthor ">José  Quintana</span>, <span class="hlFld-ContribAuthor ">Francisco  Estévez</span>, <span class="hlFld-ContribAuthor ">Bonifacio  Díaz-Chico</span>, <span class="hlFld-ContribAuthor ">Angel  Amesty</span>, <span class="hlFld-ContribAuthor ">Ana  Estévez-Braun</span>, <span class="hlFld-ContribAuthor ">Leandro  Fernández-Pérez</span>. </span><span class="cited-content_cbyCitation_article-title">A Novel Naphthoquinone-Coumarin Hybrid That Inhibits BCR-ABL1-STAT5 Oncogenic Pathway and Reduces Survival in Imatinib-Resistant Chronic Myelogenous Leukemia Cells. </span><span class="cited-content_cbyCitation_journal-name">Frontiers in Pharmacology</span><span> <strong>2019,</strong> <em>9 </em><a href="https://doi.org/10.3389/fphar.2018.01546" title="DOI URL">https://doi.org/10.3389/fphar.2018.01546</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.3389/fphar.2018.01546&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.3389%2Ffphar.2018.01546%26sid%3Dliteratum%253Aachs%26jtitle%3DFrontiers%2520in%2520Pharmacology%26atitle%3DA%252BNovel%252BNaphthoquinone-Coumarin%252BHybrid%252BThat%252BInhibits%252BBCR-ABL1-STAT5%252BOncogenic%252BPathway%252Band%252BReduces%252BSurvival%252Bin%252BImatinib-Resistant%252BChronic%252BMyelogenous%252BLeukemia%252BCells%26aulast%3DMart%25C3%25ADn-Rodr%25C3%25ADguez%26aufirst%3DPatricia%26date%3D2019%26date%3D2019%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hart S.  Dengler</span>, <span class="hlFld-ContribAuthor ">Xiumin  Wu</span>, <span class="hlFld-ContribAuthor ">Ivan  Peng</span>, <span class="hlFld-ContribAuthor ">Cornelia H.  Rinderknecht</span>, <span class="hlFld-ContribAuthor ">Youngsu  Kwon</span>, <span class="hlFld-ContribAuthor ">Eric  Suto</span>, <span class="hlFld-ContribAuthor ">Pawan Bir  Kohli</span>, <span class="hlFld-ContribAuthor ">Marya  Liimatta</span>, <span class="hlFld-ContribAuthor ">Kathy  Barrett</span>, <span class="hlFld-ContribAuthor ">Julia  Lloyd</span>, <span class="hlFld-ContribAuthor ">Gary  Cain</span>, <span class="hlFld-ContribAuthor ">Mike  Briggs</span>, <span class="hlFld-ContribAuthor ">Stephanie  Addo</span>, <span class="hlFld-ContribAuthor ">Gary  Salmon</span>, <span class="hlFld-ContribAuthor ">Savita  Ubhayakar</span>, <span class="hlFld-ContribAuthor ">Gauri  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Sheerin K.  Shahidi-Latham</span>, <span class="hlFld-ContribAuthor ">Cristine M.  Quiason-Huynh</span>, <span class="hlFld-ContribAuthor ">Janet  Jackman</span>, <span class="hlFld-ContribAuthor ">John  Liu</span>, <span class="hlFld-ContribAuthor ">Nicholas C.  Ray</span>, <span class="hlFld-ContribAuthor ">Simon C.  Goodacre</span>, <span class="hlFld-ContribAuthor ">Adam  Johnson</span>, <span class="hlFld-ContribAuthor ">Brent S.  McKenzie</span>, <span class="hlFld-ContribAuthor ">Wyne P.  Lee</span>, <span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">Jane R.  Kenny</span>, <span class="hlFld-ContribAuthor ">Nico  Ghilardi</span>. </span><span class="cited-content_cbyCitation_article-title">Lung-restricted inhibition of Janus kinase 1 is effective in rodent models of asthma. </span><span class="cited-content_cbyCitation_journal-name">Science Translational Medicine</span><span> <strong>2018,</strong> <em>10 </em>
                                    (468)
                                     , eaao2151. <a href="https://doi.org/10.1126/scitranslmed.aao2151" title="DOI URL">https://doi.org/10.1126/scitranslmed.aao2151</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1126/scitranslmed.aao2151&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1126%2Fscitranslmed.aao2151%26sid%3Dliteratum%253Aachs%26jtitle%3DScience%2520Translational%2520Medicine%26atitle%3DLung-restricted%252Binhibition%252Bof%252BJanus%252Bkinase%252B1%252Bis%252Beffective%252Bin%252Brodent%252Bmodels%252Bof%252Basthma%26aulast%3DDengler%26aufirst%3DHart%2BS.%26date%3D2018%26date%3D2018%26volume%3D10%26issue%3D468%26spage%3Deaao2151" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yifan  Zhou</span>, <span class="hlFld-ContribAuthor ">Xiao  Liu</span>, <span class="hlFld-ContribAuthor ">Youzhi  Zhang</span>, <span class="hlFld-ContribAuthor ">Long  Peng</span>, <span class="hlFld-ContribAuthor ">John Z. H.  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Residue-specific free energy analysis in ligand bindings to JAK2. </span><span class="cited-content_cbyCitation_journal-name">Molecular Physics</span><span> <strong>2018,</strong> <em>116 </em>
                                    (19-20)
                                     , 2633-2641. <a href="https://doi.org/10.1080/00268976.2018.1442596" title="DOI URL">https://doi.org/10.1080/00268976.2018.1442596</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/00268976.2018.1442596&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F00268976.2018.1442596%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Physics%26atitle%3DResidue-specific%252Bfree%252Benergy%252Banalysis%252Bin%252Bligand%252Bbindings%252Bto%252BJAK2%26aulast%3DZhou%26aufirst%3DYifan%26date%3D2018%26date%3D2018%26volume%3D116%26issue%3D19-20%26spage%3D2633%26epage%3D2641" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ramesh  Itteboina</span>, <span class="hlFld-ContribAuthor ">Srilata  Ballu</span>, <span class="hlFld-ContribAuthor ">Sree Kanth  Sivan</span>, <span class="hlFld-ContribAuthor ">Vijjulatha  Manga</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular modeling-driven approach for identification of Janus kinase 1 inhibitors through 3D-QSAR, docking and molecular dynamics simulations. </span><span class="cited-content_cbyCitation_journal-name">Journal of Receptors and Signal Transduction</span><span> <strong>2017,</strong> <em>37 </em>
                                    (5)
                                     , 453-469. <a href="https://doi.org/10.1080/10799893.2017.1328442" title="DOI URL">https://doi.org/10.1080/10799893.2017.1328442</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/10799893.2017.1328442&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F10799893.2017.1328442%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Receptors%2520and%2520Signal%2520Transduction%26atitle%3DMolecular%252Bmodeling-driven%252Bapproach%252Bfor%252Bidentification%252Bof%252BJanus%252Bkinase%252B1%252Binhibitors%252Bthrough%252B3D-QSAR%25252C%252Bdocking%252Band%252Bmolecular%252Bdynamics%252Bsimulations%26aulast%3DItteboina%26aufirst%3DRamesh%26date%3D2017%26date%3D2017%26volume%3D37%26issue%3D5%26spage%3D453%26epage%3D469" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Dávid  Bajusz</span>, <span class="hlFld-ContribAuthor ">György G.  Ferenczy</span>, <span class="hlFld-ContribAuthor ">György M.  Keserű</span>. </span><span class="cited-content_cbyCitation_article-title">Ensemble docking-based virtual screening yields novel spirocyclic JAK1 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Graphics and Modelling</span><span> <strong>2016,</strong> <em>70 </em>, 275-283. <a href="https://doi.org/10.1016/j.jmgm.2016.10.014" title="DOI URL">https://doi.org/10.1016/j.jmgm.2016.10.014</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.jmgm.2016.10.014&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.jmgm.2016.10.014%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Graphics%2520and%2520Modelling%26atitle%3DEnsemble%252Bdocking-based%252Bvirtual%252Bscreening%252Byields%252Bnovel%252Bspirocyclic%252BJAK1%252Binhibitors%26aulast%3DBajusz%26aufirst%3DD%25C3%25A1vid%26date%3D2016%26volume%3D70%26spage%3D275%26epage%3D283" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Vladimir  Simov</span>, <span class="hlFld-ContribAuthor ">Sujal V.  Deshmukh</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Dinsmore</span>, <span class="hlFld-ContribAuthor ">Fiona  Elwood</span>, <span class="hlFld-ContribAuthor ">Rafael B.  Fernandez</span>, <span class="hlFld-ContribAuthor ">Yudith  Garcia</span>, <span class="hlFld-ContribAuthor ">Craig  Gibeau</span>, <span class="hlFld-ContribAuthor ">Hakan  Gunaydin</span>, <span class="hlFld-ContribAuthor ">Joon  Jung</span>, <span class="hlFld-ContribAuthor ">Jason D.  Katz</span>, <span class="hlFld-ContribAuthor ">Brian  Kraybill</span>, <span class="hlFld-ContribAuthor ">Blair  Lapointe</span>, <span class="hlFld-ContribAuthor ">Sangita B.  Patel</span>, <span class="hlFld-ContribAuthor ">Tony  Siu</span>, <span class="hlFld-ContribAuthor ">Hua  Su</span>, <span class="hlFld-ContribAuthor ">Jonathan R.  Young</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design and development of (benz)imidazole pyridones as JAK1-selective kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2016,</strong> <em>26 </em>
                                    (7)
                                     , 1803-1808. <a href="https://doi.org/10.1016/j.bmcl.2016.02.035" title="DOI URL">https://doi.org/10.1016/j.bmcl.2016.02.035</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2016.02.035&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2016.02.035%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure-based%252Bdesign%252Band%252Bdevelopment%252Bof%252B%252528benz%252529imidazole%252Bpyridones%252Bas%252BJAK1-selective%252Bkinase%252Binhibitors%26aulast%3DSimov%26aufirst%3DVladimir%26date%3D2016%26volume%3D26%26issue%3D7%26spage%3D1803%26epage%3D1808" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">György G.  Ferenczy</span>, <span class="hlFld-ContribAuthor ">György M.  Keserű</span>. </span><span class="cited-content_cbyCitation_article-title">Ligand Efficiency Metrics and their Use in Fragment Optimizations. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2016,</strong>,, 75-98. <a href="https://doi.org/10.1002/9783527683604.ch04" title="DOI URL">https://doi.org/10.1002/9783527683604.ch04</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527683604.ch04&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527683604.ch04%26sid%3Dliteratum%253Aachs%26atitle%3DLigand%252BEfficiency%252BMetrics%252Band%252Btheir%252BUse%252Bin%252BFragment%252BOptimizations%26aulast%3DFerenczy%26aufirst%3DGy%25C3%25B6rgy%2BG.%26date%3D2016%26date%3D2016%26spage%3D75%26epage%3D98%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DFragment-based%252BDrug%252BDiscovery%252BLessons%252Band%252BOutlook%26aulast%3DErlanson%26aufirst%3DDaniel%2BA.%26date%3D2016%26volume%3D9" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jiao Jiao  Li</span>, <span class="hlFld-ContribAuthor ">Peng  Cheng</span>, <span class="hlFld-ContribAuthor ">Jing  Tu</span>, <span class="hlFld-ContribAuthor ">Hong Lin  Zhai</span>, <span class="hlFld-ContribAuthor ">Xiao Yun  Zhang</span>. </span><span class="cited-content_cbyCitation_article-title">Enhancing specificity in the Janus kinases: a study on the thienopyridine JAK2 selective mechanism combined molecular dynamics simulation. </span><span class="cited-content_cbyCitation_journal-name">Molecular BioSystems</span><span> <strong>2016,</strong> <em>12 </em>
                                    (2)
                                     , 575-587. <a href="https://doi.org/10.1039/C5MB00747J" title="DOI URL">https://doi.org/10.1039/C5MB00747J</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C5MB00747J&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC5MB00747J%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520BioSystems%26atitle%3DEnhancing%252Bspecificity%252Bin%252Bthe%252BJanus%252Bkinases%25253A%252Ba%252Bstudy%252Bon%252Bthe%252Bthienopyridine%252BJAK2%252Bselective%252Bmechanism%252Bcombined%252Bmolecular%252Bdynamics%252Bsimulation%26aulast%3DLi%26aufirst%3DJiao%2BJiao%26date%3D2016%26date%3D2016%26volume%3D12%26issue%3D2%26spage%3D575%26epage%3D587" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michael  Friedman</span>, <span class="hlFld-ContribAuthor ">Kristine E.  Frank</span>, <span class="hlFld-ContribAuthor ">Ana  Aguirre</span>, <span class="hlFld-ContribAuthor ">Maria A.  Argiriadi</span>, <span class="hlFld-ContribAuthor ">Heather  Davis</span>, <span class="hlFld-ContribAuthor ">Jeremy J.  Edmunds</span>, <span class="hlFld-ContribAuthor ">Dawn M.  George</span>, <span class="hlFld-ContribAuthor ">Jonathan S.  George</span>, <span class="hlFld-ContribAuthor ">Eric  Goedken</span>, <span class="hlFld-ContribAuthor ">Bryan  Fiamengo</span>, <span class="hlFld-ContribAuthor ">Deborah  Hyland</span>, <span class="hlFld-ContribAuthor ">Bin  Li</span>, <span class="hlFld-ContribAuthor ">Anwar  Murtaza</span>, <span class="hlFld-ContribAuthor ">Michael  Morytko</span>, <span class="hlFld-ContribAuthor ">Gagandeep  Somal</span>, <span class="hlFld-ContribAuthor ">Kent  Stewart</span>, <span class="hlFld-ContribAuthor ">Edit  Tarcsa</span>, <span class="hlFld-ContribAuthor ">Stacy  Van Epps</span>, <span class="hlFld-ContribAuthor ">Jeffrey  Voss</span>, <span class="hlFld-ContribAuthor ">Lu  Wang</span>, <span class="hlFld-ContribAuthor ">Kevin  Woller</span>, <span class="hlFld-ContribAuthor ">Neil  Wishart</span>. </span><span class="cited-content_cbyCitation_article-title">Structure activity optimization of 6H-pyrrolo[2,3-e][1,2,4]triazolo[4,3-a]pyrazines as Jak1 kinase inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2015,</strong> <em>25 </em>
                                    (20)
                                     , 4399-4404. <a href="https://doi.org/10.1016/j.bmcl.2015.09.020" title="DOI URL">https://doi.org/10.1016/j.bmcl.2015.09.020</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2015.09.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2015.09.020%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DStructure%252Bactivity%252Boptimization%252Bof%252B6H-pyrrolo%25255B2%25252C3-e%25255D%25255B1%25252C2%25252C4%25255Dtriazolo%25255B4%25252C3-a%25255Dpyrazines%252Bas%252BJak1%252Bkinase%252Binhibitors%26aulast%3DFriedman%26aufirst%3DMichael%26date%3D2015%26volume%3D25%26issue%3D20%26spage%3D4399%26epage%3D4404" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xiao  Xiong</span>, <span class="hlFld-ContribAuthor ">Haoliang  Yuan</span>, <span class="hlFld-ContribAuthor ">Yanmin  Zhang</span>, <span class="hlFld-ContribAuthor ">Jinxing  Xu</span>, <span class="hlFld-ContribAuthor ">Ting  Ran</span>, <span class="hlFld-ContribAuthor ">Haichun  Liu</span>, <span class="hlFld-ContribAuthor ">Shuai  Lu</span>, <span class="hlFld-ContribAuthor ">Anyang  Xu</span>, <span class="hlFld-ContribAuthor ">Hongmei  Li</span>, <span class="hlFld-ContribAuthor ">Yulei  Jiang</span>, <span class="hlFld-ContribAuthor ">Tao  Lu</span>, <span class="hlFld-ContribAuthor ">Yadong  Chen</span>. </span><span class="cited-content_cbyCitation_article-title">Protein flexibility oriented virtual screening strategy for JAK2 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Journal of Molecular Structure</span><span> <strong>2015,</strong> <em>1097 </em>, 136-144. <a href="https://doi.org/10.1016/j.molstruc.2015.05.007" title="DOI URL">https://doi.org/10.1016/j.molstruc.2015.05.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.molstruc.2015.05.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.molstruc.2015.05.007%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Molecular%2520Structure%26atitle%3DProtein%252Bflexibility%252Boriented%252Bvirtual%252Bscreening%252Bstrategy%252Bfor%252BJAK2%252Binhibitors%26aulast%3DXiong%26aufirst%3DXiao%26date%3D2015%26volume%3D1097%26spage%3D136%26epage%3D144" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Hiroaki  Yamagishi</span>, <span class="hlFld-ContribAuthor ">Shohei  Shirakami</span>, <span class="hlFld-ContribAuthor ">Yutaka  Nakajima</span>, <span class="hlFld-ContribAuthor ">Akira  Tanaka</span>, <span class="hlFld-ContribAuthor ">Fumie  Takahashi</span>, <span class="hlFld-ContribAuthor ">Hisao  Hamaguchi</span>, <span class="hlFld-ContribAuthor ">Keiko  Hatanaka</span>, <span class="hlFld-ContribAuthor ">Ayako  Moritomo</span>, <span class="hlFld-ContribAuthor ">Masamichi  Inami</span>, <span class="hlFld-ContribAuthor ">Yasuyuki  Higashi</span>, <span class="hlFld-ContribAuthor ">Takayuki  Inoue</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of 3,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-2(1H)-one derivatives as novel JAK inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry</span><span> <strong>2015,</strong> <em>23 </em>
                                    (15)
                                     , 4846-4859. <a href="https://doi.org/10.1016/j.bmc.2015.05.028" title="DOI URL">https://doi.org/10.1016/j.bmc.2015.05.028</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmc.2015.05.028&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmc.2015.05.028%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252B3%25252C6-dihydroimidazo%25255B4%25252C5-d%25255Dpyrrolo%25255B2%25252C3-b%25255Dpyridin-2%2525281H%252529-one%252Bderivatives%252Bas%252Bnovel%252BJAK%252Binhibitors%26aulast%3DYamagishi%26aufirst%3DHiroaki%26date%3D2015%26volume%3D23%26issue%3D15%26spage%3D4846%26epage%3D4859" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ellen R.  Laird</span>. </span><span class="cited-content_cbyCitation_article-title">Case Studies: Selective Inhibitors of Protein Kinases - Exploiting Demure Features. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 413-434. <a href="https://doi.org/10.1002/9783527673643.ch18" title="DOI URL">https://doi.org/10.1002/9783527673643.ch18</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527673643.ch18&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527673643.ch18%26sid%3Dliteratum%253Aachs%26atitle%3DCase%252BStudies%25253A%252BSelective%252BInhibitors%252Bof%252BProtein%252BKinases%252B-%252BExploiting%252BDemure%252BFeatures%26aulast%3DLaird%26aufirst%3DEllen%2BR.%26date%3D2015%26date%3D2015%26spage%3D413%26epage%3D434%26pub%3DWiley-VCH%2520Verlag%2520GmbH%2520%2526%2520Co.%2520KGaA%26atitle%3DAntitargets%252Band%252BDrug%252BSafety%26aulast%3DUrb%25C3%25A1n%26aufirst%3DL%25C3%25A1szl%25C3%25B3%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ignacio  Aliagas</span>, <span class="hlFld-ContribAuthor ">Alberto  Gobbi</span>, <span class="hlFld-ContribAuthor ">Timothy  Heffron</span>, <span class="hlFld-ContribAuthor ">Man-Ling  Lee</span>, <span class="hlFld-ContribAuthor ">Daniel F.  Ortwine</span>, <span class="hlFld-ContribAuthor ">Mark  Zak</span>, <span class="hlFld-ContribAuthor ">S. Cyrus  Khojasteh</span>. </span><span class="cited-content_cbyCitation_article-title">A probabilistic method to report predictions from a human liver microsomes stability QSAR model: a practical tool for drug discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Computer-Aided Molecular Design</span><span> <strong>2015,</strong> <em>29 </em>
                                    (4)
                                     , 327-338. <a href="https://doi.org/10.1007/s10822-015-9838-3" title="DOI URL">https://doi.org/10.1007/s10822-015-9838-3</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s10822-015-9838-3&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs10822-015-9838-3%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Computer-Aided%2520Molecular%2520Design%26atitle%3DA%252Bprobabilistic%252Bmethod%252Bto%252Breport%252Bpredictions%252Bfrom%252Ba%252Bhuman%252Bliver%252Bmicrosomes%252Bstability%252BQSAR%252Bmodel%25253A%252Ba%252Bpractical%252Btool%252Bfor%252Bdrug%252Bdiscovery%26aulast%3DAliagas%26aufirst%3DIgnacio%26date%3D2015%26date%3D2015%26volume%3D29%26issue%3D4%26spage%3D327%26epage%3D338" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Guo-Bo  Li</span>, <span class="hlFld-ContribAuthor ">Sen  Ji</span>, <span class="hlFld-ContribAuthor ">Ling-Ling  Yang</span>, <span class="hlFld-ContribAuthor ">Rong-Jie  Zhang</span>, <span class="hlFld-ContribAuthor ">Kai  Chen</span>, <span class="hlFld-ContribAuthor ">Lei  Zhong</span>, <span class="hlFld-ContribAuthor ">Shuang  Ma</span>, <span class="hlFld-ContribAuthor ">Sheng-Yong  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">LEADOPT: An automatic tool for structure-based lead optimization, and its application in structural optimizations of VEGFR2 and SYK inhibitors. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2015,</strong> <em>93 </em>, 523-538. <a href="https://doi.org/10.1016/j.ejmech.2015.02.019" title="DOI URL">https://doi.org/10.1016/j.ejmech.2015.02.019</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2015.02.019&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2015.02.019%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DLEADOPT%25253A%252BAn%252Bautomatic%252Btool%252Bfor%252Bstructure-based%252Blead%252Boptimization%25252C%252Band%252Bits%252Bapplication%252Bin%252Bstructural%252Boptimizations%252Bof%252BVEGFR2%252Band%252BSYK%252Binhibitors%26aulast%3DLi%26aufirst%3DGuo-Bo%26date%3D2015%26volume%3D93%26spage%3D523%26epage%3D538" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christel J  Menet</span>, <span class="hlFld-ContribAuthor ">Oscar  Mammoliti</span>, <span class="hlFld-ContribAuthor ">Miriam  López-Ramos</span>. </span><span class="cited-content_cbyCitation_article-title">Progress toward JAK1-selective inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2015,</strong> <em>7 </em>
                                    (2)
                                     , 203-235. <a href="https://doi.org/10.4155/fmc.14.149" title="DOI URL">https://doi.org/10.4155/fmc.14.149</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.14.149&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.14.149%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DProgress%252Btoward%252BJAK1-selective%252Binhibitors%26aulast%3DMenet%26aufirst%3DChristel%2BJ%26date%3D2015%26volume%3D7%26issue%3D2%26spage%3D203%26epage%3D235" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Norman</span>. </span><span class="cited-content_cbyCitation_article-title">Selective JAK inhibitors in development for rheumatoid arthritis. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Investigational Drugs</span><span> <strong>2014,</strong> <em>23 </em>
                                    (8)
                                     , 1067-1077. <a href="https://doi.org/10.1517/13543784.2014.918604" title="DOI URL">https://doi.org/10.1517/13543784.2014.918604</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543784.2014.918604&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543784.2014.918604%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Investigational%2520Drugs%26atitle%3DSelective%252BJAK%252Binhibitors%252Bin%252Bdevelopment%252Bfor%252Brheumatoid%252Barthritis%26aulast%3DNorman%26aufirst%3DPeter%26date%3D2014%26date%3D2014%26volume%3D23%26issue%3D8%26spage%3D1067%26epage%3D1077" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian W  Dymock</span>, <span class="hlFld-ContribAuthor ">Eugene Guorong  Yang</span>, <span class="hlFld-ContribAuthor ">Yuyi  Chu-Farseeva</span>, <span class="hlFld-ContribAuthor ">Lianbin  Yao</span>. </span><span class="cited-content_cbyCitation_article-title">Selective JAK inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Future Medicinal Chemistry</span><span> <strong>2014,</strong> <em>6 </em>
                                    (12)
                                     , 1439-1471. <a href="https://doi.org/10.4155/fmc.14.92" title="DOI URL">https://doi.org/10.4155/fmc.14.92</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/fmc.14.92&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Ffmc.14.92%26sid%3Dliteratum%253Aachs%26jtitle%3DFuture%2520Medicinal%2520Chemistry%26atitle%3DSelective%252BJAK%252Binhibitors%26aulast%3DDymock%26aufirst%3DBrian%2BW%26date%3D2014%26volume%3D6%26issue%3D12%26spage%3D1439%26epage%3D1471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christel J  Menet</span>. </span><span class="cited-content_cbyCitation_article-title">Toward selective TYK2 inhibitors as therapeutic agents for the treatment of inflammatory diseases. </span><span class="cited-content_cbyCitation_journal-name">Pharmaceutical Patent Analyst</span><span> <strong>2014,</strong> <em>3 </em>
                                    (4)
                                     , 449-466. <a href="https://doi.org/10.4155/ppa.14.23" title="DOI URL">https://doi.org/10.4155/ppa.14.23</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.4155/ppa.14.23&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.4155%2Fppa.14.23%26sid%3Dliteratum%253Aachs%26jtitle%3DPharmaceutical%2520Patent%2520Analyst%26atitle%3DToward%252Bselective%252BTYK2%252Binhibitors%252Bas%252Btherapeutic%252Bagents%252Bfor%252Bthe%252Btreatment%252Bof%252Binflammatory%252Bdiseases%26aulast%3DMenet%26aufirst%3DChristel%2BJ%26date%3D2014%26volume%3D3%26issue%3D4%26spage%3D449%26epage%3D466" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Massimo  Gadina</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in kinase inhibition. </span><span class="cited-content_cbyCitation_journal-name">Current Opinion in Rheumatology</span><span> <strong>2014,</strong> <em>26 </em>
                                    (2)
                                     , 237-243. <a href="https://doi.org/10.1097/BOR.0000000000000023" title="DOI URL">https://doi.org/10.1097/BOR.0000000000000023</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1097/BOR.0000000000000023&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1097%2FBOR.0000000000000023%26sid%3Dliteratum%253Aachs%26jtitle%3DCurrent%2520Opinion%2520in%2520Rheumatology%26atitle%3DAdvances%252Bin%252Bkinase%252Binhibition%26aulast%3DGadina%26aufirst%3DMassimo%26date%3D2014%26volume%3D26%26issue%3D2%26spage%3D237%26epage%3D243" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias  Gehringer</span>, <span class="hlFld-ContribAuthor ">Ellen  Pfaffenrot</span>, <span class="hlFld-ContribAuthor ">Silke  Bauer</span>, <span class="hlFld-ContribAuthor ">Stefan A.  Laufer</span>. </span><span class="cited-content_cbyCitation_article-title">Design and Synthesis of Tricyclic JAK3 Inhibitors with Picomolar Affinities as Novel Molecular Probes. </span><span class="cited-content_cbyCitation_journal-name">ChemMedChem</span><span> <strong>2014,</strong> <em>9 </em>
                                    (2)
                                     , 277-281. <a href="https://doi.org/10.1002/cmdc.201300520" title="DOI URL">https://doi.org/10.1002/cmdc.201300520</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/cmdc.201300520&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fcmdc.201300520%26sid%3Dliteratum%253Aachs%26jtitle%3DChemMedChem%26atitle%3DDesign%252Band%252BSynthesis%252Bof%252BTricyclic%252BJAK3%252BInhibitors%252Bwith%252BPicomolar%252BAffinities%252Bas%252BNovel%252BMolecular%252BProbes%26aulast%3DGehringer%26aufirst%3DMatthias%26date%3D2014%26date%3D2014%26volume%3D9%26issue%3D2%26spage%3D277%26epage%3D281" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Peter  Norman</span>. </span><span class="cited-content_cbyCitation_article-title">Evaluation of WO-2013040863, WO-2013041042 and WO-2013043962. Selective JAK1 inhibitors based on a 3-aminopyrazole-4-carboxamide scaffold. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Therapeutic Patents</span><span> <strong>2014,</strong> <em>24 </em>
                                    (2)
                                     , 231-237. <a href="https://doi.org/10.1517/13543776.2014.859245" title="DOI URL">https://doi.org/10.1517/13543776.2014.859245</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/13543776.2014.859245&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F13543776.2014.859245%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Therapeutic%2520Patents%26atitle%3DEvaluation%252Bof%252BWO-2013040863%25252C%252BWO-2013041042%252Band%252BWO-2013043962.%252BSelective%252BJAK1%252Binhibitors%252Bbased%252Bon%252Ba%252B3-aminopyrazole-4-carboxamide%252Bscaffold%26aulast%3DNorman%26aufirst%3DPeter%26date%3D2014%26date%3D2013%26volume%3D24%26issue%3D2%26spage%3D231%26epage%3D237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/medium/jm-2013-004895_0017.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4004895&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/medium/jm-2013-004895_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0002.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. (a) Matched pair analysis of <i>C</i>-2 H (<b>2</b>) and <i>C</i>-2 Me (<b>3</b>) imidazopyrrolopyridines. (b) X-ray structure of <b>3</b> in complex with JAK1 (gray, PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EHZ">4EHZ</a>) overlaid with a key residue difference with JAK2 (green, D939 from structure <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4F09">4F09</a>). Superscript letters indicate the following: (<i>a</i>) arithmetic mean of at least three separate runs (<i>n</i> ≥ 3); (<i>b</i>) the average coefficient of variation was less than 0.3 times the mean for biochemical assays;<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> (<i>c</i>) JAK2 <i>K</i><sub>i</sub>/JAK1 <i>K</i><sub>i</sub>; (<i>d</i>) apparent permeability in MDCK transwell culture. A:B, apical-to-basolateral.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4004895&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/medium/jm-2013-004895_0003.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0003.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. Defining the ideal calculated property space of <i>C</i>-2 H and Me imidazopyrrolopyridines.<sup><i>a</i></sup> All compounds analyzed were synthesized prior to the imidazopyrrolopyridines in Tables <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>, <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>, and <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>. Superscript letters indicate the following: (<i>a</i>) compound structures and tabulated data are listed in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>; (<i>b</i>) (whole blood EC<sub>50</sub>)/(IL-6 pSTAT3 EC<sub>50</sub>);<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> (<i>c</i>) see ref <a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">14</a>; (<i>d</i>) oral bioavailability in the rat; (<i>e</i>) apparent permeability in MDCK transwell culture; A:B, apical-to-basolateral; (<i>f</i>) in vivo clearance in the rat after IV administration; (<i>g</i>) see ref <a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">15</a>; (<i>h</i>) experimental hepatic clearance in the presence of human liver microsomes;<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a> (<i>i</i>) prospectively calculated probability of being stable in the presence of human liver microsomes.<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0003.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4004895&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/medium/jm-2013-004895_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (a) X-ray structure of <b>31</b> in complex with JAK1 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IVB">4IVB</a>, resolution = 1.9 Å). (b) X-ray structure of <b>31</b> in complex with JAK2 (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IVA">4IVA</a>, resolution = 1.5 Å). A key residue difference between JAK1 (E966) and JAK2 (D939) is highlighted in green. Notable crystallographic waters are highlighted as red spheres. Hydrogen-bonding interactions are denoted as dashed lines. The electron density of the JAK1 structure was consistent with two main conformations of the P-loop. For the sake of clarity, only one of these is depicted.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4004895&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/medium/jm-2013-004895_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. (a–c) X-ray structures of compounds <b>33</b>, <b>34</b>, and <b>1</b>, respectively, in complex with JAK1. PDB codes and resolutions are as follows: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IVC">4IVC</a>, 2.4 Å (a); <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IVD">4IVD</a>, 1.9 Å (b); <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EYG">3EYG</a>,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> 1.9 Å (c). A key residue difference between JAK1 (E966) and JAK2 (D939) is highlighted in green. Notable crystallographic waters are highlighted as red spheres. Hydrogen-bonding interactions are denoted as dashed lines. (d) Superposition of the ligands from the X-ray structures of <b>1</b>,<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a><b>31</b>, <b>33</b>, and <b>34</b> in complex with JAK1.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4004895&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig5" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/medium/jm-2013-004895_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0006.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. (a) Rat plasma exposures of <b>31</b> on days 10 and 20 of the CIA efficacy study.<sup><i>a</i></sup> (b) Mean ankle thicknesses of rats either treated or not treated with <b>31</b> in the CIA efficacy study.<sup><i>a</i></sup> Superscript letter indicates the following: (<i>a</i>) <b>31</b> was formulated in corn oil and dosed orally once daily at the indicated doses for 11 days. The first and last doses of <b>31</b> were administered on study days 10 and 20, respectively.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4004895&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/medium/jm-2013-004895_0007.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0007.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 1. Preparation of Dianiline Intermediate <b>38</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0007.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4004895&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) DIPEA, <i>i</i>-PrOH, 80 °C; (ii) H<sub>2</sub>, Pd/C, EtOH, THF, 50 °C.</p></p></figure><figure data-id="sch2" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/medium/jm-2013-004895_0008.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0008.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 2. Preparation of <i>C</i>-2 Hydroxyl Substituted Imidazopyrrolopyridine Analogues <b>5</b>–<b>13</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0008.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4004895&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) 2-hydroxyacetamide, Et<sub>3</sub>(O<sup>+</sup>)BF<sub>4</sub><sup>–</sup>, THF,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> EtOH, 25–70 °C; (ii) NaOH, H<sub>2</sub>O, EtOH or EtOH/THF, 25–50 °C; (iii) TEA, ethyl 3-chloro-3-oxopropanoate, DCM, 25 °C, then AcOH, reflux; (iv) NaBH<sub>4</sub>, EtOH, 50 °C; (v) (<i>R</i>)-(+)-lactamide, Et<sub>3</sub>(O<sup>+</sup>)BF<sub>4</sub><sup>–</sup>, THF, EtOH, 25–70 °C; (vi) (<i>S</i>)-(−)-lactamide, Et<sub>3</sub>(O<sup>+</sup>)BF<sub>4</sub><sup>–</sup>, THF,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> EtOH, 25–70 °C; (vii) Dess–Martin periodinane, DCM, 25 °C; (viii) MeMgBr, THF, −10 to 25 °C; (ix) triethyl orthoformate, 82 °C; (x) (tmp)<sub>2</sub>Mg·2LiCl, propionaldehyde, THF, 0–25 °C; (xi) preparative chiral SFC; (xii) (tmp)<sub>2</sub>Mg·2LiCl, 2-(benzyloxy)acetaldehyde, THF, 0–25 °C; (xiii) Pd(OH)<sub>2</sub>/C, MeOH, EtOH, H<sub>2</sub>, 50 psi, 25 °C.</p></p></figure><figure data-id="sch3" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/medium/jm-2013-004895_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0009.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 3. Preparation of <i>C</i>-2 (<i>R</i>)-Hydroxyethyl Imidazopyrrolopyridine Analogues <b>15</b>, <b>16</b>, <b>19</b>–<b>24</b>, and <b>31</b>–<b>34</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4004895&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) DIPEA, <i>i</i>-PrOH, 75–83 °C; (ii) H<sub>2</sub>, Pd/C, EtOH or EtOH/THF or EtOAc, 23–50 °C; (ii′) Fe, NH<sub>4</sub>Cl, EtOH, H<sub>2</sub>O, reflux; (iii) (<i>R</i>)-(+)-lactamide, Et<sub>3</sub>(O<sup>+</sup>)BF<sub>4</sub><sup>–</sup>, THF,<a onclick="showRef(event, 'ref23'); return false;" href="javascript:void(0);" class="ref ref23">(23)</a> EtOH, 23–70 °C; (iv) NaOH, H<sub>2</sub>O, EtOH or EtOH/THF or MeOH/THF, 25–60 °C. (b) 4-Piperidine diastereomers separated by preparative chiral SFC. (c) Racemic mixture. (d) Diastereomeric mixture of 4-piperidine epimers.</p></p></figure><figure data-id="sch4" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/medium/jm-2013-004895_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0010.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Preparation of <i>C</i>-2 (<i>R</i>)-Hydroxyethyl Imidazopyrrolopyridine Analogues <b>14</b>, <b>17</b>, <b>18</b>, and <b>26</b>–<b>30</b><sup>a</sup></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2013/jmcmar.2013.56.issue-11/jm4004895/production/images/large/jm-2013-004895_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm4004895&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>Reagents and conditions: (i) HCl/1,4-dioxane or TFA/H<sub>2</sub>O, 23 °C; (ii) 2,2,2-trifluoroethyl trifluoromethanesulfonate, TEA, DCM, DMF, 23 °C; (iii) NaOH, H<sub>2</sub>O, EtOH or EtOH/THF or MeOH/THF, 25–60 °C; (iv) EDC, 4-DMAP, DIPEA, 2-cyanoacetic acid (for <b>17</b>) or 3,3,3-trifluoropropanoic acid (for <b>18</b>), 23 °C; (v) 2,2,-difluoroethyl trifluoromethanesulfonate, TEA, DCM, DMF, 23 °C.</p></p></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i73">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_70776" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_70776" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 33 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span> </span><span class="NLM_article-title">Jaks, STATs, cytokine signal transduction, and immunoregulation: are we there yet?</span> <span class="citation_source-journal">Immunity</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">1</span><span class="NLM_x">–</span> <span class="NLM_lpage">11</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=1997&pages=1-11&author=J.+J.+O%E2%80%99Shea&title=Jaks%2C+STATs%2C+cytokine+signal+transduction%2C+and+immunoregulation%3A+are+we+there+yet%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DJaks%252C%2520STATs%252C%2520cytokine%2520signal%2520transduction%252C%2520and%2520immunoregulation%253A%2520are%2520we%2520there%2520yet%253F%26jtitle%3DImmunity%26date%3D1997%26volume%3D7%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Pesu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laurence, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kishore, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zwillich, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Shea, J. J.</span><span> </span><span class="NLM_article-title">Therapeutic targeting of Janus kinases</span> <span class="citation_source-journal">Immunol. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">223</span><span class="NLM_x">, </span> <span class="NLM_fpage">132</span><span class="NLM_x">–</span> <span class="NLM_lpage">142</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=16&amp;doi=10.1021%2Fjm4004895&amp;key=10.1111%2Fj.1600-065X.2008.00644.x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=8&amp;doi=10.1021%2Fjm4004895&amp;key=18613833" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref1/cit1b&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BD1cXptlGls7c%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=223&publication_year=2008&pages=132-142&author=M.+Pesuauthor=A.+Laurenceauthor=N.+Kishoreauthor=S.+H.+Zwillichauthor=G.+Chanauthor=J.+J.+O%E2%80%99Shea&title=Therapeutic+targeting+of+Janus+kinases"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit1bR"><div class="casContent"><span class="casTitleNuber">1b</span><div class="casTitle"><span class="NLM_cas:atitle">Therapeutic targeting of Janus kinases</span></div><div class="casAuthors">Pesu, Marko; Laurence, Arian; Kishore, Nandini; Zwillich, Samuel H.; Chan, Gary; O'Shea, John J.</div><div class="citationInfo"><span class="NLM_cas:title">Immunological Reviews</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">223</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">132-142</span>CODEN:
                <span class="NLM_cas:coden">IMRED2</span>;
        ISSN:<span class="NLM_cas:issn">0105-2896</span>.
    
            (<span class="NLM_cas:orgname">Blackwell Publishing Ltd.</span>)
        </div><div class="casAbstract">A review.  Cytokines play pivotal roles in immunity and inflammation, and targeting cytokines and their receptors is an effective means of treating such disorders.  Type I and II cytokine receptors assoc. with Janus family kinases (JAKs) to effect intracellular signaling.  These structurally unique protein kinases play essential and specific roles in immune cell development and function.  One JAK, JAK3, has particularly selective functions.  Mutations of this kinase underlie severe combined immunodeficiency, indicative of its crit. role in the development and function of lymphocytes.  Because JAK3 appears not to have functions outside of hematopoietic cells, this kinase has been viewed as an excellent therapeutic target for the development of a new class of immunosuppressive drugs.  In fact, several companies are developing JAK3 inhibitors, and Phase II studies are underway.  Mutations of Tyk2 cause autosomal recessive hyperIgE syndrome, and in principle, Tyk2 inhibitors might also be useful as immunosuppressive drugs.  JAK2 gain-of-function mutations (V617F) underlie a subset of disorders collectively referred to as myeloproliferative diseases and phase 2 trials using JAK inhibitors are underway in this setting.  Thus, we are learning a great deal about the feasibility and effectiveness of targeting Janus kinases, and it appears likely that this will be a fruitful strategy in a variety of settings.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr-VTmlwlhcv7Vg90H21EOLACvtfcHk0lgy05vkEb_3Og"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXptlGls7c%253D&md5=73dc15932d0eaa312bc2588bdbce404c</span></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1111%2Fj.1600-065X.2008.00644.x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1111%252Fj.1600-065X.2008.00644.x%26sid%3Dliteratum%253Aachs%26aulast%3DPesu%26aufirst%3DM.%26aulast%3DLaurence%26aufirst%3DA.%26aulast%3DKishore%26aufirst%3DN.%26aulast%3DZwillich%26aufirst%3DS.%2BH.%26aulast%3DChan%26aufirst%3DG.%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26atitle%3DTherapeutic%2520targeting%2520of%2520Janus%2520kinases%26jtitle%3DImmunol.%2520Rev.%26date%3D2008%26volume%3D223%26spage%3D132%26epage%3D142" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2"><span><span class="NLM_contrib-group">O’Shea, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pesu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Borie, D. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changelian, P. S.</span><span> </span><span class="NLM_article-title">A new modality for immunosuppression: targeting the JAK/STAT pathway</span> <span class="citation_source-journal">Nature Rev. Drug. Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">3</span><span class="NLM_x">, </span> <span class="NLM_fpage">555</span><span class="NLM_x">–</span> <span class="NLM_lpage">564</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=3&publication_year=2004&pages=555-564&author=J.+J.+O%E2%80%99Sheaauthor=M.+Pesuauthor=D.+C.+Borieauthor=P.+S.+Changelian&title=A+new+modality+for+immunosuppression%3A+targeting+the+JAK%2FSTAT+pathway"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DO%25E2%2580%2599Shea%26aufirst%3DJ.%2BJ.%26aulast%3DPesu%26aufirst%3DM.%26aulast%3DBorie%26aufirst%3DD.%2BC.%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26atitle%3DA%2520new%2520modality%2520for%2520immunosuppression%253A%2520targeting%2520the%2520JAK%252FSTAT%2520pathway%26jtitle%3DNature%2520Rev.%2520Drug.%2520Discovery%26date%3D2004%26volume%3D3%26spage%3D555%26epage%3D564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Clark, S. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kamen, R.</span><span> </span><span class="NLM_article-title">The human hematopoietic colony-stimulating factors</span> <span class="citation_source-journal">Science</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1987</span><span class="NLM_x">, </span> <span class="NLM_volume">236</span><span class="NLM_x">, </span> <span class="NLM_fpage">1229</span><span class="NLM_x">–</span> <span class="NLM_lpage">1237</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=236&publication_year=1987&pages=1229-1237&author=S.+C.+Clarkauthor=R.+Kamen&title=The+human+hematopoietic+colony-stimulating+factors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DClark%26aufirst%3DS.%2BC.%26aulast%3DKamen%26aufirst%3DR.%26atitle%3DThe%2520human%2520hematopoietic%2520colony-stimulating%2520factors%26jtitle%3DScience%26date%3D1987%26volume%3D236%26spage%3D1229%26epage%3D1237" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Metcalf, D.</span><span> </span><span class="NLM_article-title">The molecular control of cell division, differentiation commitment and maturation in haemopoietic cells</span> <span class="citation_source-journal">Nature</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">339</span><span class="NLM_x">, </span> <span class="NLM_fpage">27</span><span class="NLM_x">–</span> <span class="NLM_lpage">30</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=339&publication_year=1989&pages=27-30&author=D.+Metcalf&title=The+molecular+control+of+cell+division%2C+differentiation+commitment+and+maturation+in+haemopoietic+cells"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMetcalf%26aufirst%3DD.%26atitle%3DThe%2520molecular%2520control%2520of%2520cell%2520division%252C%2520differentiation%2520commitment%2520and%2520maturation%2520in%2520haemopoietic%2520cells%26jtitle%3DNature%26date%3D1989%26volume%3D339%26spage%3D27%26epage%3D30" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Witthuhn, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Quelle, F. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Silvennoinen, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yi, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Miura, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ihle, J. N.</span><span> </span><span class="NLM_article-title">JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietin</span> <span class="citation_source-journal">Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1993</span><span class="NLM_x">, </span> <span class="NLM_volume">74</span><span class="NLM_x">, </span> <span class="NLM_fpage">227</span><span class="NLM_x">–</span> <span class="NLM_lpage">236</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=74&publication_year=1993&pages=227-236&author=B.+A.+Witthuhnauthor=F.+W.+Quelleauthor=O.+Silvennoinenauthor=T.+Yiauthor=B.+Tangauthor=O.+Miuraauthor=J.+N.+Ihle&title=JAK2+associates+with+the+erythropoietin+receptor+and+is+tyrosine+phosphorylated+and+activated+following+stimulation+with+erythropoietin"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DWitthuhn%26aufirst%3DB.%2BA.%26aulast%3DQuelle%26aufirst%3DF.%2BW.%26aulast%3DSilvennoinen%26aufirst%3DO.%26aulast%3DYi%26aufirst%3DT.%26aulast%3DTang%26aufirst%3DB.%26aulast%3DMiura%26aufirst%3DO.%26aulast%3DIhle%26aufirst%3DJ.%2BN.%26atitle%3DJAK2%2520associates%2520with%2520the%2520erythropoietin%2520receptor%2520and%2520is%2520tyrosine%2520phosphorylated%2520and%2520activated%2520following%2520stimulation%2520with%2520erythropoietin%26jtitle%3DCell%26date%3D1993%26volume%3D74%26spage%3D227%26epage%3D236" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Lin, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Meloni, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pan, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodgers, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shepard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Li, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Galya, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Metcalf, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yue, T. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhou, J.</span><span> </span><span class="NLM_article-title">Enantioselective synthesis of Janus kinase inhibitor INCB018424 via an organocatalytic aza-Michael reaction</span> <span class="citation_source-journal">Org. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">11</span><span class="NLM_x">, </span> <span class="NLM_fpage">1999</span><span class="NLM_x">–</span> <span class="NLM_lpage">2002</span></span><div class="citationLinks">[<a href="/doi/10.1021/ol900350k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=11&publication_year=2009&pages=1999-2002&author=Q.+Linauthor=D.+Meloniauthor=Y.+Panauthor=M.+Xiaauthor=J.+Rodgersauthor=S.+Shepardauthor=M.+Liauthor=L.+Galyaauthor=B.+Metcalfauthor=T.+Y.+Yueauthor=P.+Liuauthor=J.+Zhou&title=Enantioselective+synthesis+of+Janus+kinase+inhibitor+INCB018424+via+an+organocatalytic+aza-Michael+reaction"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fol900350k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fol900350k%26sid%3Dliteratum%253Aachs%26aulast%3DLin%26aufirst%3DQ.%26aulast%3DMeloni%26aufirst%3DD.%26aulast%3DPan%26aufirst%3DY.%26aulast%3DXia%26aufirst%3DM.%26aulast%3DRodgers%26aufirst%3DJ.%26aulast%3DShepard%26aufirst%3DS.%26aulast%3DLi%26aufirst%3DM.%26aulast%3DGalya%26aufirst%3DL.%26aulast%3DMetcalf%26aufirst%3DB.%26aulast%3DYue%26aufirst%3DT.%2BY.%26aulast%3DLiu%26aufirst%3DP.%26aulast%3DZhou%26aufirst%3DJ.%26atitle%3DEnantioselective%2520synthesis%2520of%2520Janus%2520kinase%2520inhibitor%2520INCB018424%2520via%2520an%2520organocatalytic%2520aza-Michael%2520reaction%26jtitle%3DOrg.%2520Lett.%26date%3D2009%26volume%3D11%26spage%3D1999%26epage%3D2002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Flanagan, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blumenkopf, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brissette, W. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Brown, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Casavant, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shang-Poa, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doty, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elliott, E. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fisher, M. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hines, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kent, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kudlacz, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lillie, B. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magnuson, K. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McCurdy, S. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Munchhof, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Perry, B. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sawyer, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Strelevitz, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Subramanyam, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whipple, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Changelian, P. S.</span><span> </span><span class="NLM_article-title">Discovery of CP-690,550: a potent and selective Janus kinase (JAK) inhibitor for the treatment of autoimmune diseases and organ transplant rejection</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">8468</span><span class="NLM_x">–</span> <span class="NLM_lpage">8484</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1004286" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref5/cit5&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsVOgt7vP" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=8468-8484&author=M.+E.+Flanaganauthor=T.+A.+Blumenkopfauthor=W.+H.+Brissetteauthor=M.+F.+Brownauthor=J.+M.+Casavantauthor=C.+Shang-Poaauthor=J.+L.+Dotyauthor=E.+A.+Elliottauthor=M.+B.+Fisherauthor=M.+Hinesauthor=C.+Kentauthor=E.+M.+Kudlaczauthor=B.+M.+Lillieauthor=K.+S.+Magnusonauthor=S.+P.+McCurdyauthor=M.+J.+Munchhofauthor=B.+D.+Perryauthor=P.+S.+Sawyerauthor=T.+J.+Strelevitzauthor=C.+Subramanyamauthor=J.+Sunauthor=D.+A.+Whippleauthor=P.+S.+Changelian&title=Discovery+of+CP-690%2C550%3A+a+potent+and+selective+Janus+kinase+%28JAK%29+inhibitor+for+the+treatment+of+autoimmune+diseases+and+organ+transplant+rejection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit5R"><div class="casContent"><span class="casTitleNuber">5</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of CP-690,550: A Potent and Selective Janus Kinase (JAK) Inhibitor for the Treatment of Autoimmune Diseases and Organ Transplant Rejection</span></div><div class="casAuthors">Flanagan, Mark E.; Blumenkopf, Todd A.; Brissette, William H.; Brown, Matthew F.; Casavant, Jeffrey M.; Chang, Shang-Poa; Doty, Jonathan L.; Elliott, Eileen A.; Fisher, Michael B.; Hines, Michael; Kent, Craig; Kudlacz, Elizabeth M.; Lillie, Brett M.; Magnuson, Kelly S.; McCurdy, Sandra P.; Munchhof, Michael J.; Perry, Bret D.; Sawyer, Perry S.; Strelevitz, Timothy J.; Subramanyam, Chakrapani; Sun, Jianmin; Whipple, David A.; Changelian, Paul S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">53</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">8468-8484</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">There is a crit. need for safer and more convenient treatments for organ transplant rejection and autoimmune disorders such as rheumatoid arthritis.  Janus tyrosine kinases (JAK1, JAK3) are expressed in lymphoid cells and are involved in the signaling of multiple cytokines important for various T cell functions.  Blockade of the JAK1/JAK3-STAT pathway with a small mol. was anticipated to provide therapeutic immunosuppression/immunomodulation.  The Pfizer compd. library was screened against the catalytic domain of JAK3 resulting in the identification of a pyrrolopyrimidine-based series of inhibitors represented by the hexahydrocarbazolyl pyrrolopyrimidine CP-352,664.  Synthetic analogs of CP-352,664 were screened against the JAK enzymes and evaluated in an IL-2 induced T cell blast proliferation assay.  Select compds. were evaluated in rodent efficacy models of allograft rejection and destructive inflammatory arthritis.  Optimization within this chem. series led to identification of the cyanoacetylpiperidinylamino pyrrolopyrimidine CP-690,550, a potential first-in-class JAK inhibitor for treatment of autoimmune diseases and organ transplant rejection.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpbFS_8DSHkDbVg90H21EOLACvtfcHk0lgwhVRJqT4XUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsVOgt7vP&md5=c1d31ce42ab3f1c1f3029c6f4f48df1a</span></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=10.1021%2Fjm1004286&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1004286%26sid%3Dliteratum%253Aachs%26aulast%3DFlanagan%26aufirst%3DM.%2BE.%26aulast%3DBlumenkopf%26aufirst%3DT.%2BA.%26aulast%3DBrissette%26aufirst%3DW.%2BH.%26aulast%3DBrown%26aufirst%3DM.%2BF.%26aulast%3DCasavant%26aufirst%3DJ.%2BM.%26aulast%3DShang-Poa%26aufirst%3DC.%26aulast%3DDoty%26aufirst%3DJ.%2BL.%26aulast%3DElliott%26aufirst%3DE.%2BA.%26aulast%3DFisher%26aufirst%3DM.%2BB.%26aulast%3DHines%26aufirst%3DM.%26aulast%3DKent%26aufirst%3DC.%26aulast%3DKudlacz%26aufirst%3DE.%2BM.%26aulast%3DLillie%26aufirst%3DB.%2BM.%26aulast%3DMagnuson%26aufirst%3DK.%2BS.%26aulast%3DMcCurdy%26aufirst%3DS.%2BP.%26aulast%3DMunchhof%26aufirst%3DM.%2BJ.%26aulast%3DPerry%26aufirst%3DB.%2BD.%26aulast%3DSawyer%26aufirst%3DP.%2BS.%26aulast%3DStrelevitz%26aufirst%3DT.%2BJ.%26aulast%3DSubramanyam%26aufirst%3DC.%26aulast%3DSun%26aufirst%3DJ.%26aulast%3DWhipple%26aufirst%3DD.%2BA.%26aulast%3DChangelian%26aufirst%3DP.%2BS.%26atitle%3DDiscovery%2520of%2520CP-690%252C550%253A%2520a%2520potent%2520and%2520selective%2520Janus%2520kinase%2520%2528JAK%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520autoimmune%2520diseases%2520and%2520organ%2520transplant%2520rejection%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D8468%26epage%3D8484" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6"><span>INCB018424/Ruxolitnib/Jakafi is FDA-approved for the treatment of myelofibrosis. Incyte Press Release. <a href="http://investor.incyte.com/phoenix.zhtmL?c=69764&amp;p=irol-newsArticle&amp;ID=1631201&amp;highlight" class="extLink">http://investor.incyte.com/phoenix.zhtmL?c=69764&p=irol-newsArticle&ID=1631201&highlight</a> (accessed March 27, 2013). CP-690,550/Tofacitinib/Xeljanz is FDA-approved for the treatment of adults with moderately to severely active rheumatoid arthritis (RA) who have had an inadequate response or intolerance to methotrexate. Pfizer Press Release. <a href="http://press.pfizer.com/press-release/multimedia-us-food-and-drug-administration-approves-pfizers-xeljanz-tofacitinib-citrat" class="extLink">http://press.pfizer.com/press-release/multimedia-us-food-and-drug-administration-approves-pfizers-xeljanz-tofacitinib-citrat</a> (accessed March 27, 2013).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=INCB018424%2FRuxolitnib%2FJakafi+is+FDA-approved+for+the+treatment+of+myelofibrosis.+Incyte+Press+Release.+http%3A%2F%2Finvestor.incyte.com%2Fphoenix.zhtmL%3Fc%3D69764%26p%3Dirol-newsArticle%26ID%3D1631201%26highlight+%28accessed+March+27%2C+2013%29.+CP-690%2C550%2FTofacitinib%2FXeljanz+is+FDA-approved+for+the+treatment+of+adults+with+moderately+to+severely+active+rheumatoid+arthritis+%28RA%29+who+have+had+an+inadequate+response+or+intolerance+to+methotrexate.+Pfizer+Press+Release.+http%3A%2F%2Fpress.pfizer.com%2Fpress-release%2Fmultimedia-us-food-and-drug-administration-approves-pfizers-xeljanz-tofacitinib-citrat+%28accessed+March+27%2C+2013%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Zak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendonca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Balazs, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeVoss, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragovich, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eigenbrot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghilardi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gradl, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hamman, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanan, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harstad, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jin, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Koehler, M. F. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bir Kohli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulagowski, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Labadie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liimatta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lin, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupardus, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxey, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rodriguez, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savage, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubhayakar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Abbema, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xiao, Y.</span><span> </span><span class="NLM_article-title">Discovery and optimization of <i>C</i>-2 methyl imidazopyrrolopyridines as potent and orally bioavailable JAK1 inhibitors with selectivity over JAK2</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">6176</span><span class="NLM_x">–</span> <span class="NLM_lpage">6193</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300628c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BC38Xos1SmtLg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=6176-6193&author=M.+Zakauthor=R.+Mendoncaauthor=M.+Balazsauthor=K.+Barrettauthor=P.+Bergeronauthor=W.+S.+Blairauthor=C.+Changauthor=G.+Deshmukhauthor=J.+DeVossauthor=P.+S.+Dragovichauthor=C.+Eigenbrotauthor=N.+Ghilardiauthor=P.+Gibbonsauthor=S.+Gradlauthor=C.+Hammanauthor=E.+J.+Hananauthor=E.+Harstadauthor=P.+R.+Hewittauthor=C.+A.+Hurleyauthor=T.+Jinauthor=A.+Johnsonauthor=T.+Johnsonauthor=J.+R.+Kennyauthor=M.+F.+T.+Koehlerauthor=P.+Bir+Kohliauthor=J.+J.+Kulagowskiauthor=S.+Labadieauthor=J.+Liaoauthor=M.+Liimattaauthor=Z.+Linauthor=P.+J.+Lupardusauthor=R.+J.+Maxeyauthor=J.+M.+Murrayauthor=R.+Pulkauthor=M.+Rodriguezauthor=S.+Savageauthor=S.+Shiaauthor=M.+Steffekauthor=S.+Ubhayakarauthor=M.+Ultschauthor=A.+van+Abbemaauthor=S.+I.+Wardauthor=L.+Xiaoauthor=Y.+Xiao&title=Discovery+and+optimization+of+C-2+methyl+imidazopyrrolopyridines+as+potent+and+orally+bioavailable+JAK1+inhibitors+with+selectivity+over+JAK2"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery and Optimization of C-2 Methyl Imidazopyrrolopyridines as Potent and Orally Bioavailable JAK1 Inhibitors with Selectivity over JAK2</span></div><div class="casAuthors">Zak, Mark; Mendonca, Rohan; Balazs, Mercedesz; Barrett, Kathy; Bergeron, Philippe; Blair, Wade S.; Chang, Christine; Deshmukh, Gauri; DeVoss, Jason; Dragovich, Peter S.; Eigenbrot, Charles; Ghilardi, Nico; Gibbons, Paul; Gradl, Stefan; Hamman, Chris; Hanan, Emily J.; Harstad, Eric; Hewitt, Peter R.; Hurley, Christopher A.; Jin, Tian; Johnson, Adam; Johnson, Tony; Kenny, Jane R.; Koehler, Michael F. T.; Bir Kohli, Pawan; Kulagowski, Janusz J.; Labadie, Sharada; Liao, Jiangpeng; Liimatta, Marya; Lin, Zhonghua; Lupardus, Patrick J.; Maxey, Robert J.; Murray, Jeremy M.; Pulk, Rebecca; Rodriguez, Madeleine; Savage, Scott; Shia, Steven; Steffek, Micah; Ubhayakar, Savita; Ultsch, Mark; van Abbema, Anne; Ward, Stuart I.; Xiao, Ling; Xiao, Yisong</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">13</span>),
    <span class="NLM_cas:pages">6176-6193</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Herein we report the discovery of the C-2 Me substituted imidazopyrrolopyridine series and its optimization to provide potent and orally bioavailable JAK1 inhibitors with selectivity over JAK2.  The C-2 Me substituted inhibitor 4 exhibited not only improved JAK1 potency relative to unsubstituted compd. 3 but also notable JAK1 vs JAK2 selectivity (20-fold and >33-fold in biochem. and cell-based assays, resp.).  Features of the X-ray structures of 4 in complex with both JAK1 and JAK2 are delineated.  Efforts to improve the in vitro and in vivo ADME properties of 4 while maintaining JAK1 selectivity are described, culminating in the discovery of a highly optimized and balanced inhibitor (20).  Details of the biol. characterization of 20 are disclosed including JAK1 vs JAK2 selectivity levels, preclin. in vivo PK profiles, performance in an in vivo JAK1-mediated PK/PD model, and attributes of an X-ray structure in complex with JAK1.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpogQqQMRvwKbVg90H21EOLACvtfcHk0lgwhVRJqT4XUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xos1SmtLg%253D&md5=8c57a4cb02fc245ed12f6f4efdb82318</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fjm300628c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300628c%26sid%3Dliteratum%253Aachs%26aulast%3DZak%26aufirst%3DM.%26aulast%3DMendonca%26aufirst%3DR.%26aulast%3DBalazs%26aufirst%3DM.%26aulast%3DBarrett%26aufirst%3DK.%26aulast%3DBergeron%26aufirst%3DP.%26aulast%3DBlair%26aufirst%3DW.%2BS.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DDeVoss%26aufirst%3DJ.%26aulast%3DDragovich%26aufirst%3DP.%2BS.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DGhilardi%26aufirst%3DN.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DGradl%26aufirst%3DS.%26aulast%3DHamman%26aufirst%3DC.%26aulast%3DHanan%26aufirst%3DE.%2BJ.%26aulast%3DHarstad%26aufirst%3DE.%26aulast%3DHewitt%26aufirst%3DP.%2BR.%26aulast%3DHurley%26aufirst%3DC.%2BA.%26aulast%3DJin%26aufirst%3DT.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DKenny%26aufirst%3DJ.%2BR.%26aulast%3DKoehler%26aufirst%3DM.%2BF.%2BT.%26aulast%3DBir%2BKohli%26aufirst%3DP.%26aulast%3DKulagowski%26aufirst%3DJ.%2BJ.%26aulast%3DLabadie%26aufirst%3DS.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DLin%26aufirst%3DZ.%26aulast%3DLupardus%26aufirst%3DP.%2BJ.%26aulast%3DMaxey%26aufirst%3DR.%2BJ.%26aulast%3DMurray%26aufirst%3DJ.%2BM.%26aulast%3DPulk%26aufirst%3DR.%26aulast%3DRodriguez%26aufirst%3DM.%26aulast%3DSavage%26aufirst%3DS.%26aulast%3DShia%26aufirst%3DS.%26aulast%3DSteffek%26aufirst%3DM.%26aulast%3DUbhayakar%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%26aulast%3Dvan%2BAbbema%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DS.%2BI.%26aulast%3DXiao%26aufirst%3DL.%26aulast%3DXiao%26aufirst%3DY.%26atitle%3DDiscovery%2520and%2520optimization%2520of%2520C-2%2520methyl%2520imidazopyrrolopyridines%2520as%2520potent%2520and%2520orally%2520bioavailable%2520JAK1%2520inhibitors%2520with%2520selectivity%2520over%2520JAK2%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D6176%26epage%3D6193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="note"><p class="first last">A summary of previous disclosures of compounds exhibiting JAK1 vs JAK2 selectivity is presented in ref <a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">9</a>. Additionally, a number of publications describing JAK2 inhibitors with varying JAK family and other kinase selectivity profiles have appeared recently. These include:</p></div><div class="NLM_citation" id="rightTab-cit8a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Schenkel, L. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deak, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doherty, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emkey, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gu, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gunaydin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kim, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loberg, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Olivieri, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pistillo, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tang, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wan, Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wells, M. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wu, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yu, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geuns-Meyer, S.</span><span> </span><span class="NLM_article-title">Discovery of potent and highly selective thienopyridine Janus kinase 2 inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">8440</span><span class="NLM_x">–</span> <span class="NLM_lpage">8450</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200911r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=8440-8450&author=L.+B.+Schenkelauthor=X.+Huangauthor=A.+Chengauthor=H.+L.+Deakauthor=E.+Dohertyauthor=R.+Emkeyauthor=Y.+Guauthor=H.+Gunaydinauthor=J.+L.+Kimauthor=J.+Leeauthor=R.+Lobergauthor=P.+Olivieriauthor=J.+Pistilloauthor=J.+Tangauthor=Q.+Wanauthor=H.+L.+Wangauthor=S.+W.+Wangauthor=M.+C.+Wellsauthor=B.+Wuauthor=V.+Yuauthor=L.+Liuauthor=S.+Geuns-Meyer&title=Discovery+of+potent+and+highly+selective+thienopyridine+Janus+kinase+2+inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8a&amp;dbid=16384&amp;doi=10.1021%2Fjm200911r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200911r%26sid%3Dliteratum%253Aachs%26aulast%3DSchenkel%26aufirst%3DL.%2BB.%26aulast%3DHuang%26aufirst%3DX.%26aulast%3DCheng%26aufirst%3DA.%26aulast%3DDeak%26aufirst%3DH.%2BL.%26aulast%3DDoherty%26aufirst%3DE.%26aulast%3DEmkey%26aufirst%3DR.%26aulast%3DGu%26aufirst%3DY.%26aulast%3DGunaydin%26aufirst%3DH.%26aulast%3DKim%26aufirst%3DJ.%2BL.%26aulast%3DLee%26aufirst%3DJ.%26aulast%3DLoberg%26aufirst%3DR.%26aulast%3DOlivieri%26aufirst%3DP.%26aulast%3DPistillo%26aufirst%3DJ.%26aulast%3DTang%26aufirst%3DJ.%26aulast%3DWan%26aufirst%3DQ.%26aulast%3DWang%26aufirst%3DH.%2BL.%26aulast%3DWang%26aufirst%3DS.%2BW.%26aulast%3DWells%26aufirst%3DM.%2BC.%26aulast%3DWu%26aufirst%3DB.%26aulast%3DYu%26aufirst%3DV.%26aulast%3DLiu%26aufirst%3DL.%26aulast%3DGeuns-Meyer%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520potent%2520and%2520highly%2520selective%2520thienopyridine%2520Janus%2520kinase%25202%2520inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D8440%26epage%3D8450" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Lim, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taoka, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Otte, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Spencer, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinsmore, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenstein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharma, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, H. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Szewczak, A. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yin, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zugay-Murphy, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. R.</span><span> </span><span class="NLM_article-title">Discovery of 1-amino-5<i>H</i>-pyrido[4,3-<i>b</i>]indol-4-carboxamide inhibitors of Janus kinase 2 (JAK2) for the treatment of myeloproliferative disorder</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">7334</span><span class="NLM_x">–</span> <span class="NLM_lpage">7349</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200909u" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=7334-7349&author=J.+Limauthor=B.+Taokaauthor=R.+D.+Otteauthor=K.+Spencerauthor=C.+J.+Dinsmoreauthor=M.+D.+Altmanauthor=G.+Chanauthor=C.+Rosensteinauthor=S.+Sharmaauthor=H.+P.+Suauthor=A.+A.+Szewczakauthor=L.+Xuauthor=H.+Yinauthor=J.+Zugay-Murphyauthor=C.+G.+Marshallauthor=J.+R.+Young&title=Discovery+of+1-amino-5H-pyrido%5B4%2C3-b%5Dindol-4-carboxamide+inhibitors+of+Janus+kinase+2+%28JAK2%29+for+the+treatment+of+myeloproliferative+disorder"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8b&amp;dbid=16384&amp;doi=10.1021%2Fjm200909u&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200909u%26sid%3Dliteratum%253Aachs%26aulast%3DLim%26aufirst%3DJ.%26aulast%3DTaoka%26aufirst%3DB.%26aulast%3DOtte%26aufirst%3DR.%2BD.%26aulast%3DSpencer%26aufirst%3DK.%26aulast%3DDinsmore%26aufirst%3DC.%2BJ.%26aulast%3DAltman%26aufirst%3DM.%2BD.%26aulast%3DChan%26aufirst%3DG.%26aulast%3DRosenstein%26aufirst%3DC.%26aulast%3DSharma%26aufirst%3DS.%26aulast%3DSu%26aufirst%3DH.%2BP.%26aulast%3DSzewczak%26aufirst%3DA.%2BA.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DYin%26aufirst%3DH.%26aulast%3DZugay-Murphy%26aufirst%3DJ.%26aulast%3DMarshall%26aufirst%3DC.%2BG.%26aulast%3DYoung%26aufirst%3DJ.%2BR.%26atitle%3DDiscovery%2520of%25201-amino-5H-pyrido%255B4%252C3-b%255Dindol-4-carboxamide%2520inhibitors%2520of%2520Janus%2520kinase%25202%2520%2528JAK2%2529%2520for%2520the%2520treatment%2520of%2520myeloproliferative%2520disorder%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D7334%26epage%3D7349" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Siu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kozina, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jung, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenstein, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathur, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Altman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bachman, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mo, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bouthillette, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rush, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dinsmore, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marshall, C. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, J. R.</span><span> </span><span class="NLM_article-title">The discovery of tricyclic pyridone JAK2 inhibitors. Part 1: hit to lead</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">7421</span><span class="NLM_x">–</span> <span class="NLM_lpage">7425</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2010&pages=7421-7425&author=T.+Siuauthor=E.+S.+Kozinaauthor=J.+Jungauthor=C.+Rosensteinauthor=A.+Mathurauthor=M.+D.+Altmanauthor=G.+Chanauthor=L.+Xuauthor=E.+Bachmanauthor=J.+R.+Moauthor=M.+Bouthilletteauthor=T.+Rushauthor=C.+J.+Dinsmoreauthor=C.+G.+Marshallauthor=J.+R.+Young&title=The+discovery+of+tricyclic+pyridone+JAK2+inhibitors.+Part+1%3A+hit+to+lead"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiu%26aufirst%3DT.%26aulast%3DKozina%26aufirst%3DE.%2BS.%26aulast%3DJung%26aufirst%3DJ.%26aulast%3DRosenstein%26aufirst%3DC.%26aulast%3DMathur%26aufirst%3DA.%26aulast%3DAltman%26aufirst%3DM.%2BD.%26aulast%3DChan%26aufirst%3DG.%26aulast%3DXu%26aufirst%3DL.%26aulast%3DBachman%26aufirst%3DE.%26aulast%3DMo%26aufirst%3DJ.%2BR.%26aulast%3DBouthillette%26aufirst%3DM.%26aulast%3DRush%26aufirst%3DT.%26aulast%3DDinsmore%26aufirst%3DC.%2BJ.%26aulast%3DMarshall%26aufirst%3DC.%2BG.%26aulast%3DYoung%26aufirst%3DJ.%2BR.%26atitle%3DThe%2520discovery%2520of%2520tricyclic%2520pyridone%2520JAK2%2520inhibitors.%2520Part%25201%253A%2520hit%2520to%2520lead%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D20%26spage%3D7421%26epage%3D7425" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">William, A. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blanchard, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Poulsen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Teo, E. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nagaraj, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tan, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sun, E. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, K. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ong, W. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goh, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hart, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jayaraman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pasha, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ethirajulu, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wood, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dymock, B. W.</span><span> </span><span class="NLM_article-title">Discovery of the macrocycle 11-(2-pyrrolidin-1-yl-ethoxy)-14,19-dioxa-5,7,26-triaza-tetracyclo[19.3.1.1(2,6).1(8,12)]heptacosa-1(25),2(26),3,5,8,10,12(27),16,21,23-decaene (SB1518), a potent Janus kinase 2/Fms-like tyrosine kinase-3 (JAK2/FLT3) inhibitor for the treatment of myelofibrosis and lymphoma</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">4638</span><span class="NLM_x">–</span> <span class="NLM_lpage">4658</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm200326p" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=4638-4658&author=A.+D.+Williamauthor=A.+C.+Leeauthor=S.+Blanchardauthor=A.+Poulsenauthor=E.+L.+Teoauthor=H.+Nagarajauthor=E.+Tanauthor=D.+Chenauthor=M.+Williamsauthor=E.+T.+Sunauthor=K.+C.+Gohauthor=W.+C.+Ongauthor=S.+K.+Gohauthor=S.+Hartauthor=R.+Jayaramanauthor=M.+K.+Pashaauthor=K.+Ethirajuluauthor=J.+M.+Woodauthor=B.+W.+Dymock&title=Discovery+of+the+macrocycle+11-%282-pyrrolidin-1-yl-ethoxy%29-14%2C19-dioxa-5%2C7%2C26-triaza-tetracyclo%5B19.3.1.1%282%2C6%29.1%288%2C12%29%5Dheptacosa-1%2825%29%2C2%2826%29%2C3%2C5%2C8%2C10%2C12%2827%29%2C16%2C21%2C23-decaene+%28SB1518%29%2C+a+potent+Janus+kinase+2%2FFms-like+tyrosine+kinase-3+%28JAK2%2FFLT3%29+inhibitor+for+the+treatment+of+myelofibrosis+and+lymphoma"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8d&amp;dbid=16384&amp;doi=10.1021%2Fjm200326p&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm200326p%26sid%3Dliteratum%253Aachs%26aulast%3DWilliam%26aufirst%3DA.%2BD.%26aulast%3DLee%26aufirst%3DA.%2BC.%26aulast%3DBlanchard%26aufirst%3DS.%26aulast%3DPoulsen%26aufirst%3DA.%26aulast%3DTeo%26aufirst%3DE.%2BL.%26aulast%3DNagaraj%26aufirst%3DH.%26aulast%3DTan%26aufirst%3DE.%26aulast%3DChen%26aufirst%3DD.%26aulast%3DWilliams%26aufirst%3DM.%26aulast%3DSun%26aufirst%3DE.%2BT.%26aulast%3DGoh%26aufirst%3DK.%2BC.%26aulast%3DOng%26aufirst%3DW.%2BC.%26aulast%3DGoh%26aufirst%3DS.%2BK.%26aulast%3DHart%26aufirst%3DS.%26aulast%3DJayaraman%26aufirst%3DR.%26aulast%3DPasha%26aufirst%3DM.%2BK.%26aulast%3DEthirajulu%26aufirst%3DK.%26aulast%3DWood%26aufirst%3DJ.%2BM.%26aulast%3DDymock%26aufirst%3DB.%2BW.%26atitle%3DDiscovery%2520of%2520the%2520macrocycle%252011-%25282-pyrrolidin-1-yl-ethoxy%2529-14%252C19-dioxa-5%252C7%252C26-triaza-tetracyclo%255B19.3.1.1%25282%252C6%2529.1%25288%252C12%2529%255Dheptacosa-1%252825%2529%252C2%252826%2529%252C3%252C5%252C8%252C10%252C12%252827%2529%252C16%252C21%252C23-decaene%2520%2528SB1518%2529%252C%2520a%2520potent%2520Janus%2520kinase%25202%252FFms-like%2520tyrosine%2520kinase-3%2520%2528JAK2%252FFLT3%2529%2520inhibitor%2520for%2520the%2520treatment%2520of%2520myelofibrosis%2520and%2520lymphoma%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D4638%26epage%3D4658" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Ioannidis, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lamb, M. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Almeida, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Block, M. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davies, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Peng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivard, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Green, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Howard, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pollard, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Read, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alimzhanov, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bebernitz, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bell, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ye, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huszar, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zinda, M.</span><span> </span><span class="NLM_article-title">Discovery of 5-chloro-<i>N</i>2-[(1<i>S</i>)-1-(5-fluoropyrimidin-2-yl)ethyl]-<i>N</i>4-(5-methyl-1<i>H</i>-pyrazol-3-yl)pyrimidine-2,4-diamine (AZD1480) as a novel inhibitor of the Jak/Stat pathway</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">262</span><span class="NLM_x">–</span> <span class="NLM_lpage">276</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm1011319" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref8/cit8e&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BC3cXhsFarsr%252FN" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2011&pages=262-276&author=S.+Ioannidisauthor=M.+L.+Lambauthor=T.+Wangauthor=L.+Almeidaauthor=M.+H.+Blockauthor=A.+M.+Daviesauthor=B.+Pengauthor=M.+Suauthor=H.+J.+Zhangauthor=E.+Hoffmannauthor=C.+Rivardauthor=I.+Greenauthor=T.+Howardauthor=H.+Pollardauthor=J.+Readauthor=M.+Alimzhanovauthor=G.+Bebernitzauthor=K.+Bellauthor=M.+Yeauthor=D.+Huszarauthor=M.+Zinda&title=Discovery+of+5-chloro-N2-%5B%281S%29-1-%285-fluoropyrimidin-2-yl%29ethyl%5D-N4-%285-methyl-1H-pyrazol-3-yl%29pyrimidine-2%2C4-diamine+%28AZD1480%29+as+a+novel+inhibitor+of+the+Jak%2FStat+pathway"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8eR"><div class="casContent"><span class="casTitleNuber">8e</span><div class="casTitle"><span class="NLM_cas:atitle">Discovery of 5-Chloro-N2-[(1S)-1-(5-fluoropyrimidin-2-yl)ethyl]-N4-(5-methyl-1H-pyrazol-3-yl)pyrimidine-2,4-diamine (AZD1480) as a Novel Inhibitor of the Jak/Stat Pathway</span></div><div class="casAuthors">Ioannidis, Stephanos; Lamb, Michelle L.; Wang, Tao; Almeida, Lynsie; Block, Michael H.; Davies, Audrey M.; Peng, Bo; Su, Mei; Zhang, Hai-Jun; Hoffmann, Ethan; Rivard, Caroline; Green, Isabelle; Howard, Tina; Pollard, Hannah; Read, Jon; Alimzhanov, Marat; Bebernitz, Geraldine; Bell, Kirsten; Ye, Min-Wei; Huszar, Dennis; Zinda, Michael</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">262-276</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The myeloproliferative neoplasms, polycythemia vera, essential thrombocythemia, and idiopathic myelofibrosis are a heterogeneous but related group of hematol. malignancies characterized by clonal expansion of one or more myeloid lineages.  The discovery of the Jak2 V617F gain of function mutation highlighted Jak2 as a potential therapeutic target in the MPNs.  Herein, we disclose the discovery of a series of pyrazol-3-yl pyrimidin-4-amines and the identification of 9e (AZD1480) as a potent Jak2 inhibitor.  9E inhibits signaling and proliferation of Jak2 V617F cell lines in vitro, demonstrates in vivo efficacy in a TEL-Jak2 model, has excellent phys. properties and preclin. pharmacokinetics, and is currently being evaluated in Phase I clin. trials.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoMG6RQUv4HqbVg90H21EOLACvtfcHk0lhMlpFKYlZKTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXhsFarsr%252FN&md5=c8141c5b0e25a007e68b6e2567a576fe</span></div><a href="/servlet/linkout?suffix=cit8e&amp;dbid=16384&amp;doi=10.1021%2Fjm1011319&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm1011319%26sid%3Dliteratum%253Aachs%26aulast%3DIoannidis%26aufirst%3DS.%26aulast%3DLamb%26aufirst%3DM.%2BL.%26aulast%3DWang%26aufirst%3DT.%26aulast%3DAlmeida%26aufirst%3DL.%26aulast%3DBlock%26aufirst%3DM.%2BH.%26aulast%3DDavies%26aufirst%3DA.%2BM.%26aulast%3DPeng%26aufirst%3DB.%26aulast%3DSu%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DH.%2BJ.%26aulast%3DHoffmann%26aufirst%3DE.%26aulast%3DRivard%26aufirst%3DC.%26aulast%3DGreen%26aufirst%3DI.%26aulast%3DHoward%26aufirst%3DT.%26aulast%3DPollard%26aufirst%3DH.%26aulast%3DRead%26aufirst%3DJ.%26aulast%3DAlimzhanov%26aufirst%3DM.%26aulast%3DBebernitz%26aufirst%3DG.%26aulast%3DBell%26aufirst%3DK.%26aulast%3DYe%26aufirst%3DM.%26aulast%3DHuszar%26aufirst%3DD.%26aulast%3DZinda%26aufirst%3DM.%26atitle%3DDiscovery%2520of%25205-chloro-N2-%255B%25281S%2529-1-%25285-fluoropyrimidin-2-yl%2529ethyl%255D-N4-%25285-methyl-1H-pyrazol-3-yl%2529pyrimidine-2%252C4-diamine%2520%2528AZD1480%2529%2520as%2520a%2520novel%2520inhibitor%2520of%2520the%2520Jak%252FStat%2520pathway%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2011%26volume%3D54%26spage%3D262%26epage%3D276" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Wernig, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kharas, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Okabe, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moore, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leeman, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cullen, D. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gozo, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McDowell, E. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Levine, R. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Doukas, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mak, C. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Noronha, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martin, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ko, Y. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lee, B. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soll, R. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tefferi, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hood, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilliland, D. G.</span><span> </span><span class="NLM_article-title">Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera</span> <span class="citation_source-journal">Cancer Cell</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">311</span><span class="NLM_x">–</span> <span class="NLM_lpage">320</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8f&amp;dbid=16&amp;doi=10.1021%2Fjm4004895&amp;key=10.1016%2Fj.ccr.2008.02.009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8f&amp;dbid=8&amp;doi=10.1021%2Fjm4004895&amp;key=18394554" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8f&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BD1cXkslSjtrs%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=13&publication_year=2008&pages=311-320&author=G.+Wernigauthor=M.+G.+Kharasauthor=R.+Okabeauthor=S.+A.+Mooreauthor=D.+S.+Leemanauthor=D.+E.+Cullenauthor=M.+Gozoauthor=E.+P.+McDowellauthor=R.+L.+Levineauthor=J.+Doukasauthor=C.+C.+Makauthor=G.+Noronhaauthor=M.+Martinauthor=Y.+D.+Koauthor=B.+H.+Leeauthor=R.+M.+Sollauthor=A.+Tefferiauthor=J.+D.+Hoodauthor=D.+G.+Gilliland&title=Efficacy+of+TG101348%2C+a+selective+JAK2+inhibitor%2C+in+treatment+of+a+murine+model+of+JAK2V617F-induced+polycythemia+vera"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8fR"><div class="casContent"><span class="casTitleNuber">8f</span><div class="casTitle"><span class="NLM_cas:atitle">Efficacy of TG101348, a selective JAK2 inhibitor, in treatment of a murine model of JAK2V617F-induced polycythemia vera</span></div><div class="casAuthors">Wernig, Gerlinde; Kharas, Michael G.; Okabe, Rachel; Moore, Sandra A.; Leeman, Dena S.; Cullen, Dana E.; Gozo, Maricel; McDowell, Elizabeth P.; Levine, Ross L.; Doukas, John; Mak, Chi Ching; Noronha, Glenn; Martin, Michael; Ko, Yon D.; Lee, Benjamin H.; Soll, Richard M.; Tefferi, Ayalew; Hood, John D.; Gilliland, D. Gary</div><div class="citationInfo"><span class="NLM_cas:title">Cancer Cell</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">13</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">311-320</span>CODEN:
                <span class="NLM_cas:coden">CCAECI</span>;
        ISSN:<span class="NLM_cas:issn">1535-6108</span>.
    
            (<span class="NLM_cas:orgname">Cell Press</span>)
        </div><div class="casAbstract">We report that TG101348, a selective small-mol. inhibitor of JAK2 with an in vitro IC50 of ∼3 nM, shows therapeutic efficacy in a murine model of myeloproliferative disease induced by the JAK2V617F mutation.  In treated animals, there was a statistically significant redn. in hematocrit and leukocyte count, a dose-dependent redn./elimination of extramedullary hematopoiesis, and, at least in some instances, evidence for attenuation of myelofibrosis.  There were no apparent toxicities and no effect on T cell no.  In vivo responses were correlated with surrogate endpoints, including redn./elimination of JAK2V617F disease burden assessed by quant. genomic PCR, suppression of endogenous erythroid colony formation, and in vivo inhibition of JAK-STAT signal transduction as assessed by flow cytometric measurement of phosphorylated Stat5.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoSJOc4cS_lO7Vg90H21EOLACvtfcHk0lhMlpFKYlZKTg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXkslSjtrs%253D&md5=3dd923595cafebb6439dd67f026735be</span></div><a href="/servlet/linkout?suffix=cit8f&amp;dbid=16384&amp;doi=10.1016%2Fj.ccr.2008.02.009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ccr.2008.02.009%26sid%3Dliteratum%253Aachs%26aulast%3DWernig%26aufirst%3DG.%26aulast%3DKharas%26aufirst%3DM.%2BG.%26aulast%3DOkabe%26aufirst%3DR.%26aulast%3DMoore%26aufirst%3DS.%2BA.%26aulast%3DLeeman%26aufirst%3DD.%2BS.%26aulast%3DCullen%26aufirst%3DD.%2BE.%26aulast%3DGozo%26aufirst%3DM.%26aulast%3DMcDowell%26aufirst%3DE.%2BP.%26aulast%3DLevine%26aufirst%3DR.%2BL.%26aulast%3DDoukas%26aufirst%3DJ.%26aulast%3DMak%26aufirst%3DC.%2BC.%26aulast%3DNoronha%26aufirst%3DG.%26aulast%3DMartin%26aufirst%3DM.%26aulast%3DKo%26aufirst%3DY.%2BD.%26aulast%3DLee%26aufirst%3DB.%2BH.%26aulast%3DSoll%26aufirst%3DR.%2BM.%26aulast%3DTefferi%26aufirst%3DA.%26aulast%3DHood%26aufirst%3DJ.%2BD.%26aulast%3DGilliland%26aufirst%3DD.%2BG.%26atitle%3DEfficacy%2520of%2520TG101348%252C%2520a%2520selective%2520JAK2%2520inhibitor%252C%2520in%2520treatment%2520of%2520a%2520murine%2520model%2520of%2520JAK2V617F-induced%2520polycythemia%2520vera%26jtitle%3DCancer%2520Cell%26date%3D2008%26volume%3D13%26spage%3D311%26epage%3D320" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Burns, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bourke, D. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Andrau, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bu, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Charman, S. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Donohue, A. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Farrugia, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Feutrill, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joffe, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kling, M. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kurek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nero, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nguyen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Palmer, J. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Phillips, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shackleford, D. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sikanyika, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Styles, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Su, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Treutlein, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zeng, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilks, A. F.</span><span> </span><span class="NLM_article-title">Phenylaminopyrimidines as inhibitors of Janus kinases (JAKs)</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">5887</span><span class="NLM_x">–</span> <span class="NLM_lpage">5892</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=5887-5892&author=C.+J.+Burnsauthor=D.+G.+Bourkeauthor=L.+Andrauauthor=X.+Buauthor=S.+A.+Charmanauthor=A.+C.+Donohueauthor=E.+Fantinoauthor=M.+Farrugiaauthor=J.+T.+Feutrillauthor=M.+Joffeauthor=M.+R.+Klingauthor=M.+Kurekauthor=T.+L.+Neroauthor=T.+Nguyenauthor=J.+T.+Palmerauthor=I.+Phillipsauthor=D.+M.+Shacklefordauthor=H.+Sikanyikaauthor=M.+Stylesauthor=S.+Suauthor=H.+Treutleinauthor=J.+Zengauthor=A.+F.+Wilks&title=Phenylaminopyrimidines+as+inhibitors+of+Janus+kinases+%28JAKs%29"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DBurns%26aufirst%3DC.%2BJ.%26aulast%3DBourke%26aufirst%3DD.%2BG.%26aulast%3DAndrau%26aufirst%3DL.%26aulast%3DBu%26aufirst%3DX.%26aulast%3DCharman%26aufirst%3DS.%2BA.%26aulast%3DDonohue%26aufirst%3DA.%2BC.%26aulast%3DFantino%26aufirst%3DE.%26aulast%3DFarrugia%26aufirst%3DM.%26aulast%3DFeutrill%26aufirst%3DJ.%2BT.%26aulast%3DJoffe%26aufirst%3DM.%26aulast%3DKling%26aufirst%3DM.%2BR.%26aulast%3DKurek%26aufirst%3DM.%26aulast%3DNero%26aufirst%3DT.%2BL.%26aulast%3DNguyen%26aufirst%3DT.%26aulast%3DPalmer%26aufirst%3DJ.%2BT.%26aulast%3DPhillips%26aufirst%3DI.%26aulast%3DShackleford%26aufirst%3DD.%2BM.%26aulast%3DSikanyika%26aufirst%3DH.%26aulast%3DStyles%26aufirst%3DM.%26aulast%3DSu%26aufirst%3DS.%26aulast%3DTreutlein%26aufirst%3DH.%26aulast%3DZeng%26aufirst%3DJ.%26aulast%3DWilks%26aufirst%3DA.%2BF.%26atitle%3DPhenylaminopyrimidines%2520as%2520inhibitors%2520of%2520Janus%2520kinases%2520%2528JAKs%2529%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D5887%26epage%3D5892" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit8h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Hexner, E. O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Serdikoff, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jan, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Swider, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Robinson, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Angeles, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emerson, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carroll, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ruggeri, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dobrzanski, P.</span><span> </span><span class="NLM_article-title">Lestaurtinib (CEP701) is a JAK2 inhibitor that suppresses JAK2/STAT5 signaling and the proliferation of primary erythroid cells from patients with myeloproliferative disorders</span> <span class="citation_source-journal">Blood</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">111</span><span class="NLM_x">, </span> <span class="NLM_fpage">5663</span><span class="NLM_x">–</span> <span class="NLM_lpage">5671</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=111&publication_year=2008&pages=5663-5671&author=E.+O.+Hexnerauthor=C.+Serdikoffauthor=M.+Janauthor=C.+R.+Swiderauthor=C.+Robinsonauthor=S.+Yangauthor=T.+Angelesauthor=S.+G.+Emersonauthor=M.+Carrollauthor=B.+Ruggeriauthor=P.+Dobrzanski&title=Lestaurtinib+%28CEP701%29+is+a+JAK2+inhibitor+that+suppresses+JAK2%2FSTAT5+signaling+and+the+proliferation+of+primary+erythroid+cells+from+patients+with+myeloproliferative+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit8h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHexner%26aufirst%3DE.%2BO.%26aulast%3DSerdikoff%26aufirst%3DC.%26aulast%3DJan%26aufirst%3DM.%26aulast%3DSwider%26aufirst%3DC.%2BR.%26aulast%3DRobinson%26aufirst%3DC.%26aulast%3DYang%26aufirst%3DS.%26aulast%3DAngeles%26aufirst%3DT.%26aulast%3DEmerson%26aufirst%3DS.%2BG.%26aulast%3DCarroll%26aufirst%3DM.%26aulast%3DRuggeri%26aufirst%3DB.%26aulast%3DDobrzanski%26aufirst%3DP.%26atitle%3DLestaurtinib%2520%2528CEP701%2529%2520is%2520a%2520JAK2%2520inhibitor%2520that%2520suppresses%2520JAK2%252FSTAT5%2520signaling%2520and%2520the%2520proliferation%2520of%2520primary%2520erythroid%2520cells%2520from%2520patients%2520with%2520myeloproliferative%2520disorders%26jtitle%3DBlood%26date%3D2008%26volume%3D111%26spage%3D5663%26epage%3D5671" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Kulagowski, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bull, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dyke, H. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eigenbrot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghilardi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harrison, T. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hewitt, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liimatta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bir Kohli, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Maxey, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendonca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mortara, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Narukulla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubhayakar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Abbema, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waszkowycz, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zak, M.</span><span> </span><span class="NLM_article-title">Identification of Imidazo-pyrrolopyridines as Novel and Potent JAK1 Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">5901</span><span class="NLM_x">–</span> <span class="NLM_lpage">5921</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm300438j" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref9/cit9&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BC38XntVOktL0%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=5901-5921&author=J.+J.+Kulagowskiauthor=W.+Blairauthor=R.+J.+Bullauthor=C.+Changauthor=G.+Deshmukhauthor=H.+J.+Dykeauthor=C.+Eigenbrotauthor=N.+Ghilardiauthor=P.+Gibbonsauthor=T.+K.+Harrisonauthor=P.+R.+Hewittauthor=M.+Liimattaauthor=C.+A.+Hurleyauthor=A.+Johnsonauthor=T.+Johnsonauthor=J.+R.+Kennyauthor=P.+Bir+Kohliauthor=R.+J.+Maxeyauthor=R.+Mendoncaauthor=K.+Mortaraauthor=J.+Murrayauthor=R.+Narukullaauthor=S.+Shiaauthor=M.+Steffekauthor=S.+Ubhayakarauthor=M.+Ultschauthor=A.+van+Abbemaauthor=S.+I.+Wardauthor=B.+Waszkowyczauthor=M.+Zak&title=Identification+of+Imidazo-pyrrolopyridines+as+Novel+and+Potent+JAK1+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit9R"><div class="casContent"><span class="casTitleNuber">9</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of Imidazo-Pyrrolopyridines as Novel and Potent JAK1 Inhibitors</span></div><div class="casAuthors">Kulagowski, Janusz J.; Blair, Wade; Bull, Richard J.; Chang, Christine; Deshmukh, Gauri; Dyke, Hazel J.; Eigenbrot, Charles; Ghilardi, Nico; Gibbons, Paul; Harrison, Trevor K.; Hewitt, Peter R.; Liimatta, Marya; Hurley, Christopher A.; Johnson, Adam; Johnson, Tony; Kenny, Jane R.; Bir Kohli, Pawan; Maxey, Robert J.; Mendonca, Rohan; Mortara, Kyle; Murray, Jeremy; Narukulla, Raman; Shia, Steven; Steffek, Micah; Ubhayakar, Savita; Ultsch, Mark; van Abbema, Anne; Ward, Stuart I.; Waszkowycz, Bohdan; Zak, Mark</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">55</span>
        (<span class="NLM_cas:issue">12</span>),
    <span class="NLM_cas:pages">5901-5921</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A therapeutic rationale is proposed for the treatment of inflammatory diseases, such as rheumatoid arthritis (RA), by specific targeting of the JAK1 pathway.  Examn. of the preferred binding conformation of clin. effective, pan-JAK inhibitor 1 led to identification of a novel, tricyclic hinge binding scaffold 3.  Exploration of SAR through a series of cycloamino and cycloalkylamino analogs demonstrated this template to be highly tolerant of substitution, with a predisposition to moderate selectivity for the JAK1 isoform over JAK2.  This study culminated in the identification of subnanomolar JAK1 inhibitors such as 22 and 49, having excellent cell potency, good rat pharmacokinetic characteristics, and excellent kinase selectivity.  Detn. of the binding modes of the series in JAK1 and JAK2 by X-ray crystallog. supported the design of analogs to enhance affinity and selectivity.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpamrk0bG1MK7Vg90H21EOLACvtfcHk0lhrWhevSUzx7Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38XntVOktL0%253D&md5=d91bc0e24abf14adcf44caf61e3e879f</span></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=10.1021%2Fjm300438j&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm300438j%26sid%3Dliteratum%253Aachs%26aulast%3DKulagowski%26aufirst%3DJ.%2BJ.%26aulast%3DBlair%26aufirst%3DW.%26aulast%3DBull%26aufirst%3DR.%2BJ.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DDyke%26aufirst%3DH.%2BJ.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DGhilardi%26aufirst%3DN.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DHarrison%26aufirst%3DT.%2BK.%26aulast%3DHewitt%26aufirst%3DP.%2BR.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DHurley%26aufirst%3DC.%2BA.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DJohnson%26aufirst%3DT.%26aulast%3DKenny%26aufirst%3DJ.%2BR.%26aulast%3DBir%2BKohli%26aufirst%3DP.%26aulast%3DMaxey%26aufirst%3DR.%2BJ.%26aulast%3DMendonca%26aufirst%3DR.%26aulast%3DMortara%26aufirst%3DK.%26aulast%3DMurray%26aufirst%3DJ.%26aulast%3DNarukulla%26aufirst%3DR.%26aulast%3DShia%26aufirst%3DS.%26aulast%3DSteffek%26aufirst%3DM.%26aulast%3DUbhayakar%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%26aulast%3Dvan%2BAbbema%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DS.%2BI.%26aulast%3DWaszkowycz%26aufirst%3DB.%26aulast%3DZak%26aufirst%3DM.%26atitle%3DIdentification%2520of%2520Imidazo-pyrrolopyridines%2520as%2520Novel%2520and%2520Potent%2520JAK1%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D5901%26epage%3D5921" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><div class="note"><p class="first last">We recently reported on a series of <i>C</i>-2 amine-containing inhibitors capped with groups such as amides and sulfonamides. Although these groups imparted consistent JAK1 selectivity, they also produced large increases in TPSA. As such, the only P-loop combinations with sufficient membrane permeability for acceptable cell potency and oral bioavailability were highly lipophilic and nonpolar (such as cycloalkanes and norbornanes).</p></div><span class="NLM_contrib-group">Labadie, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dragovich, P. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Barrett, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blair, W. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bergeron, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Deshmukh, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eigenbrot, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ghilardi, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbons, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hurley, C. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Johnson, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kenny, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kohli, P. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kulagowski, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liimatta, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lupardus, P. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mendonca, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murray, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pulk, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shia, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steffek, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ubhayakar, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ultsch, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Abbema, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ward, S. I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zak, M.</span><span> </span><span class="NLM_article-title">Structure-based discovery of C-2 substituted imidazo-pyrrolopyridine JAK1 inhibitors with improved selectivity over JAK2</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">7627</span><span class="NLM_x">–</span> <span class="NLM_lpage">7633</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2012&pages=7627-7633&author=S.+Labadieauthor=P.+S.+Dragovichauthor=K.+Barrettauthor=W.+S.+Blairauthor=P.+Bergeronauthor=C.+Changauthor=G.+Deshmukhauthor=C.+Eigenbrotauthor=N.+Ghilardiauthor=P.+Gibbonsauthor=C.+A.+Hurleyauthor=A.+Johnsonauthor=J.+R.+Kennyauthor=P.+B.+Kohliauthor=J.+J.+Kulagowskiauthor=M.+Liimattaauthor=P.+J.+Lupardusauthor=R.+Mendoncaauthor=J.+M.+Murrayauthor=R.+Pulkauthor=S.+Shiaauthor=M.+Steffekauthor=S.+Ubhayakarauthor=M.+Ultschauthor=A.+van+Abbemaauthor=S.+I.+Wardauthor=M.+Zak&title=Structure-based+discovery+of+C-2+substituted+imidazo-pyrrolopyridine+JAK1+inhibitors+with+improved+selectivity+over+JAK2"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLabadie%26aufirst%3DS.%26aulast%3DDragovich%26aufirst%3DP.%2BS.%26aulast%3DBarrett%26aufirst%3DK.%26aulast%3DBlair%26aufirst%3DW.%2BS.%26aulast%3DBergeron%26aufirst%3DP.%26aulast%3DChang%26aufirst%3DC.%26aulast%3DDeshmukh%26aufirst%3DG.%26aulast%3DEigenbrot%26aufirst%3DC.%26aulast%3DGhilardi%26aufirst%3DN.%26aulast%3DGibbons%26aufirst%3DP.%26aulast%3DHurley%26aufirst%3DC.%2BA.%26aulast%3DJohnson%26aufirst%3DA.%26aulast%3DKenny%26aufirst%3DJ.%2BR.%26aulast%3DKohli%26aufirst%3DP.%2BB.%26aulast%3DKulagowski%26aufirst%3DJ.%2BJ.%26aulast%3DLiimatta%26aufirst%3DM.%26aulast%3DLupardus%26aufirst%3DP.%2BJ.%26aulast%3DMendonca%26aufirst%3DR.%26aulast%3DMurray%26aufirst%3DJ.%2BM.%26aulast%3DPulk%26aufirst%3DR.%26aulast%3DShia%26aufirst%3DS.%26aulast%3DSteffek%26aufirst%3DM.%26aulast%3DUbhayakar%26aufirst%3DS.%26aulast%3DUltsch%26aufirst%3DM.%26aulast%3Dvan%2BAbbema%26aufirst%3DA.%26aulast%3DWard%26aufirst%3DS.%2BI.%26aulast%3DZak%26aufirst%3DM.%26atitle%3DStructure-based%2520discovery%2520of%2520C-2%2520substituted%2520imidazo-pyrrolopyridine%2520JAK1%2520inhibitors%2520with%2520improved%2520selectivity%2520over%2520JAK2%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2012%26volume%3D22%26spage%3D7627%26epage%3D7633" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kuntz, I. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sharp, K. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kollman, P. A.</span><span> </span><span class="NLM_article-title">The maximal affinity of ligands</span> <span class="citation_source-journal">Proc. Natl. Acad. Sci U. S. A.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1999</span><span class="NLM_x">, </span> <span class="NLM_volume">96</span><span class="NLM_x">, </span> <span class="NLM_fpage">9997</span><span class="NLM_x">–</span> <span class="NLM_lpage">10002</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=16&amp;doi=10.1021%2Fjm4004895&amp;key=10.1073%2Fpnas.96.18.9997" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=8&amp;doi=10.1021%2Fjm4004895&amp;key=10468550" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11a&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADyaK1MXlvFehu7s%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=96&publication_year=1999&pages=9997-10002&author=I.+D.+Kuntzauthor=K.+Chenauthor=K.+A.+Sharpauthor=P.+A.+Kollman&title=The+maximal+affinity+of+ligands"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11aR"><div class="casContent"><span class="casTitleNuber">11a</span><div class="casTitle"><span class="NLM_cas:atitle">The maximal affinity of ligands</span></div><div class="casAuthors">Kuntz, I. D.; Chen, K.; Sharp, K. A.; Kollman, P. A.</div><div class="citationInfo"><span class="NLM_cas:title">Proceedings of the National Academy of Sciences of the United States of America</span>
        (<span class="NLM_cas:date">1999</span>),
    <span class="NLM_cas:volume">96</span>
        (<span class="NLM_cas:issue">18</span>),
    <span class="NLM_cas:pages">9997-10002</span>CODEN:
                <span class="NLM_cas:coden">PNASA6</span>;
        ISSN:<span class="NLM_cas:issn">0027-8424</span>.
    
            (<span class="NLM_cas:orgname">National Academy of Sciences</span>)
        </div><div class="casAbstract">We explore the question of what are the best ligands for macromol. targets.  A survey of exptl. data on a large no. of the strongest-binding ligands indicates that the free energy of binding increases with the no. of nonhydrogen atoms with an initial slope of ≈-1.5 kcal/mol (1 cal = 4.18 J) per atom.  For ligands that contain more than 15 nonhydrogen atoms, the free energy of binding increases very little with relative mol. mass.  This nonlinearity is largely ascribed to nonthermodynamic factors.  An anal. of the dominant interactions suggests that van der Waals interactions and hydrophobic effects provide a reasonable basis for understanding binding affinities across the entire set of ligands.  Interesting outliers that bind unusually strongly on a per atom basis include metal ions, covalently attached ligands, and a few well known complexes such as biotin-avidin.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGq0L6KZhR0TxbVg90H21EOLACvtfcHk0liYZiPqxxB-2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK1MXlvFehu7s%253D&md5=46fe894b016f3041831a2f0b71f812b1</span></div><a href="/servlet/linkout?suffix=cit11a&amp;dbid=16384&amp;doi=10.1073%2Fpnas.96.18.9997&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1073%252Fpnas.96.18.9997%26sid%3Dliteratum%253Aachs%26aulast%3DKuntz%26aufirst%3DI.%2BD.%26aulast%3DChen%26aufirst%3DK.%26aulast%3DSharp%26aufirst%3DK.%2BA.%26aulast%3DKollman%26aufirst%3DP.%2BA.%26atitle%3DThe%2520maximal%2520affinity%2520of%2520ligands%26jtitle%3DProc.%2520Natl.%2520Acad.%2520Sci%2520U.%2520S.%2520A.%26date%3D1999%26volume%3D96%26spage%3D9997%26epage%3D10002" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit11b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hopkins, A. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom, C. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=16&amp;doi=10.1021%2Fjm4004895&amp;key=10.1016%2FS1359-6446%2804%2903069-7" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=8&amp;doi=10.1021%2Fjm4004895&amp;key=15109945" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref11/cit11b&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=A.+L.+Hopkinsauthor=C.+R.+Groomauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit11bR"><div class="casContent"><span class="casTitleNuber">11b</span><div class="casTitle"><span class="NLM_cas:atitle">Ligand efficiency: a useful metric for lead selection</span></div><div class="casAuthors">Hopkins Andrew L; Groom Colin R; Alex Alexander</div><div class="citationInfo"><span class="NLM_cas:title">Drug discovery today</span>
        (<span class="NLM_cas:date">2004</span>),
    <span class="NLM_cas:volume">9</span>
        (<span class="NLM_cas:issue">10</span>),
    <span class="NLM_cas:pages">430-1</span>
        ISSN:<span class="NLM_cas:issn">1359-6446</span>.
    </div><div class="casAbstract">
                There is no expanded citation for this reference.
            </div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=LOZGTtr2ZcSdMyKW_d6RPeIHSmpohpd0fW6udTcc2eba_DOjtLSxUbntkvexoksv"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A280%3ADC%252BD2c3ht1ygtw%253D%253D&md5=eb19a1bca53247d0bd9adcb99d5817e6</span></div><a href="/servlet/linkout?suffix=cit11b&amp;dbid=16384&amp;doi=10.1016%2FS1359-6446%2804%2903069-7&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS1359-6446%252804%252903069-7%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%26aufirst%3DA.%2BL.%26aulast%3DGroom%26aufirst%3DC.%2BR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Leeson, P. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Springthorpe, B.</span><span> </span><span class="NLM_article-title">The influence of drug-like concepts on decision-making in medicinal chemistry</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">6</span><span class="NLM_x">, </span> <span class="NLM_fpage">881</span><span class="NLM_x">–</span> <span class="NLM_lpage">890</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=6&publication_year=2007&pages=881-890&author=P.+D.+Leesonauthor=B.+Springthorpe&title=The+influence+of+drug-like+concepts+on+decision-making+in+medicinal+chemistry"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLeeson%26aufirst%3DP.%2BD.%26aulast%3DSpringthorpe%26aufirst%3DB.%26atitle%3DThe%2520influence%2520of%2520drug-like%2520concepts%2520on%2520decision-making%2520in%2520medicinal%2520chemistry%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2007%26volume%3D6%26spage%3D881%26epage%3D890" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ryckmans, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edwards, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Horne, V. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Correia, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Owen, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Thompson, L. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tran, I.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tutt, M. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, T.</span><span> </span><span class="NLM_article-title">Rapid assessment of a novel series of selective CB<sub>2</sub> agonists using parallel synthesis protocols: a lipophilic efficiency (LipE) analysis</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">19</span><span class="NLM_x">, </span> <span class="NLM_fpage">4406</span><span class="NLM_x">–</span> <span class="NLM_lpage">4409</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=16&amp;doi=10.1021%2Fjm4004895&amp;key=10.1016%2Fj.bmcl.2009.05.062" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=8&amp;doi=10.1021%2Fjm4004895&amp;key=19500981" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref12/cit12b&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=19&publication_year=2009&pages=4406-4409&author=T.+Ryckmansauthor=M.+P.+Edwardsauthor=V.+A.+Horneauthor=A.+M.+Correiaauthor=D.+R.+Owenauthor=L.+R.+Thompsonauthor=I.+Tranauthor=M.+F.+Tuttauthor=T.+Young&title=Rapid+assessment+of+a+novel+series+of+selective+CB2+agonists+using+parallel+synthesis+protocols%3A+a+lipophilic+efficiency+%28LipE%29+analysis"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12bR"><div class="casContent"><span class="casTitleNuber">12b</span><div class="casTitle"><span class="NLM_cas:atitle">Rapid assessment of a novel series of selective CB2 agonists using parallel synthesis protocols: A Lipophilic Efficiency (LipE) analysis</span></div><div class="casAuthors">Ryckmans, Thomas; Edwards, Martin P.; Horne, Val A.; Correia, Ana Monica; Owen, Dafydd R.; Thompson, Lisa R.; Tran, Isabelle; Tutt, Michelle F.; Young, Tim</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">19</span>
        (<span class="NLM_cas:issue">15</span>),
    <span class="NLM_cas:pages">4406-4409</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">A series of libraries were designed using the 1-(cyclopropylmethyl)-2-alkyl-4,5,6,7-tetrahydro-1H-imidazo[4,5-c]pyridin-5-ium templates 2a-b, and Sulfonamide derivs. 11a-n proved to be potent agonists of the CB2 receptor.  Anal. of the Lipophilic Efficiency (LipE) of potent compds. provided new insight for the design of potent, metabolically stable CB2 agonists.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo1cihq9YHuO7Vg90H21EOLACvtfcHk0liYZiPqxxB-2g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXosVGlsrg%253D&md5=b62d97e5f52a594cfdd510f32d2e566f</span></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2009.05.062&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2009.05.062%26sid%3Dliteratum%253Aachs%26aulast%3DRyckmans%26aufirst%3DT.%26aulast%3DEdwards%26aufirst%3DM.%2BP.%26aulast%3DHorne%26aufirst%3DV.%2BA.%26aulast%3DCorreia%26aufirst%3DA.%2BM.%26aulast%3DOwen%26aufirst%3DD.%2BR.%26aulast%3DThompson%26aufirst%3DL.%2BR.%26aulast%3DTran%26aufirst%3DI.%26aulast%3DTutt%26aufirst%3DM.%2BF.%26aulast%3DYoung%26aufirst%3DT.%26atitle%3DRapid%2520assessment%2520of%2520a%2520novel%2520series%2520of%2520selective%2520CB2%2520agonists%2520using%2520parallel%2520synthesis%2520protocols%253A%2520a%2520lipophilic%2520efficiency%2520%2528LipE%2529%2520analysis%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2009%26volume%3D19%26spage%3D4406%26epage%3D4409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="note"><p class="first last">Descriptions of the biochemical and cell-based assays are provided in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14c"><span> Prior to synthesis, predicted LogD values were calculated using the MoKa sofware (<a href="http://www.moldiscovery.com" class="extLink">www.moldiscovery.com</a>, (ref <span class="NLM_xref">14</span>)) and a custom p<i>K</i><sub>a</sub> model (ref <span class="NLM_xref">14</span>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+Prior+to+synthesis%2C+predicted+LogD+values+were+calculated+using+the+MoKa+sofware+%28www.moldiscovery.com%2C+%28ref+14%29%29+and+a+custom+pKa+model+%28ref+14%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit14c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Milletti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storchi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sforna, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruciani, G.</span><span> </span><span class="NLM_article-title">New and original pKa prediction method using grid molecular interaction fields</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2172</span><span class="NLM_x">–</span> <span class="NLM_lpage">2181</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci700018y" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref14/cit14a&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhtFSnsLrF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2007&pages=2172-2181&author=F.+Millettiauthor=L.+Storchiauthor=G.+Sfornaauthor=G.+Cruciani&title=New+and+original+pKa+prediction+method+using+grid+molecular+interaction+fields"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14aR"><div class="casContent"><span class="casTitleNuber">14a</span><div class="casTitle"><span class="NLM_cas:atitle">New and Original pKa Prediction Method Using Grid Molecular Interaction Fields</span></div><div class="casAuthors">Milletti, Francesca; Storchi, Loriano; Sforna, Gianluca; Cruciani, Gabriele</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">47</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">2172-2181</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">One of the most important physicochem. properties of a mol. is pKa.  It is known that two parameters imperative in ADME profiling, soly., and lipophilicity are governed by pKa, and receptor binding can be influenced by pKa.  Because most drugs are ionized in physiol. conditions, pKa is particularly relevant to medicinal chem.  Despite the numerous advances in high-throughput measurements, in silico detn. is still the fastest and cheapest way of obtaining pKa.  This paper presents a new original computational method for pKa prediction of org. compds.  Descriptors were generated using the program GRID, and these descriptors are based on mol. interaction fields precomputed on a set of mol. fragments.  The new method was developed, trained, and cross-validated by using a large and diverse data set of 24 617 pKa values.  This paper presents the results for a class of 421 acidic nitrogen compds. (RMSE = 0.41, r2 = 0.97, q2 = 0.87) and for a class of 947 six-membered N-heterocyclic bases (RMSE = 0.60, r2 = 0.93, q2 = 0.85).  For external validation 28 novel compds. were selected that covered nine different ionizable groups, and 39 pKa values could be exptl. detd. by spectral gradient anal. (SGA).  Comparison of exptl. pKa with calcd. pKa demonstrated that the predictive ability of the method is good (external set, r2 = 0.85, RMSE = 0.90).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrzEk0uiS1E6rVg90H21EOLACvtfcHk0lgt8qjYZgVCjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhtFSnsLrF&md5=f2b1dec853ccb0ef1a40540d234232fb</span></div><a href="/servlet/linkout?suffix=cit14a&amp;dbid=16384&amp;doi=10.1021%2Fci700018y&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci700018y%26sid%3Dliteratum%253Aachs%26aulast%3DMilletti%26aufirst%3DF.%26aulast%3DStorchi%26aufirst%3DL.%26aulast%3DSforna%26aufirst%3DG.%26aulast%3DCruciani%26aufirst%3DG.%26atitle%3DNew%2520and%2520original%2520pKa%2520prediction%2520method%2520using%2520grid%2520molecular%2520interaction%2520fields%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2007%26volume%3D47%26spage%3D2172%26epage%3D2181" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit14b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Milletti, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Storchi, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Goracci, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bendels, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wagner, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kansy, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cruciani, G.</span><span> </span><span class="NLM_article-title">Extending p<i>K</i><sub>a</sub> prediction accuracy: high-throughput p<i>K</i><sub>a</sub> measurements to understand p<i>K</i><sub>a</sub> modulation of new chemical series</span> <span class="citation_source-journal">Eur. J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">4270</span><span class="NLM_x">–</span> <span class="NLM_lpage">4279</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=16&amp;doi=10.1021%2Fjm4004895&amp;key=10.1016%2Fj.ejmech.2010.06.026" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=8&amp;doi=10.1021%2Fjm4004895&amp;key=20633962" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref14/cit14b&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BC3cXpvFKhtLo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=4270-4279&author=F.+Millettiauthor=L.+Storchiauthor=L.+Goracciauthor=S.+Bendelsauthor=B.+Wagnerauthor=M.+Kansyauthor=G.+Cruciani&title=Extending+pKa+prediction+accuracy%3A+high-throughput+pKa+measurements+to+understand+pKa+modulation+of+new+chemical+series"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14bR"><div class="casContent"><span class="casTitleNuber">14b</span><div class="casTitle"><span class="NLM_cas:atitle">Extending pKa prediction accuracy: High-throughput pKa measurements to understand pKa modulation of new chemical series</span></div><div class="casAuthors">Milletti, Francesca; Storchi, Loriano; Goracci, Laura; Bendels, Stefanie; Wagner, Bjoern; Kansy, Manfred; Cruciani, Gabriele</div><div class="citationInfo"><span class="NLM_cas:title">European Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">45</span>
        (<span class="NLM_cas:issue">9</span>),
    <span class="NLM_cas:pages">4270-4279</span>CODEN:
                <span class="NLM_cas:coden">EJMCA5</span>;
        ISSN:<span class="NLM_cas:issn">0223-5234</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Masson SAS</span>)
        </div><div class="casAbstract">We have recently developed a tool, MoKα, to predict the pKa of org. compds. using a large dataset of over 26,500 literature pKa values as a training set.  However, predicting accurately pKa (<0.5 pH units) remains challenging for novel series, and this can be a drawback in the optimization of activity and ADME properties of lead compds.  To address this issue it is important to expand our knowledge of pKa determinants, therefore we have conducted high-throughput pKa measurements by using Spectral Gradient Anal. (SGA) on novel series of compds. selected from vendor databases.  Here we report our findings on the effect of specific chem. groups and steric constraints on the pKa of common functionalities in medicinal chem., such as amines, sulfonamides, and amides.  Furthermore, we report the pKa of ionizable groups that were not well represented in the database of literature pKa of MoKα, such as hydrazide derivs.  These findings helped us to enhance MoKα, which is here benchmarked on a set of exptl. pKa values from the Roche inhouse library (N = 5581; RMSE = 1.09; R2 = 0.82).  The accuracy of the predictions was greatly improved (RMSE = 0.49, R2 = 0.96) after training the software by using the automated tool Kibitzer with 6226 pK a values taken from a different set of Roche compds. appropriately selected, and this demonstrates the value of using high-throughput pKa measurements to expand the training set of pKa values used by the software MoKα.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrxQ9UJOAhB-rVg90H21EOLACvtfcHk0lgt8qjYZgVCjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXpvFKhtLo%253D&md5=e4c579032df7fa37ec3551c69a09257a</span></div><a href="/servlet/linkout?suffix=cit14b&amp;dbid=16384&amp;doi=10.1016%2Fj.ejmech.2010.06.026&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.ejmech.2010.06.026%26sid%3Dliteratum%253Aachs%26aulast%3DMilletti%26aufirst%3DF.%26aulast%3DStorchi%26aufirst%3DL.%26aulast%3DGoracci%26aufirst%3DL.%26aulast%3DBendels%26aufirst%3DS.%26aulast%3DWagner%26aufirst%3DB.%26aulast%3DKansy%26aufirst%3DM.%26aulast%3DCruciani%26aufirst%3DG.%26atitle%3DExtending%2520pKa%2520prediction%2520accuracy%253A%2520high-throughput%2520pKa%2520measurements%2520to%2520understand%2520pKa%2520modulation%2520of%2520new%2520chemical%2520series%26jtitle%3DEur.%2520J.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D4270%26epage%3D4279" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Ertl, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohde, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Selzer, P.</span><span> </span><span class="NLM_article-title">Fast calculation of molecular polar surface area as a sum of fragment-based contributions and its application to the prediction of drug transport properties</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">3714</span><span class="NLM_x">–</span> <span class="NLM_lpage">3717</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm000942e" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2000&pages=3714-3717&author=P.+Ertlauthor=B.+Rohdeauthor=P.+Selzer&title=Fast+calculation+of+molecular+polar+surface+area+as+a+sum+of+fragment-based+contributions+and+its+application+to+the+prediction+of+drug+transport+properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">Fast Calculation of Molecular Polar Surface Area as a Sum of Fragment-Based Contributions and Its Application to the Prediction of Drug Transport Properties</span></div><div class="casAuthors">Ertl, Peter; Rohde, Bernhard; Selzer, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">20</span>),
    <span class="NLM_cas:pages">3714-3717</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Mol. polar surface area (PSA), i.e., surface belonging to polar atoms, is a descriptor that was shown to correlate well with passive mol. transport through membranes and, therefore, allows prediction of transport properties of drugs.  The calcn. of PSA, however, is rather time-consuming because of the necessity to generate a reasonable 3D mol. geometry and the calcn. of the surface itself.  A new approach for the calcn. of the PSA is presented here, based on the summation of tabulated surface contributions of polar fragments.  The method, termed topol. PSA (TPSA), provides results which are practically identical with the 3D PSA (the correlation coeff. between 3D PSA and fragment-based TPSA for 34 810 mols. from the World Drug Index is 0.99), while the computation speed is 2-3 orders of magnitude faster.  The new methodol. may, therefore, be used for fast bioavailability screening of virtual libraries having millions of mols.  This article describes the new methodol. and shows the results of validation studies based on sets of published absorption data, including intestinal absorption, Caco-2 monolayer penetration, and blood-brain barrier penetration.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhP6Qncx_h6LVg90H21EOLACvtfcHk0lgt8qjYZgVCjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXmsFeitb4%253D&md5=23ae4e7708bd8ddeb4a24ad160a29bd6</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1021%2Fjm000942e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm000942e%26sid%3Dliteratum%253Aachs%26aulast%3DErtl%26aufirst%3DP.%26aulast%3DRohde%26aufirst%3DB.%26aulast%3DSelzer%26aufirst%3DP.%26atitle%3DFast%2520calculation%2520of%2520molecular%2520polar%2520surface%2520area%2520as%2520a%2520sum%2520of%2520fragment-based%2520contributions%2520and%2520its%2520application%2520to%2520the%2520prediction%2520of%2520drug%2520transport%2520properties%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2000%26volume%3D43%26spage%3D3714%26epage%3D3717" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><div class="note"><p class="first last">In vitro metabolic stability in the presence of liver microsomes and hepatocytes is expressed as hepatic clearance (CL<sub>H</sub>). CL<sub>H</sub> is derived from the well stirred model according to the following equation: CL<sub>H</sub> = (CL<sub>int</sub>·LBF)/(CL<sub>int</sub> + LBF), where CL<sub>int</sub> is intrinsic clearance and LBF is liver blood flow. The fraction unbound in the incubation and in blood are assumed to be 1. Human CL<sub>H</sub> values (units = mL min<sup>–1</sup> kg<sup>–1</sup>) are categorized are as follows: <6.2 = low, 6.2–15 = moderate, >15 = high. Further details on the in vitro metabolic stability experiments used to measure CL<sub>int</sub> may be found in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a> and in:</p></div><span class="NLM_contrib-group">Halladay, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wong, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jaffer, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sinhababu, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Khojasteh-Bakht, S. C.</span><span> </span><span class="NLM_article-title">Metabolic stability screen for drug discovery using cassette analysis and column switching</span> <span class="citation_source-journal">Drug Metab. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">67</span><span class="NLM_x">–</span> <span class="NLM_lpage">72</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=16&amp;doi=10.1021%2Fjm4004895&amp;key=10.2174%2F187231207779814364" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=8&amp;doi=10.1021%2Fjm4004895&amp;key=19356021" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjtleru74%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2007&pages=67-72&author=J.+S.+Halladayauthor=S.+Wongauthor=S.+M.+Jafferauthor=A.+K.+Sinhababuauthor=S.+C.+Khojasteh-Bakht&title=Metabolic+stability+screen+for+drug+discovery+using+cassette+analysis+and+column+switching"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Metabolic stability screen for drug discovery using cassette analysis and column switching</span></div><div class="casAuthors">Halladay, Jason S.; Wong, Susan; Jaffer, Sharmin M.; Sinhababu, Achintya K.; Khojasteh-Bakht, S. Cyrus</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">67-72</span>CODEN:
                <span class="NLM_cas:coden">DMLRBM</span>;
        ISSN:<span class="NLM_cas:issn">1872-3128</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">In vitro metabolic stability assays are used to screen compds. for stability in the presence of various drug metabolizing enzymes, usually cytochrome P 450 in liver prepns. (e.g., liver microsomes).  High-throughput metabolic stability assays using pooling methods have been developed to keep pace with screening requirements at the lead ADME optimization stage.  In our lab., we have improved the metabolic stability assay using the cassette anal. method, column switching, and incorporated time saving techniques in method development to yield a robust method which reduces data turnaround time, increases compd. throughput, and maximizes mass spectrometer usage.  This method can det. metabolic stability using microsomes or hepatocytes from any species.  We describe our findings following incubation of 40 different compds. with human liver microsomes and anal. by the cassette and discrete anal. methods.  Similar metabolic stability results were obtained using the cassette anal. and discrete anal. method.  An overall 70% time savings was achieved by pooling four new compds. into one sample for method development/MS optimization, cassetting four samples into one sample to minimize the no. of injections on LC/MS/MS anal., and using a column switching system to analyze the samples, which results in a two-fold decrease in the LC/MS/MS anal. time.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoKzVSm6sBe1bVg90H21EOLACvtfcHk0lgt8qjYZgVCjw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjtleru74%253D&md5=e00c66b3ca6a1eaee107c4eb81e07bf5</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.2174%2F187231207779814364&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F187231207779814364%26sid%3Dliteratum%253Aachs%26aulast%3DHalladay%26aufirst%3DJ.%2BS.%26aulast%3DWong%26aufirst%3DS.%26aulast%3DJaffer%26aufirst%3DS.%2BM.%26aulast%3DSinhababu%26aufirst%3DA.%2BK.%26aulast%3DKhojasteh-Bakht%26aufirst%3DS.%2BC.%26atitle%3DMetabolic%2520stability%2520screen%2520for%2520drug%2520discovery%2520using%2520cassette%2520analysis%2520and%2520column%2520switching%26jtitle%3DDrug%2520Metab.%2520Lett.%26date%3D2007%26volume%3D1%26spage%3D67%26epage%3D72" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="note"><p class="first last">QSAR models used to prospectively predict metabolic stability have previously been described (refs <a onclick="showRef(event, 'cit17a cit17b cit17c cit17d cit17e'); return false;" href="javascript:void(0);" class="ref cit17a cit17b cit17c cit17d cit17e">17a−17e</a>). Similarly, an internal HLM stability model was developed using experimental data from 18000 compounds spanning a variety of Genentech projects and scaffolds. A regression model was built in Pipeline Pilot (ref <a onclick="showRef(event, 'cit17f'); return false;" href="javascript:void(0);" class="ref cit17f">17f</a>) using a Support Vector Machine (refs <a onclick="showRef(event, 'cit17g'); return false;" href="javascript:void(0);" class="ref cit17g">17g</a>,<a onclick="showRef(event, 'cit17h'); return false;" href="javascript:void(0);" class="ref cit17h">17h</a>) methodology implemented in the R-Statistics (ref <a onclick="showRef(event, 'cit17i'); return false;" href="javascript:void(0);" class="ref cit17i">17i</a>) package. The following descriptors, available in Pipeline Pilot, were used: ALogP, molecular weight, number of H-bond donors, number of H-bond acceptors, number of rotatable bonds, number of atoms, number of rings, number of aromatic rings, molecular surface area, molecular polar surface area, AlogP counts (ref <a onclick="showRef(event, 'cit17j'); return false;" href="javascript:void(0);" class="ref cit17j">17j</a>), E-state keys (ref <a onclick="showRef(event, 'cit17k'); return false;" href="javascript:void(0);" class="ref cit17k">17k</a>), MDL Public Keys (refs <a onclick="showRef(event, 'cit17l'); return false;" href="javascript:void(0);" class="ref cit17l">17l</a>,<a onclick="showRef(event, 'cit17m'); return false;" href="javascript:void(0);" class="ref cit17m">17m</a>), and FCFP4 fingerprints (refs <a onclick="showRef(event, 'cit17n'); return false;" href="javascript:void(0);" class="ref cit17n">17n</a>,<a onclick="showRef(event, 'cit17o'); return false;" href="javascript:void(0);" class="ref cit17o">17o</a>). The predicted clearance was converted to the probability of a compound being stable based on a total clearance cutoff of 13 mL min<sup>–1</sup> kg<sup>–1</sup> as described in ref <a onclick="showRef(event, 'cit17p'); return false;" href="javascript:void(0);" class="ref cit17p">17p</a>. The structures of and predicted and experimental HLM stability data associated with the compounds in Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>d are tabulated in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="NLM_citation" id="rightTab-cit17a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Lee, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cucurull-Sanchez, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Du, Y. H. J.</span><span> </span><span class="NLM_article-title">Development of in silico models for human liver microsomal stability</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">665</span><span class="NLM_x">–</span> <span class="NLM_lpage">673</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2007&pages=665-673&author=P.+H.+Leeauthor=L.+Cucurull-Sanchezauthor=J.+Luauthor=Y.+H.+J.+Du&title=Development+of+in+silico+models+for+human+liver+microsomal+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DLee%26aufirst%3DP.%2BH.%26aulast%3DCucurull-Sanchez%26aufirst%3DL.%26aulast%3DLu%26aufirst%3DJ.%26aulast%3DDu%26aufirst%3DY.%2BH.%2BJ.%26atitle%3DDevelopment%2520of%2520in%2520silico%2520models%2520for%2520human%2520liver%2520microsomal%2520stability%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2007%26volume%3D21%26spage%3D665%26epage%3D673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Ekins, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gupta, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gifford, E. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liston, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Waller, C. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hohman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bunin, B. A.</span><span> </span><span class="NLM_article-title">Using Open Source Computational Tools for Predicting Human Metabolic Stability and Additional Absorption, Distribution, Metabolism, Excretion, and Toxicity Properties</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">38</span><span class="NLM_x">, </span> <span class="NLM_fpage">2083</span><span class="NLM_x">–</span> <span class="NLM_lpage">2090</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=38&publication_year=2010&pages=2083-2090&author=S.+Ekinsauthor=R.+R.+Guptaauthor=E.+M.+Giffordauthor=T.+Listonauthor=C.+L.+Wallerauthor=M.+Hohmanauthor=B.+A.+Bunin&title=Using+Open+Source+Computational+Tools+for+Predicting+Human+Metabolic+Stability+and+Additional+Absorption%2C+Distribution%2C+Metabolism%2C+Excretion%2C+and+Toxicity+Properties"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DEkins%26aufirst%3DS.%26aulast%3DGupta%26aufirst%3DR.%2BR.%26aulast%3DGifford%26aufirst%3DE.%2BM.%26aulast%3DListon%26aufirst%3DT.%26aulast%3DWaller%26aufirst%3DC.%2BL.%26aulast%3DHohman%26aufirst%3DM.%26aulast%3DBunin%26aufirst%3DB.%2BA.%26atitle%3DUsing%2520Open%2520Source%2520Computational%2520Tools%2520for%2520Predicting%2520Human%2520Metabolic%2520Stability%2520and%2520Additional%2520Absorption%252C%2520Distribution%252C%2520Metabolism%252C%2520Excretion%252C%2520and%2520Toxicity%2520Properties%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2010%26volume%3D38%26spage%3D2083%26epage%3D2090" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Hu, Y. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Unwalla, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bikker, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Di, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humblet, C.</span><span> </span><span class="NLM_article-title">Development of QSAR models for microsomal stability: identification of good and bad structural features for rat, human and mouse microsomal stability</span> <span class="citation_source-journal">J. Comput.-Aided Mol. Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">23</span><span class="NLM_x">–</span> <span class="NLM_lpage">35</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2010&pages=23-35&author=Y.+B.+Huauthor=R.+Unwallaauthor=R.+A.+Dennyauthor=J.+Bikkerauthor=L.+Diauthor=C.+Humblet&title=Development+of+QSAR+models+for+microsomal+stability%3A+identification+of+good+and+bad+structural+features+for+rat%2C+human+and+mouse+microsomal+stability"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17c&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHu%26aufirst%3DY.%2BB.%26aulast%3DUnwalla%26aufirst%3DR.%26aulast%3DDenny%26aufirst%3DR.%2BA.%26aulast%3DBikker%26aufirst%3DJ.%26aulast%3DDi%26aufirst%3DL.%26aulast%3DHumblet%26aufirst%3DC.%26atitle%3DDevelopment%2520of%2520QSAR%2520models%2520for%2520microsomal%2520stability%253A%2520identification%2520of%2520good%2520and%2520bad%2520structural%2520features%2520for%2520rat%252C%2520human%2520and%2520mouse%2520microsomal%2520stability%26jtitle%3DJ.%2520Comput.-Aided%2520Mol.%2520Des.%26date%3D2010%26volume%3D24%26spage%3D23%26epage%3D35" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Sakiyama, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yuki, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Moriya, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hattori, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suzuki, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shimada, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Honma, T.</span><span> </span><span class="NLM_article-title">Predicting human liver microsomal stability with machine learning techniques</span> <span class="citation_source-journal">J. Mol. Graphics Modell.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">26</span><span class="NLM_x">, </span> <span class="NLM_fpage">907</span><span class="NLM_x">–</span> <span class="NLM_lpage">915</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=16&amp;doi=10.1021%2Fjm4004895&amp;key=10.1016%2Fj.jmgm.2007.06.005" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=8&amp;doi=10.1021%2Fjm4004895&amp;key=17683964" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17d&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BD2sXhsVOksL7K" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=26&publication_year=2008&pages=907-915&author=Y.+Sakiyamaauthor=H.+Yukiauthor=T.+Moriyaauthor=K.+Hattoriauthor=M.+Suzukiauthor=K.+Shimadaauthor=T.+Honma&title=Predicting+human+liver+microsomal+stability+with+machine+learning+techniques"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17dR"><div class="casContent"><span class="casTitleNuber">17d</span><div class="casTitle"><span class="NLM_cas:atitle">Predicting human liver microsomal stability with machine learning techniques</span></div><div class="casAuthors">Sakiyama, Yojiro; Yuki, Hitomi; Moriya, Takashi; Hattori, Kazunari; Suzuki, Misaki; Shimada, Kaoru; Honma, Teruki</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Graphics & Modelling</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">26</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">907-915</span>CODEN:
                <span class="NLM_cas:coden">JMGMFI</span>;
        ISSN:<span class="NLM_cas:issn">1093-3263</span>.
    
            (<span class="NLM_cas:orgname">Elsevier B.V.</span>)
        </div><div class="casAbstract">To ensure a continuing pipeline in pharmaceutical research, lead candidates must possess appropriate metabolic stability in the drug discovery process.  In vitro ADMET (absorption, distribution, metab., elimination, and toxicity) screening provides us with useful information regarding the metabolic stability of compds.  However, before the synthesis stage, an efficient process is required in order to deal with the vast quantity of data from large compd. libraries and high-throughput screening.  Here we have derived a relationship between the chem. structure and its metabolic stability for a data set of inhouse compds. by means of various in silico machine learning such as random forest, support vector machine (SVM), logistic regression, and recursive partitioning.  For model building, 1952 proprietary compds. comprising two classes (stable/unstable) were used with 193 descriptors calcd. by Mol. Operating Environment.  The results using test compds. have demonstrated that all classifiers yielded satisfactory results (accuracy > 0.8, sensitivity > 0.9, specificity > 0.6, and precision > 0.8).  Above all, classification by random forest as well as SVM yielded kappa values of approx. 0.7 in an independent validation set, slightly higher than other classification tools.  These results suggest that nonlinear/ensemble-based classification methods might prove useful in the area of in silico ADME modeling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpHqP0YZdkk8bVg90H21EOLACvtfcHk0ljy74RWD-VaMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXhsVOksL7K&md5=26a7b42e84a7d5f4fdc3ac42444c4dc2</span></div><a href="/servlet/linkout?suffix=cit17d&amp;dbid=16384&amp;doi=10.1016%2Fj.jmgm.2007.06.005&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmgm.2007.06.005%26sid%3Dliteratum%253Aachs%26aulast%3DSakiyama%26aufirst%3DY.%26aulast%3DYuki%26aufirst%3DH.%26aulast%3DMoriya%26aufirst%3DT.%26aulast%3DHattori%26aufirst%3DK.%26aulast%3DSuzuki%26aufirst%3DM.%26aulast%3DShimada%26aufirst%3DK.%26aulast%3DHonma%26aufirst%3DT.%26atitle%3DPredicting%2520human%2520liver%2520microsomal%2520stability%2520with%2520machine%2520learning%2520techniques%26jtitle%3DJ.%2520Mol.%2520Graphics%2520Modell.%26date%3D2008%26volume%3D26%26spage%3D907%26epage%3D915" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Langowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Long, A.</span><span> </span><span class="NLM_article-title">Computer systems for the prediction of xenobiotic metabolism</span> <span class="citation_source-journal">Adv. Drug Delivery Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">54</span><span class="NLM_x">, </span> <span class="NLM_fpage">407</span><span class="NLM_x">–</span> <span class="NLM_lpage">415</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17e&amp;dbid=16&amp;doi=10.1021%2Fjm4004895&amp;key=10.1016%2FS0169-409X%2802%2900011-X" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17e&amp;dbid=8&amp;doi=10.1021%2Fjm4004895&amp;key=11922955" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref17/cit17e&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BD38Xitlarurw%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=54&publication_year=2002&pages=407-415&author=J.+Langowskiauthor=A.+Long&title=Computer+systems+for+the+prediction+of+xenobiotic+metabolism"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17eR"><div class="casContent"><span class="casTitleNuber">17e</span><div class="casTitle"><span class="NLM_cas:atitle">Computer systems for the prediction of xenobiotic metabolism</span></div><div class="casAuthors">Langowski, Jan; Long, Anthony</div><div class="citationInfo"><span class="NLM_cas:title">Advanced Drug Delivery Reviews</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">54</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">407-415</span>CODEN:
                <span class="NLM_cas:coden">ADDREP</span>;
        ISSN:<span class="NLM_cas:issn">0169-409X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Science Ireland Ltd.</span>)
        </div><div class="casAbstract">A review.  The aim of pharmaceutical research and development is to ensure a continuing pipeline of new chem. entities (NCEs) displaying high therapeutic efficacy with few or no side effects.  Failure of promising lead candidates late in the drug discovery processes is regarded as com. unacceptable in today's increasingly competitive business environment.  An inappropriate ADME/Toxicity profile in humans is the major cause of failure of lead candidates in late clin. stages of drug development.  Combinatorial chem. techniques coupled with high throughput screening protocols means that pharmaceutical companies are now dealing with an unprecedented no. of NCEs on an annual basis.  As a consequence, screening for undesirable ADME/Toxicity properties in the early stages of drug development, preferably pre-synthesis, is now considered the essential paradigm.  In silico assessment of NCEs is rapidly emerging as the next wave of technol. for early ADME/Toxicity prediction.  In this review, we discuss the major com. available products for the assessing the potential metabolic activity of xenobiotic substances in mammalian systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr7VWmlpZzEN7Vg90H21EOLACvtfcHk0ljy74RWD-VaMA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38Xitlarurw%253D&md5=22cdfcc6286a06331b459ada2bdfb116</span></div><a href="/servlet/linkout?suffix=cit17e&amp;dbid=16384&amp;doi=10.1016%2FS0169-409X%2802%2900011-X&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252FS0169-409X%252802%252900011-X%26sid%3Dliteratum%253Aachs%26aulast%3DLangowski%26aufirst%3DJ.%26aulast%3DLong%26aufirst%3DA.%26atitle%3DComputer%2520systems%2520for%2520the%2520prediction%2520of%2520xenobiotic%2520metabolism%26jtitle%3DAdv.%2520Drug%2520Delivery%2520Rev.%26date%3D2002%26volume%3D54%26spage%3D407%26epage%3D415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17f"><span><span class="NLM_label">(f) </span>Pipeline Pilot, <span class="NLM_edition">v7.5</span>; <span class="NLM_publisher-name">Accelrys Inc.</span>: <span class="NLM_publisher-loc">San Diego, CA</span>; <a href="http://accelrys.com/products/pipeline-pilot/" class="extLink">http://accelrys.com/products/pipeline-pilot/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Pipeline+Pilot%2C+v7.5%3B+Accelrys+Inc.%3A+San+Diego%2C+CA%3B+http%3A%2F%2Faccelrys.com%2Fproducts%2Fpipeline-pilot%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17f&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcomputer-program%26sid%3Dliteratum%253Aachs%26jtitle%3DPipeline%2520Pilot%26pub%3DAccelrys%2520Inc" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Warmuth, M. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ratsch, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mathieson, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Putta, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lemmen, C.</span><span> </span><span class="NLM_article-title">Active learning with support vector machines in the drug discovery process</span> <span class="citation_source-journal">J. Chem. Inf. Comput. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2003</span><span class="NLM_x">, </span> <span class="NLM_volume">43</span><span class="NLM_x">, </span> <span class="NLM_fpage">667</span><span class="NLM_x">–</span> <span class="NLM_lpage">673</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci025620t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17g&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BD3sXhtVOjtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=43&publication_year=2003&pages=667-673&author=M.+K.+Warmuthauthor=J.+Liaoauthor=G.+Ratschauthor=M.+Mathiesonauthor=S.+Puttaauthor=C.+Lemmen&title=Active+learning+with+support+vector+machines+in+the+drug+discovery+process"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17gR"><div class="casContent"><span class="casTitleNuber">17g</span><div class="casTitle"><span class="NLM_cas:atitle">Active Learning with Support Vector Machines in the Drug Discovery Process</span></div><div class="casAuthors">Warmuth, Manfred K.; Liao, Jun; Raetsch, Gunnar; Mathieson, Michael; Putta, Santosh; Lemmen, Christian</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">2003</span>),
    <span class="NLM_cas:volume">43</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">667-673</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">We investigate the following data mining problem from computer-aided drug design: from a large collection of compds., find those that bind to a target mol. in as few iterations of biochem. testing as possible.  In each iteration a comparatively small batch of compds. is screened for binding activity toward this target.  We employed the so-called "active learning paradigm" from Machine Learning for selecting the successive batches.  Our main selection strategy is based on the max. margin hyperplane-generated by "Support Vector Machines".  This hyperplane separates the current set of active from the inactive compds. and has the largest possible distance from any labeled compd.  We perform a thorough comparative study of various other selection strategies on data sets provided by DuPont Pharmaceuticals and show that the strategies based on the max. margin hyperplane clearly outperform the simpler ones.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoHjRog0YMu-bVg90H21EOLACvtfcHk0liL0YFNytNzmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3sXhtVOjtbk%253D&md5=0b618cf608a54dbec37c820e7fdf1fab</span></div><a href="/servlet/linkout?suffix=cit17g&amp;dbid=16384&amp;doi=10.1021%2Fci025620t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci025620t%26sid%3Dliteratum%253Aachs%26aulast%3DWarmuth%26aufirst%3DM.%2BK.%26aulast%3DLiao%26aufirst%3DJ.%26aulast%3DRatsch%26aufirst%3DG.%26aulast%3DMathieson%26aufirst%3DM.%26aulast%3DPutta%26aufirst%3DS.%26aulast%3DLemmen%26aufirst%3DC.%26atitle%3DActive%2520learning%2520with%2520support%2520vector%2520machines%2520in%2520the%2520drug%2520discovery%2520process%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D2003%26volume%3D43%26spage%3D667%26epage%3D673" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">Ivanciuc, O.</span><span> </span><span class="NLM_article-title">Applications of support vector machines in chemistry</span> <span class="citation_source-journal">Rev. Comput. Chem</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">23</span><span class="NLM_x">, </span> <span class="NLM_fpage">291</span><span class="NLM_x">–</span> <span class="NLM_lpage">400</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref17/cit17h&amp;dbid=16&amp;doi=10.1021%2Fjm4004895&amp;key=10.1002%2F9780470116449.ch6" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref17/cit17h&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BD2sXisFWquro%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=23&publication_year=2007&pages=291-400&author=O.+Ivanciuc&title=Applications+of+support+vector+machines+in+chemistry"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17hR"><div class="casContent"><span class="casTitleNuber">17h</span><div class="casTitle"><span class="NLM_cas:atitle">Applications of support vector machines in chemistry</span></div><div class="casAuthors">Ivanciuc, Ovidiu</div><div class="citationInfo"><span class="NLM_cas:title">Reviews in Computational Chemistry</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">23</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">291-400</span>CODEN:
                <span class="NLM_cas:coden">RCCHEY</span>;
        ISSN:<span class="NLM_cas:issn">1069-3599</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH</span>)
        </div><div class="casAbstract">A review.  Kernel-based techniques (such as support vector machines, Bayes point machines, kernel principal component anal., and Gaussian processes) represent a major development in machine learning algorithms.  Support vector machines (SVM) are group of supervised learning methods that can be applied to classification or regression.  SVM find numerous applications in chem., such as drug design, quant. structure-activity relationship (QSAR), chemometrics, sensors (for prediction of sensor data), chem. engineering (fault detection and process modeling), and text mining (automatic recognition of scientific information).</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpUVx9qkWtwmLVg90H21EOLACvtfcHk0liL0YFNytNzmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXisFWquro%253D&md5=e03e7f81c77e322395ad747e917c3489</span></div><a href="/servlet/linkout?suffix=cit17h&amp;dbid=16384&amp;doi=10.1002%2F9780470116449.ch6&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252F9780470116449.ch6%26sid%3Dliteratum%253Aachs%26aulast%3DIvanciuc%26aufirst%3DO.%26atitle%3DApplications%2520of%2520support%2520vector%2520machines%2520in%2520chemistry%26jtitle%3DRev.%2520Comput.%2520Chem%26date%3D2007%26volume%3D23%26spage%3D291%26epage%3D400" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17i"><span><span class="NLM_label">(i) </span>R Project for Statistical Computing, (R-3.2.1); <a href="http://www.r-project.org/" class="extLink">www.r-project.org/</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=R+Project+for+Statistical+Computing%2C+%28R-3.2.1%29%3B+www.r-project.org%2F."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17i&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26jtitle%3DR%2520Project%2520for%2520Statistical%2520Computing%252C%2520%2528R-3.2.1%2529" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17j"><span><span class="NLM_label">(j) </span><span class="NLM_contrib-group">Ghose, A. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Viswanadhan, V. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wendoloski, J. J.</span><span> </span><span class="NLM_article-title">Prediction of hydrophobic (lipophilic) properties of small organic molecules using fragmental methods: an analysis of ALOGP and CLOGP methods</span> <span class="citation_source-journal">J. Phys. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">102</span><span class="NLM_x">, </span> <span class="NLM_fpage">3762</span><span class="NLM_x">–</span> <span class="NLM_lpage">3772</span></span><div class="citationLinks">[<a href="/doi/10.1021/jp980230o" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=102&publication_year=1998&pages=3762-3772&author=A.+K.+Ghoseauthor=V.+N.+Viswanadhanauthor=J.+J.+Wendoloski&title=Prediction+of+hydrophobic+%28lipophilic%29+properties+of+small+organic+molecules+using+fragmental+methods%3A+an+analysis+of+ALOGP+and+CLOGP+methods"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17j&amp;dbid=16384&amp;doi=10.1021%2Fjp980230o&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjp980230o%26sid%3Dliteratum%253Aachs%26aulast%3DGhose%26aufirst%3DA.%2BK.%26aulast%3DViswanadhan%26aufirst%3DV.%2BN.%26aulast%3DWendoloski%26aufirst%3DJ.%2BJ.%26atitle%3DPrediction%2520of%2520hydrophobic%2520%2528lipophilic%2529%2520properties%2520of%2520small%2520organic%2520molecules%2520using%2520fragmental%2520methods%253A%2520an%2520analysis%2520of%2520ALOGP%2520and%2520CLOGP%2520methods%26jtitle%3DJ.%2520Phys.%2520Chem.%26date%3D1998%26volume%3D102%26spage%3D3762%26epage%3D3772" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17k"><span><span class="NLM_label">(k) </span><span class="NLM_contrib-group">Hall, L. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kier, L. B.</span><span> </span><span class="NLM_article-title">The E-state as the basis for molecular structure space definition and structure similarity</span> <span class="citation_source-journal">J. Chem. Inf. Comput. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">40</span><span class="NLM_x">, </span> <span class="NLM_fpage">784</span><span class="NLM_x">–</span> <span class="NLM_lpage">791</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci990140w" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17k&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BD3cXitFCqt7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=40&publication_year=2000&pages=784-791&author=L.+H.+Hallauthor=L.+B.+Kier&title=The+E-state+as+the+basis+for+molecular+structure+space+definition+and+structure+similarity"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17kR"><div class="casContent"><span class="casTitleNuber">17k</span><div class="casTitle"><span class="NLM_cas:atitle">The E-state as the basis for molecular structure space definition and structure similarity</span></div><div class="casAuthors">Hall, Lowell H.; Kier, Lemont B.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">40</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">784-791</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The electrotopol. state (E-state) is presented as a representation of mol. structure useful for definition of a space for chem. structures.  This E-state representation provides the basis for chem. database management.  The E-state formalism is presented along with its extension to the atom-type E-state.  An approach to database organization, using polychlorobiphenyls as examples, reveals the descriptive power of the E-state paradigm.  A well-organized chem. database may be searched to find structures similar to a target structure with the expectation that such structures may exhibit properties similar to the target.  Searches using the atom-type E-state indexes are demonstrated with two example drug mols.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpWamwEV3jxR7Vg90H21EOLACvtfcHk0liL0YFNytNzmQ"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3cXitFCqt7k%253D&md5=6b8643b23ea396e9cbda90e2e489da26</span></div><a href="/servlet/linkout?suffix=cit17k&amp;dbid=16384&amp;doi=10.1021%2Fci990140w&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci990140w%26sid%3Dliteratum%253Aachs%26aulast%3DHall%26aufirst%3DL.%2BH.%26aulast%3DKier%26aufirst%3DL.%2BB.%26atitle%3DThe%2520E-state%2520as%2520the%2520basis%2520for%2520molecular%2520structure%2520space%2520definition%2520and%2520structure%2520similarity%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D2000%26volume%3D40%26spage%3D784%26epage%3D791" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17l"><span><span class="NLM_label">(l) </span><span class="NLM_contrib-group">Durant, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leland, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Henry, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nourse, J. G.</span><span> </span><span class="NLM_article-title">Reoptimization of MDL keys for use in drug discovery</span> <span class="citation_source-journal">J. Chem. Inf. Comput. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">42</span><span class="NLM_x">, </span> <span class="NLM_fpage">1273</span><span class="NLM_x">–</span> <span class="NLM_lpage">1280</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci010132r" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17l&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BD38XmvFKktLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=42&publication_year=2002&pages=1273-1280&author=J.+L.+Durantauthor=B.+A.+Lelandauthor=D.+R.+Henryauthor=J.+G.+Nourse&title=Reoptimization+of+MDL+keys+for+use+in+drug+discovery"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17lR"><div class="casContent"><span class="casTitleNuber">17l</span><div class="casTitle"><span class="NLM_cas:atitle">Reoptimization of MDL Keys for Use in Drug Discovery</span></div><div class="casAuthors">Durant, Joseph L.; Leland, Burton A.; Henry, Douglas R.; Nourse, James G.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">2002</span>),
    <span class="NLM_cas:volume">42</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">1273-1280</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">For a no. of years MDL products have exposed both 166 bit and 960 bit keysets based on 2D descriptors.  These keysets were originally constructed and optimized for substructure searching.  We report on improvements in the performance of MDL keysets which are reoptimized for use in mol. similarity.  Classification performance for a test data set of 957 compds. was increased from 0.65 for the 166 bit keyset and 0.67 for the 960 bit keyset to 0.71 for a surprisal S/N pruned keyset contg. 208 bits and 0.71 for a genetic algorithm optimized keyset contg. 548 bits.  We present an overview of the underlying technol. supporting the definition of descriptors and the encoding of these descriptors into keysets.  This technol. allows definition of descriptors as combinations of atom properties, bond properties, and at. neighborhoods at various topol. sepns. as well as supporting a no. of custom descriptors.  These descriptors can then be used to set one or more bits in a keyset.  We constructed various keysets and optimized their performance in clustering bioactive substances.  Performance was measured using methodol. developed by Briem and Lessel. "Directed pruning" was carried out by eliminating bits from the keysets on the basis of random selection, values of the surprisal of the bit, or values of the surprisal S/N ratio of the bit.  The random pruning expt. highlighted the insensitivity of keyset performance for keyset lengths of more than 1000 bits.  Contrary to initial expectations, pruning on the basis of the surprisal values of the various bits resulted in keysets which underperformed those resulting from random pruning.  In contrast, pruning on the basis of the surprisal S/N ratio was found to yield keysets which performed better than those resulting from random pruning.  We also explored the use of genetic algorithms in the selection of optimal keysets.  Once more the performance was only a weak function of keyset size, and the optimizations failed to identify a single globally optimal keyset.  Instead multiple, equally optimal keysets could be produced which had relatively low overlap of the descriptors they encoded.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrR2BdLvQ_QybVg90H21EOLACvtfcHk0ljYyF-ZfZWY6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD38XmvFKktLY%253D&md5=424323cf6bab93c4356ace7575d3f0ca</span></div><a href="/servlet/linkout?suffix=cit17l&amp;dbid=16384&amp;doi=10.1021%2Fci010132r&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci010132r%26sid%3Dliteratum%253Aachs%26aulast%3DDurant%26aufirst%3DJ.%2BL.%26aulast%3DLeland%26aufirst%3DB.%2BA.%26aulast%3DHenry%26aufirst%3DD.%2BR.%26aulast%3DNourse%26aufirst%3DJ.%2BG.%26atitle%3DReoptimization%2520of%2520MDL%2520keys%2520for%2520use%2520in%2520drug%2520discovery%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D2002%26volume%3D42%26spage%3D1273%26epage%3D1280" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17m"><span><span class="NLM_label">(m) </span><span class="NLM_contrib-group">Henry, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Durant, J. L.</span><span> </span><span class="NLM_article-title">Optimization of MDL substructure search keys for the prediction of activity and toxicity</span> <span class="citation_source-journal">Chemom. Chemoinf.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2005</span><span class="NLM_x">, </span> <span class="NLM_volume">894</span><span class="NLM_x">, </span> <span class="NLM_fpage">145</span><span class="NLM_x">–</span> <span class="NLM_lpage">156</span></span><div class="citationLinks">[<a href="/doi/10.1021/bk-2005-0894.ch010" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=894&publication_year=2005&pages=145-156&author=D.+R.+Henryauthor=J.+L.+Durant&title=Optimization+of+MDL+substructure+search+keys+for+the+prediction+of+activity+and+toxicity"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17m&amp;dbid=16384&amp;doi=10.1021%2Fbk-2005-0894.ch010&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fbk-2005-0894.ch010%26sid%3Dliteratum%253Aachs%26aulast%3DHenry%26aufirst%3DD.%2BR.%26aulast%3DDurant%26aufirst%3DJ.%2BL.%26atitle%3DOptimization%2520of%2520MDL%2520substructure%2520search%2520keys%2520for%2520the%2520prediction%2520of%2520activity%2520and%2520toxicity%26jtitle%3DChemom.%2520Chemoinf.%26date%3D2005%26volume%3D894%26spage%3D145%26epage%3D156" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17n"><span><span class="NLM_label">(n) </span><span class="NLM_contrib-group">Muchmore, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Edmunds, J. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stewart, K. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajduk, P. J.</span><span> </span><span class="NLM_article-title">Cheminformatic Tools for Medicinal Chemists</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">53</span><span class="NLM_x">, </span> <span class="NLM_fpage">4830</span><span class="NLM_x">–</span> <span class="NLM_lpage">4841</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm100164z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=53&publication_year=2010&pages=4830-4841&author=S.+W.+Muchmoreauthor=J.+J.+Edmundsauthor=K.+D.+Stewartauthor=P.+J.+Hajduk&title=Cheminformatic+Tools+for+Medicinal+Chemists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17n&amp;dbid=16384&amp;doi=10.1021%2Fjm100164z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm100164z%26sid%3Dliteratum%253Aachs%26aulast%3DMuchmore%26aufirst%3DS.%2BW.%26aulast%3DEdmunds%26aufirst%3DJ.%2BJ.%26aulast%3DStewart%26aufirst%3DK.%2BD.%26aulast%3DHajduk%26aufirst%3DP.%2BJ.%26atitle%3DCheminformatic%2520Tools%2520for%2520Medicinal%2520Chemists%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2010%26volume%3D53%26spage%3D4830%26epage%3D4841" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17o"><span><span class="NLM_label">(o) </span><span class="NLM_contrib-group">Rogers, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hahn, M.</span><span> </span><span class="NLM_article-title">Extended-Connectivity Fingerprints</span> <span class="citation_source-journal">J. Chem. Inf. Model.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">742</span><span class="NLM_x">–</span> <span class="NLM_lpage">754</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci100050t" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17o&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BC3cXlt1Onsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2010&pages=742-754&author=D.+Rogersauthor=M.+Hahn&title=Extended-Connectivity+Fingerprints"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17oR"><div class="casContent"><span class="casTitleNuber">17o</span><div class="casTitle"><span class="NLM_cas:atitle">Extended-Connectivity Fingerprints</span></div><div class="casAuthors">Rogers, David; Hahn, Mathew</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Modeling</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">50</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">742-754</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">1549-9596</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">Extended-connectivity fingerprints (ECFPs) are a novel class of topol. fingerprints for mol. characterization.  Historically, topol. fingerprints were developed for substructure and similarity searching.  ECFPs were developed specifically for structure-activity modeling.  ECFPs are circular fingerprints with a no. of useful qualities: they can be very rapidly calcd.; they are not predefined and can represent an essentially infinite no. of different mol. features (including stereochem. information); their features represent the presence of particular substructures, allowing easier interpretation of anal. results; and the ECFP algorithm can be tailored to generate different types of circular fingerprints, optimized for different uses.  While the use of ECFPs has been widely adopted and validated, a description of their implementation has not previously been presented in the literature.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGra43orI-Y7lbVg90H21EOLACvtfcHk0ljYyF-ZfZWY6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXlt1Onsbg%253D&md5=cd6c736cd7a3d280b67f5316acce8006</span></div><a href="/servlet/linkout?suffix=cit17o&amp;dbid=16384&amp;doi=10.1021%2Fci100050t&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci100050t%26sid%3Dliteratum%253Aachs%26aulast%3DRogers%26aufirst%3DD.%26aulast%3DHahn%26aufirst%3DM.%26atitle%3DExtended-Connectivity%2520Fingerprints%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Model.%26date%3D2010%26volume%3D50%26spage%3D742%26epage%3D754" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit17p"><span><span class="NLM_label">(p) </span><span class="NLM_contrib-group">Ortwine, D. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Aliagas, I.</span><span> </span><span class="NLM_article-title">Physicochemical and DMPK in silico models: facilitating their use by medicinal chemists</span> <span class="citation_source-journal">Mol. Pharmaceutics</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">1153</span><span class="NLM_x">–</span> <span class="NLM_lpage">1161</span></span><div class="citationLinks">[<a href="/doi/10.1021/mp3006193" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref17/cit17p&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BC3sXitlCisrc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2013&pages=1153-1161&author=D.+F.+Ortwineauthor=I.+Aliagas&title=Physicochemical+and+DMPK+in+silico+models%3A+facilitating+their+use+by+medicinal+chemists"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit17pR"><div class="casContent"><span class="casTitleNuber">17p</span><div class="casTitle"><span class="NLM_cas:atitle">Physicochemical and DMPK In Silico Models: Facilitating Their Use by Medicinal Chemists</span></div><div class="casAuthors">Ortwine, Daniel F.; Aliagas, Ignacio</div><div class="citationInfo"><span class="NLM_cas:title">Molecular Pharmaceutics</span>
        (<span class="NLM_cas:date">2013</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1153-1161</span>CODEN:
                <span class="NLM_cas:coden">MPOHBP</span>;
        ISSN:<span class="NLM_cas:issn">1543-8384</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A review.  It is known that the developability of drugs is related to their physicochem. and DMPK properties.  Given the time and expense involved in discovering and developing new drugs, maximizing the chance of success by calcg. properties ahead of chem. synthesis and testing, and only acting on those candidates whose properties fall into a desired range, would seem to make sense.  This paper provides an overview of calculable physicochem. and DMPK properties, an assessment of their relative difficulty of their calcn. and accuracy, and available software.  Methods companies have employed to communicate results will be discussed, including the use of composite scoring functions and ranking schemes.  Calcns. do no good if chemists will not use them to prioritize synthesis decisions.  Strategies are presented for facilitating model usage.  An approach adopted at Genentech for presenting results that involves the close coupling of property calcns. with 3D structure based drug design is described.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqr8BxpmosD5bVg90H21EOLACvtfcHk0ljYyF-ZfZWY6Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3sXitlCisrc%253D&md5=84324c98019337caa0570d6711d7877d</span></div><a href="/servlet/linkout?suffix=cit17p&amp;dbid=16384&amp;doi=10.1021%2Fmp3006193&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fmp3006193%26sid%3Dliteratum%253Aachs%26aulast%3DOrtwine%26aufirst%3DD.%2BF.%26aulast%3DAliagas%26aufirst%3DI.%26atitle%3DPhysicochemical%2520and%2520DMPK%2520in%2520silico%2520models%253A%2520facilitating%2520their%2520use%2520by%2520medicinal%2520chemists%26jtitle%3DMol.%2520Pharmaceutics%26date%3D2013%26volume%3D10%26spage%3D1153%26epage%3D1161" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Williams, N. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bamert, R. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patel, O.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Walden, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wilks, A. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fantino, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rossjohn, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lucet, I. S.</span><span> </span><span class="NLM_article-title">Dissecting specificity in the Janus kinases: the structures of JAK-specific inhibitors complexed to the JAK1 and JAK2 protein tyrosine kinase domains</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">387</span><span class="NLM_x">, </span> <span class="NLM_fpage">219</span><span class="NLM_x">–</span> <span class="NLM_lpage">232</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=16&amp;doi=10.1021%2Fjm4004895&amp;key=10.1016%2Fj.jmb.2009.01.041" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=8&amp;doi=10.1021%2Fjm4004895&amp;key=19361440" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref18/cit18&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BD1MXivVegtbo%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=387&publication_year=2009&pages=219-232&author=N.+K.+Williamsauthor=R.+S.+Bamertauthor=O.+Patelauthor=C.+Wangauthor=P.+M.+Waldenauthor=A.+F.+Wilksauthor=E.+Fantinoauthor=J.+Rossjohnauthor=I.+S.+Lucet&title=Dissecting+specificity+in+the+Janus+kinases%3A+the+structures+of+JAK-specific+inhibitors+complexed+to+the+JAK1+and+JAK2+protein+tyrosine+kinase+domains"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit18R"><div class="casContent"><span class="casTitleNuber">18</span><div class="casTitle"><span class="NLM_cas:atitle">Dissecting Specificity in the Janus Kinases: The Structures of JAK-Specific Inhibitors Complexed to the JAK1 and JAK2 Protein Tyrosine Kinase Domains</span></div><div class="casAuthors">Williams, Neal K.; Bamert, Rebecca S.; Patel, Onisha; Wang, Christina; Walden, Patricia M.; Wilks, Andrew F.; Fantino, Emmanuelle; Rossjohn, Jamie; Lucet, Isabelle S.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">387</span>
        (<span class="NLM_cas:issue">1</span>),
    <span class="NLM_cas:pages">219-232</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">The Janus kinases (JAKs) are a pivotal family of protein tyrosine kinases (PTKs) that play prominent roles in numerous cytokine signaling pathways, with aberrant JAK activity assocd. with a variety of hematopoietic malignancies, cardiovascular diseases and immune-related disorders.  Whereas the structures of the JAK2 and JAK3 PTK domains have been detd., the structure of the JAK1 PTK domain is unknown.  Here, we report the high-resoln. crystal structures of the "active form" of the JAK1 PTK domain in complex with two JAK inhibitors, a tetracyclic pyridone 2-t-butyl-9-fluoro-3,6-dihydro-7H-benz[h]-imidaz[4,5-f]isoquinoline-7-one (CMP6) and (3R,4R)-3-[4-methyl-3-[N-methyl-N-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropionitrile (CP-690,550), and compare them with the corresponding JAK2 PTK inhibitor complexes.  Both inhibitors bound in a similar manner to JAK1, namely buried deep within a constricted ATP-binding site, thereby providing a basis for the potent inhibition of JAK1.  As expected, the mode of inhibitor binding in JAK1 was very similar to that obsd. in JAK2, highlighting the challenges in developing JAK-specific inhibitors that target the ATP-binding site.  Nevertheless, differences surrounding the JAK1 and JAK2 ATP-binding sites were apparent, thereby providing a platform for the rational design of JAK2- and JAK1-specific inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGpQDLkMkCgiLbVg90H21EOLACvtfcHk0li5XKex5OdVUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXivVegtbo%253D&md5=79957755d04323057b5acf7e9d2c56ca</span></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2009.01.041&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2009.01.041%26sid%3Dliteratum%253Aachs%26aulast%3DWilliams%26aufirst%3DN.%2BK.%26aulast%3DBamert%26aufirst%3DR.%2BS.%26aulast%3DPatel%26aufirst%3DO.%26aulast%3DWang%26aufirst%3DC.%26aulast%3DWalden%26aufirst%3DP.%2BM.%26aulast%3DWilks%26aufirst%3DA.%2BF.%26aulast%3DFantino%26aufirst%3DE.%26aulast%3DRossjohn%26aufirst%3DJ.%26aulast%3DLucet%26aufirst%3DI.%2BS.%26atitle%3DDissecting%2520specificity%2520in%2520the%2520Janus%2520kinases%253A%2520the%2520structures%2520of%2520JAK-specific%2520inhibitors%2520complexed%2520to%2520the%2520JAK1%2520and%2520JAK2%2520protein%2520tyrosine%2520kinase%2520domains%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2009%26volume%3D387%26spage%3D219%26epage%3D232" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Chrencik, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Patny, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leung, I. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Korniski, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Emmons, T. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hall, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Weinberg, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gormley, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Day, J. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hirsch, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kiefer, J. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Leone, J. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischer, H. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sommers, C. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, H. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jacobsen, E. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tenbrink, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tomasselli, A. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Benson, T. E.</span><span> </span><span class="NLM_article-title">Structural and thermodynamic characterization of the TYK2 and JAK3 kinase domains in complex with CP-690550 and CMP-6</span> <span class="citation_source-journal">J. Mol. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">400</span><span class="NLM_x">, </span> <span class="NLM_fpage">413</span><span class="NLM_x">–</span> <span class="NLM_lpage">433</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=16&amp;doi=10.1021%2Fjm4004895&amp;key=10.1016%2Fj.jmb.2010.05.020" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=8&amp;doi=10.1021%2Fjm4004895&amp;key=20478313" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref19/cit19&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BC3cXos1ylt7g%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=400&publication_year=2010&pages=413-433&author=J.+E.+Chrencikauthor=A.+Patnyauthor=I.+K.+Leungauthor=B.+Korniskiauthor=T.+L.+Emmonsauthor=T.+Hallauthor=R.+A.+Weinbergauthor=J.+A.+Gormleyauthor=J.+M.+Williamsauthor=J.+E.+Dayauthor=J.+L.+Hirschauthor=J.+R.+Kieferauthor=J.+W.+Leoneauthor=H.+D.+Fischerauthor=C.+D.+Sommersauthor=H.+C.+Huangauthor=E.+J.+Jacobsenauthor=R.+E.+Tenbrinkauthor=A.+G.+Tomasselliauthor=T.+E.+Benson&title=Structural+and+thermodynamic+characterization+of+the+TYK2+and+JAK3+kinase+domains+in+complex+with+CP-690550+and+CMP-6"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit19R"><div class="casContent"><span class="casTitleNuber">19</span><div class="casTitle"><span class="NLM_cas:atitle">Structural and Thermodynamic Characterization of the TYK2 and JAK3 Kinase Domains in Complex with CP-690550 and CMP-6</span></div><div class="casAuthors">Chrencik, Jill E.; Patny, Akshay; Leung, Iris K.; Korniski, Brian; Emmons, Thomas L.; Hall, Troii; Weinberg, Robin A.; Gormley, Jennifer A.; Williams, Jennifer M.; Day, Jacqueline E.; Hirsch, Jeffrey L.; Kiefer, James R.; Leone, Joseph W.; Fischer, H. David; Sommers, Cynthia D.; Huang, Horng-Chih; Jacobsen, E. J.; Tenbrink, Ruth E.; Tomasselli, Alfredo G.; Benson, Timothy E.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Molecular Biology</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">400</span>
        (<span class="NLM_cas:issue">3</span>),
    <span class="NLM_cas:pages">413-433</span>CODEN:
                <span class="NLM_cas:coden">JMOBAK</span>;
        ISSN:<span class="NLM_cas:issn">0022-2836</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Janus kinases (JAKs) are crit. regulators of cytokine pathways and attractive targets of therapeutic value in both inflammatory and myeloproliferative diseases.  Although the crystal structures of active JAK1 and JAK2 kinase domains have been reported recently with the clin. compd. CP-690550, the structures of both TYK2 and JAK3 with CP-690550 have remained outstanding.  Here, we report the crystal structures of TYK2, a first in class structure, and JAK3 in complex with PAN-JAK inhibitors CP-690550 ((3R,4R)-3-[4-methyl-3-[N-methyl-N-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)amino]piperidin-1-yl]-3-oxopropionitrile) and CMP-6 (tetracyclic pyridone 2-t-butyl-9-fluoro-3,6-dihydro-7H-benz[h]-imidaz[4,5-f]isoquinoline-7-one), both of which bind in the ATP-binding cavities of both JAK isoenzymes in orientations similar to that obsd. in crystal structures of JAK1 and JAK2.  Addnl., a complete thermodn. characterization of JAK/CP-690550 complex formation was completed by isothermal titrn. calorimetry, indicating the crit. role of the nitrile group from the CP-690550 compd.  Finally, computational anal. using WaterMap further highlights the crit. positioning of the CP-690550 nitrile group in the displacement of an unfavorable water mol. beneath the glycine-rich loop.  Taken together, the data emphasize the outstanding properties of the kinome-selective JAK inhibitor CP-690550, as well as the challenges in obtaining JAK isoenzyme-selective inhibitors due to the overall structural and sequence similarities between the TYK2, JAK1, JAK2 and JAK3 isoenzymes.  Nevertheless, subtle amino acid variations of residues lining the ligand-binding cavity of the JAK enzymes, as well as the global positioning of the glycine-rich loop, might provide the initial clues to obtaining JAK-isoenzyme selective inhibitors.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGp5dnGkvq0jPbVg90H21EOLACvtfcHk0li5XKex5OdVUA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXos1ylt7g%253D&md5=1b1efc3d6f913143dc9113e4ac1c4c60</span></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1016%2Fj.jmb.2010.05.020&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.jmb.2010.05.020%26sid%3Dliteratum%253Aachs%26aulast%3DChrencik%26aufirst%3DJ.%2BE.%26aulast%3DPatny%26aufirst%3DA.%26aulast%3DLeung%26aufirst%3DI.%2BK.%26aulast%3DKorniski%26aufirst%3DB.%26aulast%3DEmmons%26aufirst%3DT.%2BL.%26aulast%3DHall%26aufirst%3DT.%26aulast%3DWeinberg%26aufirst%3DR.%2BA.%26aulast%3DGormley%26aufirst%3DJ.%2BA.%26aulast%3DWilliams%26aufirst%3DJ.%2BM.%26aulast%3DDay%26aufirst%3DJ.%2BE.%26aulast%3DHirsch%26aufirst%3DJ.%2BL.%26aulast%3DKiefer%26aufirst%3DJ.%2BR.%26aulast%3DLeone%26aufirst%3DJ.%2BW.%26aulast%3DFischer%26aufirst%3DH.%2BD.%26aulast%3DSommers%26aufirst%3DC.%2BD.%26aulast%3DHuang%26aufirst%3DH.%2BC.%26aulast%3DJacobsen%26aufirst%3DE.%2BJ.%26aulast%3DTenbrink%26aufirst%3DR.%2BE.%26aulast%3DTomasselli%26aufirst%3DA.%2BG.%26aulast%3DBenson%26aufirst%3DT.%2BE.%26atitle%3DStructural%2520and%2520thermodynamic%2520characterization%2520of%2520the%2520TYK2%2520and%2520JAK3%2520kinase%2520domains%2520in%2520complex%2520with%2520CP-690550%2520and%2520CMP-6%26jtitle%3DJ.%2520Mol.%2520Biol.%26date%3D2010%26volume%3D400%26spage%3D413%26epage%3D433" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><div class="note"><p class="first last">The maximum achievable oral bioavailability (<i>F</i><sub>max</sub>) is the product of the fraction absorbed (<i>F</i><sub>a</sub>), the fraction escaping intestinal metabolism (<i>F</i><sub>g</sub>), and the fraction escaping hepatic metabolism (<i>F</i><sub>h</sub>), as expressed by the equation: <i>F</i><sub>max</sub> = <i>F</i><sub>a</sub>·<i>F</i><sub>g</sub>·<i>F</i><sub>h</sub>. Assuming a best case scenario of no intestinal wall metabolism, and complete absorption of the oral dose (<i>F</i><sub>g</sub> and <i>F</i><sub>a</sub> = 1), the equation is simplified to <i>F</i><sub>max</sub> = <i>F</i><sub>h</sub>. Because <i>F</i><sub>h</sub> = 1 – CL/<i>Q</i><sub>h</sub>, where CL is clearance and <i>Q</i><sub>h</sub> is hepatic blood flow, it is apparent that the maximum achievable bioavailability should be controlled by clearance according to the equation: <i>F</i><sub>max</sub> = 1 – CL/<i>Q</i><sub>h</sub>. Hepatic blood flows of 70, 31, and 44 mL min<sup>–1</sup> kg<sup>–1</sup> were used for rat, dog, and cyno <i>F</i><sub>max</sub> calculations, respectively. See:</p></div><span class="NLM_contrib-group">Rautio, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kumpulainen, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heimbach, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oliyai, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Oh, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Järvinen, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Savolainen, J.</span><span> </span><span class="NLM_article-title">Prodrugs: design and clinical applications</span> <span class="citation_source-journal">Nature Rev. Drug Discovery</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">7</span><span class="NLM_x">, </span> <span class="NLM_fpage">255</span><span class="NLM_x">–</span> <span class="NLM_lpage">270</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=7&publication_year=2008&pages=255-270&author=J.+Rautioauthor=H.+Kumpulainenauthor=T.+Heimbachauthor=R.+Oliyaiauthor=D.+Ohauthor=T.+J%C3%A4rvinenauthor=J.+Savolainen&title=Prodrugs%3A+design+and+clinical+applications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DRautio%26aufirst%3DJ.%26aulast%3DKumpulainen%26aufirst%3DH.%26aulast%3DHeimbach%26aufirst%3DT.%26aulast%3DOliyai%26aufirst%3DR.%26aulast%3DOh%26aufirst%3DD.%26aulast%3DJ%25C3%25A4rvinen%26aufirst%3DT.%26aulast%3DSavolainen%26aufirst%3DJ.%26atitle%3DProdrugs%253A%2520design%2520and%2520clinical%2520applications%26jtitle%3DNature%2520Rev.%2520Drug%2520Discovery%26date%3D2008%26volume%3D7%26spage%3D255%26epage%3D270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="note"><p class="first last">Detailed experimental procedures were previously published in ref <a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">7</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref22"><div class="reference"><strong class="refLabel"><a href="#ref22" class="rightTabRefNumLink">22</a></strong><div class="NLM_citation" id="rightTab-cit22"><span><span class="NLM_contrib-group">Meerwein, H.</span><span> </span><span class="NLM_article-title">Triethyloxonium fluoroborate</span>.  <span class="citation_source-journal">Org. Synth.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1973</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">1080</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=1973&pages=1080&author=H.+Meerwein&title=Triethyloxonium+fluoroborate"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit22&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DMeerwein%26aufirst%3DH.%26atitle%3DTriethyloxonium%2520fluoroborate%26jtitle%3DOrg.%2520Synth.%26date%3D1973%26volume%3D5%26spage%3D1080" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref23"><div class="reference"><strong class="refLabel"><a href="#ref23" class="rightTabRefNumLink">23</a></strong><div class="NLM_citation" id="rightTab-cit23a"><span><span class="NLM_label">(a) </span><div class="note"><p class="first last">In some instances when the imidate formation with triethyloxonium tetrafluoroborate was performed in THF, polymerization of the solvent occurred to form a viscous mass and the reaction could not be continued. Similar observations were previously reported:</p></div><span class="NLM_contrib-group">Vartak, A. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Crooks, P. A.</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">13</span><span class="NLM_x">, </span> <span class="NLM_fpage">415</span></span><div class="citationLinks">[<a href="/doi/10.1021/op8002689" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=In+some+instances+when+the+imidate+formation+with+triethyloxonium+tetrafluoroborate+was+performed+in+THF%2C+polymerization+of+the+solvent+occurred+to+form+a+viscous+mass+and+the+reaction+could+not+be+continued.+Similar+observations+were+previously+reported%3AVartak%2C+A.+P.%3B+Crooks%2C+P.+A.Org.+Process+Res.+Dev.+2009%2C+13%2C+415"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit23a&amp;dbid=16384&amp;doi=10.1021%2Fop8002689&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop8002689%26sid%3Dliteratum%253Aachs%26aulast%3DVartak%26aufirst%3DA.%2BP.%26aulast%3DCrooks%26aufirst%3DP.%2BA.%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2009%26volume%3D13%26spage%3D415" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit23b"><span><span class="NLM_label">(b) </span><div class="note"><p class="first last">Imidate formation can also be carried out in DCM:</p></div><span class="NLM_contrib-group">Kiessling, A. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McClure, C. K.</span> <span class="citation_source-journal">Synth. Commun.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1997</span><span class="NLM_x">, </span> <span class="NLM_volume">27</span><span class="NLM_x">, </span> <span class="NLM_fpage">923</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=16&amp;doi=10.1021%2Fjm4004895&amp;key=10.1080%2F00397919708004212" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref23/cit23b&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADyaK2sXhsVKhs7w%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=Imidate+formation+can+also+be+carried+out+in+DCM%3AKiessling%2C+A.+J.%3B+McClure%2C+C.+K.Synth.+Commun.+1997%2C+27%2C+923"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit23bR"><div class="casContent"><span class="casTitleNuber">23b</span><div class="casTitle"><span class="NLM_cas:atitle">The conversion of amides to esters with Meerwein's reagent. Application to the synthesis of a carfentanil precursor</span></div><div class="casAuthors">Kiessling, Anthony J.; McClure, Cynthia K.</div><div class="citationInfo"><span class="NLM_cas:title">Synthetic Communications</span>
        (<span class="NLM_cas:date">1997</span>),
    <span class="NLM_cas:volume">27</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">923-937</span>CODEN:
                <span class="NLM_cas:coden">SYNCAV</span>;
        ISSN:<span class="NLM_cas:issn">0039-7911</span>.
    
            (<span class="NLM_cas:orgname">Dekker</span>)
        </div><div class="casAbstract">An efficient two step transformation of 1° and 2° amides to Me and Et esters has been developed using trimethyl- and triethyloxonium tetrafluoroborates and dil. acid.  This methodol. was applied to 1-benzyl-4-phenylamino-4-piperidinecarboxamide, a precursor in the synthesis of carfentanil, to produce the Me ester in 60% yield and the Et ester in 80% yield.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrpYd1ptRbsPrVg90H21EOLACvtfcHk0ljoLNUlteNM0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2sXhsVKhs7w%253D&md5=5fbc207d2766914932d48fec7cfeed5e</span></div><a href="/servlet/linkout?suffix=cit23b&amp;dbid=16384&amp;doi=10.1080%2F00397919708004212&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1080%252F00397919708004212%26sid%3Dliteratum%253Aachs%26aulast%3DKiessling%26aufirst%3DA.%2BJ.%26aulast%3DMcClure%26aufirst%3DC.%2BK.%26jtitle%3DSynth.%2520Commun.%26date%3D1997%26volume%3D27%26spage%3D923" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref24"><div class="reference"><strong class="refLabel"><a href="#ref24" class="rightTabRefNumLink">24</a></strong><div class="NLM_citation" id="rightTab-cit24"><span><span class="NLM_contrib-group">Clososki, G. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rohbogner, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Knochel, P.</span><span> </span><span class="NLM_article-title">Direct Magnesiation of Polyfunctionalized Arenes and Heteroarenes Using (tmp)<sub>2</sub>Mg·2LiCl</span> <span class="citation_source-journal">Angew. Chem., Int. Ed.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">46</span><span class="NLM_x">, </span> <span class="NLM_fpage">7681</span><span class="NLM_x">–</span> <span class="NLM_lpage">7684</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=16&amp;doi=10.1021%2Fjm4004895&amp;key=10.1002%2Fanie.200701487" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref24/cit24&amp;dbid=32&amp;doi=10.1021%2Fjm4004895&amp;key=1%3ACAS%3A528%3ADC%252BD2sXht1Sis7%252FJ" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=46&publication_year=2007&pages=7681-7684&author=G.+C.+Clososkiauthor=C.+J.+Rohbognerauthor=P.+Knochel&title=Direct+Magnesiation+of+Polyfunctionalized+Arenes+and+Heteroarenes+Using+%28tmp%292Mg%C2%B72LiCl"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit24R"><div class="casContent"><span class="casTitleNuber">24</span><div class="casTitle"><span class="NLM_cas:atitle">Direct magnesiation of polyfunctionalized arenes and heteroarenes using (tmp)2Mg·2LiCl</span></div><div class="casAuthors">Clososki, Giuliano C.; Rohbogner, Christoph J.; Knochel, Paul</div><div class="citationInfo"><span class="NLM_cas:title">Angewandte Chemie, International Edition</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">46</span>
        (<span class="NLM_cas:issue">40</span>),
    <span class="NLM_cas:pages">7681-7684</span>CODEN:
                <span class="NLM_cas:coden">ACIEF5</span>;
        ISSN:<span class="NLM_cas:issn">1433-7851</span>.
    
            (<span class="NLM_cas:orgname">Wiley-VCH Verlag GmbH & Co. KGaA</span>)
        </div><div class="casAbstract">Outstripping lithium bases: A wide range of polyfunctional aryl and heteroaryl magnesium reagents were efficiently prepd. in THF by direct magnesiation with (tmp)2Mg·2 LiCl, an exceptionally active base.  These compds. can serve as intermediates in natural product synthesis.  In an example, a palladium-catalyzed cross-coupling reaction is used to prep. a deriv. of salicylic acid.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGopEYCo4TfzVLVg90H21EOLACvtfcHk0ljoLNUlteNM0w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXht1Sis7%252FJ&md5=5ce38a6493e68eba86e153bc744b61c5</span></div><a href="/servlet/linkout?suffix=cit24&amp;dbid=16384&amp;doi=10.1002%2Fanie.200701487&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1002%252Fanie.200701487%26sid%3Dliteratum%253Aachs%26aulast%3DClososki%26aufirst%3DG.%2BC.%26aulast%3DRohbogner%26aufirst%3DC.%2BJ.%26aulast%3DKnochel%26aufirst%3DP.%26atitle%3DDirect%2520Magnesiation%2520of%2520Polyfunctionalized%2520Arenes%2520and%2520Heteroarenes%2520Using%2520%2528tmp%25292Mg%25C2%25B72LiCl%26jtitle%3DAngew.%2520Chem.%252C%2520Int.%2520Ed.%26date%3D2007%26volume%3D46%26spage%3D7681%26epage%3D7684" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref25"><div class="reference"><strong class="refLabel"><a href="#ref25" class="rightTabRefNumLink">25</a></strong><div class="note"><p class="first last">All amines were either purchased from commercial sources, synthesized as described in the references in the <a class="ref internalNav" href="#sec5" aria-label="Experimental Section">Experimental Section</a> or synthesized by the methods in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref26"><div class="reference"><strong class="refLabel"><a href="#ref26" class="rightTabRefNumLink">26</a></strong><div class="NLM_citation" id="rightTab-cit26"><span><span class="NLM_contrib-group">Broo, A.; Holm, P.; Judkins, R.; Li, L.; Lindstedt-Alstermark, E.; Sandberg, P.; Swanson, M.; Weidolf, L.; Mrickmann, K.</span><span> </span><span class="NLM_article-title">Non-anilinic derivatives of isothiazol-3(2<i>H</i>)-one 1,2-dioxides as Liver X receptor modulators</span>. WO2006073366,<span class="NLM_x"> </span><span class="NLM_year">2006</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2006&author=A.+Broo&author=P.+Holm&author=R.+Judkins&author=L.+Li&author=E.+Lindstedt-Alstermark&author=P.+Sandberg&author=M.+Swanson&author=L.+Weidolf&author=K.+Mrickmann&title=Non-anilinic+derivatives+of+isothiazol-3%282H%29-one+1%2C2-dioxides+as+Liver+X+receptor+modulators"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit26&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DBroo%26aufirst%3DA.%26atitle%3DNon-anilinic%2520derivatives%2520of%2520isothiazol-3%25282H%2529-one%25201%252C2-dioxides%2520as%2520Liver%2520X%2520receptor%2520modulators%26date%3D2006" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref27"><div class="reference"><strong class="refLabel"><a href="#ref27" class="rightTabRefNumLink">27</a></strong><div class="note"><p class="first last">Prepared as described in the <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>.</p></div><div class="citationLinks"><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div></div></div></li><li id="rightTab-ref28"><div class="reference"><strong class="refLabel"><a href="#ref28" class="rightTabRefNumLink">28</a></strong><div class="NLM_citation" id="rightTab-cit28"><span><span class="NLM_contrib-group">Savage, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Babu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mao, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cao, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ge, Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ma, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Jiang, G.</span><span> </span><span class="NLM_article-title">Kilogram synthesis of (<i>S</i>)-3-aminopyran from <span class="smallcaps smallerCapital">l</span>-glutamic acid</span> <span class="citation_source-journal">Synlett</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2013</span><span class="NLM_x">, </span> <span class="NLM_volume">24</span><span class="NLM_x">, </span> <span class="NLM_fpage">987</span><span class="NLM_x">–</span> <span class="NLM_lpage">990</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=24&publication_year=2013&pages=987-990&author=S.+Savageauthor=S.+Babuauthor=M.+Zakauthor=Z.+Maoauthor=J.+Caoauthor=Y.+Geauthor=D.+Maauthor=G.+Jiang&title=Kilogram+synthesis+of+%28S%29-3-aminopyran+from+l-glutamic+acid"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit28&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSavage%26aufirst%3DS.%26aulast%3DBabu%26aufirst%3DS.%26aulast%3DZak%26aufirst%3DM.%26aulast%3DMao%26aufirst%3DZ.%26aulast%3DCao%26aufirst%3DJ.%26aulast%3DGe%26aufirst%3DY.%26aulast%3DMa%26aufirst%3DD.%26aulast%3DJiang%26aufirst%3DG.%26atitle%3DKilogram%2520synthesis%2520of%2520%2528S%2529-3-aminopyran%2520from%2520l-glutamic%2520acid%26jtitle%3DSynlett%26date%3D2013%26volume%3D24%26spage%3D987%26epage%3D990" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref29"><div class="reference"><strong class="refLabel"><a href="#ref29" class="rightTabRefNumLink">29</a></strong><div class="NLM_citation" id="rightTab-cit29"><span><span class="NLM_contrib-group">Brocklehurst, C. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Laumen, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">La Vecchia, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shaw, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vögtle, M.</span><span> </span><span class="NLM_article-title">Diastereoisomeric salt formation and enzyme-catalyzed kinetic resolution as complementary methods for the chiral separation of <i>cis</i>-/<i>trans</i>-enantiomers of 3-aminocyclohexanol</span> <span class="citation_source-journal">Org. Process Res. Dev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">15</span><span class="NLM_x">, </span> <span class="NLM_fpage">294</span><span class="NLM_x">–</span> <span class="NLM_lpage">300</span></span><div class="citationLinks">[<a href="/doi/10.1021/op1002424" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=15&publication_year=2011&pages=294-300&author=C.+E.+Brocklehurstauthor=K.+Laumenauthor=L.+La+Vecchiaauthor=D.+Shawauthor=M.+V%C3%B6gtle&title=Diastereoisomeric+salt+formation+and+enzyme-catalyzed+kinetic+resolution+as+complementary+methods+for+the+chiral+separation+of+cis-%2Ftrans-enantiomers+of+3-aminocyclohexanol"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit29&amp;dbid=16384&amp;doi=10.1021%2Fop1002424&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fop1002424%26sid%3Dliteratum%253Aachs%26aulast%3DBrocklehurst%26aufirst%3DC.%2BE.%26aulast%3DLaumen%26aufirst%3DK.%26aulast%3DLa%2BVecchia%26aufirst%3DL.%26aulast%3DShaw%26aufirst%3DD.%26aulast%3DV%25C3%25B6gtle%26aufirst%3DM.%26atitle%3DDiastereoisomeric%2520salt%2520formation%2520and%2520enzyme-catalyzed%2520kinetic%2520resolution%2520as%2520complementary%2520methods%2520for%2520the%2520chiral%2520separation%2520of%2520cis-%252Ftrans-enantiomers%2520of%25203-aminocyclohexanol%26jtitle%3DOrg.%2520Process%2520Res.%2520Dev.%26date%3D2011%26volume%3D15%26spage%3D294%26epage%3D300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref30"><div class="reference"><strong class="refLabel"><a href="#ref30" class="rightTabRefNumLink">30</a></strong><div class="NLM_citation" id="rightTab-cit30"><span><span class="NLM_contrib-group">Sekiguchi, Y.; Kanuma, K.; Omodera, K.; Busujima, T.; Tran, T.; Han, S.; Casper, M.; Kramer, B. A.; Semple, G.; Zou, N.</span><span> </span><span class="NLM_article-title">Quinoline, tetrahydroquinoline and pyrimidine derivatives as MCH antagonist</span>. EP1464335,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=Y.+Sekiguchi&author=K.+Kanuma&author=K.+Omodera&author=T.+Busujima&author=T.+Tran&author=S.+Han&author=M.+Casper&author=B.+A.+Kramer&author=G.+Semple&author=N.+Zou&title=Quinoline%2C+tetrahydroquinoline+and+pyrimidine+derivatives+as+MCH+antagonist"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit30&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSekiguchi%26aufirst%3DY.%26atitle%3DQuinoline%252C%2520tetrahydroquinoline%2520and%2520pyrimidine%2520derivatives%2520as%2520MCH%2520antagonist%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref31"><div class="reference"><strong class="refLabel"><a href="#ref31" class="rightTabRefNumLink">31</a></strong><div class="NLM_citation" id="rightTab-cit31"><span><span class="NLM_contrib-group">Sekiguchi, Y.i; Kanuma, K.; Omodera, K.; Busujima, T.; Tran, T.; Han, S.; Casper, M.; Kramer, B. A.</span><span> </span><span class="NLM_article-title">Preparation of novel quinazolines as MCH receptor antagonists</span>. WO2004087680,<span class="NLM_x"> </span><span class="NLM_year">2004</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2004&author=Y.i+Sekiguchi&author=K.+Kanuma&author=K.+Omodera&author=T.+Busujima&author=T.+Tran&author=S.+Han&author=M.+Casper&author=B.+A.+Kramer&title=Preparation+of+novel+quinazolines+as+MCH+receptor+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit31&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DSekiguchi%26aufirst%3DY.i%26atitle%3DPreparation%2520of%2520novel%2520quinazolines%2520as%2520MCH%2520receptor%2520antagonists%26date%3D2004" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref32"><div class="reference"><strong class="refLabel"><a href="#ref32" class="rightTabRefNumLink">32</a></strong><div class="NLM_citation" id="rightTab-cit32"><span><span class="NLM_contrib-group">Thompson, W.; Young, S. D.; Phillips, B. T.; Munson, P.; Whitter, W.; Liverton, N.; Dieckhaus, C.; Butcher, J.; Mccauley, J. A.; Mcintyre, C. J.; Layton, M. E.; Sanderson, P. E.</span><span> </span><span class="NLM_article-title">4-Cycloalkylaminopyrazolopyrimidine NMDA/NR2B antagonists</span>. US20050054658.<span class="NLM_x"> </span><span class="NLM_year">2005</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2005&author=W.+Thompson&author=S.+D.+Young&author=B.+T.+Phillips&author=P.+Munson&author=W.+Whitter&author=N.+Liverton&author=C.+Dieckhaus&author=J.+Butcher&author=J.+A.+Mccauley&author=C.+J.+Mcintyre&author=M.+E.+Layton&author=P.+E.+Sanderson&title=4-Cycloalkylaminopyrazolopyrimidine+NMDA%2FNR2B+antagonists"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit32&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DThompson%26aufirst%3DW.%26atitle%3D4-Cycloalkylaminopyrazolopyrimidine%2520NMDA%252FNR2B%2520antagonists%26date%3D2005" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref33"><div class="reference"><strong class="refLabel"><a href="#ref33" class="rightTabRefNumLink">33</a></strong><div class="NLM_citation" id="rightTab-cit33"><span><span class="NLM_contrib-group">Aahlin, K.; Arvidsson, P. I.; Besidski, Y.; Nilsson, L. I.</span><span> </span><span class="NLM_article-title">Preparation of cyano group containing isoindoline derivatives for treating pain disorders</span>. WO2009145719,<span class="NLM_x"> </span><span class="NLM_year">2009</span>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2009&author=K.+Aahlin&author=P.+I.+Arvidsson&author=Y.+Besidski&author=L.+I.+Nilsson&title=Preparation+of+cyano+group+containing+isoindoline+derivatives+for+treating+pain+disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit33&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dpatent%26sid%3Dliteratum%253Aachs%26aulast%3DAahlin%26aufirst%3DK.%26atitle%3DPreparation%2520of%2520cyano%2520group%2520containing%2520isoindoline%2520derivatives%2520for%2520treating%2520pain%2520disorders%26date%3D2009" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EHZ" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EHZ','PDB','4EHZ'); return false;">PDB: 4EHZ</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4F09" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4F09','PDB','4F09'); return false;">PDB: 4F09</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IVB" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IVB','PDB','4IVB'); return false;">PDB: 4IVB</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IVA" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IVA','PDB','4IVA'); return false;">PDB: 4IVA</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IVC" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IVC','PDB','4IVC'); return false;">PDB: 4IVC</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IVD" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IVD','PDB','4IVD'); return false;">PDB: 4IVD</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EYG" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3EYG','PDB','3EYG'); return false;">PDB: 3EYG</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i67"><a href="/doi/suppl/10.1021/jm4004895">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_23456"></div></div></div></div></div><hr /></hr><p class="last">Synthetic procedures for <b>16a</b>, <b>33a</b>, <b>34a</b>, and <b>25</b>; identities of kinases in Table <a class="ref showTableEvent internalNav" href="#tbl6">6</a> and % inhibition by <b>21</b>, <b>26</b>, <b>29</b>, <b>31</b>, <b>33</b>, and <b>34</b>; biochemical JAK3 and TYK2 <i>K</i><sub>i</sub> values of <b>1</b>–<b>34</b>; tabulated compound structures and data used to produce the graphs in Figure <a id="rightTab-" class=" internalNav" href="#fig2">2</a>. Details of: in vitro and in vivo ADME experimental procedures, JAK enzymatic and cellular assays (low serum and whole blood), in vitro hERG assay, CIA efficacy study of <b>31</b> in the rat, protein expression/purification, and crystallographic methods and procedures for <b>31</b> (in complex with JAK1 and JAK2) and <b>33</b> and <b>34</b> (in complex with JAK1), thermodynamic solubility methods, and analytical LCMS and SFC conditions. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm4004895/suppl_file/jm4004895_si_001.pdf">jm4004895_si_001.pdf (865.83 kb)</a></li></ul></div></div><span class="author-information-subsection-header">Accession Codes</span><p class="last">PDB numbers: <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4EHZ">4EHZ</a> for <b>2</b> complexed with JAK1, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4F09">4F09</a> for <b>2</b> complexed with JAK2, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IVB">4IVB</a> for <b>31</b> complexed with JAK1, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IVA">4IVA</a> for <b>31</b> complexed with JAK2, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IVC">4IVC</a> for <b>33</b> complexed with JAK1, <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4IVD">4IVD</a> for <b>34</b> complexed with JAK1.</p><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm4004895&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bwebsite%3Awebsite%3Aacspubs%3Barticle%3Aarticle%3A10.1021%2Fjm4004895%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2013.56.issue-11%3BpageGroup%3Astring%3APublication+Pages%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm4004895" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                4MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-b425991822a79ada59b3.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-fb88834b824b41b135ad.js"></script>

<script type="text/javascript" src="/wro/ke1q~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"667983ee8d8ad96a","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.6.0","si":10}'></script>
</body>
</html>
